<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36399343</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Association of Pregnancy Characteristics and Maternal Mortality With Amniotic Fluid Embolism.</ArticleTitle><Pagination><StartPage>e2242842</StartPage><MedlinePgn>e2242842</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2242842</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.42842</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Amniotic fluid embolism (AFE) is an uncommon pregnancy complication but is associated with high maternal mortality. Because of the rarity of AFE, associated risks factors and maternal outcomes have been relatively understudied.</AbstractText><AbstractText Label="OBJECTIVE">To examine the clinical, pregnancy, and delivery characteristics and the maternal outcomes related to AFE in a recent period in the US.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This retrospective cohort study examined hospital deliveries from January 1, 2016, to December 31, 2019, from the Healthcare Cost and Utilization Project's National Inpatient Sample.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was clinical, pregnancy, and delivery characteristics of AFE, assessed with a multivariable binary logistic regression model. The coprimary outcome was failure to rescue, defined as maternal mortality after AFE. Associations with other severe maternal morbidity indicators and failure to rescue per clinical and pregnancy characteristics were also assessed.</AbstractText><AbstractText Label="RESULTS">A total of 14&#x202f;684&#x202f;135 deliveries were examined, with AFE diagnosed in 880 women, corresponding to an incidence rate of 6.0 per 100&#x202f;000 deliveries. The cohort-level median patient age was 29 years (IQR, 25-33 years). In a multivariable analysis, (1) patient factors of older age, Asian and Black race, Western US region, pregestational hypertension, asthma, illicit substance use, and grand multiparity; (2) pregnancy factors of placental accreta spectrum (PAS), placental abruption, uterine rupture, polyhydramnios, chorioamnionitis, preeclampsia, fetal growth restriction, and fetal demise; and (3) delivery factors of early gestational age, cervical ripening, cesarean delivery, operative delivery, and manual removal were associated with AFE. Among these characteristics, PAS had the largest association with AFE (adjusted odds ratio [aOR], 10.01; 95% CI, 7.03-14.24). When stratified by the PAS subtypes, more severe forms of PAS had a greater association with AFE (aOR for increta and percreta, 17.35; 95% CI, 10.21-28.48; and aOR for accreta, 7.62; 95% CI, 4.83-12.01). Patients who had AFE were more likely to have coagulopathy (aOR, 24.68; 95% CI, 19.38-31.44), cardiac arrest (aOR, 24.56; 95% CI, 17.84-33.81), and adult respiratory distress syndrome (aOR, 10.72; 95% CI, 8.09-14.20). The failure-to-rescue rate after AFE was 17.0% overall. However, the failure-to-rescue rate exceeded 30% when AFE co-occurred with other severe maternal morbidity indicators: 45.8% for AFE, cardiac arrest, and coagulopathy; 43.2% for AFE, shock, and cardiac rhythm conversion; and 38.6% for AFE, cardiac arrest, coagulopathy, and shock. The failure-to-rescue rate after AFE also exceeded 30% when AFE occurred in the setting of placental pathology: 42.9% for AFE and PAS and 31.3% for AFE and placental abruption.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This contemporaneous, national-level analysis validated previously known risk factors for AFE and confirmed the dismal outcomes of pregnancy complicated by AFE. The association between PAS and AFE, which was not previously reported, warrants further investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazza</LastName><ForeName>Genevieve R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youssefzadeh</LastName><ForeName>Ariane C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klar</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Freiburg Faculty of Medicine, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunze</LastName><ForeName>Mirjam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Freiburg Faculty of Medicine, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuzaki</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gynecology, Osaka International Cancer Institute, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelbaum</LastName><ForeName>Rachel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Reproductive Endocrinology &amp; Infertility, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouzounian</LastName><ForeName>Joseph G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norris Comprehensive Cancer Center, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Netw Open. 2022 Nov 1;5(11):e2242850. doi: 10.1001/jamanetworkopen.2022.42850.</RefSource><PMID Version="1">36399346</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="Y">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000037" MajorTopicYN="Y">Abruptio Placentae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Klar reported receiving personal fees from Cooper Surgical and KLS Martin outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36399343</ArticleId><ArticleId IdType="pmc">PMC9675004</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.42842</ArticleId><ArticleId IdType="pii">2798663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. Accessed May 14, 2022. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm</Citation></Reference><Reference><Citation>Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009;201(5):445.e1-445.e13. doi:10.1016/j.ajog.2009.04.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2009.04.052</ArticleId><ArticleId IdType="pmc">PMC3401570</ArticleId><ArticleId IdType="pubmed">19879393</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008;199(1):36.e1-36.e5. doi:10.1016/j.ajog.2008.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2008.03.007</ArticleId><ArticleId IdType="pubmed">18455140</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG. 2016;123(1):100-109. doi:10.1111/1471-0528.13300</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13300</ArticleId><ArticleId IdType="pubmed">25683758</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 2008;199(1):49.e1-49.e8. doi:10.1016/j.ajog.2007.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2007.11.061</ArticleId><ArticleId IdType="pubmed">18295171</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick KE, van den Akker T, Bloemenkamp KWM, et al. . Risk factors, management, and outcomes of amniotic fluid embolism: a multicountry, population-based cohort and nested case-control study. PLoS Med. 2019;16(11):e1002962. doi:10.1371/journal.pmed.1002962</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002962</ArticleId><ArticleId IdType="pmc">PMC6850527</ArticleId><ArticleId IdType="pubmed">31714909</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Berg C, Brocklehurst P, et al. . Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth. 2012;12:7. doi:10.1186/1471-2393-12-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2393-12-7</ArticleId><ArticleId IdType="pmc">PMC3305555</ArticleId><ArticleId IdType="pubmed">22325370</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ; UK Obstetric Surveillance System . Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol. 2010;115(5):910-917. doi:10.1097/AOG.0b013e3181d9f629</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181d9f629</ArticleId><ArticleId IdType="pubmed">20410762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MS, Rouleau J, Baskett TF, Joseph KS; Maternal Health Study Group of the Canadian Perinatal Surveillance System . Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet. 2006;368(9545):1444-1448. doi:10.1016/S0140-6736(06)69607-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69607-4</ArticleId><ArticleId IdType="pubmed">17055946</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts CL, Algert CS, Knight M, Morris JM. Amniotic fluid embolism in an Australian population-based cohort. BJOG. 2010;117(11):1417-1421. doi:10.1111/j.1471-0528.2010.02656.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2010.02656.x</ArticleId><ArticleId IdType="pubmed">21126320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco LD, Saade G, Hankins GD, Clark SL; Society for Maternal-Fetal Medicine (SMFM) . Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol. 2016;215(2):B16-B24. doi:10.1016/j.ajog.2016.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.03.012</ArticleId><ArticleId IdType="pubmed">26987420</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SL, Romero R, Dildy GA, et al. . Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016;215(4):408-412. doi:10.1016/j.ajog.2016.06.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.06.037</ArticleId><ArticleId IdType="pmc">PMC5072279</ArticleId><ArticleId IdType="pubmed">27372270</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford IA, Moaddab A, Dildy GA, et al. . Amniotic fluid embolism syndrome: analysis of the Unites States International Registry. Am J Obstet Gynecol MFM. 2020;2(2):100083. doi:10.1016/j.ajogmf.2019.100083</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2019.100083</ArticleId><ArticleId IdType="pmc">PMC8500673</ArticleId><ArticleId IdType="pubmed">33345954</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SL. Amniotic fluid embolism. Obstet Gynecol. 2014;123(2, pt 1):337-348. doi:10.1097/AOG.0000000000000107</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000000107</ArticleId><ArticleId IdType="pubmed">24402585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshirsaz AA, Clark SL. Amniotic fluid embolism. Obstet Gynecol Clin North Am. 2016;43(4):779-790. doi:10.1016/j.ogc.2016.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ogc.2016.07.001</ArticleId><ArticleId IdType="pubmed">27816160</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality. Overview of the National (Nationwide) Inpatient Sample . Accessed May 8, 2022. https://www.hcup-us.ahrq.gov/nisoverview.jsp</Citation></Reference><Reference><Citation>Ghaferi AA, Schwartz TA, Pawlik TM. STROBE reporting guidelines for observational studies. JAMA Surg. 2021;156(6):577-578. doi:10.1001/jamasurg.2021.0528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.0528</ArticleId><ArticleId IdType="pubmed">33825815</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. How Does CDC Identify Severe Maternal Morbidity? Accessed May 8, 2022. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm</Citation></Reference><Reference><Citation>Matsuo K, Mandelbaum RS, Matsuzaki S, et al. . Decreasing failure-to-rescue from severe maternal morbidity at cesarean delivery: recent US trends. JAMA Surg. 2021;156(6):585-587. doi:10.1001/jamasurg.2021.0600</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.0600</ArticleId><ArticleId IdType="pmc">PMC8060881</ArticleId><ArticleId IdType="pubmed">33881490</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott M. ICD-10-PCS coding advice for labor induction. CMQCC. Accessed May 10, 2022. https://www.cmqcc.org/sites/default/files/ICD10%20Labor%20Induction%20FINAL_8.3.16.pdf</Citation></Reference><Reference><Citation>Greenland S, Daniel R, Pearce N. Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int J Epidemiol. 2016;45(2):565-575. doi:10.1093/ije/dyw040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw040</ArticleId><ArticleId IdType="pmc">PMC4864881</ArticleId><ArticleId IdType="pubmed">27097747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo K, Violette CJ, Mandelbaum RS, et al. . Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasia. Am J Obstet Gynecol. 2022;227(2):255.e1-255.e18. doi:10.1016/j.ajog.2022.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2022.04.032</ArticleId><ArticleId IdType="pubmed">35487326</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529-1536. doi:10.1056/NEJMcp1709324</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1709324</ArticleId><ArticleId IdType="pubmed">29669225</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson RG, Ruggieri J, Siddiqui MM. Amniotic fluid embolism: definitive diagnosis in a survivor. Am Rev Respir Dis. 1979;120(1):187-192. doi:10.1164/arrd.1979.120.1.187</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/arrd.1979.120.1.187</ArticleId><ArticleId IdType="pubmed">380421</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbison L, Bell L. Anaphylactoid syndrome after intrauterine pressure catheter placement. Obstet Gynecol. 2010;115(2, pt 2):407-408. doi:10.1097/AOG.0b013e3181b5c8cc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181b5c8cc</ArticleId><ArticleId IdType="pubmed">20093860</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo K, Lynch MA, Kopelman JN, Atlas RO. Anaphylactoid syndrome of pregnancy immediately after intrauterine pressure catheter placement. Am J Obstet Gynecol. 2008;198(2):e8-e9. doi:10.1016/j.ajog.2007.09.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2007.09.035</ArticleId><ArticleId IdType="pubmed">18068141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinn JJ, Eisenberg E, Artis Dickerson S, et al. . Maternal mortality in the United States: research gaps, opportunities, and priorities. Am J Obstet Gynecol. 2020;223(4):486-492.e6. doi:10.1016/j.ajog.2020.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.07.021</ArticleId><ArticleId IdType="pmc">PMC7564012</ArticleId><ArticleId IdType="pubmed">32682858</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs CA, Montgomery DM, Toner LE, Dildy GA; Patient Safety and Quality Committee, Society for Maternal-Fetal Medicine . Society for Maternal-Fetal Medicine Special Statement: checklist for initial management of amniotic fluid embolism. Am J Obstet Gynecol. 2021;224(4):B29-B32. doi:10.1016/j.ajog.2021.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.01.001</ArticleId><ArticleId IdType="pubmed">33417901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco LD, Clark SL, Klassen M, Hankins GDV. Amniotic fluid embolism: principles of early clinical management. Am J Obstet Gynecol. 2020;222(1):48-52. doi:10.1016/j.ajog.2019.07.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2019.07.036</ArticleId><ArticleId IdType="pubmed">31376394</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodeo S, Cavoretto PI, Seidenari A, et al. . Second trimester uterine arteries pulsatility index is a function of placental pathology and provides insights on stillbirth aetiology: a multicenter matched case-control study. Placenta. 2022;121:7-13. doi:10.1016/j.placenta.2022.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2022.02.021</ArticleId><ArticleId IdType="pubmed">35245721</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford IA, Moaddab A, Dildy GA, et al. . Evaluation of proposed criteria for research reporting of amniotic fluid embolism. Am J Obstet Gynecol. 2019;220(3):285-287. doi:10.1016/j.ajog.2018.11.1099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2018.11.1099</ArticleId><ArticleId IdType="pmc">PMC6497410</ArticleId><ArticleId IdType="pubmed">30481492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37591957</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>4970</StartPage><MedlinePgn>4970</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4970</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-40734-8</ELocationID><Abstract><AbstractText>In preclinical studies rapamycin was found to target neuroinflammation, by expanding regulatory T cells, and affecting autophagy, two pillars of amyotrophic lateral sclerosis (ALS) pathogenesis. Herein we report a multicenter, randomized, double-blind trial, in 63 ALS patients who were randomly assigned in a 1:1:1 ratio to receive rapamycin 2&#x2009;mg/m<sup>2</sup>/day,1&#x2009;mg/m<sup>2</sup>/day or placebo (EUDRACT 2016-002399-28; NCT03359538). The primary outcome, the number of patients exhibiting an increase &gt;30% in regulatory T cells from baseline to treatment end, was not attained. Secondary outcomes were changes from baseline of T, B, NK cell subpopulations, inflammasome mRNA expression and activation status, S6-ribosomal protein phosphorylation, neurofilaments; clinical outcome measures of disease progression; survival; safety and quality of life. Of the secondary outcomes, rapamycin decreased mRNA relative expression of the pro-inflammatory cytokine IL-18, reduced plasmatic IL-18 protein, and increased the percentage of classical monocytes and memory switched B cells, although no corrections were applied for multiple tests. In conclusion, we show that rapamycin treatment is well tolerated and provides reassuring safety findings in ALS patients, but further trials are necessary to understand the biological and clinical effects of this drug in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9244-9782</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. jessica.mandrioli@unimore.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy. jessica.mandrioli@unimore.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Statistical and Methodological Support to Clinical Research, Azienda Ospedaliero-Universitaria, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zucchi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences PhD Program, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>De Biasi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Banchelli</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Statistical and Methodological Support to Clinical Research, Azienda Ospedaliero-Universitaria, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Tartaro</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1799-6567</Identifier><AffiliationInfo><Affiliation>Unit of Statistical and Methodological Support to Clinical Research, Azienda Ospedaliero-Universitaria, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fini</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianferrari</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4260-0915</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, St. Agostino-Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinti</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicenter, Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto Maugeri IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerardi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicenter, Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarlarini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicenter, Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ALS Centre, Neurologic Clinic, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0197-1880</Identifier><AffiliationInfo><Affiliation>ALS Centre, Neurologic Clinic, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scognamiglio</LastName><ForeName>Ada</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, Neurologic Clinic, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Regionale Specializzato Malattie del Motoneurone, Azienda Ospedale Universit&#xe0; di Padova, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortuna</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauria</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>3rd Neurology Unit and ALS Centre, IRCCS 'Carlo Besta' Neurological Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bella</LastName><ForeName>Eleonora Dalla</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>3rd Neurology Unit and ALS Centre, IRCCS 'Carlo Besta' Neurological Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caponnetto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitatio&#x146; Ophthalmology, Genetics, Mother and Child Disease, Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitatio&#x146; Ophthalmology, Genetics, Mother and Child Disease, Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chio</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>'Rita Levi Montalcini' Department of Neurosciences, ALS Centre, University of Turin and Azienda Ospedaliero Universitaria Citt&#xe0; della Salute e della Scienza, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5122-7243</Identifier><AffiliationInfo><Affiliation>'Rita Levi Montalcini' Department of Neurosciences, ALS Centre, University of Turin and Azienda Ospedaliero Universitaria Citt&#xe0; della Salute e della Scienza, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cossarizza</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5381-1558</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Cardiovascular Research, via Irnerio 48, 40126, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020382">Interleukin-18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012269">Ribosomal Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020382" MajorTopicYN="N">Interleukin-18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012269" MajorTopicYN="N">Ribosomal Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.M. reports receiving advisory board fees from Biogen, Amylix and Italfarmaco, grant support from Roche, and grant support from Pfizer (active study drug for this study by grant number Wi211892 to J.M.). ACh received consulting fees from Biogen, Cytokinetics, Amylyx. ACa reports receiving advisory board fees from Biogen and Amylix, and grant support from Cytokinetics. GL reports scientific advisory for CSL Behring, Biogen Inc, Vertex Pharmaceuticals Incorporated, Chromocell Corporation, Janssen Pharmaceuticals, Inc, Lilly, and the Bracco Group. C.L. has served as a scientific consultant for Mitsubishi Tanabe Pharma Europe, Cytokinetics, Neuraltus, and Italfarmaco. R.D.A., E.Z., S.D.B., F.B., I.M., C.S., D.L.T., R.V., N.F., G.G., M.P., F.G., C.T., L.M., F.D.M., A.S., G.S., A.F., E.D.B., C.C., G.M., A.Co. declare no competing interests. Disclosure forms provided by the authors are available with the full text of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37591957</ArticleId><ArticleId IdType="pmc">PMC10435464</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-40734-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-40734-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthur KC, et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune Pharm. 2013;8:888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020;11:279. doi: 10.3389/fneur.2020.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00279</ArticleId><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani S, et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 2022;13:6733. doi: 10.1038/s41467-022-34526-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34526-9</ArticleId><ArticleId IdType="pmc">PMC9643478</ArticleId><ArticleId IdType="pubmed">36347843</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. ALS patients&#x2019; regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530. doi: 10.1172/jci.insight.89530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89530</ArticleId><ArticleId IdType="pmc">PMC5333967</ArticleId><ArticleId IdType="pubmed">28289705</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahama M, Akira S, Saitoh T. Autophagy limits activation of the inflammasomes. Immunol. Rev. 2018;281:62&#x2013;73. doi: 10.1111/imr.12613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12613</ArticleId><ArticleId IdType="pubmed">29248000</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;ladeau C, Sandhu JK. Aberrant NLRP3 inflammasome activation ignites the fire of inflammation in neuromuscular diseases. Int J. Mol. Sci. 2021;22:6068. doi: 10.3390/ijms22116068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116068</ArticleId><ArticleId IdType="pmc">PMC8200055</ArticleId><ArticleId IdType="pubmed">34199845</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275&#x2013;291. doi: 10.1016/j.neuron.2014.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.034</ArticleId><ArticleId IdType="pmc">PMC4223653</ArticleId><ArticleId IdType="pubmed">25374355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004;36:585&#x2013;595. doi: 10.1038/ng1362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1362</ArticleId><ArticleId IdType="pubmed">15146184</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, et al. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J. Biol. Chem. 2009;284:27416&#x2013;27424. doi: 10.1074/jbc.M109.031278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031278</ArticleId><ArticleId IdType="pmc">PMC2785671</ArticleId><ArticleId IdType="pubmed">19651785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chennampally P, et al. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin. Sci. Rep. 2021;11:18168. doi: 10.1038/s41598-021-97405-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97405-1</ArticleId><ArticleId IdType="pmc">PMC8438029</ArticleId><ArticleId IdType="pubmed">34518579</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, et al. Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Hum. Mol. Genet. 2015;24:1682&#x2013;1690. doi: 10.1093/hmg/ddu580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu580</ArticleId><ArticleId IdType="pubmed">25410659</ArticleId></ArticleIdList></Reference><Reference><Citation>Deivasigamani S, Verma HK, Ueda R, Ratnaparkhi A, Ratnaparkhi GS. A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis. Biol. Open. 2014;3:1127&#x2013;1138. doi: 10.1242/bio.201410066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.201410066</ArticleId><ArticleId IdType="pmc">PMC4232771</ArticleId><ArticleId IdType="pubmed">25361581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, et al. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) Medicines. 2018;97:e111&#x2013;e119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6024184</ArticleId><ArticleId IdType="pubmed">29901635</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannelli I, et al. Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. Brain Commun. 2021;3:fcab141. doi: 10.1093/braincomms/fcab141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab141</ArticleId><ArticleId IdType="pmc">PMC8364666</ArticleId><ArticleId IdType="pubmed">34409288</ArticleId></ArticleIdList></Reference><Reference><Citation>Candela-Boix MR, et al. Population pharmacokinetics models of sirolimus in renal transplant patients: a systematic review. Farm Hosp. 2021;45:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">35379113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchegolev Y, et al. Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells. Chem. Biol. Interact. 2020;330:109243. doi: 10.1016/j.cbi.2020.109243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2020.109243</ArticleId><ArticleId IdType="pubmed">32861747</ArticleId></ArticleIdList></Reference><Reference><Citation>Neklesa TK, Davis RW. Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex. Proc. Natl Acad. Sci. USA. 2008;105:15166&#x2013;15171. doi: 10.1073/pnas.0807712105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807712105</ArticleId><ArticleId IdType="pmc">PMC2567509</ArticleId><ArticleId IdType="pubmed">18812505</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarnath S, et al. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy. 2010;6:523&#x2013;541. doi: 10.4161/auto.6.4.11811.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.4.11811</ArticleId><ArticleId IdType="pmc">PMC3707503</ArticleId><ArticleId IdType="pubmed">20404486</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Shea A. E. et al. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention. Clin Immunol. 2022:109095.</Citation><ArticleIdList><ArticleId IdType="pubmed">35973640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A, Giacoppo S, Bramanti P, Mazzon E. NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model. Inflammation. 2018;41:93&#x2013;103. doi: 10.1007/s10753-017-0667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0667-5</ArticleId><ArticleId IdType="pubmed">28936769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, et al. The expression of active CD11b monocytes in blood and disease progression in amyotrophic lateral Sclerosis. Int J. Mol. Sci. 2022;23:3370. doi: 10.3390/ijms23063370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063370</ArticleId><ArticleId IdType="pmc">PMC8952310</ArticleId><ArticleId IdType="pubmed">35328793</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis. Sci. Rep. 2020;10:15295. doi: 10.1038/s41598-020-72247-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72247-5</ArticleId><ArticleId IdType="pmc">PMC7499429</ArticleId><ArticleId IdType="pubmed">32943739</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan I, et al. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 2009;10:1292&#x2013;1299. doi: 10.1038/ni.1814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1814</ArticleId><ArticleId IdType="pubmed">19855380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kl&#xe4;ppe U, et al. Cardiac troponin T is elevated and increases longitudinally in ALS patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2022;23:58&#x2013;65. doi: 10.1080/21678421.2021.1939384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1939384</ArticleId><ArticleId IdType="pubmed">34151677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E, et al. The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial. Brain. 2021;144:2635&#x2013;2647. doi: 10.1093/brain/awab167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab167</ArticleId><ArticleId IdType="pmc">PMC8557337</ArticleId><ArticleId IdType="pubmed">33905493</ArticleId></ArticleIdList></Reference><Reference><Citation>Esselin F, et al. Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients. CNS Neurosci. Ther. 2022;28:1532&#x2013;1538. doi: 10.1111/cns.13894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13894</ArticleId><ArticleId IdType="pmc">PMC9437233</ArticleId><ArticleId IdType="pubmed">35751632</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, et al. Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer T, et al. Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study. Eur. J. Neurol. 2023;6:1600&#x2013;1610. doi: 10.1111/ene.15773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15773</ArticleId><ArticleId IdType="pubmed">36899448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, et al. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD. Mol. Neurodegener. 2021;16:1. doi: 10.1186/s13024-020-00420-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00420-5</ArticleId><ArticleId IdType="pmc">PMC7792109</ArticleId><ArticleId IdType="pubmed">33413517</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. Amyotrophic lateral sclerosis clinical trials and interpretation of functional end points and fluid biomarkers: a review. JAMA Neurol. 2022;79:1312&#x2013;1318. doi: 10.1001/jamaneurol.2022.3282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.3282</ArticleId><ArticleId IdType="pubmed">36251310</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, et al. Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412&#x2013;425. doi: 10.4161/auto.7.4.14541.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14541</ArticleId><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, et al. Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol. Neurodegener. 2013;8:31. doi: 10.1186/1750-1326-8-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-31</ArticleId><ArticleId IdType="pmc">PMC3847677</ArticleId><ArticleId IdType="pubmed">24025516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CW, Lin MJ, Shen CK. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J. Neurogenet. 2015;29:59&#x2013;68. doi: 10.3109/01677063.2015.1077832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pubmed">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 2009;210:73&#x2013;79. doi: 10.1016/j.jneuroim.2009.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.02.012</ArticleId><ArticleId IdType="pubmed">19307024</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293&#x2013;1314. doi: 10.1093/brain/awr074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr074</ArticleId><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36307749</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Echocardiography findings in amniotic fluid embolism: a systematic review of the literature.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>160</EndPage><MedlinePgn>151-160</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-022-02343-9</ELocationID><Abstract><AbstractText Label="PURPOSE">Amniotic fluid embolism (AFE) is a leading cause of obstetrical cardiac arrest and maternal morbidity. The pathogenesis of hemodynamic collapse is thought to be from right ventricular (RV) failure; however, there is a paucity of data documenting echocardiography findings in this population. We undertook a systematic review of the literature to evaluate the echocardiography findings in patients with AFE.</AbstractText><AbstractText Label="SOURCES">We retrieved all case reports and case series reporting AFE in Embase and MEDLINE from inception to 20 November 2021. Studies reporting AFE diagnosed by fulfilling at least one of three different proposed AFE criteria and echocardiography findings during hospitalization were included. Patient and echocardiographic data were retrieved, and univariate logistic regression analysis was performed for outcomes of interest. Bias was assessed using the Joanna Briggs Institute clinical appraisal tool for case series.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">Eighty publications reporting on 84 patients were included in the final review. Fifty-five out of 82 patients with data (67%) showed RV dysfunction, including 11/82 (13%) with biventricular dysfunction; 14/82 (17%) had normal systolic function. No data on RV or left ventricular function were reported for two patients. The presence of RV dysfunction on echocardiography was associated with cardiac arrest (odds ratio [OR], 3.66; 95% confidence interval [CI], 1.39 to 9.67; P = 0.009), and a composite risk of cardiac arrest, maternal death or use of extracorporeal membrane oxygenation (OR, 3.86; 95% CI, 1.43 to 10.4; P = 0.007). A low risk of bias was observed in 15/84 (18%) cases.</AbstractText><AbstractText Label="CONCLUSIONS">Right ventricular dysfunction on echocardiography is a common finding in AFE and is associated with a high risk of cardiac arrest. The finding of RV dysfunction on echocardiography may help diagnose AFE and help triage the highest risk patients with AFE.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42021271323); registered 1 September 2021.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simard</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Stephen S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care, Jewish General Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koolian</LastName><ForeName>Maral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abenhaim</LastName><ForeName>Haim A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipes</LastName><ForeName>Jed</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3309-7537</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada. jed.lipes@mcgill.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care, Jewish General Hospital, McGill University, Montr&#xe9;al, QC, Canada. jed.lipes@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Observations &#xe9;chocardiographiques lors d&#x2019;une embolie de liquide amniotique : une revue syst&#xe9;matique de la litt&#xe9;rature.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="Y">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: L&#x2019;embolie amniotique (EA) est l&#x2019;une des principales causes d&#x2019;arr&#xea;t cardiaque obst&#xe9;trical et de morbidit&#xe9; maternelle. Il est pr&#xe9;sum&#xe9; que la pathogen&#xe8;se du choc h&#xe9;modynamique provient d&#x2019;une d&#xe9;faillance ventriculaire droite (VD). Cependant, il y a peu de donn&#xe9;es documentant les constatations de l&#x2019;examen &#xe9;chocardiographique dans cette population. Nous avons effectu&#xe9; une revue syst&#xe9;matique des donn&#xe9;es probantes visant &#xe0; &#xe9;valuer l&#x2019;utilit&#xe9; de l&#x2019;&#xe9;chocardiographie chez les patientes atteintes d&#x2019;embolie amniotique.</AbstractText><AbstractText Label="SOURCES" NlmCategory="METHODS">Nous avons &#xe9;valu&#xe9; tous les rapports de cas et s&#xe9;ries de cas rapportant une EA dans les bases de donn&#xe9;es Embase et MEDLINE de leur cr&#xe9;ation jusqu&#x2019;au 20 novembre 2021. Les &#xe9;tudes rapportant une EA diagnostiqu&#xe9;e en remplissant au moins l&#x2019;un des trois crit&#xe8;res d&#x2019;EA propos&#xe9;s et les r&#xe9;sultats &#xe9;chocardiographiques pendant l&#x2019;hospitalisation ont &#xe9;t&#xe9; incluses. Les donn&#xe9;es sur les patientes et &#xe9;chocardiographiques ont &#xe9;t&#xe9; collig&#xe9;es, et une analyse de r&#xe9;gression logistique univari&#xe9;e a &#xe9;t&#xe9; effectu&#xe9;e pour les issues cliniques d&#x2019;int&#xe9;r&#xea;t. Le risque de biais a &#xe9;t&#xe9; &#xe9;valu&#xe9; &#xe0; l&#x2019;aide de l&#x2019;outil d&#x2019;&#xe9;valuation clinique de l&#x2019;Institut Joanna Briggs pour les s&#xe9;ries de cas.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES" NlmCategory="UNASSIGNED">Quatre-vingts publications incluant 84 patientes ont &#xe9;t&#xe9; incluses dans la revue finale. Cinquante-cinq des 82 patientes pr&#xe9;sentant des donn&#xe9;es (67&#xa0;%) avaient une dysfonction du VD incluant 11/82 (13&#xa0;%) avec une dysfonction biventriculaire. Quatorze patientes sur 82 (17 %) avaient une fonction systolique normale. Aucune donn&#xe9;e sur la fonction du ventricule droit ou gauche n&#x2019;a &#xe9;t&#xe9; rapport&#xe9;e pour deux patientes. La pr&#xe9;sence d&#x2019;une dysfonction du VD &#xe0; l&#x2019;&#xe9;chocardiographie &#xe9;tait associ&#xe9;e &#xe0; un arr&#xea;t cardiaque (rapport de cotes [RC], 3,66; intervalle de confiance &#xe0; 95 % [IC], 1,39 &#xe0; 9,67; P = 0,009), et &#xe0; un risque composite d&#x2019;arr&#xea;t cardiaque, de d&#xe9;c&#xe8;s maternel ou d&#x2019;utilisation de l&#x2019;oxyg&#xe9;nation par membrane extracorporelle (ECMO) (RC, 3,86; IC 95 %, 1,43 &#xe0; 10,4; P = 0,007). Un faible risque de biais a &#xe9;t&#xe9; observ&#xe9; dans 15/84 (18&#xa0;%) des cas.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">La dysfonction ventriculaire droite &#xe0; l&#x2019;&#xe9;chocardiographie est une constatation courante dans l&#x2019;embolie amniotique et est associ&#xe9;e &#xe0; un risque &#xe9;lev&#xe9; d&#x2019;arr&#xea;t cardiaque. La d&#xe9;couverte d&#x2019;une dysfonction du VD &#xe0; l&#x2019;&#xe9;chocardiographie peut aider &#xe0; diagnostiquer l&#x2019;embolie amniotique et &#xe0; identifier les patientes atteintes d&#x2019;embolie amniotique les plus &#xe0; risque. ENREGISTREMENT DE L&#x2019;&#xe9;TUD: PROSPERO (CRD42021271323); enregistr&#xe9;e le 1er septembre 2021.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">POCUS</Keyword><Keyword MajorTopicYN="N">amniotic fluid embolism</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">maternal cardiac arrest</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36307749</ArticleId><ArticleId IdType="doi">10.1007/s12630-022-02343-9</ArticleId><ArticleId IdType="pii">10.1007/s12630-022-02343-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013; 209: e1&#x2013;7. https://doi.org/10.1016/j.ajog.2013.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2013.07.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshirsaz AA, Clark SL. Amniotic fluid embolism. Obstet Gynecol Clin North Am 2016; 43: 779&#x2013;90. https://doi.org/10.1016/j.ogc.2016.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ogc.2016.07.001</ArticleId><ArticleId IdType="pubmed">27816160</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhyre JM. Maternal mortality. Curr Opin Anaesthesiol 2012; 25: 277&#x2013;85. https://doi.org/10.1097/aco.0b013e3283530580</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0b013e3283530580</ArticleId><ArticleId IdType="pubmed">22459982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito F, Akasaka J, Koike N, Uekuri C, Shigemitsu A, Kobayashi H. Incidence, diagnosis and pathophysiology of amniotic fluid embolism. J Obstet Gynaecol 2014; 34: 580&#x2013;4. https://doi.org/10.3109/01443615.2014.919996</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01443615.2014.919996</ArticleId><ArticleId IdType="pubmed">24865116</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol 2016; 215: 408&#x2013;12. https://doi.org/10.1016/j.ajog.2016.06.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.06.037</ArticleId><ArticleId IdType="pubmed">27372270</ArticleId><ArticleId IdType="pmc">5072279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res 2014; 40: 1507&#x2013;17. https://doi.org/10.1111/jog.12428</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.12428</ArticleId><ArticleId IdType="pubmed">24888909</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG 2016; 123: 100&#x2013;9. https://doi.org/10.1111/1471-0528.13300</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13300</ArticleId><ArticleId IdType="pubmed">25683758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford IA, Moaddab A, Dildy GA, et al. Evaluation of proposed criteria for research reporting of amniotic fluid embolism. Am J Obstet Gynecol 2019; 220: 285&#x2013;7. https://doi.org/10.1016/j.ajog.2018.11.1099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2018.11.1099</ArticleId><ArticleId IdType="pubmed">30481492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H, Akasaka J, Naruse K, et al. Comparison of the different definition criteria for the diagnosis of amniotic fluid embolism. J Clin Diagn Res 2017; 11: QC18&#x2013;21. https://doi.org/10.7860/jcdr/2017/26746.10283</Citation></Reference><Reference><Citation>Ponzio-Klijanienko A, Vincent-Rohfritsch A, Girault A, Le Ray C, Goffinet F, Bonnet MP. Evaluation of the 4 diagnosis criteria proposed by the SMFM and the AFE foundation for amniotic fluid embolism in a monocentric population. J Gynecol Obstet Hum Reprod 2020; 49: 101821. https://doi.org/10.1016/j.jogoh.2020.101821</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jogoh.2020.101821</ArticleId><ArticleId IdType="pubmed">32474192</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson AJ, Greer IA. Non-haemorrhagic obstetric shock. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 19&#x2013;41. https://doi.org/10.1053/beog.1999.0061</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/beog.1999.0061</ArticleId><ArticleId IdType="pubmed">10789258</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SL. A biomarker for amniotic fluid embolism: the search continues. BJOG 2021; 128: 1974. https://doi.org/10.1111/1471-0528.16833</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.16833</ArticleId><ArticleId IdType="pubmed">34228892</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard C, Yang S, Koolian M, Shear R, Rudski L, Lipes J. The role of echocardiography in amniotic fluid embolism: a case series and review of the literature. Can J Anesth 2021; 68: 1541&#x2013;8. https://doi.org/10.1007/s12630-021-02065-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-021-02065-4</ArticleId><ArticleId IdType="pubmed">34312822</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco P, Abdo-Cuza A. Point-of-care ultrasound in the critically ill pregnant or postpartum patient: what every intensivist should know. Intensive Care Med 2019; 45: 1123&#x2013;6. https://doi.org/10.1007/s00134-019-05682-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05682-2</ArticleId><ArticleId IdType="pubmed">31270577</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z, Barker TH, Moola S, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 2020; 18: 2127&#x2013;33. https://doi.org/10.11124/jbisrir-d-19-00099</Citation></Reference><Reference><Citation>Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score. PloS One 2014; 9: e93240. https://doi.org/10.1371/journal.pone.0093240</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093240</ArticleId><ArticleId IdType="pubmed">24728139</ArticleId><ArticleId IdType="pmc">3984105</ArticleId></ArticleIdList></Reference><Reference><Citation>Barriuso V, Pombar X, Bankowski HA. The use of therapeutic hypothermia in the management of amniotic fluid embolism. Obstet Med 2013; 6: 92&#x2013;3. https://doi.org/10.1258/om.2011.110069</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/om.2011.110069</ArticleId><ArticleId IdType="pubmed">27757166</ArticleId><ArticleId IdType="pmc">5052767</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis E, Prota C, Matturro R, Citro R. Amniotic fluid embolism in a grown-up congenital heart disease patient. J Cardiovasc Echogr 2019; 29: 20&#x2013;2. https://doi.org/10.4103/jcecho.jcecho_64_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcecho.jcecho_64_18</ArticleId><ArticleId IdType="pubmed">31008034</ArticleId><ArticleId IdType="pmc">6450229</ArticleId></ArticleIdList></Reference><Reference><Citation>Maack KH, Munk K, Dahl K, J&#xf8;rgensen HH, Christiansen A, Helmig RB. Right heart masses demonstrated by echocardiography in a patient with amniotic fluid embolism during labour. Acta Anaesthesiol Scand 2018; 62: 134&#x2013;7. https://doi.org/10.1111/aas.13006</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13006</ArticleId><ArticleId IdType="pubmed">28983905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, Jassar AS. Case 33-2019: a 35-year-old woman with cardiopulmonary arrest during cesarean section. N Engl J Med 2019; 381: 1664&#x2013;73. https://doi.org/10.1056/nejmcpc1904046</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmcpc1904046</ArticleId><ArticleId IdType="pubmed">31644848</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A, Knight DS, Augustine DX, et al. Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography. Echo Res Pract 2020; 7: G19&#x2013;41. https://doi.org/10.1530/erp-19-0051</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/erp-19-0051</ArticleId><ArticleId IdType="pubmed">32105053</ArticleId><ArticleId IdType="pmc">7077526</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandoli GE, Sciaccaluga C, Bandera F, et al. Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings. Heart Fail Rev 2021; 26: 263&#x2013;75. https://doi.org/10.1007/s10741-020-10014-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-020-10014-4</ArticleId><ArticleId IdType="pubmed">32860180</ArticleId></ArticleIdList></Reference><Reference><Citation>Viau-Lapointe J, Filewod N. Extracorporeal therapies for amniotic fluid embolism. Obstet Gynecol 2019; 134: 989&#x2013;94. https://doi.org/10.1097/aog.0000000000003513</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aog.0000000000003513</ArticleId><ArticleId IdType="pubmed">31599831</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabi M, Burstein BJ, Anavekar NS, Kashani KB, Jentzer JC. Associations of vasopressor requirements with echocardiographic parameters after out-of-hospital cardiac arrest. J Intensive Care Med 2022; 37: 518&#x2013;27. https://doi.org/10.1177/0885066621998936</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066621998936</ArticleId><ArticleId IdType="pubmed">34044666</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 2009; 201: e1&#x2013;13. https://doi.org/10.1016/j.ajog.2009.04.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2009.04.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfw&#xe9;n L, Hildebrand K, Schierbeck S, et al. Focused cardiac ultrasound after return of spontaneous circulation in cardiac-arrest patients. Resuscitation 2019; 142: 16&#x2013;22. https://doi.org/10.1016/j.resuscitation.2019.06.282</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2019.06.282</ArticleId><ArticleId IdType="pubmed">31279947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zengin S, Yavuz E, Al B, et al. Benefits of cardiac sonography performed by a non-expert sonographer in patients with non-traumatic cardiopulmonary arrest. Resuscitation 2016; 102: 105&#x2013;9. https://doi.org/10.1016/j.resuscitation.2016.02.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2016.02.025</ArticleId><ArticleId IdType="pubmed">26956840</ArticleId></ArticleIdList></Reference><Reference><Citation>Balki M, Liu S, Le&#xf3;n JA, Baghirzada L. Epidemiology of cardiac arrest during hospitalization for delivery in canada: a nationwide study. Anesth Analg 2017; 124: 890&#x2013;7. https://doi.org/10.1213/ane.0000000000001877</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000001877</ArticleId><ArticleId IdType="pubmed">28151819</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill JO, Iqbal R, McGarry K. "Thrombus in transit"--the role of echocardiography in the diagnosis of massive pulmonary embolism and a review of the literature. Acta Cardiol 2002; 57: 291&#x2013;4. https://doi.org/10.2143/ac.57.4.2005429</Citation><ArticleIdList><ArticleId IdType="doi">10.2143/ac.57.4.2005429</ArticleId><ArticleId IdType="pubmed">12222699</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen F, Wang L, Yang W, Chen Y. From appearance to essence: 10&#xa0;years review of atypical amniotic fluid embolism. Arch Gynecol Obstet 2016; 293: 329&#x2013;34. https://doi.org/10.1007/s00404-015-3785-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-015-3785-z</ArticleId><ArticleId IdType="pubmed">26092134</ArticleId></ArticleIdList></Reference><Reference><Citation>Albaroudi B, Haddad M, Albaroudi O, Abdel-Rahman ME, Jarman R, Harris T. Assessing left ventricular systolic function by emergency physician using point of care echocardiography compared to expert: systematic review and meta-analysis. Eur J Emerg Med 2022; 29: 18&#x2013;32. https://doi.org/10.1097/mej.0000000000000866</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mej.0000000000000866</ArticleId><ArticleId IdType="pubmed">34406134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37170123</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-7922</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>World journal of emergency surgery : WJES</Title><ISOAbbreviation>World J Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>The unrestricted global effort to complete the COOL trial.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13017-023-00500-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe complicated intra-abdominal sepsis (SCIAS) has an increasing incidence with mortality rates over 80% in some settings. Mortality typically results from disruption of the gastrointestinal tract, progressive and self-perpetuating bio-mediator generation, systemic inflammation, and multiple organ failure. A further therapeutic option may be open abdomen (OA) management with negative peritoneal pressure therapy (NPPT) to remove inflammatory ascites and attenuate the systemic damage from SCIAS, although there are definite risks of leaving the abdomen open whenever it might possibly be closed. This potential therapeutic paradigm is the rationale being assessed in the Closed Or Open after Laparotomy (COOL trial) ( https://clinicaltrials.gov/ct2/show/NCT03163095 ). Initially, the COOL trial received Industry sponsorship; however, this funding mandated the use of a specific trademarked and expensive NPPT device in half of the patients allocated to the intervention (open) arm. In August 2022, the 3&#xa0;M/Acelity Corporation without consultation but within the terms of the contract canceled the financial support of the trial. Although creating financial difficulty, there is now no restriction on specific NPPT devices and removing a cost-prohibitive intervention creates an opportunity to expand the COOL trial to a truly global basis. This document describes the evolution of the COOL trial, with a focus on future opportunities for global growth of the study.</AbstractText><AbstractText Label="METHODS">The COOL trial is the largest prospective randomized controlled trial examining the random allocation of SCIAS patients intra-operatively to either formal closure of the fascia or the use of the OA with an application of an NPPT dressing. Patients are eligible if they have free uncontained intraperitoneal contamination and physiologic derangements exemplified by septic shock OR severely adverse predicted clinical outcomes. The primary outcome is intended to definitively inform global practice by conclusively evaluating 90-day survival. Initial recruitment has been lower than hoped but satisfactory, and the COOL steering committee and trial investigators intend with increased global support to continue enrollment until recruitment ensures a definitive answer.</AbstractText><AbstractText Label="DISCUSSION">OA is mandated in many cases of SCIAS such as the risk of abdominal compartment syndrome associated with closure, or a planned second look as for example part of "damage control"; however, improved source control (locally and systemically) is the most uncertain indication for an OA. The COOL trial seeks to expand potential sites and proceed with the evaluation of NPPT agnostic to device, to properly examine the hypothesis that this treatment attenuates systemic damage and improves survival. This approach will not affect internal validity and should improve the external validity of any observed results of the intervention.</AbstractText><AbstractText Label="TRIAL REGISTRATION">National Institutes of Health ( https://clinicaltrials.gov/ct2/show/NCT03163095 ).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Critical Care Medicine, University of Calgary, Foothills Medical Centre, Calgary, AB, EG23T2N 2T9, Canada. Andrew.kirkpatrick@albertahealthservices.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coccolini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>General, Emergency and Trauma Surgery Department, Pisa University Hospital, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolonen</LastName><ForeName>Matti</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minor</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Critical Care Medicine and Surgery, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catena</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Bufalini Hospital, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gois</LastName><ForeName>Emanuel</ForeName><Initials>E</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Surgery, Londrina State University, and National COOL Coordinator for Brazil, Londrina, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Departments of Critical Care Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary and Foothills Medical Centre, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansaloni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>General Surgery I, San Matteo Hospital Pavia, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarugi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Surgery and Trauma Center, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartaglia</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Surgery and Trauma Center, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioannidis</LastName><ForeName>Orestis</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>4th Department of Surgery, Medical School, Aristotle University of Thessaloniki, General Hospital "George Papanikolaou", Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Letterkenny University Hospital, Donegal, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colak</LastName><ForeName>Elif</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Samsun, Samsun Training and Research Hospital, Samsun, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hameed</LastName><ForeName>S Morad</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampela</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnoletti</LastName><ForeName>Vanni</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Chief Anesthesiology, Bufalini Hospital, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Global Project Manager, COOL Trial and the TeleMentored Ultrasound Supported Medical Interventions Research Group, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garraway</LastName><ForeName>Naisan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Critical Care Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Macerata Hospital, Global Alliance for Infections in Surgery, Macerata, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Chad G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Trauma and Acute Care Surgery, Foothills Medical Center, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>Neil G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voght</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julien</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, NSHA-Queen Elizabeth II Health Sciences Center, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroeker</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Critical Care Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faris</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiruta</LastName><ForeName>Corina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Alberta Health Services, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Ernest E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Ernest E. Moore Shock Trauma Center, University of Colorado, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammons</LastName><ForeName>Lee Anne</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Denver Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anestiadou</LastName><ForeName>Elissavet</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>4th Department of Surgery, Medical School, Aristotle University of Thessaloniki, General Hospital "George Papanikolaou", Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendinelli</LastName><ForeName>Cino</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>John Hunter Hospital, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouliaris</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Surgery Department of Koutlimbaneio, Triantafylleio General Hospital of Larissa, Larissa, Thessaly, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Rosemarry</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>John Hunter Hospital, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceresoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General and Emergency Surgery, School of Medicine and Surgery, Milano-Bicocca University, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Chirurgia Generale E d'Urgenza, Ospedale M. Bufalini - Cesena, AUSL Della Romagna, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurrado</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, Unit of Academic General Surgery "V. Bonomo", University of Bari "A. Moro", Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezende-Neto</LastName><ForeName>Joao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Trauma and Acute Care Surgery, General Surgery, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isik</LastName><ForeName>Arda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Surgery Department, Istanbul Medeniyet University School of Medicine Istanbul, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cremonini</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Surgery and Trauma Center, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strambi</LastName><ForeName>Silivia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Surgery and Trauma Center, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koukoulis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>General Surgery Department of Koutlimbaneio, Triantafylleio General Hospital of Larissa, Larissa, Thessaly, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Testini</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, Unit of Academic General Surgery "V. Bonomo", University of Bari "A. Moro", Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trpcic</LastName><ForeName>Sandy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Trauma and Acute Care Surgery, General Surgery, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasculli</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, Unit of Academic General Surgery "V. Bonomo", University of Bari "A. Moro", Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picariello</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>General Surgery Unit, Ospedale M. Buffalini Di Cesena, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Zidan</LastName><ForeName>Fikri</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Afe Babalola University Multisystem Hospital, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augustin</LastName><ForeName>Goran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alconchel</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Virgen de la Arrixaca University Hospital IMIB-Arrixaca, Ctra. Madrid-Cartagena, S/N, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altinel</LastName><ForeName>Yuksel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bagcilar Research and Training Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez Amin</LastName><ForeName>Luz Adriana</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-7336-8162</Identifier><AffiliationInfo><Affiliation>Nurse Master of Nursing, Professor and Coordinator of the teaching-service relationship, Faculty of Health Sciences, University of Sucre, Sincelejo, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aranda-Narv&#xe1;ez</LastName><ForeName>Jos&#xe9; Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Trauma and Emergency Surgery Unit. General, Digestive and Transplantation Surgery Department, University Regional Hospital of M&#xe1;laga, Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baraket</LastName><ForeName>Oussama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Bizerte Hospital, Bizerte, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biffl</LastName><ForeName>Walter L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Scripps Clinic Medical Group, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiocchi</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonavina</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Milan Medical School, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brisinda</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardinali</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, General Hospital Madonna del Soccorso, San Benedetto del Tronto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celotti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Surgery Unit, UO Chirurgia Generale - Ospedale Maggiore Di Cremona, Cremona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaouch</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Visceral and Digestive Surgery, Monastir University, Monastir, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarello</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Azienda Sanitaria Provinciale Di Cosenza, Cosenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Campus Bio-Medico, University Campus Bio-Medico of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de'Angelis</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Colorectal and Digestive Surgery Unit-DIGEST Department, Beaujon University Hospital AP-HP, University Paris Cit&#xe9;, Clichy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Manzini</LastName><ForeName>Nicolo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Cattinara University Hospital, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delibegovic</LastName><ForeName>Samir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Proctology, Clinic for Surgery, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Saverio</LastName><ForeName>Salomone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, University of Insubria, University Hospital of Varese, ASST Sette Laghi, Regione Lombardia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Simone</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unit of Digestive and Metabolic Minimally Invasive Surgery, Clinique Saint Louis, Poissy, Poissy, Ile de France, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Emergency and General Surgery, Guastalla Hospital, AUSL Reggio Emilia, Guastalla, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubuisson</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Chirurgie Digestive, Service de Chirurgie Vasculaire Et, G&#xe9;n&#xe9;rale University Hospital of Bordeaux FR, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fransvea</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico A, Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garulli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department Head of Surgery, Infermi Hospital, Rimini, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency and General Consultant Surgeon, Nuovo Ospedale "S. Stefano", Azienda ASL Toscana Centro, Prato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Surgery Unit, Hospital Universit&#xe1;rio Terezinha de Jesus, SUPREMA, Juiz de Fora, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayati</LastName><ForeName>Firdaus</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jinjian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Aini Fahriza</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Hospital Umum Sarawak/Universiti Malaysia, Sarawak, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huei</LastName><ForeName>Tan Jih</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Hospital Sultanah Aminah, Johor Bahru, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jailani</LastName><ForeName>Ruhi Fadzlyana</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Universiti Sains Islam Malaysia, Nilai, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mansoor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Surgery, University Hospitals, Sussex, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Alfonso Palmieri</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Universidad de Sucre, Medicine Program, Cl&#xed;nica Santa Mar&#xed;a, Sincelejo, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbrain</LastName><ForeName>Manu L N G</ForeName><Initials>MLNG</Initials><AffiliationInfo><Affiliation>First Department of Anaesthesiology and Intensive Therapy, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Fluid Academy, Lovenjoel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marwah</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBeth</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihailescu</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tameside and Glossop Integrated Care NHSFT, Ashton-under-Lyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Madonna del Soccorso Hospital - San Benedetto del Tronto, Italy, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulita</LastName><ForeName>Francesk</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, General University Hospital of Patras, Rio, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murzi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgical Science, Cagliari State University, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Ahmad Tarmizi</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Hospital Angkatan Tentera Tuanku Mizan, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parmar</LastName><ForeName>Simran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pak</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Surgery, King George's Medical University, Lucknow, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Michael Pak-Kai</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>School of Medical Sciences &amp; Hospital, Universiti Sains Malaysia, Kelantan, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantalone</LastName><ForeName>Desire</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podda</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Surgery, Cagliari University Hospital, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puccioni</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Sacred Heart, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasa</LastName><ForeName>Kemal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Surgery, H&#xfc;seyin Kemal Ra&#x15f;a, Anadolu Medical Center, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jianan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roscio</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of General and Minimally Invasive Surgery, ASST Valle Olona, Busto Arsizio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Sanchez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Trauma and Emergency Surgery Unit. General, Digestive and Transplantation Surgery Department, University Regional Hospital of M&#xe1;laga, Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sganga</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Sacred Heart, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheiterle</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Surgery Unit and Trauma Team, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slavchev</LastName><ForeName>Mihail</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Plovdiv Medical University, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smirnov</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, South Ural State Medical University, Chelyabinsk City, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivedi</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Jaime Andres Gonzalez</ForeName><Initials>JAG</Initials><AffiliationInfo><Affiliation>Clinica Santa Maria, Sincelejo, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waledziak</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Military Institute of Medicine, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xenaki</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, University Hospital of Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Desmond</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiuwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakaria</LastName><ForeName>Andee Dzulkarnean</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Medical Sciences and Hospital USM, Universiti Sains Malaysia, Georgetown, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakaria</LastName><ForeName>Zaidi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Medical Sciences and Hospital USM, Universiti Sains Malaysia, Georgetown, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03163095</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Emerg Surg</MedlineTA><NlmUniqueID>101266603</NlmUniqueID><ISSNLinking>1749-7922</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="Y">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Global health</Keyword><Keyword MajorTopicYN="N">Intraperitoneal sepsis</Keyword><Keyword MajorTopicYN="N">Laparotomy</Keyword><Keyword MajorTopicYN="N">Multiple organ dysfunction</Keyword><Keyword MajorTopicYN="N">Open abdomen</Keyword><Keyword MajorTopicYN="N">Peritonitis</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>Andrew W Kirkpatrick serves as the PI of the COOL trial, as a member of the Canadian Forces Medical Services, and has consulted for the 3&#xa0;m/Acelity Corporation, Zoll Medical, Innovative Trauma Care, CSL Behring, and the Statesman&#x2019;s Group. Federico Coccolini, Matti Tolonen reported no declarations. Samuel Minor reported receiving research support and speaking honoraria from COOK Biotech. Emanuel Gois Jr. reported no declarations. Fausto Catena, Christopher J Doig, Michael D Hill, Luca Ansaloni, Massimo Chiurgi, Dario Tartaglia, Orestis Ioannidis reported no declarations. Michael Sugrue reported consultancy for 3&#xa0;M/Acelity and Novus Scientific. Elif Colak: reported no declarations. S Morad Hameed reported being the Founder of T6 Health Systems. Hanna Lampela, Vanni Agnoletti reported no declarations. Jessica L McKee reported consultancies with the Aceso, Innovative Trauma Care, Andrew W Kirkpatrick, and Zoll Corporations, as well as consulting with the Geneva Foundation and South Trail Psychology. Naisan Garraway, Massimo Sartelli, Chad G Ball reported no declarations. Neil G Parry reported being a medical advisor for Front Line Medical Technologies &#x2013; Cobra REBOA. Kelly Voght, Lisa Julien, Jenna Kroeker reported no declarations. Derek J Roberts, Peter Faris, Corina Tiruta, Ernest E Moore, Lee Ann Ammons, Elissavet Anestiadou, Cino Bendinelli, Konstantinos Bouliaris, Rosemarry Carroll, Marco Ceresoli, Francesco Favi, Angela Gurrado, Joao Rezende-Neto, Arda Isik, Camilla Cremonini, Silivia Strambi, Georgios Konstantoudakis, Mario Testini, Sandy Trpcic, Alessandro Pasculli, Erika Picariello, Fikri Abu-Zidan, Ademola Adeyeye, Goran Augustin, Felipe Alconchel, Yuksel Altinel, Luz Adriana Hernandez Amin, Jos&#xe9; Manuel-Narv&#xe1;ez, Oussama Baraket, Walter L Biffl, Gian Luca Baiocchi, Luigi Bonavina, Giuseppe Brisinda, Luca Cardinali, Andrea Celotti, Mohamed Chaouch, Maria Michela Chiarello, Gianluca Costa, Nicola de&#x2019;Angelis, Nicolo de Manzini, Samir Delibegovic, Salomone Di Saverio, Belinda De Simone reported no declarations. Dr Vincent Dubuisson received speaking honoraria from 3&#xa0;M-Acelity in 2021 for a conference about how to manage an OA, at the congress of the French Association of Surgery. Pietro Fransvea, Luca Garulli, Alessio Giordano, Carlos Gomes, Firdaus Hayati, Jinjian Huang, Aini Fahriza Ibrahim, Tan Jih Huei, Ruhi Fadzlyana Jailani, Mansoor Khan, Alfonso Palmieri Luna reported no declarations. Manu L.N.G. Malbrain reported he is co-founder, past-President and current Treasurer of WSACS (The Abdominal Compartment Society, http://www.wsacs.org). He is a member of the medical advisory Board of Pulsion Medical Systems (part of Getinge group), Serenno Medical, Potrero Medical, Sentinel Medical and Baxter. He consults for BBraun, Becton Dickinson, ConvaTec, Spiegelberg, and Holtech Medical and received speaker's fees from PeerVoice. He holds stock options for Serenno and Potrero. Sanjay Marwah, Paul McBeth, Andrei Mihailescu, Alessia Morello, Francesk Mulita, Valentia Murzi, Ahmad Tarmizi Mohammad, Simran Parmar, Ajay Pal, Michael Pak-Kai Wong, Desire Pantalone, Mauro Podda, Caterina Puccioni, Kemal Rasa, Jianan Ren, Francesco Roscio, Antonio Gonzalez-Sanchez, Gabriele Sganga, Maximilian Scheiterle, Mihail Slavchev, Dmitry Smirnov, Lorenzo Tosi, Anand Trivedi, Jaime Andres Gonzalez Vega, Maciej Waledziak, Sofia Xenaki, Desmond Winter, Xiuwen Wu, Andee Dzulkarnean Zakaria reported no declarations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37170123</ArticleId><ArticleId IdType="pmc">PMC10173926</ArticleId><ArticleId IdType="doi">10.1186/s13017-023-00500-z</ArticleId><ArticleId IdType="pii">10.1186/s13017-023-00500-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, et al. Closed or open after source control laparotomy for severe complicated intra-abdominal sepsis (the COOL trial): study protocol for a randomized controlled trial. World J Emerg Surg. 2018;13:26. doi: 10.1186/s13017-018-0183-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-018-0183-4</ArticleId><ArticleId IdType="pmc">PMC6015449</ArticleId><ArticleId IdType="pubmed">29977328</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health. 2012;2(1):010404. doi: 10.7189/jogh.01.010404.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.01.010404</ArticleId><ArticleId IdType="pmc">PMC3484761</ArticleId><ArticleId IdType="pubmed">23198133</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259&#x2013;272. doi: 10.1164/rccm.201504-0781OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcomes, and associated costs of care. Crit Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade E, Tamber PS, Vincent JL. The surviving sepsis campaign: raising awareness to reduce mortality. Crit Care. 2003;7:1&#x2013;2. doi: 10.1186/cc1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc1876</ArticleId><ArticleId IdType="pmc">PMC154124</ArticleId><ArticleId IdType="pubmed">12617727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17&#x2013;60. doi: 10.1007/s00134-007-0934-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0934-2</ArticleId><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296&#x2013;327. doi: 10.1097/01.CCM.0000298158.12101.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000298158.12101.41</ArticleId><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Abu-Zidan FM, Catena F, Griffiths EA, Di Saverio S, Coimbra R, et al. Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study) World J Emerg Surgery. 2015;10:61. doi: 10.1186/s13017-015-0055-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-015-0055-0</ArticleId><ArticleId IdType="pmc">PMC4681030</ArticleId><ArticleId IdType="pubmed">26677396</ArticleId></ArticleIdList></Reference><Reference><Citation>Szakmany T, Lundin RM, Sharif B, Ellis G, Morgan P, Kopczynska M, et al. Sepsis prevalence and outcome on the general wards and emergency departments in wales: results of a multi-centre, observational, point prevalence study. PLoS ONE. 2016;11(12):e0167230. doi: 10.1371/journal.pone.0167230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167230</ArticleId><ArticleId IdType="pmc">PMC5132245</ArticleId><ArticleId IdType="pubmed">27907062</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard: World Health Organization; 2022 [cited 2022 Dec 21 2022]. Available from: https://covid19.who.int/data.</Citation></Reference><Reference><Citation>World Health Organization. Injuries and violence: World Health Organization; 2022 [Available from: https://www.who.int/news-room/fact-sheets/detail/injuries-and-violence#:~:text=Key%20facts%201%20Injuries%20%E2%80%93%20both%20unintentional%20and,of%20all%20years%20lived%20with%20disability.%20More%20items.</Citation></Reference><Reference><Citation>Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. Rockville, MD; 2016.Contract No.: 27359025.</Citation><ArticleIdList><ArticleId IdType="pubmed">27359025</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts DJ, Ball CG, Kirkpatrick AW. Increased pressure within the abdominal compartment: intra-abdominal hypertension and the abdominal compartment syndrome. Curr Opin Crit Care. 2016;22(2):174&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">26844989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Hamilton DR, McKee JL, MacDonald B, Pelosi P, Ball CG, et al. Do we have the guts to go? The abdominal compartment, intra-abdominal hypertension, the human microbiome and exploration class space missions. Can J Surg. 2020;63(6):E581&#x2013;E593. doi: 10.1503/cjs019219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs019219</ArticleId><ArticleId IdType="pmc">PMC7747844</ArticleId><ArticleId IdType="pubmed">33278908</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements TW, Tolonen M, Ball CG, Kirkpatrick AW. Secondary peritonitis and intra-abdominal sepsis: an increasingly global disease in search of better systemic therapies. Scand J Surg. 2021;110(2):139&#x2013;149. doi: 10.1177/1457496920984078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1457496920984078</ArticleId><ArticleId IdType="pubmed">33406974</ArticleId></ArticleIdList></Reference><Reference><Citation>Alverdy JC, Hyoju SK, Weigerinck M, Gilbert JA. The gut microbiome and the mechanism of surgical infection. Br J Surg. 2017;104(2):e14&#x2013;e23. doi: 10.1002/bjs.10405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10405</ArticleId><ArticleId IdType="pmc">PMC7938814</ArticleId><ArticleId IdType="pubmed">28121030</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyton K, Alverdy JC. The gut microbiota and gastrointestinal surgery. Nat Rev Gastroenterol Hepatol. 2017;14(1):43&#x2013;54. doi: 10.1038/nrgastro.2016.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.139</ArticleId><ArticleId IdType="pubmed">27729657</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A, et al. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189(10):1204&#x2013;1213. doi: 10.1164/rccm.201310-1875OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201310-1875OC</ArticleId><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltran MA, Biffl WL, et al. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015;10:35. doi: 10.1186/s13017-015-0032-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-015-0032-7</ArticleId><ArticleId IdType="pmc">PMC4534034</ArticleId><ArticleId IdType="pubmed">26269709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Ansaloni L, Coccolini F, Corbella D, Moore EE, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg. 2014;9:37. doi: 10.1186/1749-7922-9-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-9-37</ArticleId><ArticleId IdType="pmc">PMC4039043</ArticleId><ArticleId IdType="pubmed">24883079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Ansaloni L, Moore E, Malangoni M, Velmahos G, et al. Complicated intra-abdominal infections in a worldwide context: an observational prospective study (CIAOW Study) World J Emerg Surg. 2013;8(1):1. doi: 10.1186/1749-7922-8-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-8-1</ArticleId><ArticleId IdType="pmc">PMC3538624</ArticleId><ArticleId IdType="pubmed">23286785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8(1):3. doi: 10.1186/1749-7922-8-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-8-3</ArticleId><ArticleId IdType="pmc">PMC3545734</ArticleId><ArticleId IdType="pubmed">23294512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE. Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia. Surg Infect (Larchmt) 2015;16(6):785&#x2013;793. doi: 10.1089/sur.2014.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2014.166</ArticleId><ArticleId IdType="pubmed">26258265</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, et al. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA, J Am Med Assoc. 2007;298(8):865&#x2013;872. doi: 10.1001/jama.298.8.865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.8.865</ArticleId><ArticleId IdType="pubmed">17712070</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathens AB, Rotstein OD. Therapeutic options in peritonitis. Surg Clin North Am. 1994;74(3):677&#x2013;692. doi: 10.1016/S0039-6109(16)46336-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6109(16)46336-X</ArticleId><ArticleId IdType="pubmed">8197537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosscha K, van Vroonhoven TJ, van der Werken C. Surgical management of severe secondary peritonitis. Br J Surg. 1999;86(11):1371&#x2013;1377. doi: 10.1046/j.1365-2168.1999.01258.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2168.1999.01258.x</ArticleId><ArticleId IdType="pubmed">10583280</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppaniemi A, Kimball EJ, De Laet I, Malbrain ML, Balogh ZJ, De Waele JJ. Management of abdominal sepsis&#x2013;a paradigm shift? Anaesthesiol Intense Therapy. 2015;47(4):400&#x2013;408. doi: 10.5603/AIT.a2015.0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.a2015.0026</ArticleId><ArticleId IdType="pubmed">25973662</ArticleId></ArticleIdList></Reference><Reference><Citation>De Waele JJ. Abdominal sepsis. Curr Infect Disease Rep. 2016;18(8):23. doi: 10.1007/s11908-016-0531-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-016-0531-z</ArticleId><ArticleId IdType="pubmed">27363829</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ. Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg. 2002;89(12):1516&#x2013;1524. doi: 10.1046/j.1365-2168.2002.02293.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2168.2002.02293.x</ArticleId><ArticleId IdType="pubmed">12445059</ArticleId></ArticleIdList></Reference><Reference><Citation>Opmeer BC, Boer KR, van Ruler O, Reitsma JB, Gooszen HG, de Graaf PW, et al. Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial. Crit Care. 2010;14(3):R97. doi: 10.1186/cc9032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9032</ArticleId><ArticleId IdType="pmc">PMC2911734</ArticleId><ArticleId IdType="pubmed">20507557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190&#x2013;1206. doi: 10.1007/s00134-013-2906-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2906-z</ArticleId><ArticleId IdType="pmc">PMC3680657</ArticleId><ArticleId IdType="pubmed">23673399</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM, Dellinger RP, Vincent JL, Masur H, Angus DC. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med. 2014;42(7):1714&#x2013;1721. doi: 10.1097/CCM.0000000000000325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000325</ArticleId><ArticleId IdType="pmc">PMC4135726</ArticleId><ArticleId IdType="pubmed">24717456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile LF, Moldawer LL. HMGB1 as a therapeutic target for sepsis: it's all in the timing! Expert Opin Ther Targets. 2014;18(3):243&#x2013;245. doi: 10.1517/14728222.2014.883380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2014.883380</ArticleId><ArticleId IdType="pmc">PMC5119516</ArticleId><ArticleId IdType="pubmed">24479494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Roberts DJ, Faris PD, Ball CG, Kubes P, Tiruta C, et al. Active negative pressure peritoneal therapy after abbreviated laparotomy: the intraperitoneal vacuum randomized controlled trial. Ann Surg. 2015;262(1):38&#x2013;46. doi: 10.1097/SLA.0000000000001095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001095</ArticleId><ArticleId IdType="pmc">PMC4463030</ArticleId><ArticleId IdType="pubmed">25536308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheatham ML, Demetriades D, Fabian TC, Kaplan MJ, Miles WS, Schreiber MA, et al. Prospective study examining clinical outcomes associated with a negative pressure wound therapy system and Barker's vacuum packing technique. World J Surg. 2013;37(9):2018&#x2013;2030. doi: 10.1007/s00268-013-2080-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-013-2080-z</ArticleId><ArticleId IdType="pmc">PMC3742953</ArticleId><ArticleId IdType="pubmed">23674252</ArticleId></ArticleIdList></Reference><Reference><Citation>Malig MS, Jenne CN, Ball CG, Roberts DJ, Xiao Z, Kirkpatrick AW. High mobility group box-1 protein and outcomes in critically Ill surgical patients requiring open abdominal management. Mediators Inflamm. 2017;2017:6305387. doi: 10.1155/2017/6305387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6305387</ArticleId><ArticleId IdType="pmc">PMC5329691</ArticleId><ArticleId IdType="pubmed">28286376</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A, Hsee L, Mathur S, Civil I. Damage-control laparotomy in nontrauma patients: review of indications and outcomes. J Trauma Acute Care Surg. 2013;75(3):365&#x2013;368. doi: 10.1097/TA.0b013e31829cb65e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31829cb65e</ArticleId><ArticleId IdType="pubmed">23928745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruns BR, Ahmad SA, O'Meara L, Tesoriero R, Lauerman M, Klyushnenkova E, et al. Nontrauma open abdomens: a prospective observational study. J Trauma Acute Care Surg. 2016;80(4):631&#x2013;636. doi: 10.1097/TA.0000000000000958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000958</ArticleId><ArticleId IdType="pubmed">26808023</ArticleId></ArticleIdList></Reference><Reference><Citation>Goussous N, Jenkins DH, Zielinski MD. Primary fascial closure after damage control laparotomy: sepsis vs haemorrhage. Injury. 2014;45(1):151&#x2013;155. doi: 10.1016/j.injury.2013.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.01.039</ArticleId><ArticleId IdType="pubmed">23453268</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Biffl W, Catena F, Ceresoli M, Chiara O, Cimbanassi S, et al. The open abdomen, indications, management and definitive closure. World J Emerg Surg. 2015;10:32. doi: 10.1186/s13017-015-0026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-015-0026-5</ArticleId><ArticleId IdType="pmc">PMC4515003</ArticleId><ArticleId IdType="pubmed">26213565</ArticleId></ArticleIdList></Reference><Reference><Citation>Atema JJ, Gans SL, Boermeester MA. Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients. World J Surg. 2015;39(4):912&#x2013;925. doi: 10.1007/s00268-014-2883-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-014-2883-6</ArticleId><ArticleId IdType="pubmed">25446477</ArticleId></ArticleIdList></Reference><Reference><Citation>Quyn AJ, Johnston C, Hall D, Chambers A, Arapova N, Ogston S, et al. The open abdomen and temporary abdominal closure systems&#x2013;historical evolution and systematic review. Colorectal Dis. 2012;14(8):e429&#x2013;e438. doi: 10.1111/j.1463-1318.2012.03045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2012.03045.x</ArticleId><ArticleId IdType="pubmed">22487141</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JW, Gracias VH, Schwab CW, Reilly PM, Kauder DR, Shapiro MB, et al. Evolution in damage control for exsanguinating penetrating abdominal injury. J Trauma. 2001;51:261&#x2013;271. doi: 10.1097/00005373-200108000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200108000-00007</ArticleId><ArticleId IdType="pubmed">11493783</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvin JA, Podbielski J, Vincent LE, Fox EE, Moore LJ, Cotton BA, et al. Damage control laparotomy trial: design, rationale and implemenation of a randomized controlled trial. Trauma Surg Acute Care OPen. 2017;2:1&#x2013;5. doi: 10.1136/tsaco-2017-000083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2017-000083</ArticleId><ArticleId IdType="pmc">PMC5877899</ArticleId><ArticleId IdType="pubmed">29766087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch QM, Osterhout LM, Ashraf A, Podbielski J, Kozar RA, Wade CE, et al. Current use of damage-control laparotomy, closure rates, and predictors of early fascial closure at the first take-back. J Trauma. 2011;70(6):1429&#x2013;1436.</Citation><ArticleIdList><ArticleId IdType="pubmed">21817981</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvin JA, Wray CJ, Steward J, Lawless RA, McNutt MK, Love JD, et al. Control the damage: morbidity and mortality after emergent trauma laparotomy. Am J Surg. 2016;212(1):34&#x2013;39. doi: 10.1016/j.amjsurg.2015.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2015.10.014</ArticleId><ArticleId IdType="pubmed">26754456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zizzo M, Castro Ruiz C, Zanelli M, Bassi MC, Sanguedolce F, Ascani S, et al. Damage control surgery for the treatment of perforated acute colonic diverticulitis: a systematic review. Medicine (Baltimore) 2020;99(48):e23323. doi: 10.1097/MD.0000000000023323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023323</ArticleId><ArticleId IdType="pmc">PMC7710165</ArticleId><ArticleId IdType="pubmed">33235095</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Montori G, Ceresoli M, Catena F, Moore EE, Ivatury R, et al. The role of open abdomen in non-trauma patient: WSES Consensus Paper. World J Emerg Surg. 2017;12:39. doi: 10.1186/s13017-017-0146-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-017-0146-1</ArticleId><ArticleId IdType="pmc">PMC5557069</ArticleId><ArticleId IdType="pubmed">28814969</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Ansaloni L, Coccolini F, Griffiths EA, Abu-Zidan FM, et al. WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency setting. World J Emerg Surg. 2016;11:37. doi: 10.1186/s13017-016-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-016-0095-0</ArticleId><ArticleId IdType="pmc">PMC4966807</ArticleId><ArticleId IdType="pubmed">27478494</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Wang K, Gong J, Liu Z, Gong J, Zeng Z, et al. Negative pressure wound therapy for managing the open abdomen in non-trauma patients. Cochrane Database Syst Rev. 2022;5:1013710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073087</ArticleId><ArticleId IdType="pubmed">35514120</ArticleId></ArticleIdList></Reference><Reference><Citation>Robledo FA, Luque-de-Leon E, Suarez R, Sanchez P, de-la-Fuente M, Vargas A, et al. Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial. Surg Infect. 2007;8(1):63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">17381398</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts DJ, Zygun DA, Grendar J, Ball CG, Robertson HL, Ouellet JF, et al. Negative-pressure wound therapy for critically ill adults with open abdominal wounds: a systematic review. J Trauma Acute Care Surg. 2012;73(3):629&#x2013;639. doi: 10.1097/TA.0b013e31825c130e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31825c130e</ArticleId><ArticleId IdType="pubmed">22929494</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Ceresoli M, Kluger Y, Kirkpatrick A, Montori G, Salvetti F, et al. Open abdomen and entero-atmospheric fistulae: an interim analysis from the International Register of Open Abdomen (IROA) Injury. 2019;50(1):160&#x2013;166. doi: 10.1016/j.injury.2018.09.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.09.040</ArticleId><ArticleId IdType="pubmed">30274755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, et al. Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock. 2010;34(5):525&#x2013;534. doi: 10.1097/SHK.0b013e3181e14cd2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181e14cd2</ArticleId><ArticleId IdType="pubmed">20823698</ArticleId></ArticleIdList></Reference><Reference><Citation>Emr B, Sadowsky D, Azhar N, Gatto LA, An G, Nieman G, et al. Removal of Inflammatory Ascites is Associated with Dynamic Modification of Local and Systemic Inflammation along with Prevention of Acute Lung Injury: In Vivo and In Silico Studies. Shock. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962670</ArticleId><ArticleId IdType="pubmed">24430553</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts DJ, Jenne CN, Ball CG, Tiruta C, Leger C, Xiao Z, et al. Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial. Trials. 2013;14:141. doi: 10.1186/1745-6215-14-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-14-141</ArticleId><ArticleId IdType="pmc">PMC3662623</ArticleId><ArticleId IdType="pubmed">23680127</ArticleId></ArticleIdList></Reference><Reference><Citation>Person B, Dorfman T, Bahouth H, Osman A, Assalia A, Kluger Y. Abbreviated emergency laparotomy in the non-trauma setting. World J Emerg Surg. 2009;4:41. doi: 10.1186/1749-7922-4-41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-4-41</ArticleId><ArticleId IdType="pmc">PMC2783027</ArticleId><ArticleId IdType="pubmed">19925649</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Ren J, McKee JL, Kirkpatrick AW. 2023 updates on the closed or open after-source control for severe complicated intraabdominal sepsis (COOL) trial. World J Surg Infect. 2022;1(2):47&#x2013;49. doi: 10.4103/wjsi.wjsi_1_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/wjsi.wjsi_1_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta S, Bjarnason T, Petersson U, Palsson B, Wanhainen A, Svensson M, et al. Multicentre prospective study of fascial closure rate after open abdomen with vacuum and mesh-mediated fascial traction. Br J Surg. 2011;98(5):735&#x2013;743. doi: 10.1002/bjs.7383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.7383</ArticleId><ArticleId IdType="pubmed">21462176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhi AN, Minor S. Management of the open abdomen using combination therapy with ABRA and ABThera systems. Can J Surg. 2014;57(5):314&#x2013;319. doi: 10.1503/cjs.026613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs.026613</ArticleId><ArticleId IdType="pmc">PMC4183677</ArticleId><ArticleId IdType="pubmed">25265104</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JW, Matheson PJ, Franklin GA, Harbrecht BG, Richardson JD, Garrison RN. Randomized controlled trial evaluating the efficacy of peritoneal resuscitation in the management of trauma patients undergoing damage control surgery. J Am Coll Surg. 2017;224(4):396&#x2013;404. doi: 10.1016/j.jamcollsurg.2016.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2016.12.047</ArticleId><ArticleId IdType="pubmed">28137537</ArticleId></ArticleIdList></Reference><Reference><Citation>Posadas-Calleja JG, Stelfox HT, Ferland A, Zuege DJ, Niven DJ, Berthiaume L, et al. Derivation of a PIRO score for prediction of mortality in surgical patients with intra-abdominal sepsis/severe sepsis/septic shock. Am J Crit Care. (in press).</Citation><ArticleIdList><ArticleId IdType="pubmed">29961664</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolonen M, Coccolini F, Ansaloni L, Sartelli M, Roberts DJ, McKee JL, et al. Getting the invite list right: A Discussion of sepsis severity scoring systems in severe complicared intra-abdominal sepsis and randomized trial inclusion criteria. World J Emerg Surg. (in press).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889572</ArticleId><ArticleId IdType="pubmed">29636790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney EJ, Bugaev N, Appelbaum R, Goldenberg-Sandau A, Baltazar GA, Posluszny J, et al. Management of the open abdomen: a systematic review with meta-analysis and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2022;93(3):e110&#x2013;e118. doi: 10.1097/TA.0000000000003683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000003683</ArticleId><ArticleId IdType="pubmed">35546420</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell A, Chang M, Fabian T, Franz M, Kaplan M, Moore F, et al. Management of the open abdomen: from initial operation to definitive closure. Am Surg. 2009;75(11 Suppl):S1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19998714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharrock AE, Barker T, Yuen HM, Rickard R, Tai N. Management and closure of the open abdomen after damage control laparotomy for trauma. A Syst Rev Meta-anal Injury. 2016;47(2):296&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">26462958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi: 10.1186/s13054-020-02950-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02950-2</ArticleId><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorck M, Kirkpatrick AW, Cheatham M, Kaplan M, Leppaniemi A, De Waele JJ. Amended classification of the open abdomen. Scand J Surg. 2016;105(1):5&#x2013;10. doi: 10.1177/1457496916631853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1457496916631853</ArticleId><ArticleId IdType="pubmed">26929286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjarnason T, Montgomery A, Acosta S, Petersson U. Evaluation of the open abdomen classification system: a validity and reliability analysis. World J Surg. 2014;38(12):3112&#x2013;3124. doi: 10.1007/s00268-014-2716-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-014-2716-7</ArticleId><ArticleId IdType="pubmed">25231700</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien PA, Vetter D, Staiger RD, Slankamenac K, Mehra T, Graf R, et al. The comprehensive complication index (CCI(R)): added value and clinical perspectives 3 years "Down the Line". Ann Surg. 2017;265(6):1045&#x2013;1050. doi: 10.1097/SLA.0000000000002132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002132</ArticleId><ArticleId IdType="pubmed">28486288</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;213. doi: 10.1097/01.sla.0000133083.54934.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng-Kamstra JS, Rennert-May E, McKee J, Lundgren S, Manns B, Kirkpatrick AW. Protocol for a parallel economic evaluation of a trial comparing two surgical strategies in severe complicated intra-abdominal sepsis: the COOL-cost study. World J Emerg Surg. 2020;15(1):15. doi: 10.1186/s13017-020-00294-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-020-00294-4</ArticleId><ArticleId IdType="pmc">PMC7035651</ArticleId><ArticleId IdType="pubmed">32085778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Roberts DJ, Faris PD, Ball CG, Kubes P, Tiruta C, et al. Active negative pressure peritoneal therapy after abbreviated laparotomy: the intraperitoneal vacuum randomized controlled trial. Ann Surg. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4463030</ArticleId><ArticleId IdType="pubmed">25536308</ArticleId></ArticleIdList></Reference><Reference><Citation>Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, et al. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2) Trials. 2009;10:49. doi: 10.1186/1745-6215-10-49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-10-49</ArticleId><ArticleId IdType="pmc">PMC2723099</ArticleId><ArticleId IdType="pubmed">19580665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303(12):1180&#x2013;1187. doi: 10.1001/jama.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.310</ArticleId><ArticleId IdType="pubmed">20332404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol. 2008;61(3):241&#x2013;246. doi: 10.1016/j.jclinepi.2007.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.07.016</ArticleId><ArticleId IdType="pubmed">18226746</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141&#x2013;145. doi: 10.1056/NEJM198707163170304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198707163170304</ArticleId><ArticleId IdType="pubmed">3600702</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig CJ, Page SA, McKee JL, Moore EE, Abu-Zidan FM, Carroll R, et al. Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis. World J Emerg Surg. 2019;14:39. doi: 10.1186/s13017-019-0259-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-019-0259-9</ArticleId><ArticleId IdType="pmc">PMC6683332</ArticleId><ArticleId IdType="pubmed">31404221</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig CJ, Page SA, McKee JL, Moore EE, Abu-Zidan FM, Carroll R, et al. Correction to: Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis. World J Emerg Surg. 2019;14:47. doi: 10.1186/s13017-019-0268-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-019-0268-8</ArticleId><ArticleId IdType="pmc">PMC6796476</ArticleId><ArticleId IdType="pubmed">31636693</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery. 1994;115(6):707&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">8197563</ArticleId></ArticleIdList></Reference><Reference><Citation>Smithson M, McLeod MC, Chu DI, Kennedy G, Morris M, Chen H, et al. NIH funding of researchers in surgery: decreased career development awards over time. J Surg Res. 2021;266:6&#x2013;12. doi: 10.1016/j.jss.2021.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2021.02.053</ArticleId><ArticleId IdType="pmc">PMC8338795</ArticleId><ArticleId IdType="pubmed">33975029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Edwards BL, Brooks KD, Newhook TE, Slingluff CL., Jr Recent trends in National Institutes of Health funding for surgery: 2003 to 2013. Am J Surg. 2015;209(6):1083&#x2013;1089. doi: 10.1016/j.amjsurg.2015.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2015.01.015</ArticleId><ArticleId IdType="pmc">PMC4446185</ArticleId><ArticleId IdType="pubmed">25929766</ArticleId></ArticleIdList></Reference><Reference><Citation>McCulloch P, Feinberg J, Philippou Y, Kolias A, Kehoe S, Lancaster G, et al. Progress in clinical research in surgery and IDEAL. Lancet. 2018;392(10141):88&#x2013;94. doi: 10.1016/S0140-6736(18)30102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30102-8</ArticleId><ArticleId IdType="pubmed">29361334</ArticleId></ArticleIdList></Reference><Reference><Citation>McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324(7351):1448&#x2013;1451. doi: 10.1136/bmj.324.7351.1448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7351.1448</ArticleId><ArticleId IdType="pmc">PMC1123389</ArticleId><ArticleId IdType="pubmed">12065273</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R. Surgical research or comic opera: questions, but few answers. Lancet. 1996;347:984&#x2013;985. doi: 10.1016/S0140-6736(96)90137-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)90137-3</ArticleId><ArticleId IdType="pubmed">8606606</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson M, Stokes RG, Arndt T. The Thalidomide Catastrophe: How it hapened, who was responsible and why te search for justice continues after more than six decades. Cranbrook, Exeter: Onwards and Upwards Publishers; 2018. p. 2018.</Citation></Reference><Reference><Citation>Kirkpatrick AW, Sugrue M, McKee JL, Pereira BM, Roberts DJ, De Waele JJ, et al. Update from the Abdominal Compartment Society (WSACS) on intra-abdominal hypertension and abdominal compartment syndrome: past, present, and future beyond Banff 2017. Anaesthesiol Intensive Ther. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28502071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantle PM, Cotton BA. Balanced resuscitation in trauma management. Surg Clin North Am. 2017;97(5):999&#x2013;1014. doi: 10.1016/j.suc.2017.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2017.06.002</ArticleId><ArticleId IdType="pubmed">28958369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Holcomb JB. Optimal fluid therapy for traumatic hemorrhagic shock. Crit Care Clin. 2017;33(1):15&#x2013;36. doi: 10.1016/j.ccc.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5131713</ArticleId><ArticleId IdType="pubmed">27894494</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph B, Zangbar B, Pandit V, Vercruysse G, Aziz H, Kulvatunyou N, et al. The conjoint effect of reduced crystalloid administration and decreased damage-control laparotomy use in the development of abdominal compartment syndrome. J Trauma Acute Care Surg. 2014;76(2):457&#x2013;461. doi: 10.1097/TA.0b013e3182a9ea44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182a9ea44</ArticleId><ArticleId IdType="pubmed">24398772</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber MA. The beginning of the end for damage control surgery. Br J Surg. 2012;99(Suppl 1):10&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22441850</ArticleId></ArticleIdList></Reference><Reference><Citation>Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Therapy. 2014;46(5):361&#x2013;380. doi: 10.5603/AIT.2014.0060.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.2014.0060</ArticleId><ArticleId IdType="pubmed">25432556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs R, Wise RD, Myatchin I, Vanhonacker D, Minini A, Mekeirele M, et al. Fluid management, intra-abdominal hypertension and the abdominal compartment syndrome: a narrative review. Life (Basel). 2022;12(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9502789</ArticleId><ArticleId IdType="pubmed">36143427</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftus TJ, Jordan JR, Croft CA, Smith RS, Efron PA, Mohr AM, et al. Temporary abdominal closure for trauma and intra-abdominal sepsis: different patients, different outcomes. J Trauma Acute Care Surg. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5250565</ArticleId><ArticleId IdType="pubmed">27787442</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL. Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med. 1997;25(2):372&#x2013;374. doi: 10.1097/00003246-199702000-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199702000-00029</ArticleId><ArticleId IdType="pubmed">9034279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Deutschman CS, Singer M. Do we need a new definition of sepsis? Intensive Care Med. 2015;41(5):909&#x2013;911. doi: 10.1007/s00134-015-3680-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3680-x</ArticleId><ArticleId IdType="pubmed">25643905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubiak BD, Albert SP, Gatto LA, Vieau CJ, Roy SK, Snyder KP, et al. A Clinically Applicable Porcine Model of Septic and Ischemia/Reperfusion-Induced Shock and Multiple Organ Injury. J Surg Res.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3061050</ArticleId><ArticleId IdType="pubmed">21193206</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction, syndrome. Crit Care Med. 2001;29:S99&#x2013;S106. doi: 10.1097/00003246-200107001-00032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107001-00032</ArticleId><ArticleId IdType="pubmed">11445742</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D, Mayers I. Multiple organ dysfunction syndrome: a naarative review. Can J Surg. 2001;48:502&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">11394523</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the celllular level. Crit Care Clin. 2005;21:177&#x2013;196. doi: 10.1016/j.ccc.2005.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2005.01.005</ArticleId><ArticleId IdType="pubmed">15781156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Xiao J, Jenne CN, Roberts DJ. Inflammatory mediators in intra-abdominal sepsis. In: Bassetti M, Martin-Loeches I, editors. Sartelli M. Abdominal Sepsis. Hot Topics in Acute Care Surgery and Trauma. Cham: Springer; 2018. pp. 15&#x2013;28.</Citation></Reference><Reference><Citation>Kirkpatrick AW, Coccolini F, McDonald BR, Roberts DJ. Definition, Pathophysiology, and Pathobiology of Intra-Abdominal Hypertension and the Abdominal Compartment Syndrome. In: Coccolini F, Malbrain MLNG, Kirkpatrick AW, Gamberini E, editors. Compartment Syndrome. Hot Topics in Acute Care Surgery and Trauma. Cham: Springer; 2021. pp. 51&#x2013;62.</Citation></Reference><Reference><Citation>Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res. 1997;70(2):107&#x2013;112. doi: 10.1006/jsre.1997.5071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsre.1997.5071</ArticleId><ArticleId IdType="pubmed">9237883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao YM, Redl H, Bahrami S, Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998;47(5):201&#x2013;210. doi: 10.1007/s000110050318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000110050318</ArticleId><ArticleId IdType="pubmed">9657252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Buller HR, Hoek FJ, et al. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993;114(3):564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">7690162</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheingraber S, Bauerfeind F, Bohme J, Dralle H. Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg. 2001;181(4):301&#x2013;308. doi: 10.1016/S0002-9610(01)00587-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(01)00587-6</ArticleId><ArticleId IdType="pubmed">11438263</ArticleId></ArticleIdList></Reference><Reference><Citation>van Berge Henegouwen MI, van der Poll T, van Deventer SJ, Gouma DJ. Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am J Surg. 1998;175(4):311&#x2013;316. doi: 10.1016/S0002-9610(98)00010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(98)00010-5</ArticleId><ArticleId IdType="pubmed">9568659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansson K, Redler B, Truedsson L, Magnuson A, Matthiessen P, Andersson M, et al. Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction. Am J Surg. 2004;187(3):372&#x2013;377. doi: 10.1016/j.amjsurg.2003.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2003.12.019</ArticleId><ArticleId IdType="pubmed">15006565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks T, Bleichrodt RP, Lomme RM, De Man BM, van Goor H, Buyne OR. Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J Am Coll Surg. 2010;211(2):263&#x2013;270. doi: 10.1016/j.jamcollsurg.2010.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.03.038</ArticleId><ArticleId IdType="pubmed">20670866</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg. 1995;130(12):1314&#x2013;9; discussion 9&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">7492280</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau L, Shek PN. Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med. 2000;28(3):788&#x2013;794. doi: 10.1097/00003246-200003000-00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200003000-00030</ArticleId><ArticleId IdType="pubmed">10752831</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med. 2003;31(8):2228&#x2013;2237. doi: 10.1097/01.CCM.0000087326.59341.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000087326.59341.51</ArticleId><ArticleId IdType="pubmed">12973184</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Fumagalli R, Cruz DN, Brienza N, Giunta F. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Contrib Nephrol. 2010;167:83&#x2013;90. doi: 10.1159/000315922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315922</ArticleId><ArticleId IdType="pubmed">20519902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, et al. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. Contrib Nephrol. 2010;166:73&#x2013;82. doi: 10.1159/000314855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000314855</ArticleId><ArticleId IdType="pubmed">20472994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care. 2005;9(4):R294&#x2013;302. doi: 10.1186/cc3529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3529</ArticleId><ArticleId IdType="pmc">PMC1269433</ArticleId><ArticleId IdType="pubmed">16137340</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna R, Benedetti M, Morelli A, Rocco M, Diana L, Prezioso G, et al. Clinical effects of laparotomy with perioperative continuous peritoneal lavage and postoperative hemofiltration in patients with severe acute pancreatitis. World J Emerg Surg. 2009;4:45. doi: 10.1186/1749-7922-4-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-4-45</ArticleId><ArticleId IdType="pmc">PMC2803451</ArticleId><ArticleId IdType="pubmed">20015376</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings WC, Wood CD, Guernsey JM. Continuous postoperative lavage in the treatment of peritoneal sepsis. Dis Colon Rectum. 1982;25(7):641&#x2013;643. doi: 10.1007/BF02629531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02629531</ArticleId><ArticleId IdType="pubmed">7128362</ArticleId></ArticleIdList></Reference><Reference><Citation>De Waele JJ, Hesse UJ, Pattyn P, Decruyenaere J, de Hemptinne B. Postoperative lavage and on demand surgical intervention in the treatment of acute necrotizing pancreatitis. Acta Chir Belg. 2000;100(1):16&#x2013;20. doi: 10.1080/00015458.2000.12098509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015458.2000.12098509</ArticleId><ArticleId IdType="pubmed">10776522</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz A, Bolke E, Peiper M, Schulte am Esch J, Steinbach G, van Griensven M, et al. Inflammatory peritoneal reaction after perforated appendicitis: continuous peritoneal lavage versus non lavage. Eur J Med Res. 2007;12(5):200&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17513191</ArticleId></ArticleIdList></Reference><Reference><Citation>Buanes TA, Andersen GP, Jacobsen U, Nygaard K. Perforated appendicitis with generalized peritonitis. Prospective, randomized evaluation of closed postoperative peritoneal lavage. Eur J Surg. 1991;157(4):277&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">1677283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallerback B, Andersson C, Englund N, Glise H, Nihlberg A, Solhaug J, et al. A prospective randomized study of continuous peritoneal lavage postoperatively in the treatment of purulent peritonitis. Surg Gynecol Obstet. 1986;163(5):433&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">3535135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, et al. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14(5&#x2013;6):257&#x2013;263. doi: 10.2119/2007-00108.Nakada.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00108.Nakada</ArticleId><ArticleId IdType="pmc">PMC2263139</ArticleId><ArticleId IdType="pubmed">18327291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann JN, Faist E, Deppisch R, Hartl WH, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Contrib Nephrol. 1995;116:76&#x2013;79. doi: 10.1159/000424616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000424616</ArticleId><ArticleId IdType="pubmed">8529385</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner C, Schuster S, Plachky J, Hofer S, Martin E, Weigand MA. Hemofiltration and immune response in severe sepsis. J Surg Res. 2007;142(1):59&#x2013;65. doi: 10.1016/j.jss.2006.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2006.09.019</ArticleId><ArticleId IdType="pubmed">17716608</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975&#x2013;984. doi: 10.1007/s00134-015-3751-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3751-z</ArticleId><ArticleId IdType="pmc">PMC4477725</ArticleId><ArticleId IdType="pubmed">25862039</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS ONE. 2017;12(10):e0187015. doi: 10.1371/journal.pone.0187015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187015</ArticleId><ArticleId IdType="pmc">PMC5662220</ArticleId><ArticleId IdType="pubmed">29084247</ArticleId></ArticleIdList></Reference><Reference><Citation>Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcagni V, et al. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004;30:822&#x2013;829. doi: 10.1007/s00134-004-2169-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-004-2169-9</ArticleId><ArticleId IdType="pubmed">14758472</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantefeve G, Hellman R, Pajot O, Thirion M, Bleichner G, Mentec H. Abdominal compartment syndrome and intraabdominal sepsis. Acta Clin Belg. 2007;62:S240. doi: 10.1179/acb.2007.62.s1.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/acb.2007.62.s1.021</ArticleId><ArticleId IdType="pubmed">24881714</ArticleId></ArticleIdList></Reference><Reference><Citation>Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Holcomb JB, Ware DN, et al. Secondary abdominal compartment syndrome is an elusive early complication of traumatic shock resuscitation. Am J Surg. 2002;184:538&#x2013;544. doi: 10.1016/S0002-9610(02)01050-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(02)01050-4</ArticleId><ArticleId IdType="pubmed">12488160</ArticleId></ArticleIdList></Reference><Reference><Citation>Regueira T, Bruhn A, Hasbun P, Aguirre M, Romero C, Llanos O, et al. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care. 2008;23(4):461&#x2013;467. doi: 10.1016/j.jcrc.2007.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2007.12.013</ArticleId><ArticleId IdType="pubmed">19056007</ArticleId></ArticleIdList></Reference><Reference><Citation>Regueira T, Hasbun P, Rebolledo R, Galindo J, Aguirre M, Romero C, et al. Intraabdominal hypertension in patients with septic shock. Am Surg. 2007;73(9):865&#x2013;870. doi: 10.1177/000313480707300907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313480707300907</ArticleId><ArticleId IdType="pubmed">17939414</ArticleId></ArticleIdList></Reference><Reference><Citation>Reintam A, Parm P, Kitus R, Kern H, Starkopf J. Intra-abdominal hypetension as a risk factor of death in patients with severe sepsis or septic shock. Crit Care. 2007;11:S130. doi: 10.1186/cc5479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5479</ArticleId></ArticleIdList></Reference><Reference><Citation>McBeth PB, Leger C, Ball CG, Ouelett JF, Tiruta C, Laupland KB, et al. Intra-abdominal hypertension and intra-abdominal sepsis: critical concepts and possibilties. Int J Intensive Care. 2011;19&#x2013;26.</Citation></Reference><Reference><Citation>Kirkpatrick AW, Roberts DJ, De Waele J, Laupland K. Is intra-abdominal hypertension a missing factor that drives multiple organ dysfunction syndrome? Crit Care. 2014;18(2):124. doi: 10.1186/cc13785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13785</ArticleId><ArticleId IdType="pmc">PMC4057196</ArticleId><ArticleId IdType="pubmed">25030025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Wei Z, Liu X, Li X, Yuan Z, Zheng J, et al. The role of intestinal mucosa injury induced by intra-abdominal hypertension in the development of abdominal compartment syndrome and multiple organ dysfunction syndrome. Crit Care. (in press).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057115</ArticleId><ArticleId IdType="pubmed">24321230</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng Y, Zhang K, Fan J, Yi M, Ge Q, Chen L, et al. Effect of acute, slightly increased intra-abdominal pressure on intestinal permeability and oxidative stress in a rat model. PLoS ONE. 2014;9(10):e109350. doi: 10.1371/journal.pone.0109350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109350</ArticleId><ArticleId IdType="pmc">PMC4190173</ArticleId><ArticleId IdType="pubmed">25295715</ArticleId></ArticleIdList></Reference><Reference><Citation>Briel M, Elger BS, McLennan S, Schandelmaier S, von Elm E, Satalkar P. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada. Trials. 2021;22(1):844. doi: 10.1186/s13063-021-05818-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05818-0</ArticleId><ArticleId IdType="pmc">PMC8613940</ArticleId><ArticleId IdType="pubmed">34823582</ArticleId></ArticleIdList></Reference><Reference><Citation>Briel M, Olu KK, von Elm E, Kasenda B, Alturki R, Agarwal A, et al. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable. J Clin Epidemiol. 2016;80:8&#x2013;15. doi: 10.1016/j.jclinepi.2016.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.07.016</ArticleId><ArticleId IdType="pubmed">27498376</ArticleId></ArticleIdList></Reference><Reference><Citation>Posadas-Calleja JG, Stelfox HT, Ferland A, Zuege DJ, Niven DJ, Berthiaume L, et al. Derivation of a PIRO score for prediction of mortality in surgical patients with intra-abdominal sepsis. Am J Crit Care. 2018;27(4):287&#x2013;294. doi: 10.4037/ajcc2018576.</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/ajcc2018576</ArticleId><ArticleId IdType="pubmed">29961664</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Me A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Asessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39579639</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0852</ISSN><JournalIssue CitedMedium="Internet"><Volume>214</Volume><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of cancer (Oxford, England : 1990)</Title><ISOAbbreviation>Eur J Cancer</ISOAbbreviation></Journal><ArticleTitle>Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study.</ArticleTitle><Pagination><StartPage>115140</StartPage><MedlinePgn>115140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejca.2024.115140</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0959-8049(24)01747-7</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The purpose of this nationwide registry-based cohort study was to outline pancreatic cancer risk after benign gallbladder disease (GBD). Anatomically adjacent cancers were investigated to address incidental findings.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included all Swedes aged 20-79 years with histologically confirmed GBD (cholecystitis and/or cholecystectomy) in 1992-2016 and five matched non-exposed population comparators. Follow-up started one month after GBD and incidence rates (IR) and hazard ratios (HR) with 95&#xa0;% confidence intervals (CI) up to 15 years after GBD were estimated using Poisson and Cox regression, respectively. Fully adjusted models included sex, age, year, education, type 2 diabetes, obesity, smoking-, and alcohol-related disorders. Analyses were stratified by follow-up and flexible parametric models applied to assess time-varying effects. Interaction models were used to identify patient groups at risk.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">680 and 1890 incident pancreatic cancers were detected over 15 years in 130907 GBD exposed and 571618 non-exposed, respectively. An excess pancreatic cancer risk was mainly seen within the first 2 years; IR: 84 [95&#xa0;% CI 73,95] versus 31 [95&#xa0;% CI 27,34] per 100000 person-years corresponding to an HR of 2.74 [95&#xa0;% CI 2.31,3.25]. The same pattern was noted for duodenal cancer while primary liver cancer risk was elevated across follow-up. An initial extrahepatic biliary cancer risk elevation shifted to a reduction over time. The 2-year pancreatic cancer risk was augmented in younger (age 20-49) individuals, HR 7.64 [95&#xa0;% CI 3.73,15.65].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings urge more studies on the clinical follow-up the first years after cholecystitis to detect early pancreatic cancer.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radkiewicz</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Surgery and Oncology, Capio Sankt G&#xf6;rans Sjukhus, Stockholm, Sweden. Electronic address: cecilia.radkiewicz@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludvigsson</LastName><ForeName>Jonas F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Pediatrics, &#xd6;rebro University Hospital, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparrelid</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emilsson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; General Practice Research Unit (AFE) and Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway; V&#xe5;rdcentralen V&#xe4;rmlands Nys&#xe4;ter and Centre for Clinical Research, County Council of V&#xe4;rmland, V&#xe4;rmland, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Cancer</MedlineTA><NlmUniqueID>9005373</NlmUniqueID><ISSNLinking>0959-8049</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005705" MajorTopicYN="Y">Gallbladder Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002763" MajorTopicYN="N">Cholecystectomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult</Keyword><Keyword MajorTopicYN="N">Biliary Tract Neoplasms</Keyword><Keyword MajorTopicYN="N">Cholecystectomy</Keyword><Keyword MajorTopicYN="N">Cholelithiasis</Keyword><Keyword MajorTopicYN="N">Cohort Studies</Keyword><Keyword MajorTopicYN="N">Duodenal Neoplasms</Keyword><Keyword MajorTopicYN="N">Humans</Keyword><Keyword MajorTopicYN="N">Liver Neoplasms</Keyword><Keyword MajorTopicYN="N">Pancreatic Neoplasms</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jonas F. Ludvigsson has coordinated an unrelated study on behalf of the Swedish IBD quality register (SWIBREG) that received funding from Janssen corporation, received financial support from MSD developing a paper reviewing national healthcare registers in China, and has an ongoing research collaboration on celiac disease with Takeda. The other authors declare no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>18</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>23</Day><Hour>18</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39579639</ArticleId><ArticleId IdType="doi">10.1016/j.ejca.2024.115140</ArticleId><ArticleId IdType="pii">S0959-8049(24)01747-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38943300</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1119-3077</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Nigerian journal of clinical practice</Title><ISOAbbreviation>Niger J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Low Pressure versus Standard Pressure Pneumoperitoneum in Laparoscopic Appendectomy: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>754</StartPage><EndPage>758</EndPage><MedlinePgn>754-758</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/njcp.njcp_802_23</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The creation of pneumoperitoneum using higher pressure is believed to be associated with increased postoperative abdominal pain.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This study aimed to compare postoperative abdominal pain following low pressure laparoscopic appendectomy and standard pressure laparoscopic appendectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective, double-blind, randomized controlled trial of 54 patients aged between 18 and 56 years with clinical and/or radiologic diagnosis of acute appendicitis. The patients were randomly allocated to two groups: low pressure laparoscopic appendectomy (n = 26) and standard pressure laparoscopic appendectomy (n = 28). The intra-abdominal pressure was kept in either low pressure (9 mm Hg) or standard pressure (13 mm Hg). Abdominal and shoulder pain scores were assessed using the visual analog scale at 6 hours and 3 days post procedure. Postoperative analgesia requirement, duration of surgery, complications, and hospital stay were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both groups match for the demographic parameters. Three patients required conversion from low to standard pressure. There was no difference between the two groups in terms of abdominal pain (P = 0.86) and shoulder pain (P = 0.33), duration of surgery (P = 0.51), complications (P = 0.17), and length of hospital stay (P = 0.83).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of low pressure pneumoperitoneum did not reduce the incidence of abdominal pain in patients who had laparoscopic appendectomy. Patients with acute appendicitis can be treated with either low or normal pressure pneumoperitoneum depending on the experience of the surgeon.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Copyright: &#xa9; 2024 Nigerian Journal of Clinical Practice.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adenuga</LastName><ForeName>A T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cedarcrest Hospitals, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olakada</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical Student, College of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cedarcrest Hospitals, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aniero</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cedarcrest Hospitals, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Niger J Clin Pract</MedlineTA><NlmUniqueID>101150032</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001062" MajorTopicYN="Y">Appendectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011028" MajorTopicYN="Y">Pneumoperitoneum, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001064" MajorTopicYN="Y">Appendicitis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="Y">Pain, Postoperative</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015746" MajorTopicYN="N">Abdominal Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>2</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38943300</ArticleId><ArticleId IdType="doi">10.4103/njcp.njcp_802_23</ArticleId><ArticleId IdType="pii">01253091-202406000-00010</ArticleId></ArticleIdList><ReferenceList><Title>R EFERENCES</Title><Reference><Citation>Alfa-Wali M, Osaghae S. Practice, training and safety of laparoscopic surgery in low and middle-income countries. World J Gastrointest Surg 2017;9:13&#x2013;7.</Citation></Reference><Reference><Citation>Balogun OS, Osinowo AO, Olajide TO, Lawal AO, Adesanya AA, Atoyebi OA, et al. Development and practice of laparoscopic surgery in a Nigerian tertiary hospital. Niger J Clin Pract 2020;23:1368&#x2013;74.</Citation></Reference><Reference><Citation>Adisa AO, Alatise OI, Arowolo OA, Lawal OO. Laparoscopic appendectomy in a nigerian teaching hospital. JSLS 2012;16:576&#x2013;9.</Citation></Reference><Reference><Citation>Ortenzi M, Montori G, Sartori A, Balla A, Botteri E, Piatto G, et al. Low-pressure versus standard-pressure pneumoperitoneum in laparoscopic cholecystectomy: A systematic review and meta-analysis of randomized controlled trials. Surg Endosc 2022;36:7092&#x2013;113.</Citation></Reference><Reference><Citation>&#xd6;zdemir-van Brunschot DMD, van Laarhoven KCJHM, Scheffer GJ, Pouwels S, Wever KE, Warl&#xe9; MC. What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review. Surg Endosc 2016;30:2049&#x2013;65.</Citation></Reference><Reference><Citation>Neudecker J, Sauerland S, Neugebauer E, Bergamaschi R, Bonjer HJ, Cuschieri A, et al. The european association for endoscopic surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery. Surg Endosc 2002;16:1121&#x2013;43.</Citation></Reference><Reference><Citation>Berbero&#x1e7;lu M, Dilek ON, Ercan F, Kati I, &#xd6;zmen M. The effect of CO2 insufflation rate on the postlaparoscopic shoulder pain. J Laparoendosc Adv Surg Tech A 1998;8:273&#x2013;7.</Citation></Reference><Reference><Citation>Yasir M, Mehta KS, Banday VH, Aiman A, Masood I, Iqbal B. Evaluation of post operative shoulder tip pain in low pressure versus standard pressure pneumoperitoneum during laparoscopic cholecystectomy. Surgeon 2012;10:71&#x2013;4.</Citation></Reference><Reference><Citation>Sen S, Morrison B, O&#x2019;Rourke K, Jones C. Analgesia for enhanced recovery after surgery in laparoscopic surgery. Dig Med Res 2019;2:25&#x2013;9.</Citation></Reference><Reference><Citation>Lehr R. Sixteen S-Squared Over D-Squared : A relation for crude sample size estimates. Stat Med 1992;11:1099&#x2013;102.</Citation></Reference><Reference><Citation>Cristiano I. Lessons in biostatistics understanding the effect size and its measures. Biochem Medica 2016;26:150&#x2013;63.</Citation></Reference><Reference><Citation>Barczy&#x144;ski M, Herman RM. A prospective randomized trial on comparison of low-pressure (LP) and standard-pressure (SP) pneumoperitoneum for laparoscopic cholecystectomy. Surg Endosc 2003;17:533&#x2013;8.</Citation></Reference><Reference><Citation>Chok KS, Yuen WK, Lau H, Fan ST. Prospective randomized trial on low-pressure versus standard-pressure pneumoperitoneum in outpatient laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech 2006;16:383&#x2013;6.</Citation></Reference><Reference><Citation>Sandhu T, Yamada S, Ariyakachon V, Chakrabandhu T, Chongruksut W, Ko-Iam W. Low-pressure pneumoperitoneum versus standard pneumoperitoneum in laparoscopic cholecystectomy, a prospective randomized clinical trial. Surg Endosc 2009;23:1044&#x2013;7.</Citation></Reference><Reference><Citation>Gurusamy KS, Vaughan J, Davidson BR. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014;2014:CD006930.</Citation></Reference><Reference><Citation>Gin E, Lowen D, Tacey M, Hodgson R. Reduced laparoscopic intra-abdominal pressure during laparoscopic cholecystectomy and its effect on post-operative pain: A double-blinded randomised control trial. J Gastrointest Surg 2021;25:2806&#x2013;13.</Citation></Reference><Reference><Citation>Mishra A, Bains L, Jesudin G, Aruparayil N, Singh R, Shashi. Evaluation of gasless laparoscopy as a tool for minimal access surgery in low-to middle-income countries: A Phase II noninferiority randomized controlled study. J Am Coll Surg 2020;231:511&#x2013;9.</Citation></Reference><Reference><Citation>Binda MM. Humidification during laparoscopic surgery: Overview of the clinical benefits of using humidified gas during laparoscopic surgery. Arch Gynecol Obstet 2015;292:955&#x2013;71.</Citation></Reference><Reference><Citation>Mixter CG, Meeker LD, Gavin TJ. Preemptive pain control in patients having laparoscopic hernia repair: A comparison of ketorolac and ibuprofen. Arch Surg 1998;133:432&#x2013;7.</Citation></Reference><Reference><Citation>Cunniffe MG, McAnena OJ, Dar MA, Calleary J, Flynn N. A prospective randomized trial of intraoperative bupivacaine irrigation for management of shoulder-tip pain following laparoscopy. Am J Surg 1998;176:258&#x2013;61.</Citation></Reference><Reference><Citation>Jackson S, Laurence A, Hill J. Does post-laparoscopy pain relate to residual carbon dioxide? Anaesthesia 1996;51:485&#x2013;7.</Citation></Reference><Reference><Citation>Rahimzadeh P, Faiz SHR, Latifi-Naibin K, Alimian M. A comparison of effect of preemptive versus postoperative use of ultrasound-guided bilateral transversus abdominis plane (TAP) block on pain relief after laparoscopic cholecystectomy. Sci Rep 2022;12:623.</Citation></Reference><Reference><Citation>Nasajiyan N, Javaherfourosh F, Ghomeishi A, Akhondzadeh R, Pazyar F, Hamoonpou N. Comparison of low and standard pressure gas injection at abdominal cavity on postoperative nausea and vomiting in laparoscopic cholecystectomy. Pakistan J Med Sci 2014;30:1083&#x2013;7.</Citation></Reference><Reference><Citation>Joshipura VP, Haribhakti SP, Patel NR, Naik RP, Soni HN, Patel B, et al. A prospective randomized, controlled study comparing low pressure versus high pressure pneumoperitoneum during laparoscopic cholecystectomy. Surg Laparosc Endosc Percutaneous Tech 2009;19:234&#x2013;40.</Citation></Reference><Reference><Citation>Warl&#xe9; MC, Berkers AW, Langenhuijsen JF, van der Jagt MF, Dooper PM, Kloke HJ, et al. Low-pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize live donors&#x2019; comfort. Clin Transplant 2013;27:E478&#x2013;83.</Citation></Reference><Reference><Citation>Kyle EB, Maheux-Lacroix S, Boutin A, Laberge PY, Lemyre M. Low vs standard pressures in gynecologic laparoscopy: A systematic review. JSLS 2016;20:e2015.00113.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37486144</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2091</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of antimicrobial chemotherapy</Title><ISOAbbreviation>J Antimicrob Chemother</ISOAbbreviation></Journal><ArticleTitle>Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study.</ArticleTitle><Pagination><StartPage>2217</StartPage><EndPage>2227</EndPage><MedlinePgn>2217-2227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkad227</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To investigate complication rates of acute sinusitis in general practice, and whether antibiotic prescribing had an impact on complication rate.</AbstractText><AbstractText Label="METHODS">All adult patients diagnosed with sinusitis in Norwegian general practice between 1 July 2012 and 30 June 2019 were included. GP consultation data from the Norwegian Control and Payment for Health Reimbursements Database were linked with antibiotic prescriptions (Norwegian Prescription Database) and hospital admissions (Norwegian Patient Registry). Main outcomes were sinusitis-related hospitalizations and severe complications within 30 days. Logistic regression was used to estimate associations between antibiotic prescriptions, prespecified risk factors, individual GP prescribing quintile, and outcomes.</AbstractText><AbstractText Label="RESULTS">A total of 711&#x200a;069 episodes of acute sinusitis in 415&#x200a;781 patients were identified. During the study period, both annual episode rate (from 30.2 to 21.2 per 1000 inhabitants) and antibiotic prescription rate (63.3% to 46.5%; P&#x200a;&lt;&#x200a;0.001) decreased. Yearly hospitalization rate was stable at 10.0 cases per 10&#x200a;000 sinusitis episodes and the corresponding rate of severe complications was 3.2, with no yearly change (P&#x200a;=&#x200a;0.765). Antibiotic prescribing was associated with increased risk of hospitalization [adjusted OR 1.8 (95% CI 1.5-2.1)] but not with severe complications. Individual GP prescribing quintile was not associated with any of the outcomes, whereas risk factors such as previous drug abuse, or head injury, skull surgery or malformations, and being immunocompromised were significantly associated with increased risk of both outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">Severe complications of acute sinusitis were rare and no protective effect of high prescribing practice among GPs was found. Recommendations to further reduce antibiotic prescribing are generally encouraged, except for high-risk groups.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skow</LastName><ForeName>Marius</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0489-1985</Identifier><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fossum</LastName><ForeName>Guro H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf8;ye</LastName><ForeName>Sigurd</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straand</LastName><ForeName>J&#xf8;rund</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe6;nd</LastName><ForeName>Anja Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emilsson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>V&#xe5;rdcentralen V&#xe4;rmlands Nys&#xe4;ter and Centre for Clinical Research, County Council of V&#xe4;rmland, Varmlands Nysater, Karlstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Science, University of &#xd6;rebro, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Antimicrob Chemother</MedlineTA><NlmUniqueID>7513617</NlmUniqueID><ISSNLinking>0305-7453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012852" MajorTopicYN="Y">Sinusitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058006" MajorTopicYN="Y">General Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>9</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37486144</ArticleId><ArticleId IdType="pmc">PMC10477136</ArticleId><ArticleId IdType="doi">10.1093/jac/dkad227</ArticleId><ArticleId IdType="pii">7229916</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fokkens WJ, Lund VJ, Hopkins Cet al. . European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020; 58 Suppl S29: 1&#x2013;464. 10.4193/Rhin20.600</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.600</ArticleId><ArticleId IdType="pubmed">32077450</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;ye S, Frich J, Lindb&#x153;k M. Delayed prescribing for upper respiratory tract infections: a qualitative study of GPs&#x2019; views and experiences. Br J Gen Pract 2010; 60: 907&#x2013;12. 10.3399/bjgp10X544087</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp10X544087</ArticleId><ArticleId IdType="pmc">PMC2991744</ArticleId><ArticleId IdType="pubmed">21144201</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada T, Hoogland J, Hansen JGet al. . Diagnostic prediction models for CT-confirmed and bacterial rhinosinusitis in primary care: individual participant data meta-analysis. Br J Gen Pract 2022; 72: e601&#x2013;e8. 10.3399/BJGP.2021.0585</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0585</ArticleId><ArticleId IdType="pmc">PMC9282805</ArticleId><ArticleId IdType="pubmed">35817585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemiengre MB, van Driel ML, Merenstein Det al. . Antibiotics for acute rhinosinusitis in adults. Cochrane Database Syst Rev 2018; issue 9: CD006089. 10.1002/14651858.CD006089.pub5</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006089.pub5</ArticleId><ArticleId IdType="pmc">PMC6513448</ArticleId><ArticleId IdType="pubmed">30198548</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaume F, Quint&#xf3; L, Alobid Iet al. . Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open 2018; 8: e018788. 10.1136/bmjopen-2017-018788</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-018788</ArticleId><ArticleId IdType="pmc">PMC5878244</ArticleId><ArticleId IdType="pubmed">29391364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouwels KB, Dolk FCK, Smith DRMet al. . Actual versus &#x2018;ideal&#x2019; antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother 2018; 73: 19&#x2013;26. 10.1093/jac/dkx502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkx502</ArticleId><ArticleId IdType="pmc">PMC5890776</ArticleId><ArticleId IdType="pubmed">29490060</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bodegraven B, Palin V, Mistry Cet al. . Infection-related complications after common infection in association with new antibiotic prescribing in primary care: retrospective cohort study using linked electronic health records. BMJ Open 2021; 11: e041218. 10.1136/bmjopen-2020-041218</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041218</ArticleId><ArticleId IdType="pmc">PMC7813359</ArticleId><ArticleId IdType="pubmed">33452190</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharbi M, Drysdale JH, Lishman Het al. . Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ 2019; 364: l525. 10.1136/bmj.l525</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l525</ArticleId><ArticleId IdType="pmc">PMC6391656</ArticleId><ArticleId IdType="pubmed">30814048</ArticleId></ArticleIdList></Reference><Reference><Citation>Skow M, Fossum GH, H&#xf8;ye Set al. . Antibiotic treatment of respiratory tract infections in adults in Norwegian general practice. JAC Antimicrobial Resist 2023; 5: dlac135. 10.1093/jacamr/dlac135</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jacamr/dlac135</ArticleId><ArticleId IdType="pmc">PMC9825809</ArticleId><ArticleId IdType="pubmed">36632357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen FS, Hoffmans R, Georgalas Cet al. . Complications of acute rhinosinusitis in The Netherlands. Fam Pract 2012; 29: 147&#x2013;53. 10.1093/fampra/cmr062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmr062</ArticleId><ArticleId IdType="pubmed">21896505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair CF, Berkowitz RG. Prior antibiotic therapy for acute sinusitis in children and the development of subperiosteal orbital abscess. Int J Pediatr Otorhi 2007; 71: 1003&#x2013;6. 10.1016/j.ijporl.2007.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2007.02.013</ArticleId><ArticleId IdType="pubmed">17481738</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Johnson AM, Islam Aet al. . Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK general practice research database. BMJ 2007; 335: 982. 10.1136/bmj.39345.405243.BE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39345.405243.BE</ArticleId><ArticleId IdType="pmc">PMC2072032</ArticleId><ArticleId IdType="pubmed">17947744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushen R, Francis NA. Antibiotic use and serious complications following acute otitis media and acute sinusitis: a retrospective cohort study. Br J Gen Pract 2020; 70: e255&#x2013;e63. 10.3399/bjgp20X708821</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp20X708821</ArticleId><ArticleId IdType="pmc">PMC7065682</ArticleId><ArticleId IdType="pubmed">32152042</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . International Classification of Primary Care, 2nd edition (ICPC-2). 2003.https://www.who.int/standards/classifications/other-classifications/international-classification-of-primary-care.</Citation></Reference><Reference><Citation>
WHO Collaborating Centre for Drug Statistics Methodology . ATC/DDD Index. https://www.whocc.no/atc_ddd_index/.</Citation></Reference><Reference><Citation>
Norwegian Directorate of Health . National Guidelines for Antibiotics in Primary Health Care. https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-primaerhelsetjenesten/infeksjoner-i-ovre-luftveier#akutt-sinusitt.</Citation></Reference><Reference><Citation>
ECDC . Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report 2021. 2022.https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2021.</Citation></Reference><Reference><Citation>Walle-Hansen MM, H&#xf8;ye S. Geographic variation in antibiotic consumption&#x2014;is it due to doctors&#x2019; prescribing or patients&#x2019; consulting? Antibiotics (Basel) 2018; 7: 26. 10.3390/antibiotics7010026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics7010026</ArticleId><ArticleId IdType="pmc">PMC5872137</ArticleId><ArticleId IdType="pubmed">29558417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjelstad S, H&#xf8;ye S, Straand Jet al. . Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ 2013; 347: f4403. 10.1136/bmj.f4403</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f4403</ArticleId><ArticleId IdType="pmc">PMC3724398</ArticleId><ArticleId IdType="pubmed">23894178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sideris G, Davoutis E, Panagoulis Eet al. . A systematic review of intracranial complications in adults with Pott puffy tumor over four decades. Brain Sci 2023; 13: 587. 10.3390/brainsci13040587</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13040587</ArticleId><ArticleId IdType="pmc">PMC10137007</ArticleId><ArticleId IdType="pubmed">37190552</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayman GL, Adams GL, Paugh DRet al. . Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope 1991; 101: 234&#x2013;9. 10.1288/00005537-199103000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-199103000-00003</ArticleId><ArticleId IdType="pubmed">2000009</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll D, Klossek JM, Barbaza MO. Prospective study of 43 severe complications of acute rhinosinusitis. Rev Laryngol Otol Rhinol (Bord) 2006; 127: 195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">17315782</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaiyasate S, Fooanant S, Navacharoen Net al. . The complications of sinusitis in a tertiary care hospital: types, patient characteristics, and outcomes. Int J Otolaryngol 2015; 2015: 709302. 10.1155/2015/709302</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/709302</ArticleId><ArticleId IdType="pmc">PMC4333333</ArticleId><ArticleId IdType="pubmed">25722725</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge RW, Story A, Hwang SWet al. . Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet 2018; 391: 241&#x2013;50. 10.1016/S0140-6736(17)31869-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31869-X</ArticleId><ArticleId IdType="pmc">PMC5803132</ArticleId><ArticleId IdType="pubmed">29137869</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy NL, Baggs J, See Iet al. . Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012&#x2013;2017. Clin Infect Dis 2020; 71: e37&#x2013;44. 10.1093/cid/ciaa008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa008</ArticleId><ArticleId IdType="pmc">PMC7900878</ArticleId><ArticleId IdType="pubmed">31907515</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinkenberg J, Hetlevik &#xd8;, Sandvik Het al. . Reasons for acute referrals to hospital from general practitioners and out-of-hours doctors in Norway: a registry-based observational study. BMC Health Serv Res 2022; 22: 78. 10.1186/s12913-021-07444-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-07444-7</ArticleId><ArticleId IdType="pmc">PMC8761320</ArticleId><ArticleId IdType="pubmed">35033069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Moore MV, Little Pet al. . Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. BMJ 2016; 354: i3410. 10.1136/bmj.i3410</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i3410</ArticleId><ArticleId IdType="pmc">PMC4933936</ArticleId><ArticleId IdType="pubmed">27378578</ArticleId></ArticleIdList></Reference><Reference><Citation>
Norwegian Ministry of Health and Care Services . National Strategy against Antibiotic Resistance 2015&#x2013;2020. 2015.https://www.regjeringen.no/contentassets/5eaf66ac392143b3b2054aed90b85210/antibiotic-resistance-engelsk-lavopploslig-versjon-for-nett-10-09-15.pdf.</Citation></Reference><Reference><Citation>Cars T, Eriksson I, Granath Aet al. . Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study. BMJ Open 2017; 7: e016221. 10.1136/bmjopen-2017-016221</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016221</ArticleId><ArticleId IdType="pmc">PMC5695332</ArticleId><ArticleId IdType="pubmed">29146635</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman C, Svensson M, Schmidt Iet al. . Reduced dispensing of prescribed antibiotics during the COVID-19 pandemic has not increased severe complications from common infections. BMC Public Health 2022; 22: 252. 10.1186/s12889-022-12692-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-12692-1</ArticleId><ArticleId IdType="pmc">PMC8822723</ArticleId><ArticleId IdType="pubmed">35135517</ArticleId></ArticleIdList></Reference><Reference><Citation>Babar-Craig H, Gupta Y, Lund VJ. British Rhinological Society audit of the role of antibiotics in complications of acute rhinosinusitis: a national prospective audit. Rhinology 2010; 48: 344&#x2013;7. 10.4193/Rhino09.130</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino09.130</ArticleId><ArticleId IdType="pubmed">21038027</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mograbi A, Ritter A, Najjar Eet al. . Orbital complications of rhinosinusitis in the adult population: analysis of cases presenting to a tertiary medical center over a 13-year period. Ann Otol Rhinol Laryngol 2019; 128: 563&#x2013;8. 10.1177/0003489419832624</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489419832624</ArticleId><ArticleId IdType="pubmed">30788974</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl&#xe9;n E, Collin J, Hellman Jet al. . The effect of absent or deferred antibiotic treatment on complications of common infections in primary care. Int J Infect Dis 2022; 124: 181&#x2013;6. 10.1016/j.ijid.2022.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.036</ArticleId><ArticleId IdType="pubmed">36209977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronberg O, Tyrstrup M, Ekblom Ket al. . Diagnosis-linked antibiotic prescribing in Swedish primary care - a comparison between in-hours and out-of-hours. BMC Infect Dis 2020; 20: 616. 10.1186/s12879-020-05334-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05334-7</ArticleId><ArticleId IdType="pmc">PMC7441551</ArticleId><ArticleId IdType="pubmed">32819280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Finley R, Weese Set al. . Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007&#x2013;2013. PLoS One 2017; 12: e0181957. 10.1371/journal.pone.0181957</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181957</ArticleId><ArticleId IdType="pmc">PMC5531515</ArticleId><ArticleId IdType="pubmed">28750020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouwels KB, Dolk FCK, Smith DRMet al. . Explaining variation in antibiotic prescribing between general practices in the UK. J Antimicrob Chemother 2018; 73: ii27&#x2013;35. 10.1093/jac/dkx501</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkx501</ArticleId><ArticleId IdType="pmc">PMC5890680</ArticleId><ArticleId IdType="pubmed">29490059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjelstad S, Straand J, Dalen Iet al. . Do general practitioners&#x2019; consultation rates influence their prescribing patterns of antibiotics for acute respiratory tract infections? J Antimicrob Chemother 2011; 66: 2425&#x2013;33. 10.1093/jac/dkr295</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkr295</ArticleId><ArticleId IdType="pubmed">21784782</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthrie I, Malcolm W, Nogueira Ret al. . Associations between declining antibiotic use in primary care in Scotland and hospitalization with infection and patient satisfaction: longitudinal population study. J Antimicrob Chemother 2022; 77: 2561&#x2013;8. 10.1093/jac/dkac191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkac191</ArticleId><ArticleId IdType="pmc">PMC9410667</ArticleId><ArticleId IdType="pubmed">35748617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Sun X, Charlton Jet al. . Serious bacterial infections and antibiotic prescribing in primary care: cohort study using electronic health records in the UK. BMJ Open 2020; 10: e036975. 10.1136/bmjopen-2020-</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-</ArticleId><ArticleId IdType="pmc">PMC7050314</ArticleId><ArticleId IdType="pubmed">32114481</ArticleId></ArticleIdList></Reference><Reference><Citation>
NORM/NORM-VET 2021 . Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. 2022.https://www.fhi.no/contentassets/c183b18ccc4a4005a6b9cfae28c97351/norm-norm-vet-2021.pdf.</Citation></Reference><Reference><Citation>
Norwegian Directorate of Health . Regular General Practitioner statistics: developmental trends and changes in the Regular General Practice Scheme (in Norwegian). https://www.helsedirektoratet.no/statistikk/fastlegestatistikk.</Citation></Reference><Reference><Citation>van Walraven C, Austin P. Administrative database research has unique characteristics that can risk biased results. J Clin Epidemiol 2012; 65: 126&#x2013;31. 10.1016/j.jclinepi.2011.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.08.002</ArticleId><ArticleId IdType="pubmed">22075111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sporaland GL, Mouland G, Bratland Bet al. . General practitioners&#x2019; use of ICPC diagnoses and their correspondence with patient record notes. Tidsskr Nor Laegeforen 2019; 139: 1468&#x2013;72. 10.4045/tidsskr.18.0440</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.18.0440</ArticleId><ArticleId IdType="pubmed">31642635</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38109996</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-9333</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>American journal of obstetrics &amp; gynecology MFM</Title><ISOAbbreviation>Am J Obstet Gynecol MFM</ISOAbbreviation></Journal><ArticleTitle>Use of cell salvage at the time of cesarean delivery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>101257</StartPage><MedlinePgn>101257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajogmf.2023.101257</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2589-9333(23)00399-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Excess blood loss from obstetrical hemorrhage requires transfusion of donor blood, a finite resource. Intraoperative cell salvage collects a patient's own blood that has been lost during cesarean delivery and returns it to their own circulation. We performed a meta-analysis to examine the perioperative outcomes in patients receiving cell salvage at the time of cesarean delivery.</AbstractText><AbstractText Label="DATA SOURCES">Scopus, PubMed, Cochrane Central Register of Controlled Trials, Ovid Medline, and clinicaltrials.gov were searched from database inception through October 2023.</AbstractText><AbstractText Label="STUDY ELIGIBILITY CRITERIA">Eligible studies included randomized controlled trials comparing the use of cell salvage to standard-of-care during cesarean delivery.</AbstractText><AbstractText Label="METHODS">Two authors independently extracted data. Preferred Reporting Items of Systematic Reviews and Meta-Analysis guidelines were used for data extraction and quality assessment. The primary outcomes were the rate of donor blood transfusion and change in hemoglobin level. The secondary outcomes included transfusion reaction, amniotic fluid embolism, and length of hospital stay. Results were summarized as weighted mean difference or risk ratio with associated 95% confidence intervals. Heterogeneity was measured using Higgins I<sup>2</sup>.</AbstractText><AbstractText Label="RESULTS">A total of 5 randomized controlled trials (n=3361) comparing cell salvage to standard care during cesarean delivery met the inclusion criteria. Primary analysis showed a significant decrease in receiving allogeneic blood transfusion with intraoperative cell salvage use vs standard care (odds ratio, 0.32; 95% confidence interval, 0.23-0.46), with no change in hemoglobin drop (mean difference, -0.77; 95% confidence interval, -1.67 to -0.14). The secondary outcomes showed no difference in transfusion reaction (odds ratio, 0.56; 95% confidence interval, 0.06-5.59), and length of hospital stay (mean difference, -1.90; 95% confidence interval, -4.85 to 1.06). No cases of amniotic fluid embolism were reported among the 1685 patients who received cell salvage.</AbstractText><AbstractText Label="CONCLUSION">Use of cell salvage during cesarean delivery reduced the overall need for allogeneic blood transfusion without increasing the risk of complications, including no cases of amniotic fluid embolism.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Neel S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA. Electronic address: neel.iyer@jefferson.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanuja</LastName><ForeName>Kavisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Kouatly</LastName><ForeName>Huda B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Obstet Gynecol MFM</MedlineTA><NlmUniqueID>101746609</NlmUniqueID><ISSNLinking>2589-9333</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057725" MajorTopicYN="Y">Operative Blood Salvage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006473" MajorTopicYN="N">Postpartum Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autologous transfusion</Keyword><Keyword MajorTopicYN="N">cell salvage</Keyword><Keyword MajorTopicYN="N">cesarean delivery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38109996</ArticleId><ArticleId IdType="doi">10.1016/j.ajogmf.2023.101257</ArticleId><ArticleId IdType="pii">S2589-9333(23)00399-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28282766</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4954</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title><ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation></Journal><ArticleTitle>Risk factors for fatality in amniotic fluid embolism: a systematic review and analysis of a data pool.</ArticleTitle><Pagination><StartPage>661</StartPage><EndPage>665</EndPage><MedlinePgn>661-665</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2017.1293034</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Investigating risk factors for amniotic fluid embolism (AFE)-induced fatality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of cases of AFE available on PubMed, Scielo, Scopus and AJOL databases that occurred from 1990 to 2015 was carried out. After careful reading of titles, abstracts and full texts, case reports of AFE were reviewed. Risk factors for AFE were considered as independent variables in logistic regression models. The first model was built on the whole data pool. The second model was built on typical cases of AFE, according to the classical triad of symptoms (heart, lungs, coagulopathy). The dependent variable was fatality in both models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">177 cases of AFE were assessed in the first model, while 121 typical cases of AFE were assessed in the second model. Among typical cases of AFE, only oxytocin infusion during labour increases the likelihood of death (odds ratio 2.890, 95% confidence interval 1.166-7.164, p&#x2009;=&#x2009;0.022). No risk factors for fatality were found in the whole data pool.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further research on national registries should focus on the behaviour of oxytocin infusion during labour in AFE cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Indraccolo</LastName><ForeName>Ugo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>a Complex Operative Unit of Obstetrics and Gynecology , "Alto Tevere" Hospital of Citt&#xe0; di Castello, ASL 1 Umbria , Citt&#xe0; di Castello , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battistoni</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>b Department of Gynecological, Obstetrical, and Urological Sciences , "Sapienza" University of Rome , Rome , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastrantonio</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>b Department of Gynecological, Obstetrical, and Urological Sciences , "Sapienza" University of Rome , Rome , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Iorio</LastName><ForeName>Romolo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>c Department of Surgical and Clinical Sciences and Translational Medicine , "Sapienza" University of Rome , Rome , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Pantaleo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>d Department of Morphology, Surgery and Experimental Medicine , University of Ferrara , Ferrara , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indraccolo</LastName><ForeName>Salvatore Renato</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>b Department of Gynecological, Obstetrical, and Urological Sciences , "Sapienza" University of Rome , Rome , Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Matern Fetal Neonatal Med</MedlineTA><NlmUniqueID>101136916</NlmUniqueID><ISSNLinking>1476-4954</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amniotic fluid embolism</Keyword><Keyword MajorTopicYN="N">delivery</Keyword><Keyword MajorTopicYN="N">labour induction</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">oxytocin infusion</Keyword><Keyword MajorTopicYN="N">pregnancy complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28282766</ArticleId><ArticleId IdType="doi">10.1080/14767058.2017.1293034</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29166810</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4954</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title><ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation></Journal><ArticleTitle>Anesthetic management of amniotic fluid embolism -- a multi-center, retrospective, cohort study.</ArticleTitle><Pagination><StartPage>1262</StartPage><EndPage>1266</EndPage><MedlinePgn>1262-1266</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2017.1404024</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Amniotic fluid embolism (AFE) is a rare and potentially lethal obstetric complication, commonly occurring during labor, delivery, or immediately postpartum. There is a paucity of data regarding incidence, risk factors, and clinical management. Our primary objective in this study was to evaluate clinical presentation of AFE and delineate anesthesia management of these cases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This 10 years retrospective multi-center cohort study was performed in five tertiary university-affiliated medical centers, between the years 2005 and 2015. All documented cases of AFE identified according to the ICD guidelines were reviewed manually to determine eligibility for AFE according to Clark's criteria. All cases confirming Clark's diagnosis were included in the cohort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Throughout the study period, 20 cases of AFE were identified, with an incidence of 4.1 per 100,000 births. Average age at presentation was 35&#x2009;&#xb1;&#x2009;5 years. Seventy percent of cases presented during vaginal delivery, 20% occurred throughout a cesarean delivery, and 10% occurred during a dilation and evacuation procedure. The most common presenting symptom was sudden loss of consciousness in 12 parturients (66.7%), fetal bradycardia in 11 parturients (55%), and shortness of breath in 10 parturients (50%). Perimortem cesarean section was performed in 55% of cases, although only one case was performed in the delivery suite, while all others were performed in the operating room. Echocardiography was performed in 60% of the cases and all were pathological. Furthermore, 20% of cases were connected to an extracorporeal membrane oxygenation machine. There was a 15% mortality rate of 15%. A further 15% suffered major neurological disability, 25% suffered minor neurological morbidity, and 45% survived without severe complications.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AFE is associated with significant maternal morbidity. This study highlights the importance of providing advanced training for the delivery suite staff for cases of maternal cardiovascular collapse secondary to AFE and increasing awareness for this rare and devastating obstetric condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skolnik</LastName><ForeName>Shiri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Anesthesia, and Sackler Faculty of Medicine , Rabin Medical Center, Beilinson Hospital, Petach Tikvah Israel, Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioscovich</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>b Department of Anesthesia , Shaare Zedek Medical Center, Hebrew University of Jerusalem , Jerusalem , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eidelman</LastName><ForeName>Leonid A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>a Department of Anesthesia, and Sackler Faculty of Medicine , Rabin Medical Center, Beilinson Hospital, Petach Tikvah Israel, Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Atara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Department of Anesthesia, and Sackler Faculty of Medicine , Rabin Medical Center, Beilinson Hospital, Petach Tikvah Israel, Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shmueli</LastName><ForeName>Anat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>c Department of Obstetrics and Gynecology, and Sackler Faculty of Medicine , Rabin Medical Center, Beilinson Hospital, Petach Tikvah Israel, Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aviram</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>d Lis Maternity and Women's Hospital, Tel Aviv Sourasky Medical Center , Sackler Faculty of Medicine , Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orbach-Zinger</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Anesthesia, and Sackler Faculty of Medicine , Rabin Medical Center, Beilinson Hospital, Petach Tikvah Israel, Tel Aviv University , Tel Aviv , Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Matern Fetal Neonatal Med</MedlineTA><NlmUniqueID>101136916</NlmUniqueID><ISSNLinking>1476-4954</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Matern Fetal Neonatal Med. 2019 Sep;32(17):2953. doi: 10.1080/14767058.2017.1414742.</RefSource><PMID Version="1">29228841</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000773" MajorTopicYN="N">Anesthesia, Obstetrical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036861" MajorTopicYN="N">Delivery, Obstetric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005315" MajorTopicYN="N">Fetal Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007743" MajorTopicYN="N">Labor, Obstetric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007744" MajorTopicYN="N">Obstetric Labor Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011644" MajorTopicYN="N">Puerperal Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014474" MajorTopicYN="N">Unconsciousness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amniotic fluid</Keyword><Keyword MajorTopicYN="N">embolism</Keyword><Keyword MajorTopicYN="N">maternal morbidity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29166810</ArticleId><ArticleId IdType="doi">10.1080/14767058.2017.1404024</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39735018</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Risk Factors and Outcomes of Acute Pulmonary Embolism in African Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>e74673</StartPage><MedlinePgn>e74673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e74673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.74673</ELocationID><Abstract><AbstractText>Pulmonary embolism is a common cause of morbidity and mortality. Numerous risk factors have been identified that predispose patients to this disease. This study aims to identify these risk factors and the possible outcomes (recovery or mortality) after receiving treatment from any hospital. Healthcare is expensive in Africa, hence hindering its easy accessibility.&#xa0; PubMed, Scopus, and African Journals Online were searched from the database inception to October 2024 to identify relevant studies. A total of 719 articles were identified, for which 172 duplicate articles were removed. After screening 592 articles by title and abstract, 508 were excluded. Eighty-four articles were screened by full text to determine their eligibility. Finally, 13 articles were used in the final qualitative analysis. We included original research published in English in peer-reviewed journals from January 2000 to September 2024 that reported the risk factors and outcomes of pulmonary embolism, and studies that used computed tomography pulmonary angiography as a diagnosis of acute pulmonary embolism in patients more than 18 years old, irrespective of gender and medical or surgical condition, managed in any African hospital, were included. In total, 7650 patients were included in 13 articles, from 10 countries (Nigeria, Togo, Angola, Kenya, Cameroon, South Africa, Sierra Leone, Egypt, DR Congo, and Ethiopia), and 861 patients had pulmonary embolism. The mean age of the reported patients ranged from 40.8 to 64.4 years across the studies. There were 309 male and 552 female patients diagnosed with pulmonary embolism. The study types included in this review are retrospective studies,&#xa0;cross-sectional studies, and case-control studies. Deep vein thrombosis (DVT), heart disease, immobilization, obesity, smoking, recent surgery, and malignancy were the most commonly identified risk factors across the included articles. Pulmonary embolism contributes significantly to morbidity and mortality among African patients, with key risk factors including DVT, immobilization, heart disease, obesity, smoking, recent surgery, malignancy, pregnancy, and contraceptive use. Limited diagnostic resources in low-resource settings pose a major challenge, but adopting affordable diagnostic alternatives and clinical algorithms could improve outcomes by enabling earlier diagnosis and timely treatment. The availability and implementation of a standardized PE treatment protocol will ensure quality care, decrease mortality, and increase recovery rates.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Okeke et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okeke</LastName><ForeName>Collins C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadi</LastName><ForeName>Emmanuel S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hallel Hospital and Maternity, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebiliekwe</LastName><ForeName>Onyinye E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeocha</LastName><ForeName>Ifunanya R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nnanna Okoro</LastName><ForeName>Emeka</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Imo State University College of Medicine, Owerri, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nduji</LastName><ForeName>Oluchi J</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Abia State University, Uturu, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Undie</LastName><ForeName>Malipeh-Unim</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Surgery Interest Group of Africa, Lagos, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngige</LastName><ForeName>Onyinye</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eze-Odurukwe</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Salford Royal NHS Foundation Trust, Manchester, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezema</LastName><ForeName>Chinecherem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyeogulu</LastName><ForeName>Afamefuna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Afe Babalola University, Ado Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obuseh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Delta State University Teaching Hospital, Oghara, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okonta</LastName><ForeName>Kelechi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Unit, Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39735018</ArticleId><ArticleId IdType="pmc">PMC11681974</ArticleId><ArticleId IdType="doi">10.7759/cureus.74673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pulmonary embolism. Tarbox AK, Swaroop M. Int J Crit Illn Inj Sci. 2013;3:69&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665123</ArticleId><ArticleId IdType="pubmed">23724389</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology, pathophysiology, and natural history of pulmonary embolism. Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Semin Intervent Radiol. 2018;35:92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986574</ArticleId><ArticleId IdType="pubmed">29872243</ArticleId></ArticleIdList></Reference><Reference><Citation>Global incidence and case fatality rate of pulmonary embolism following major surgery: a protocol for a systematic review and meta-analysis of cohort studies. Temgoua MN, Tochie JN, Noubiap JJ, Agbor VN, Danwang C, Endomba FT, Nkemngu NJ. Syst Rev. 2017;6:240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5716368</ArticleId><ArticleId IdType="pubmed">29202836</ArticleId></ArticleIdList></Reference><Reference><Citation>Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: vital registration data from 123&#xa0;countries. Barco S, Valerio L, Gallo A, et al. Res Pract Thromb Haemost. 2021;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268665</ArticleId><ArticleId IdType="pubmed">34263098</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AL. Pulmonary embolism symptoms and diagnosis.  [
Oct;
2024 
]. 2024. https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-embolism/symptoms-diagnosis https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-embolism/symptoms-diagnosis</Citation></Reference><Reference><Citation>Pulmonary embolism. Essien EO, Rali P, Mathai SC. Med Clin North Am. 2019;103:549&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30955521</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary embolism (PE) clinical presentation. 2024. https://emedicine.medscape.com/article/300901-clinical https://emedicine.medscape.com/article/300901-clinical</Citation></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical appraisal tools.  [
Oct;
2024 
]. 2024. https://jbi.global/critical-appraisal-tools https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Acute pulmonary thromboembolism: a retrospective study in a Nigerian private tertiary hospital. Ogunkoya J, Oluwole A, Adefuye B, Adebola-Yusuf AO, Ehioghae O. https://www.ajol.info/index.php/ahr/article/view/226821 Ann Health Res. 2021;7:107&#x2013;117.</Citation></Reference><Reference><Citation>Pulmonary embolism at the University Hospital Campus of Lome (Togo): a retrospective study about 51 cases [Article in French] Pessinaba S, Atti YD, Baragou S, et al. Pan Afr Med J. 2017;27:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567959</ArticleId><ArticleId IdType="pubmed">28904659</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical profile, management and outcomes of patients with pulmonary embolism: a retrospective tertiary centre study in Angola. Manuel A, Aufico A, Africano R, et al.  https://pubmed.ncbi.nlm.nih.gov/28556850/ Cardiovasc J Afr. 2017;28:356&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885046</ArticleId><ArticleId IdType="pubmed">28556850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary thromboembolism in an East African tertiary referral hospital. Ogeng'o JA, Obimbo MM, Olabu BO, Gatonga PM, Ong'era D. J Thromb Thrombolysis. 2011;32:386&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">21674133</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute pulmonary embolism in the era of multi-detector CT: a reality in sub-Saharan Africa. Tambe J, Moifo B, Fongang E, Guegang E, Juimo AG. BMC Med Imaging. 2012;12:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485620</ArticleId><ArticleId IdType="pubmed">23072500</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical presentation and diagnostic work up of suspected pulmonary embolism in a district hospital emergency centre serving a high HIV/TB burden population. Bulajic B, Welzel T, Vallabh K. Afr J Emerg Med. 2019;9:134&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742596</ArticleId><ArticleId IdType="pubmed">31528531</ArticleId></ArticleIdList></Reference><Reference><Citation>The clinical features and management of pulmonary embolism at Chris Hani Baragwanath Academic Hospital. Meel S, Peter A, Menezes C. https://pmc.ncbi.nlm.nih.gov/articles/PMC8424778/ Afr J Thorac Crit Care Med. 2018;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8424778</ArticleId><ArticleId IdType="pubmed">34541509</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute pulmonary embolism in an intensive care unit setting in Sierra Leone. Russell JB, Baio S, Koroma TR, et al.  https://pubmed.ncbi.nlm.nih.gov/36260002/ West Afr J Med. 2022;39:997&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">36260002</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient characteristics and predictors of pulmonary embolism in patients infected with COVID - 19 in Upper Egypt. Hussein A, Khalaf AM, Alsharawy LA, Abdelrazek G, Shafiq Awad M. Vasc Health Risk Manag. 2023;19:201&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10084826</ArticleId><ArticleId IdType="pubmed">37050930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary embolism: epidemiological data and diagnosis in Kinshasa hospitals. Bakebe A, Kashongwe I, Mulenga C, et al. Int J Tuberc Lung Dis. 2017;21:875&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">28786795</ArticleId></ArticleIdList></Reference><Reference><Citation>The value of electrocardiography in predicting inpatient mortality in patients with acute pulmonary embolism: a cross sectional analysis. Raghubeer N, Lahri S, Hendrikse C. Afr J Emerg Med. 2024;14:65&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10899042</ArticleId><ArticleId IdType="pubmed">38425642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital survival of patients with pulmonary embolism in a country with limited resources case of the city of Kinshasa. Marc TB, Michel TP, Florence M, et al. BMC Cardiovasc Disord. 2023;23:439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10476371</ArticleId><ArticleId IdType="pubmed">37667172</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and factors associated with pulmonary embolism among RT-PCR confirmed Covid-19 patients with upfront CT pulmonary angiography in Ethiopia: a nested casecontrol study. Belayneh EK, Leulseged TW, Tarekegn TK, et al.  https://www.ajol.info/index.php/emj/article/view/249901 Ethiop Med J. 2023;61:1.</Citation></Reference><Reference><Citation>Prevalence and risk factors of pulmonary embolism in COPD patients complicated with secondary polycythemia. Li J, Xiong Y, Li S, et al. Int J Chron Obstruct Pulmon Dis. 2024;19:2371&#x2013;2385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11542496</ArticleId><ArticleId IdType="pubmed">39512997</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Arch Intern Med. 2000;160:809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective study of risk factors for pulmonary embolism in women. Goldhaber SZ, Grodstein F, Stampfer MJ, et al.  https://pubmed.ncbi.nlm.nih.gov/9039882/ JAMA. 1997;277:642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039882</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and risk factors for pulmonary embolism in the postpartum period. Morris JM, Algert CS, Roberts CL. J Thromb Haemost. 2010;8:998&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">20128859</ArticleId></ArticleIdList></Reference><Reference><Citation>Antenatal pulmonary embolism: risk factors, management and outcomes. Knight M. BJOG. 2008;115:453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">18201281</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for pulmonary embolism. The Framingham study. Goldhaber SZ, Savage DD, Garrison RJ, et al. Am J Med. 1983;74:1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">6859053</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factor and mortality in patients with pulmonary embolism combined with infectious disease. Lee GD, Ju S, Kim JY, et al. Tuberc Respir Dis (Seoul) 2020;83:157&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105430</ArticleId><ArticleId IdType="pubmed">32185917</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics, risk factors, and outcomes of acute pulmonary embolism in Asian population. Bumroongkit C, Deesomchok A, Liwsrisakun C, et al. J Clin Med. 2022;11:6954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741370</ArticleId><ArticleId IdType="pubmed">36498530</ArticleId></ArticleIdList></Reference><Reference><Citation>Outpatient treatment of pulmonary embolism with dalteparin. Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS. https://pubmed.ncbi.nlm.nih.gov/10739374/ Thromb Haemost. 2000;83:209&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739374</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. Planer D, Yanko S, Matok I, et al. CMAJ. 2023;195:0&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281204</ArticleId><ArticleId IdType="pubmed">37336568</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of interventions for intermediate to high-risk pulmonary embolism: a network meta-analysis. Ishisaka Y, Watanabe A, Fujisaki T, et al. Catheter Cardiovasc Interv. 2023;102:249&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">37269229</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of anticoagulation,&#xa0;catheter-directed thrombolysis, or systemic thrombolysis in acute&#xa0;pulmonary embolism. Zhang RS, Maqsood MH, Sharp AS, et al. JACC Cardiovasc Interv. 2023;16:2644&#x2013;2651.</Citation><ArticleIdList><ArticleId IdType="pubmed">37855802</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term mortality in patients with pulmonary embolism: results in a single-center registry. Eckelt J, Hobohm L, Merten MC, et al. Res Pract Thromb Haemost. 2023;7:100280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10439384</ArticleId><ArticleId IdType="pubmed">37601025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuberculosis and venous thromboembolism: a case series. Goncalves IM, Alves DC, Carvalho A, do Ceu Brito M, Calvario F, Duarte R. Cases J. 2009;2:9333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2804722</ArticleId><ArticleId IdType="pubmed">20066058</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of venous thromboembolism in tuberculosis patients. Ambrosetti M, Ferrarese M, Codecasa LR, Besozzi G, Sarassi A, Viggiani P, Migliori GB. Respiration. 2006;73:396.</Citation><ArticleIdList><ArticleId IdType="pubmed">16439829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuberculose (TB)  [
Nov;
2024 
]. 2024. https://www.afro.who.int/health-topics/tuberculosis-tb https://www.afro.who.int/health-topics/tuberculosis-tb</Citation></Reference><Reference><Citation>HIV/AIDS.  [
Nov;
2024 
]. 2024. https://www.afro.who.int/health-topics/hivaids https://www.afro.who.int/health-topics/hivaids</Citation></Reference><Reference><Citation>Acute pulmonary embolism in patients with HIV disease. Howling SJ, Shaw PJ, Miller RF. Sex Transm Infect. 1999;75:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758180</ArticleId><ArticleId IdType="pubmed">10448338</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolic disease in the HIV-infected patient. Malek J, Rogers R, Kufera J, Hirshon JM. Am J Emerg Med. 2011;29:278&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">20825798</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS and thrombosis: retrospective study of 131 HIV-infected patients. Saif MW, Bona R, Greenberg B. AIDS Patient Care STDS. 2001;15:311&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40662276</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Prevalence of hypertension in Africa in the last two decades: Systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">cvaf125</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvaf125</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Despite being the most common cardiovascular risk factor, the actual burden of hypertension is poorly characterized in Africa. We meta-analyzed the most extensive pooled data to determine the overall prevalence of hypertension in Africa.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Following PRISMA guidelines, we systematically searched Google Scholar, PubMed, ScienceDirect, and Web of Science databases to retrieve prevalence studies only on hypertension among Africans published between 2002 and 2023. Furthermore, we meta-analyzed the crude and age-adjusted prevalences of hypertension using a random effect model due to the expected high heterogeneity, with logit transformation of the original proportions.Seventy-eight (out of an initial 779 screened) articles with complete data were included, with a total number of hypertension cases of 71,004 and a denominator population of 286,575, mostly from community-based studies in 23 countries. The pooled crude prevalence of hypertension was 28&#x2e31;5/100 persons [95% confidence interval (CI):&#x2009;25&#x2e31;3%-31&#x2e31;8%] and a 95% prediction interval of 7&#x2e31;6%-65&#x2e31;6%; the pooled prevalence increased with age and was highest among the aged &#x2265;75 years: 51&#x2e31;4% (95%CI: 42&#x2e31;0%-60&#x2e31;6%) and remained highest in the Southern Africa region overall (34&#x2e31;8%) and in the last decade (2013-2023; 44&#x2e31;5%). The point estimate of the pooled crude prevalence was higher among urban dwellers, 32&#x2e31;9% (95%CI: 26&#x2e31;8%-39&#x2e31;5%), than rural residents, 26&#x2e31;3% (95%CI: 20&#x2e31;4%-33&#x2e31;3%). In a subset of twenty-one articles reporting age stratification consistent with the WHO standard population, the pooled age-standardized prevalence was 27&#x2e31;2/100 persons (95%CI: 20&#x2e31;9%-33&#x2e31;6%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The burden of hypertension remains high, especially in urban areas and with increasing age. Frequent screening and treatment are recommended, especially in urban areas.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olowoyo</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0802-8505</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Federal Teaching Hospital, Ido-Ekiti, &#xa0;Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, &#xa0;Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okekunle</LastName><ForeName>Akinkunmi Paul</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Seoul National University 08826 Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Gerontology Branch, National Institute on Aging, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asowata</LastName><ForeName>Osahon Jeffery</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Medical Statistics, University of Ibadan, 200284, Ibadan, &#xa0;Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atolani</LastName><ForeName>Segun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Federal Teaching Hospital, Ido-Ekiti, &#xa0;Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, &#xa0;Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morsy</LastName><ForeName>Moustafa I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>School of Infection &amp; Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caiazzo</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Infection &amp; Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaye</LastName><ForeName>Bamba</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Alliance for Medical Research in Africa (AMedRA), Dakar, Senegal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadan</LastName><ForeName>David Danladi</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Medical Statistics, University of Ibadan, 200284, Ibadan, &#xa0;Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruzzese</LastName><ForeName>Dario</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9911-4646</Identifier><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzik</LastName><ForeName>Tomasz J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine; Centre for Medical Genomics Omicron, Jagiellonian University Collegium Medicum, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Africa-Europe CoRE in Non-Communicable Diseases &amp; Multimorbidity, African Research Universities Alliance (ARUA) &amp; The Guild of European Research-intensive Universities, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maffia</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3926-4225</Identifier><AffiliationInfo><Affiliation>School of Infection &amp; Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Africa-Europe CoRE in Non-Communicable Diseases &amp; Multimorbidity, African Research Universities Alliance (ARUA) &amp; The Guild of European Research-intensive Universities, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Cardiovascular &amp; Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owolabi</LastName><ForeName>Mayowa O</ForeName><Initials>MO</Initials><Identifier Source="ORCID">0000-0003-1146-3070</Identifier><AffiliationInfo><Affiliation>Africa-Europe CoRE in Non-Communicable Diseases &amp; Multimorbidity, African Research Universities Alliance (ARUA) &amp; The Guild of European Research-intensive Universities, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, University College Hospital, University of Ibadan, 200284, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, 200284, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Lebanese American University of Beirut, Lebanon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blossom Specialist Medical Center, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40662276</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvaf125</ArticleId><ArticleId IdType="pii">8202222</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17055946</PMID><DateCompleted><Year>2006</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>368</Volume><Issue>9545</Issue><PubDate><Year>2006</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.</ArticleTitle><Pagination><StartPage>1444</StartPage><EndPage>1448</EndPage><MedlinePgn>1444-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amniotic-fluid embolism is a rare, but serious and often fatal maternal complication of delivery, of which the cause is unknown. We undertook an epidemiological study to investigate the association between amniotic-fluid embolism and medical induction of labour.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used a population-based cohort of 3 million hospital deliveries in Canada between 1991 and 2002 to assess the associations between overall and fatal rates of amniotic-fluid embolism and medical and surgical induction, maternal age, fetal presentation, mode of delivery, and pregnancy and labour complications.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Total rate of amniotic-fluid embolism was 14.8 per 100,000 multiple-birth deliveries and 6.0 per 100,000 singleton deliveries (odds ratio 2.5 [95% CI 0.9-6.2]). Of the 180 cases of amniotic-fluid embolism in women with singleton deliveries during the study period, 24 (13%) were fatal. We saw no significant temporal increase in occurrence of amniotic-fluid embolism for total or fatal cases. Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism (adjusted odds ratio 1.8 [1.3-2.7]), and the association was stronger for fatal cases (crude odds ratio 3.5 [1.5-8.4]). Maternal age of 35 years or older, caesarean or instrumental vaginal delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption, eclampsia, and fetal distress were also associated with an increased risk.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Medical induction of labour seems to increase the risk of amniotic-fluid embolism. Although the absolute excess risk is low, women and physicians should be aware of this risk when making decisions about elective labour induction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Department of Epidemiology and Biostatistics, McGill University Faculty of Medicine, Montreal, QC, Canada. michael.kramer@mcgill.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Baskett</LastName><ForeName>Thomas F</ForeName><Initials>TF</Initials></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>K S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><CollectiveName>Maternal Health Study Group of the Canadian Perinatal Surveillance System</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2006 Oct 21;368(9545):1399-401. doi: 10.1016/S0140-6736(06)69581-0.</RefSource><PMID Version="1">17055926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="Y">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007751" MajorTopicYN="Y">Labor, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008423" MajorTopicYN="N">Maternal Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>11</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17055946</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(06)69607-4</ArticleId><ArticleId IdType="pii">S0140-6736(06)69607-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40152587</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Ketamine infusion for pain control in severely injured patients: Results of a randomized controlled trial.</ArticleTitle><Pagination><StartPage>858</StartPage><EndPage>866</EndPage><MedlinePgn>858-866</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000004602</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Opiate-based pain regimens remain the cornerstone of pain management following traumatic injury, but issues related to opioids have driven research into alternative analgesics. Adjunctive ketamine has been increasingly used to decrease opioid use, but little evidence exists to support its efficacy within the trauma population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective, randomized, double-blind placebo-controlled trial of severely injured (Injury Severity Score [ISS], &#x2265;15) adult patients (aged 18-64 years) admitted to a Level 1 trauma center was conducted. Exclusion criteria included Glasgow Coma Scale score of &lt;14, ISS of &lt;15, pregnancy, and chronic opiate use. All patients were prescribed a patient-controlled analgesia in addition to being randomized to either adjustable dose ketamine starting at 3 &#x3bc;g/kg/min or an equivalent rate of 0.9% normal saline. Study drug and patient-controlled analgesia titration were allowed as part of a treatment algorithm. The primary outcome was reduction in oral morphine equivalent (OME) utilization at 24 hours.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We performed a planned interim analysis upon reaching a predetermined enrollment goal. Forty-two of 78 patients (53.8%) were randomized to the experimental arm. Both groups were similar in makeup and had a median ISS of 22 (19, 28.5). The median OMEs in adjustable dose ketamine and placebo groups were 110.6 (55.7, 191.7) and 99.2 (50.6, 172.6), respectively ( p = 0.85). No significant difference in OME was found in 24- to 48-hour or the entire 48-hour study period. Adjustable dose ketamine had no impact on pain scores throughout the study period when compared with placebo (4.9 vs. 4.7, p = 0.95). These findings met the futility cutoff, and enrollment was terminated.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Adjustable dose ketamine failed to reduce OME totals or pain scores in a severely injured trauma cohort when compared with placebo at any time point. Additional studies are necessary to determine if there is any benefit for adjuvant ketamine in different trauma subpopulations.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Therapeutic/Care Management; Level I.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Association for the Surgery of Trauma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carver</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials><Identifier Source="ORCID">0000-0001-9904-2152</Identifier><AffiliationInfo><Affiliation>From the Division of Trauma and Critical Care Surgery, Department of Surgery (T.W.C., W.J.P., J.A.G., C.T., M.M.-W., J.R.P., M.E.S., D.J.M., A.F.E., M.A.d.M., T.A.d.R-C.), Division of Regional Anesthesia and Acute Pain Management (R.T.), and Division of Biostatistics, Institute for Health &amp; Equity (A.S., Y.Y.), Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peppard</LastName><ForeName>William J</ForeName><Initials>WJ</Initials></Author><Author ValidYN="Y"><LastName>Gellings</LastName><ForeName>Jaclyn A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Thapa</LastName><ForeName>Rozalin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Trevino</LastName><ForeName>Colleen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Mantz-Wichman</LastName><ForeName>Margo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Peschman</LastName><ForeName>Jacob R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>Aniko</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yushan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Milia</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Elegbede</LastName><ForeName>Anuoluwapo F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>de Moya</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>de Roon-Cassini</LastName><ForeName>Terri A</ForeName><Initials>TA</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT no. 042</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016058" MajorTopicYN="N">Analgesia, Patient-Controlled</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="Y">Analgesics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="Y">Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ketamine</Keyword><Keyword MajorTopicYN="N">opioids</Keyword><Keyword MajorTopicYN="N">pain management</Keyword><Keyword MajorTopicYN="N">severe injury</Keyword><Keyword MajorTopicYN="N">trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>28</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40152587</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000004602</ArticleId><ArticleId IdType="pii">01586154-202506000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gross JL, Perate AR, Elkassabany NM. Pain management in trauma in the age of the opioid crisis. Anesthesiol Clin . 2019;37:79&#x2013;91.</Citation></Reference><Reference><Citation>Alghnam S, Castillo R. Traumatic injuries and persistent opioid use in the USA: findings from a nationally representative survey. Inj Prev . 2017;23:87&#x2013;92.</Citation></Reference><Reference><Citation>Harvin JA, Truong VTT, Green CE, Allen L, Murry J, Radosevich JJ, et al. Opioid exposure after injury in United States trauma centers: a prospective, multicenter observational study. J Trauma Acute Care Surg . 2020;88:816&#x2013;824.</Citation></Reference><Reference><Citation>Cote C, Berube M, Moore L, Lauzier F, Tremblay L, Belzile E, et al. Strategies aimed at preventing long-term opioid use in trauma and orthopaedic surgery: a scoping review. BMC Musculoskelet Disord . 2022;23:238.</Citation></Reference><Reference><Citation>Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med . 2010;11:1859&#x2013;1871.</Citation></Reference><Reference><Citation>deRoon-Cassini TA, Hunt JC, Geier TJ, Warren AM, Ruggiero KJ, Scott K, et al. Screening and treating hospitalized trauma survivors for posttraumatic stress disorder and depression. J Trauma Acute Care Surg . 2019;87:440&#x2013;450.</Citation></Reference><Reference><Citation>Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg . 2004;99:482&#x2013;495.</Citation></Reference><Reference><Citation>Lui F, Ng KF. Adjuvant analgesics in acute pain. Expert Opin Pharmacother . 2011;12:363&#x2013;385.</Citation></Reference><Reference><Citation>Ahern TL, Herring AA, Anderson ES, Madia VA, Fahimi J, Frazee BW. The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med . 2015;33:197&#x2013;201.</Citation></Reference><Reference><Citation>Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med . 2018;43:456&#x2013;466.</Citation></Reference><Reference><Citation>Sleigh J, Harvey M, Voss L, Denny B. Ketamine &#x2014; more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care . 2014;4:76&#x2013;81.</Citation></Reference><Reference><Citation>Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet . 2016;55:1059&#x2013;1077.</Citation></Reference><Reference><Citation>Barrett W, Buxhoeveden M, Dhillon S. Ketamine: a versatile tool for anesthesia and analgesia. Curr Opin Anaesthesiol . 2020;33:633&#x2013;638.</Citation></Reference><Reference><Citation>Bell RF, Dahl JB, Moore RA, Kalso E. Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand . 2005;49:1405&#x2013;1428.</Citation></Reference><Reference><Citation>Zakine J, Samarcq D, Lorne E, Moubarak M, Montravers P, Beloucif S, et al. Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study. Anesth Analg . 2008;106:1856&#x2013;1861.</Citation></Reference><Reference><Citation>Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth . 2011;58:911&#x2013;923.</Citation></Reference><Reference><Citation>Losing AK, Jones JM, Keric A, Briggs SE, Leedahl DD. Ketamine infusion therapy as an alternative pain control strategy in patients with multi-trauma including rib fracture; case report and literature review. Bull Emerg Trauma . 2016;4:165&#x2013;169.</Citation></Reference><Reference><Citation>Pruskowski KA, Harbourt K, Pajoumand M, Chui SJ, Reynolds HN. Impact of ketamine use on adjunctive analgesic and sedative medications in critically ill trauma patients. Pharmacotherapy . 2017;37:1537&#x2013;1544.</Citation></Reference><Reference><Citation>Walters MK, Farhat J, Bischoff J, Foss M, Evans C. Ketamine as an analgesic adjuvant in adult trauma intensive care unit patients with rib fracture. Ann Pharmacother . 2018;52:849&#x2013;854.</Citation></Reference><Reference><Citation>Mullins CF, Kugler NW, Luc M, Peppard WJ, Paul JS. Adjunct ketamine infusions provide improved acute traumatic and post-surgical pain management. J Pharmacol Med Chem . 2018;2:36&#x2013;38.</Citation></Reference><Reference><Citation>Takieddine SC, Droege CA, Ernst N, Droege ME, Webb M, Branson RD, et al. Ketamine versus hydromorphone patient-controlled analgesia for acute pain in trauma patients. J Surg Res . 2018;225:6&#x2013;14.</Citation></Reference><Reference><Citation>Peppard W, Carver T. Ketamine for the management of acute pain and agitation in the ICU: future, fiction or just another drug-induced hallucination? Ann Pharmacol Pharm . 2017;2:1059.</Citation></Reference><Reference><Citation>Kugler NW, Carver TW, Juul J, Peppard WJ, Boyle K, Drescher KM, et al. Ketamine infusion for pain control in elderly patients with multiple rib fractures: results of a randomized controlled trial. J Trauma Acute Care Surg . 2019;87:1181&#x2013;1188.</Citation></Reference><Reference><Citation>Carver TW, Kugler NW, Juul J, Peppard WJ, Drescher KM, Somberg LB, et al. Ketamine infusion for pain control in adult patients with multiple rib fractures: results of a randomized control trial. J Trauma Acute Care Surg . 2019;86:181&#x2013;188.</Citation></Reference><Reference><Citation>Klugh JM, Puzio TJ, Wandling MW, Guy-Frank CJ, Green C, Sergot PB, et al. Ketamine for acute pain after trauma (KAPT): a pragmatic, randomized clinical trial. J Trauma Acute Care Surg . 2024;97:514&#x2013;519.</Citation></Reference><Reference><Citation>Nordness MF, Hayhurst CJ, Pandharipande P. Current perspectives on the assessment and management of pain in the intensive care unit. J Pain Res . 2021;14:1733&#x2013;1744.</Citation></Reference><Reference><Citation>DeMets DL, Lan KK. Interim analysis: the alpha spending function approach. Stat Med . 1994;13:1341&#x2013;1352 discussion 1353&#x2013;6.</Citation></Reference><Reference><Citation>Hwang I, Shih W, De Cani J. Group sequential designs using a family of type I error probability spending functions. Stat Med . 1990;9:1439&#x2013;1445.</Citation></Reference><Reference><Citation>Jouguelet-Lacoste J, La Colla L, Schilling D, Chelly JE. The use of intravenous infusion or single dose of low-dose ketamine for postoperative analgesia: a review of the current literature. Pain Med . 2015;16:383&#x2013;403.</Citation></Reference><Reference><Citation>Spilman SK, Lechtenberg GT, Hahn KD, Fuchsen EA, Olson SD, Swegle JR, et al. Is pain really undertreated? Challenges of addressing pain in trauma patients during prehospital transport and trauma resuscitation. Injury . 2016;47:2018&#x2013;2024.</Citation></Reference><Reference><Citation>Karmakar MK, Ho AM. Acute pain management of patients with multiple fractured ribs. J Trauma . 2003;54:615&#x2013;625.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32643613</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>7S</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of shoulder and elbow surgery</Title><ISOAbbreviation>J Shoulder Elbow Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review of reversing pseudoparalysis of the shoulder due to massive, irreparable rotator cuff tears.</ArticleTitle><Pagination><StartPage>S87</StartPage><EndPage>S91</EndPage><MedlinePgn>S87-S91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jse.2020.04.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1058-2746(20)30394-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Correcting pseudoparalysis of the shoulder due to massive rotator cuff tear is challenging. The most reliable treatment for restoring active shoulder elevation is debatable. Therefore, the purpose of this systematic review was to evaluate the success of various treatment options for reversing pseudoparalysis due to massive rotator cuff tear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A search was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines of the MEDLINE database, Cochrane database, Sportdiscus, and Google Scholar database for articles evaluating shoulder pseudoparalysis due to massive rotator cuff tears.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine articles evaluating reverse total shoulder arthroplasty (RTSA), superior capsular reconstruction (SCR), and rehabilitation programs were included in the study. Though there was variability, the definition of pseudoparalysis was active forward elevation (AFE) less than 90&#xb0; with preserved passive range of motion (ROM). Reversal of pseudoparalysis was defined as restoration of AFE greater than 90&#xb0;. The overall rate of reversal of pseudoparalysis across studies was similar for RTSA (96% &#xb1; 17%) and SCR (94% &#xb1; 3%). However, there was a difference in average improvement in AFE for RTSA (56&#xb0; &#xb1; 11&#xb0;) and SCR (106&#xb0; &#xb1; 20&#xb0;). A progressive rehabilitation program described improvements in a single study with 82% reversal of pseudoparalysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The available Level IV evidence suggests that RTSA and SCR reliably reverse pseudoparalysis in most patients with massive, irreparable rotator cuff tears. However, the dissimilar improvements in ROM suggest that a more consistent definition of pseudoparalysis is warranted. Future randomized controlled trials are needed to determine the best treatment approach for patients with massive irreparable rotator cuff tears.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dickerson</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mercy Clinic Orthopedics, Rogers, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pill</LastName><ForeName>Stephan G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Steadman Hawkins Clinic of the Carolinas, Prisma Health-Upstate, Greenville, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longstaffe</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pan Am Clinic, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanley</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ATI Physical Therapy, Greenville, SC, USA; SC Center for Effectiveness Research in Orthopaedics, Greenville, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thigpen</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>ATI Physical Therapy, Greenville, SC, USA; SC Center for Effectiveness Research in Orthopaedics, Greenville, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissenberth</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Steadman Hawkins Clinic of the Carolinas, Prisma Health-Upstate, Greenville, SC, USA. Electronic address: mike.kissenberth@hawkinsfoundation.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Shoulder Elbow Surg</MedlineTA><NlmUniqueID>9206499</NlmUniqueID><ISSNLinking>1058-2746</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001178" MajorTopicYN="Y">Arthroplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072228" MajorTopicYN="N">Arthroplasty, Replacement, Shoulder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="Y">Muscle Weakness</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070636" MajorTopicYN="N">Rotator Cuff Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012785" MajorTopicYN="N">Shoulder Joint</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pseudoparalysis</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">reverse shoulder arthroplasty</Keyword><Keyword MajorTopicYN="N">superior capsular reconstruction</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32643613</ArticleId><ArticleId IdType="doi">10.1016/j.jse.2020.04.039</ArticleId><ArticleId IdType="pii">S1058-2746(20)30394-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33719164</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1447-0756</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>The journal of obstetrics and gynaecology research</Title><ISOAbbreviation>J Obstet Gynaecol Res</ISOAbbreviation></Journal><ArticleTitle>Biochemical effects of intraoperative cell salvage and autotransfusion during cesarean section: A prospective pilot study.</ArticleTitle><Pagination><StartPage>1743</StartPage><EndPage>1750</EndPage><MedlinePgn>1743-1750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jog.14738</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Intraoperative cell salvage and autotransfusion (ICSA) is a useful technique for women undergoing cesarean sections who are predicted to experience significant bleeding. This method can reduce allogeneic transfusions as well as its associated risks and costs. Amniotic fluid embolism (AFE) is an abnormal maternal response to ICSA similar to the classic systemic inflammatory response syndrome, but its mechanism is not well understood. This study was conducted to investigate the biochemical aspects of AFE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective case-controlled pilot study was conducted in a general perinatal hospital in Japan. ICSA was performed using a two-step retransfusion process. Blood samples were collected presurgery, immediately postsurgery, and 24&#x2009;h after surgery. Changes in sialyl Tn antigen (STN), complement C3 and C4, fibrinogen, and fibrin degradation product and D-dimer, C1 esterase inhibitor, and interleukin-8 (all considered AFE-related markers) activities were compared between patients who underwent cesarean sections with ICSA (ICSA group) versus without ICSA (control group).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fibrinogen levels were significantly lower in the ICSA group than in the control group before surgery but not immediately after or 24&#x2009;h after surgery. D-dimer was significantly higher immediately after surgery but not 24&#x2009;h later. STN was significantly lower only before surgery. None of the AFE-related markers showed significant differences between the groups after 24&#x2009;h. No adverse events were observed in the ICSA group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no clinical evidence that ICSA alters the biochemical statuses of AFE-related markers in a manner that could lead to adverse maternal responses.</AbstractText><CopyrightInformation>&#xa9; 2021 Japan Society of Obstetrics and Gynecology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayata</LastName><ForeName>Eijiro</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8555-3007</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakata</LastName><ForeName>Masahiko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3621-1251</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takano</LastName><ForeName>Mayumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagasaki</LastName><ForeName>Sumito</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oji</LastName><ForeName>Ayako</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuma</LastName><ForeName>Junya</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Mineto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Toho University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Obstet Gynaecol Res</MedlineTA><NlmUniqueID>9612761</NlmUniqueID><ISSNLinking>1341-8076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="Y">Embolism, Amniotic Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amniotic fluid embolism</Keyword><Keyword MajorTopicYN="N">autotransfusion</Keyword><Keyword MajorTopicYN="N">biochemical marker</Keyword><Keyword MajorTopicYN="N">disseminated intravascular coagulation</Keyword><Keyword MajorTopicYN="N">intraoperative cell salvage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>15</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33719164</ArticleId><ArticleId IdType="doi">10.1111/jog.14738</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Dhariwal SK, Khan KS, Allard S, Wilson M, Moore P, SALVO study group. Does current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section. Curr Opin Obstet Gynecol. 2014;26:425-30.</Citation></Reference><Reference><Citation>Morikawa M, Kuramoto A, Nakayama M, Oguchi H, Hasegawa M, Funakoshi T, et al. Intraoperative red cell salvage during obstetric surgery in 50 Japanese women. Int J Gynaecol Obstet. 2015;128:256-9.</Citation></Reference><Reference><Citation>Khan KS, Moore PAS, Wilson MJ, Hooper R, Allard S, Wrench I, et al. Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO). PLoS Med. 2017;14:e1002471.</Citation></Reference><Reference><Citation>Sullivan IJ, Ralph CJ. Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases. Anaesthesia. 2019;74:976-83.</Citation></Reference><Reference><Citation>Albright CM, Rouse DJ, Werner EF. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol. 2014;124:690-6.</Citation></Reference><Reference><Citation>Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol. 1986;154:104-6.</Citation></Reference><Reference><Citation>Clark SL. Amniotic fluid embolism. Obstet Gynecol. 2014;123:337-48.</Citation></Reference><Reference><Citation>Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey AW, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016;215:408-12.</Citation></Reference><Reference><Citation>Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses. 2007;68:1019-25.</Citation></Reference><Reference><Citation>Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res. 2014;40:1507-17.</Citation></Reference><Reference><Citation>Tamura N, Kimura S, Farhana M, Uchida T, Suzuki K, Sugihara K, et al. C1 esterase inhibitor activity in amniotic fluid embolism. Crit Care Med. 2014;42:1392-6.</Citation></Reference><Reference><Citation>McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care. 2010;38:492-9.</Citation></Reference><Reference><Citation>Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000;92:1531-6.</Citation></Reference><Reference><Citation>Fong J, Gurewitsch ED, Kump L, Klein R. Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol. 1999;93:968-72.</Citation></Reference><Reference><Citation>Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective caesarean section. Br J Anaesth. 2008;101:225-9.</Citation></Reference><Reference><Citation>Keeling MM, Gray LA, Brink MA, Hillerich VK, Bland KI. Intraoperative autotransfusion. Experience in 725 consecutive cases. Ann Surg. 1983;197:536-41.</Citation></Reference><Reference><Citation>Zichella L, Gramolini R. Autotransfusion during cesarean section. Am J Obstet Gynecol. 1990;162:295.</Citation></Reference><Reference><Citation>Okunuga A, Skelton VA. Use of cell salvage in patients with sickle cell trait. Int J Obstet Anesth. 2009;18:90-1. author reply 91.</Citation></Reference><Reference><Citation>Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17:37-45.</Citation></Reference><Reference><Citation>Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;172:1158-67. discussion 1167-1169.</Citation></Reference><Reference><Citation>Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009;201(445):e1-13.</Citation></Reference><Reference><Citation>Courtney LD. Amniotic fluid embolism. Obstet Gynecol Surv. 1974;29:169-77.</Citation></Reference><Reference><Citation>Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol. 2001;97:510-4.</Citation></Reference><Reference><Citation>Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology. 2003;99:652-5.</Citation></Reference><Reference><Citation>Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T. Determining zinc coproporphyrin in maternal plasma-a new method for diagnosing amniotic fluid embolism. Clin Chem. 1992;38:526-9.</Citation></Reference><Reference><Citation>Legrand M, Rossignol M, Dreux S, Luton D, Ventr&#xe9; C, Barranger E, et al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism*. Crit Care Med. 2012;40:2059-63.</Citation></Reference><Reference><Citation>Sreelakshmi TR, Eldridge J. Acute hypotension associated with leucocyte depletion filters during cell salvaged blood transfusion. Anaesthesia. 2010;65:742-4.</Citation></Reference><Reference><Citation>Waldron S. Hypotension associated with leucocyte depletion filters following cell salvage in obstetrics. Anaesthesia. 2011;66:133-4.</Citation></Reference><Reference><Citation>Ram&#xed;rez G, Romero A, Garc&#xed;a-Vallejo JJ, Mu&#xf1;oz M. Detection and removal of fat particles from postoperative salvaged blood in orthopedic surgery. Transfusion. 2002;42:66-75.</Citation></Reference><Reference><Citation>Bernstein HH, Rosenblatt MA, Gettes M, Lockwood C. The ability of the Haemonetics 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg. 1997;85:831-3.</Citation></Reference><Reference><Citation>Weiskopf RB. Erythrocyte salvage during cesarean section. Anesthesiology. 2000;92:1519-22.</Citation></Reference><Reference><Citation>Catling S, Joels L. Cell salvage in obstetrics: the time has come. BJOG. 2005;112:131-2.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36961213</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4040</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Neurosurgery</Title><ISOAbbreviation>Neurosurgery</ISOAbbreviation></Journal><ArticleTitle>Awake Craniotomy in Africa: A Scoping Review of Literature and Proposed Solutions to Tackle Challenges.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>291</EndPage><MedlinePgn>274-291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1227/neu.0000000000002453</ELocationID><Abstract><AbstractText Label="BACKGROUND">Awake craniotomy (AC) is a common neurosurgical procedure for the resection of lesions in eloquent brain areas, which has the advantage of avoiding general anesthesia to reduce associated complications and costs. A significant resource limitation in low- and middle-income countries constrains the usage of AC.</AbstractText><AbstractText Label="OBJECTIVE">To review the published literature on AC in African countries, identify challenges, and propose pragmatic solutions by practicing neurosurgeons in Africa.</AbstractText><AbstractText Label="METHODS">We conducted a scoping review under Preferred Reporting Items for Systematic Reviews and Meta-Analysis-Scoping Review guidelines across 3 databases (PubMed, Scopus, and Web of Science). English articles investigating AC in Africa were included.</AbstractText><AbstractText Label="RESULTS">Nineteen studies consisting of 396 patients were included. Egypt was the most represented country with 8 studies (42.1%), followed by Nigeria with 6 records (31.6%). Glioma was the most common lesion type, corresponding to 120 of 396 patients (30.3%), followed by epilepsy in 71 patients (17.9%). Awake-awake-awake was the most common protocol used in 7 studies (36.8%). Sixteen studies (84.2%) contained adult patients. The youngest reported AC patient was 11 years old, whereas the oldest one was 92. Nine studies (47.4%) reported infrastructure limitations for performing AC, including the lack of funding, intraoperative monitoring equipment, imaging, medications, and limited human resources.</AbstractText><AbstractText Label="CONCLUSION">Despite many constraints, AC is being safely performed in low-resource settings. International collaborations among centers are a move forward, but adequate resources and management are essential to make AC an accessible procedure in many more African neurosurgical centers.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Congress of Neurological Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mofatteh</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2458-0447</Identifier><AffiliationInfo><Affiliation>School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashayekhi</LastName><ForeName>Mohammad Sadegh</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arfaie</LastName><ForeName>Saman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeleye</LastName><ForeName>Amos Olufemi</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolayemi</LastName><ForeName>Edward Olaoluwa</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>Neurosurgery Unit, Department of Surgery, Evercare Hospital Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghomsi</LastName><ForeName>Nathalie C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Neurosurgery Department, Felix Houphouet Boigny Unversity Abidjan, Cote d'Ivoire.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shlobin</LastName><ForeName>Nathan A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morsy</LastName><ForeName>Ahmed A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esene</LastName><ForeName>Ignatius N</ForeName><Initials>IN</Initials><AffiliationInfo><Affiliation>Neurosurgery Division, Faculty of Health Sciences, University of Bamenda, Bambili, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laeke</LastName><ForeName>Tsegazeab</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurosurgery Division, Department of Surgery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awad</LastName><ForeName>Ahmed K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ain-shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labuschagne</LastName><ForeName>Jason J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abebe</LastName><ForeName>Yared Nigusie</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Haramaya University Hiwot Fana Comprehensive Specialized Hospital, Harar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabang</LastName><ForeName>John Nute</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Edward Francis Small Teaching Hospital, Banjul, Gambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okunlola</LastName><ForeName>Abiodun Idowu</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Federal Teaching Hospital Ido Ekiti and Afe Babalola University, Ado Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrie</LastName><ForeName>Umaru</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lekuya</LastName><ForeName>Herv&#xe9; Monka</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Makerere University/Mulago Hospital, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idi Marcel</LastName><ForeName>Ehanga</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, College of Surgeons of East, Central and Southern Africa/Mulago Hospital, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabulo</LastName><ForeName>Kantenga Dieu Merci</ForeName><Initials>KDM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Jason Sendwe General Provincial Hospital, Lubumbashi, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bankole</LastName><ForeName>Nourou Dine Adeniran</ForeName><Initials>NDA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, H&#xf4;pital Des Sp&#xe9;cialit&#xe9;s, WFNS Rabat Training Center For Young, African Neurosurgeons, Faculty of Medicine, Mohammed V University, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edem</LastName><ForeName>Idara J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikwuegbuenyi</LastName><ForeName>Chibuikem A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Research Department, Association of Future African Neurosurgeons, Yaounde, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguembu</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Higher Institute of Health Sciences, Universit&#xe9; des Montagnes, Bangangt&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zolo</LastName><ForeName>Yvan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Global Surgery Division, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernstein</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Department of Surgery, University of Toronto, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temmy Latner Center for Palliative Care, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurosurgery</MedlineTA><NlmUniqueID>7802914</NlmUniqueID><ISSNLinking>0148-396X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="Y">Brain Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="N">Craniotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="Y">Glioma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="N">Wakefulness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36961213</ArticleId><ArticleId IdType="pmc">PMC10319364</ArticleId><ArticleId IdType="doi">10.1227/neu.0000000000002453</ArticleId><ArticleId IdType="pii">00006123-202308000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dewan MC, Rattani A, Fieggen G, et al. Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive summary of the global neurosurgery initiative at the program in global surgery and social change. J Neurosurg. 2019;130(4):1055-1064.</Citation><ArticleIdList><ArticleId IdType="pubmed">29701548</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelgadir J, Tran T, Muhindo A, et al. Estimating the cost of neurosurgical procedures in a low-income setting: an observational economic analysis. World Neurosurg. 2017;101:651-657.</Citation><ArticleIdList><ArticleId IdType="pubmed">28216396</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459001</ArticleId><ArticleId IdType="pubmed">30879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziedzic T, Bernstein M. Awake craniotomy for brain tumor: indications, technique and benefits. Expert Rev Neurother. 2014;14(12):1405-1415.</Citation><ArticleIdList><ArticleId IdType="pubmed">25413123</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrauf SI, Vuong P, Patel R, et al. &#x201c;Awake&#x201d; clipping of cerebral aneurysms: report of initial series. J Neurosurg. 2017;127(2):311-318.</Citation><ArticleIdList><ArticleId IdType="pubmed">27767401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulroy E, Robertson N, Macdonald L, Bok A, Simpson M. Patients' perioperative experience of awake deep-brain stimulation for Parkinson disease. World Neurosurg. 2017;105:526-528.</Citation><ArticleIdList><ArticleId IdType="pubmed">28606582</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkin K, Gabrovski K, Karazapryanov P, et al. Awake epilepsy surgery in patients with focal cortical dysplasia. World Neurosurg. 2021;151:e257&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33872840</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MD, Bernstein M. Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg. 1999;90(1):35-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10413153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravesteijn BY, Keizer ME, Vincent AJPE, Schouten JW, Stolker RJ, Klimek M. Awake craniotomy versus craniotomy under general anesthesia for the surgical treatment of insular glioma: choices and outcomes. Neurol Res. 2018;40(2):87-96.</Citation><ArticleIdList><ArticleId IdType="pubmed">29168669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojaxhi E, Louie C, ReFaey K, et al. Reduced pain and opioid use in the early postoperative period in patients undergoing a frontotemporal craniotomy under regional vs general anesthesia. World Neurosurg. 2021;150:e31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">33684585</ArticleId></ArticleIdList></Reference><Reference><Citation>July J, Manninen P, Lai J, Yao Z, Bernstein M. The history of awake craniotomy for brain tumor and its spread into Asia. Surg Neurol. 2009;71(5):621-624. discussion 624-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18452979</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino J, Gomez E, Bilbao JL, Due&#xf1;as JC, V&#xe1;zquez-Barquero A. Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas. Acta Neurochir. 2013;155(1):41-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23132374</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe KL, Zhou G, July J, et al. Teaching and sustainably implementing awake craniotomy in resource-poor settings. World Neurosurg. 2013;80(6):e171&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">23871816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall S, Kabwama S, Sadek A-R, et al. Awake craniotomy for tumour resection: the safety and feasibility of a simple technique. Interdiscip Neurosurg. 2021;24:101070.</Citation></Reference><Reference><Citation>Hervey-Jumper SL, Li J, Lau D, et al. Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period. J Neurosurg. 2015;123(2):325-339.</Citation><ArticleIdList><ArticleId IdType="pubmed">25909573</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanac&#xf4;r C, Duffau H. Analysis of legal, cultural, and socioeconomic parameters in low-grade glioma management: variability across countries and implications for awake surgery. World Neurosurg. 2018;120:47-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">30170145</ArticleId></ArticleIdList></Reference><Reference><Citation>Serletis D, Bernstein M. Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg. 2007;107(1):1-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17639865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansur A, Oswari S, Perdana Wahjoepramono PO, Kusdiansah M, Bernstein M. Awake craniotomy in a low- to middle-income country: a sustainability analysis. World Neurosurg. 2018;37(4):332-341.</Citation><ArticleIdList><ArticleId IdType="pubmed">30055366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi SZY, de Koning R, Egiz A, et al. Management and outcomes of low-grade gliomas in Africa: a scoping review. Ann Med Surg. 2022;74:103246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762355</ArticleId><ArticleId IdType="pubmed">35070291</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeleye AO, Idowu OK, Ghadirpour R, Iaccarino C. Minicraniotomy under local anesthesia and monitored sedation for the operative treatment of uncomplicated traumatic acute extradural hematoma. World Neurosurg. 2020;142:513-519.</Citation><ArticleIdList><ArticleId IdType="pubmed">32389868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MZ, Fadel NA, Abouldahab HA. Awake craniotomy versus general anesthesia for managing eloquent cortex low-grade gliomas. Neurosciences (Riyadh) 2009;14(3):263-272.</Citation><ArticleIdList><ArticleId IdType="pubmed">21048628</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdou SA, Shehab HA, Samir EM, Eissa EM. Preliminary evaluation of ketofol-based sedation for awake craniotomy procedures. Egypt J Anaesth. 2010;26(4):293-297.</Citation></Reference><Reference><Citation>Aboeldahab H, Hegazy A, Salah A, Tarif T. Is the usage of mannitol mandatory in awake craniotomy? A comparative study. Egypt J Anaesth. 2011;27(1):39-44.</Citation></Reference><Reference><Citation>Elbakry AE, Ibrahim E. Propofol-dexmedetomidine versus propofol-remifentanil conscious sedation for awake craniotomy during epilepsy surgery. Minerva Anestesiol. 2017;83(12):1248-1254.</Citation><ArticleIdList><ArticleId IdType="pubmed">28631453</ArticleId></ArticleIdList></Reference><Reference><Citation>Waly S, Nasr Y, Morsy A. Quasi-experiment as an initial experience for conscious sedation in awake craniotomy: dexmedetomidine versus midazolam. Res Opin Anesth Intensive Care 2020;7(1):31.</Citation></Reference><Reference><Citation>Nasr YM, Waly SH, Morsy AA. Scalp block for awake craniotomy: lidocaine-bupivacaine versus lidocaine-bupivacaine with adjuvants. Egypt J Anaesth. 2020;36(1):7-15.</Citation></Reference><Reference><Citation>Abdelhameed E, Abdelghany MS, Abdelkhalek H, Elatrozy HIS. Awake surgery for lesions near eloquent brain under scalp block and clinical monitoring: experience of single center with limited resources. Egypt J Neurol Psychiatry Neurosurg. 2021;57(1):78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205193</ArticleId><ArticleId IdType="pubmed">34149281</ArticleId></ArticleIdList></Reference><Reference><Citation>Morsy AA, Ismail AM, Nasr YM, Waly SH, Abdelhameed EA. Predictors of stimulation-induced seizures during perirolandic glioma resection using intraoperative mapping techniques. Surg Neurol Int. 2021;12:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053429</ArticleId><ArticleId IdType="pubmed">33880222</ArticleId></ArticleIdList></Reference><Reference><Citation>Idowu OK, Adeleye AO, Amanor-Boadu SD. Awake craniotomy for intracranial lesions: an audit of the anaesthetists&#x2019; initial experience at the University College Hospital, Ibadan. Egypt J Anaesth. 2016;32(4):559-564.</Citation></Reference><Reference><Citation>Balogun JA, Idowu OK, Malomo AO. Challenging the myth of outpatient craniotomy for brain tumor in a Sub-Saharan African setting: a case series of two patients in Ibadan, Nigeria. Surg Neurol Int. 2019;10:71-76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744755</ArticleId><ArticleId IdType="pubmed">31528409</ArticleId></ArticleIdList></Reference><Reference><Citation>Okunlola A, Okunlola C, Babalola O, et al. Challenges and Prospects of Awake Craniotomy in a Resource-Poor Setting; 2019.Refstyled.</Citation></Reference><Reference><Citation>Okunlola AI, Babalola OF, Okunlola CK, Akinmade A, Abiola P, Orewole TO. Awake craniotomy in neurosurgery: shall we do it more often?. Interdiscip Neurosurg. 2020;21:100770.</Citation></Reference><Reference><Citation>Okunlola AI. Awake craniotomy in a Covid-19 positive patient: the challenges and outcome. Interdiscip Neurosurg. 2021;24:101064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834066</ArticleId><ArticleId IdType="pubmed">33520666</ArticleId></ArticleIdList></Reference><Reference><Citation>Okunlola AI, Ibijola AA, Babalola OF, Okunlola CK, Erinomo OO. Parasagittal cystic meningioma mimicking hemangioblastoma: a case report. Surg Neurol Int. 2021;12:368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422409</ArticleId><ArticleId IdType="pubmed">34513135</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed H, Arbab M, Aldeaf S. Initial experience with awake craniotomy in Sudan. Sudan J Med Sci. 2008;3(2):171-175.</Citation></Reference><Reference><Citation>Mohamed H, Mohamed M, Mohaned A, Arbab M, Salim A, Aldeaf S. Awake craniotomy, an unusual indication. J Neurol Neurosci. 2013;4(3):1-7.</Citation></Reference><Reference><Citation>Meziane M, Elkoundi A, Ahtil R, Guazaz M, Mustapha B, Haimeur C. Anaesthetic management for awake craniotomy in brain glioma resection: initial experience in Military Hospital Mohamed V of Rabat. Pan Afr Med J. 2017;27:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567967</ArticleId><ArticleId IdType="pubmed">28904684</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyaich Z, Hajhouji F, Laghmari M, et al. Awake craniotomy with functional mapping for glioma resection in a limited-resource-setting: preliminary experience from a lower-middle income country. World Neurosurg. 2020;139:200-207.</Citation><ArticleIdList><ArticleId IdType="pubmed">32311556</ArticleId></ArticleIdList></Reference><Reference><Citation>Labuschagne J, Lee CA, Mutyaba D, Mbanje T, Sibanda C. Awake craniotomy in a child: assessment of eligibility with a simulated theatre experience. Case Rep Anesthesiol. 2020;2020:1-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361895</ArticleId><ArticleId IdType="pubmed">32695521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sills AK. Current treatment approaches to surgery for brain metastases. Neurosurgery 2005;57(5):S24-S32. discusssion S1-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237284</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda R, Coello AF, De Benedictis A, Martinoni M, Duffau H. Awake mapping for resection of cavernous angioma and surrounding gliosis in the left dominant hemisphere: surgical technique and functional results: clinical article. J Neurosurg. 2012;117(6):1076-1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">23039148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonen T, Sela G, Yanakee R, Ram Z, Grossman R. Surgery-independent language function decline in patients undergoing awake craniotomy. World Neurosurg. 2017;99:674-679.</Citation><ArticleIdList><ArticleId IdType="pubmed">28034812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua TH, See AAQ, Ang BT, King NKK. Awake craniotomy for resection of brain metastases: a systematic review. World Neurosurg. 2018;120:e1128&#x2013;e1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">30205215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitnikov AR, Grigoryan YA, Mishnyakova LP. Awake craniotomy without sedation in treatment of patients with lesional epilepsy. Surg Neurol Int. 2018;9(1):177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130149</ArticleId><ArticleId IdType="pubmed">30221022</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo RA, Vivas-Buitrago T, Sabsevitz DS, Middlebrooks EH, Quinones-Hinojosa A. Awake craniotomy with cortical and subcortical speech mapping for supramarginal cavernoma resection. World Neurosurg. 2020;141:260.</Citation><ArticleIdList><ArticleId IdType="pubmed">32585378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AT, Pillai P, Guran E, et al. Anesthetic management of awake craniotomy for resection of the language and motor cortex vascular malformations. World Neurosurg. 2020;143:e136&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">32736129</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettel N, Bharadwaj S, Venkatraghavan L, Mehta J, Bernstein M, Manninen PH. Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial &#x2020; &#x2020;Euroanaesthesia Congress, May 31, 2015, Berlin, Germany, and Canadian Anesthesiologists&#x2019; Society Annual Meeting, June 20, 2015, Ottawa, Canada. &#x2021; &#x2021;This Article is accompanied by Editorial Aew113. Br J Anaesth. 2016;116(6):811-821.</Citation><ArticleIdList><ArticleId IdType="pubmed">27099154</ArticleId></ArticleIdList></Reference><Reference><Citation>Prontera A, Baroni S, Marudi A, et al. Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil. Drug Des Dev Ther. 2017;11:593-598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344434</ArticleId><ArticleId IdType="pubmed">28424537</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuliffe N, Nicholson S, Rigamonti A, et al. Awake craniotomy using dexmedetomidine and scalp blocks: a retrospective cohort study. Can J Anesth. 2018;65(10):1129-1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">29978278</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill J, Viguier D, Kieffer V, et al. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg Pediatr. 2004;101(2):152-158.</Citation><ArticleIdList><ArticleId IdType="pubmed">15835102</ArticleId></ArticleIdList></Reference><Reference><Citation>Delion M, Terminassian A, Lehousse T, et al. Specificities of awake craniotomy and brain mapping in children for resection of supratentorial tumors in the language area. World Neurosurg. 2015;84(6):1645-1652.</Citation><ArticleIdList><ArticleId IdType="pubmed">26164190</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallud J, Dezamis E. Functional and oncological outcomes following awake surgical resection using intraoperative cortico-subcortical functional mapping for supratentorial gliomas located in eloquent areas. Neurochirurgie 2017;63(3):208-218.</Citation><ArticleIdList><ArticleId IdType="pubmed">28161013</ArticleId></ArticleIdList></Reference><Reference><Citation>McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008;63(4):700-708. author reply 707-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18981880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacko O, Lauwers-Cances V, Brauge D, Sesay M, Brenner A, Roux FE. Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery 2011;68(5):1192-1199. discussion 1198-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21273923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerritsen JKW, Vi&#xeb;tor CL, Rizopoulos D, et al. Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study. Acta Neurochir. 2019;161(2):307-315.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahon BZ, Miozzo M, Pilcher WH. Direct electrical stimulation mapping of cognitive functions in the human brain. Cogn Neuropsychol. 2019;36(3-4):97-102.</Citation><ArticleIdList><ArticleId IdType="pubmed">31514643</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux FE, Boulanouar K, Lotterie JA, Mejdoubi M, LeSage JP, Berry I. Language functional magnetic resonance imaging in preoperative assessment of language areas: correlation with direct cortical stimulation. Neurosurgery 2003;52(6):1335-1347; discussion 1345-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12762879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nossek E, Matot I, Shahar T, et al. Intraoperative seizures during awake craniotomy: incidence and consequences: analysis of 477 patients. Neurosurgery 2013;73(1):135-140. ; discussion 140.</Citation><ArticleIdList><ArticleId IdType="pubmed">23615101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gernsback JE, Kolcun JPG, Starke RM, Ivan ME, Komotar RJ. Who needs sleep? An analysis of patient tolerance in awake craniotomy. World Neurosurg. 2018;118:e842&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">30026153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sader E, Yee P, Hodaie M. Assessing barriers to neurosurgical care in sub-saharan africa: the role of resources and infrastructure. World Neurosurg. 2017;98:682-688.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27506409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewell D, Smith M. Awake craniotomy: anesthetic considerations based on outcome evidence. Curr Opin Anaesthesiol. 2019;32(5):546-552.</Citation><ArticleIdList><ArticleId IdType="pubmed">31107256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramall A, Djimbaye H, Tolessa C, Biluts H, Abebe M, Bernstein M. Attitudes toward neurosurgery in a low-income country: a qualitative study. World Neurosurg. 2014;82(5):560-566.</Citation><ArticleIdList><ArticleId IdType="pubmed">24836580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissani N, Cherkaoui Rhazouani O, Souirti Z, et al. Epilepsy in Morocco: realities, pitfalls and prospects. Epilepsia Open 2021;6(1):13-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918313</ArticleId><ArticleId IdType="pubmed">33681643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbole GI, Adeyomoye AO, Badu-Peprah A, Mensah Y, Nzeh DA. Survey of magnetic resonance imaging availability in West Africa. Pan Afr Med J. 2018;30:240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295297</ArticleId><ArticleId IdType="pubmed">30574259</ArticleId></ArticleIdList></Reference><Reference><Citation>Turel MK, Bernstein M. Outpatient neurosurgery. Expert Rev Neurother. 2016;16(4):425-436.</Citation><ArticleIdList><ArticleId IdType="pubmed">26908054</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassiri F, Li L, Badhiwala JH, et al. Hospital costs associated with inpatient versus outpatient awake craniotomy for resection of brain tumors. J Clin Neurosci. 2019;59:162-166.</Citation><ArticleIdList><ArticleId IdType="pubmed">30414812</ArticleId></ArticleIdList></Reference><Reference><Citation>Mofatteh M, Mashayekhi MS, Arfaie S, et al. Stress, anxiety, and depression associated with awake craniotomy: a systematic review. Neurosurgery 2022;92(2):225-240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815094</ArticleId><ArticleId IdType="pubmed">36580643</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanshard HJ, Chung F, Manninen PH, Taylor MD, Bernstein M. Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg. 2001;92(1):89-94.</Citation><ArticleIdList><ArticleId IdType="pubmed">11133607</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas JG, Gadgil N, Samson SL, Takashima M, Yoshor D. Prospective trial of a short hospital stay protocol after endoscopic endonasal pituitary adenoma surgery. World Neurosurg. 2014;81(3-4):576-583.</Citation><ArticleIdList><ArticleId IdType="pubmed">24239739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sughrue ME, Bonney PA, Choi L, Teo C. Early discharge after surgery for intra-axial brain tumors. World Neurosurg. 2015;84(2):505-510.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892244</ArticleId></ArticleIdList></Reference><Reference><Citation>Enam S, Khan S, Nathani K, Shafiq F. Awake craniotomy in developing countries: review of hurdles. IJS Short Rep. 2017;2(1):5.</Citation></Reference><Reference><Citation>Beauregard CL, Friedman WA. Routine use of postoperative ICU care for elective craniotomy: a cost-benefit analysis. Surg Neurol. 2003;60(6):483-489. dicussion 489.</Citation><ArticleIdList><ArticleId IdType="pubmed">14670660</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhondali O, Genty C, Halle C, et al. Do patients still require admission to an intensive care unit after elective craniotomy for brain surgery?. J Neurosurg Anesthesiol. 2011;23(2):118-123.</Citation><ArticleIdList><ArticleId IdType="pubmed">21270644</ArticleId></ArticleIdList></Reference><Reference><Citation>Uche EO, Ezomike UO, Chukwu JC, Ituen MA. Intensive care unit admissions in Federal Medical Centre Umuahia south east Nigeria. Niger J Med. 2012;21(1):70-73.</Citation><ArticleIdList><ArticleId IdType="pubmed">23301452</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukoja M, Riviello E, Gavrilovic S, et al. A survey on critical care resources and practices in low- and middle-income countries. Glob Heart 2014;9(3):337-342. e1-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25667185</ArticleId></ArticleIdList></Reference><Reference><Citation>Quimby AE, Shamy MCF, Rothwell DM, Liu EY, Dowlatshahi D, Stotts G. A novel neuroscience intermediate-level care unit model: retrospective analysis of impact on patient flow and safety. Neurohospitalist 2017;7(2):83-90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382654</ArticleId><ArticleId IdType="pubmed">28400902</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzi P, Bergese SD, Viloria A, Puente EG, Abdel-Rasoul M, Chiocca EA. A retrospective cohort-matched comparison of conscious sedation versus general anesthesia for supratentorial glioma resection. Clinical article. J Neurosurg. 2011;114(3):633-639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256674</ArticleId><ArticleId IdType="pubmed">20560720</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown T, Shah AH, Bregy A, et al. Awake craniotomy for brain tumor resection: the rule rather than the exception?. J Neurosurg Anesthesiol. 2013;25(3):240-247.</Citation><ArticleIdList><ArticleId IdType="pubmed">23603885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein M. Outpatient craniotomy for brain tumor: a pilot feasibility study in 46 patients. Can J Neurol Sci. 2001;28(2):120-124.</Citation><ArticleIdList><ArticleId IdType="pubmed">11383935</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulton M, Bernstein M. Outpatient brain tumor surgery: innovation in surgical neurooncology. J Neurosurg. 2008;108(4):649-654.</Citation><ArticleIdList><ArticleId IdType="pubmed">18377241</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrabba G, Venkatraghavan L, Bernstein M. Day surgery awake craniotomy for removing brain tumours: technical note describing a simple protocol. Minim Invasive Neurosurg. 2008;51(04):208-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">18683111</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy PL, Weidmann C, Bernstein M. Day-case neurosurgery for brain tumours: the early United Kingdom experience. Br J Neurosurg. 2008;22(3):360-367.</Citation><ArticleIdList><ArticleId IdType="pubmed">18568724</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual JSG, Duffau H. The need to consider return to work as a main outcome in patients undergoing surgery for diffuse low-grade glioma: a systematic review. Acta Neurochir. 2022;164(10):2789-2809.</Citation><ArticleIdList><ArticleId IdType="pubmed">35945356</ArticleId></ArticleIdList></Reference><Reference><Citation>You H, Qiao H. Intraoperative neuromonitoring during resection of gliomas involving eloquent areas. Front Neurol. 2021;12:658680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260928</ArticleId><ArticleId IdType="pubmed">34248818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavrador JP, Gioti I, Hoppe S, et al. Altered motor excitability in patients with diffuse gliomas involving motor eloquent areas: the impact of tumor grading. Neurosurgery 2021;88(1):183-192.</Citation><ArticleIdList><ArticleId IdType="pubmed">32888309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavrador JP, Ghimire P, Brogna C, et al. Pre- and intraoperative mapping for tumors in the primary motor cortex: decision-making process in surgical resection. J Neurol Surg A Cent Eur Neurosurg. 2021;82(04):333-343.</Citation><ArticleIdList><ArticleId IdType="pubmed">32438419</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeble H, Lavrador JP, Pereira N, et al. Electromagnetic navigation systems and intraoperative neuromonitoring: reliability and feasibility study. Oper Neurosurg. 2021;20(4):373-382.</Citation><ArticleIdList><ArticleId IdType="pubmed">33432974</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffau H, Lopes M, Arthuis F, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76(6):845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1739650</ArticleId><ArticleId IdType="pubmed">15897509</ArticleId></ArticleIdList></Reference><Reference><Citation>Trebuchon A, Guye M, Tcherniack V, Tramoni E, Bruder N, Metellus P. Int&#xe9;r&#xea;t du monitoring &#xe9;lectrophysiologique au cours d&#x2019;une chirurgie &#xe9;veill&#xe9;e en neurochirurgie. Ann Fran&#xe7;aises d'Anesth&#xe9;sie de R&#xe9;animation 2012;31(6):e87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683402</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Tamura M, Chernov MF, Ikuta S, Muragaki Y, Maruyama T. Neurophysiological monitoring and awake craniotomy for resection of intracranial gliomas. Prog Neurol Surg. 2018;30:117-158.</Citation><ArticleIdList><ArticleId IdType="pubmed">29241172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mofatteh M. Neurosurgery and artificial intelligence. AIMS Neurosci. 2021;8(4):477-495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611194</ArticleId><ArticleId IdType="pubmed">34877400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mofatteh M, Mashayekhi MS, Arfaie S, et al. Augmented and virtual reality usage in awake craniotomy: a systematic review. Neurosurg Rev. 2022;46(1):19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9760592</ArticleId><ArticleId IdType="pubmed">36529827</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimble G, McStravick C, Farling P, et al. Awake craniotomy for glioma resection: technical aspects and initial results in a single institution. Br J Neurosurg. 2015;29(6):836-842.</Citation><ArticleIdList><ArticleId IdType="pubmed">26168299</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal RTM, Barcellos BM, Landeiro JA. Technical aspects of awake craniotomy with mapping for brain tumors in a limited resource setting. World Neurosurg. 2018;113:67-72.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SS, McCutcheon IE, Suki D, et al. Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients. Neurosurgery 2009;64(5):836-846. ; discussion 345-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19404147</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankstein U, Dakurah T, Bagan M, Hodaie M. Structured online neurosurgical education as a novel method of education delivery in the developing World. World Neurosurg. 2011;76(3-4):224-230.</Citation><ArticleIdList><ArticleId IdType="pubmed">21986410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadotte DW, Sedney C, Djimbaye H, Bernstein M. A qualitative assessment of the benefits and challenges of international neurosurgical teaching collaboration in Ethiopia. World Neurosurg. 2014;82(6):980-986.</Citation><ArticleIdList><ArticleId IdType="pubmed">25196401</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallah PN, Bernstein M. Unifying a fragmented effort: a qualitative framework for improving international surgical teaching collaborations. Global Health 2017;13(1):70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588718</ArticleId><ArticleId IdType="pubmed">28882188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39362934</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>A scoping review of reporting gaps in FDA-approved AI medical devices.</ArticleTitle><Pagination><StartPage>273</StartPage><MedlinePgn>273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-024-01270-x</ELocationID><Abstract><AbstractText>Machine learning and artificial intelligence (AI/ML) models in healthcare may exacerbate health biases. Regulatory oversight is critical in evaluating the safety and effectiveness of AI/ML devices in clinical settings. We conducted a scoping review on the 692 FDA-approved AI/ML-enabled medical devices approved from 1995-2023 to examine transparency, safety reporting, and sociodemographic representation. Only 3.6% of approvals reported race/ethnicity, 99.1% provided no socioeconomic data. 81.6% did not report the age of study subjects. Only 46.1% provided comprehensive detailed results of performance studies; only 1.9% included a link to a scientific publication with safety and efficacy data. Only 9.0% contained a prospective study for post-market surveillance. Despite the growing number of market-approved medical devices, our data shows that FDA reporting data remains inconsistent. Demographic and socioeconomic characteristics are underreported, exacerbating the risk of algorithmic bias and health disparity.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Muralidharan</LastName><ForeName>Vijaytha</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-0226-8468</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94304, USA. vmurali5@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Adewale</LastName><ForeName>Boluwatife Adeleye</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Caroline J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-5620-303X</Identifier><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nta</LastName><ForeName>Mfon Thelma</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ademiju</LastName><ForeName>Peter Oluwaduyilemi</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>Intron Health, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathmarajah</LastName><ForeName>Pirunthan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hang</LastName><ForeName>Man Kien</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Co:Helm, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adesanya</LastName><ForeName>Oluwafolajimi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Illinois, Urbana-Champaign, Urbana, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullateef</LastName><ForeName>Ridwanullah Olamide</ForeName><Initials>RO</Initials><Identifier Source="ORCID">0000-0002-9405-870X</Identifier><AffiliationInfo><Affiliation>Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College Research and Innovation Hub (CRIH), College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babatunde</LastName><ForeName>Abdulhammed Opeyemi</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajibade</LastName><ForeName>Abdulquddus</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyeka</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zhou Ran</ForeName><Initials>ZR</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daneshjou</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7988-9356</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olatunji</LastName><ForeName>Tobi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0009-7214-2132</Identifier><AffiliationInfo><Affiliation>Intron Health, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39362934</ArticleId><ArticleId IdType="pmc">PMC11450195</ArticleId><ArticleId IdType="doi">10.1038/s41746-024-01270-x</ArticleId><ArticleId IdType="pii">10.1038/s41746-024-01270-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>U.S. Food and Drug Administration (FDA). Artificial intelligence and machine learning (AI/ML)-enabled medical devices. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices (2024).</Citation></Reference><Reference><Citation>Center for Devices and Radiological Health. Medical Device Development Tools (MDDT). https://www.fda.gov/medical-devices/medical-device-development-tools-mddt (2024).</Citation></Reference><Reference><Citation>Ajraoui, S. &amp; Ballester, B. R. Apple Watch AFib history feature makes medical device history. https://www.iqvia.com/blogs/2024/05/apple-watch-afib-history-feature-makes-medical-device-history (2024).</Citation></Reference><Reference><Citation>Panch, T., Mattie, H. &amp; Atun, R. Artificial intelligence and algorithmic bias: implications for health systems. J. Glob. Health9, 020318 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6875681</ArticleId><ArticleId IdType="pubmed">31788229</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, C. H. et al. Ageism and artificial intelligence: protocol for a scoping review. JMIR Res. Protoc.11, e33211 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9227654</ArticleId><ArticleId IdType="pubmed">35679118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, H. &amp; Nachum, O. Identifying and correcting label bias in machine learning. Proc. Mach. Learn. Res.108, 4621&#x2013;4630 (2020).</Citation></Reference><Reference><Citation>Chen, R. J. et al. Algorithmic fairness in artificial intelligence for medicine and healthcare. Nat. Biomed. Eng.7, 719&#x2013;742 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10632090</ArticleId><ArticleId IdType="pubmed">37380750</ArticleId></ArticleIdList></Reference><Reference><Citation>Norori, N., Hu, Q., Aellen, F. M., Faraci, F. D. &amp; Tzovara, A. Addressing bias in big data and AI for health care: a call for open science. Patterns2, 100347 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515002</ArticleId><ArticleId IdType="pubmed">34693373</ArticleId></ArticleIdList></Reference><Reference><Citation>The Pew Charitable Trusts. How FDA regulates artificial intelligence in medical products. https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2021/08/how-fda-regulates-artificial-intelligence-in-medical-products (2021).</Citation></Reference><Reference><Citation>Wu, E. et al. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat. Med.27, 582&#x2013;584 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33820998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, E. et al. Toward stronger FDA approval standards for AI medical devices. HAI Policy Brief. 1&#x2013;6 (2022).</Citation></Reference><Reference><Citation>Mashar, M. et al. Artificial intelligence algorithms in health care: is the current Food and Drug Administration regulation sufficient? JMIR AI2, e42940 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11041443</ArticleId><ArticleId IdType="pubmed">38875544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, M. I. et al. A systematic review of the barriers to the implementation of artificial intelligence in healthcare. Cureus15, e46454 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10623210</ArticleId><ArticleId IdType="pubmed">37927664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazer, L. H. et al. Bias in artificial intelligence algorithms and recommendations for mitigation. PLoS Digit. Health2, e0000278 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287014</ArticleId><ArticleId IdType="pubmed">37347721</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado, J. et al. Bias in algorithms of AI systems developed for COVID-19: a scoping review. J. Bioeth. Inq.19, 407&#x2013;419 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9463236</ArticleId><ArticleId IdType="pubmed">35857214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiens, J. et al. Do no harm: a roadmap for responsible machine learning for health care. Nat. Med.25, 1337&#x2013;1340 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31427808</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox&#x2010;Rawlings, S. R., Gottschalk, L. B., Doamekpor, L. A. &amp; Zuckerman, D. M. Diversity in medical device clinical trials: do we know what works for which patients? Milbank Q.96, 499&#x2013;529 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6131322</ArticleId><ArticleId IdType="pubmed">30203600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond, A., Jain, B., Celi, L. A. &amp; Stanford, F. C. An extension to the FDA approval process is needed to achieve AI equity. Nat. Mach. Intell.5, 96&#x2013;97 (2023).</Citation></Reference><Reference><Citation>Abernethy, A. et al. The promise of digital health: then, now, and the future. NAM Perspect.202210.31478/202206e (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499383</ArticleId><ArticleId IdType="pubmed">36177208</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration. Artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD) action plan. https://www.fda.gov/media/145022/download?attachment (2021).</Citation></Reference><Reference><Citation>Mittermaier, M., Raza, M. M. &amp; Kvedar, J. C. Bias in AI-based models for medical applications: challenges and mitigation strategies. Npj Digital Med.6, 113 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10264403</ArticleId><ArticleId IdType="pubmed">37311802</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora, A. et al. The value of standards for health datasets in artificial intelligence-based applications. Nat. Med.29, 2929&#x2013;2938 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10667100</ArticleId><ArticleId IdType="pubmed">37884627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cary, M. P. et al. Mitigating racial and ethnic bias and advancing health equity in clinical algorithms: a scoping review. Health Aff.42, 1359&#x2013;1368 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10668606</ArticleId><ArticleId IdType="pubmed">37782868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara, E. Fairness and bias in artificial intelligence: a brief survey of sources, impacts, and mitigation strategies. Sci6, 3 (2023).</Citation></Reference><Reference><Citation>d&#x2019;Elia, A. et al. Artificial intelligence and health inequities in primary care: a systematic scoping review and framework. Fam. Med. Community Health10, e001670 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716837</ArticleId><ArticleId IdType="pubmed">36450391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurevich, E., El Hassan, B. &amp; El Morr, C. Equity within AI systems: what can health leaders expect? Health Manag. Forum36, 119&#x2013;124 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9976641</ArticleId><ArticleId IdType="pubmed">36226507</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomasian, N. M., Eickhoff, C. &amp; Adashi, E. Y. Advancing health equity with artificial intelligence. J. Public Health Policy42, 602&#x2013;611 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607970</ArticleId><ArticleId IdType="pubmed">34811466</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik, K. E. et al. Digital determinants of health: health data poverty amplifies existing health disparities&#x2014;a scoping review. PLoS Digit Health2, e0000313 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10569513</ArticleId><ArticleId IdType="pubmed">37824445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G. &amp; King, D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med.17, 195 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821018</ArticleId><ArticleId IdType="pubmed">31665002</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol, E. J. Welcoming new guidelines for AI clinical research. Nat. Med.26, 1318&#x2013;1320 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32908274</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, B. L., Murphy, A. &amp; Robinson, E. Accelerating health disparities research with artificial intelligence. Front. Digit. Health6, 1330160 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10844447</ArticleId><ArticleId IdType="pubmed">38322109</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer, Z., Powers, B., Vogeli, C. &amp; Mullainathan, S. Dissecting racial bias in an algorithm used to manage the health of populations. Science366, 447&#x2013;453 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31649194</ArticleId></ArticleIdList></Reference><Reference><Citation>Muralidharan, V., Burgart, A., Daneshjou, R. &amp; Rose, S. Recommendations for the use of pediatric data in artificial intelligence and machine learning ACCEPT-AI. npj Digital Med.6, 166 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482936</ArticleId><ArticleId IdType="pubmed">37673925</ArticleId></ArticleIdList></Reference><Reference><Citation>Busnatu, &#x218;. et al. Clinical applications of artificial intelligence&#x2014;an updated overview. J. Clin. Med.11, 2265 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9031863</ArticleId><ArticleId IdType="pubmed">35456357</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, C. D., Lopez, L., Ouyang, D., Zou, J. Y. &amp; He, B. Video-based deep learning for automated assessment of left ventricular ejection fraction in pediatric patients. J. Am. Soc. Echocardiogr.36, 482&#x2013;489 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36754100</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kolfschooten, H. The AI cycle of health inequity and digital ageism: mitigating biases through the EU regulatory framework on medical devices. J. Law Biosci.10, lsad031 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709664</ArticleId><ArticleId IdType="pubmed">38075950</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi, G. et al. FDA-approved artificial intelligence and machine learning (AI/ML)-enabled medical devices: an updated landscape. Electronics13, 498 (2024).</Citation></Reference><Reference><Citation>Berghea, E. C. et al. Integrating artificial intelligence in pediatric healthcare: parental perceptions and ethical implications. Children11, 240 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10887612</ArticleId><ArticleId IdType="pubmed">38397353</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: MEDO ARIA [Premarket notification submission K200356]. https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200356.pdf (2020).</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: EarliPoint System [Premarket notification submission K213882]. https://www.accessdata.fda.gov/cdrh_docs/pdf21/K213882.pdf (2021).</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). De Novo summary (DEN200069): Cognoa ASD Diagnosis Aid. https://www.accessdata.fda.gov/cdrh_docs/pdf20/DEN200069.pdf (2020).</Citation></Reference><Reference><Citation>Shenoy, P. &amp; Harugeri, A. Elderly patients&#x2019; participation in clinical trials. Perspect. Clin. Res.6, 184&#x2013;187 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4640010</ArticleId><ArticleId IdType="pubmed">26623388</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC), National Center for Health (NIH) Statistics. Older adult health. https://www.cdc.gov/nchs/fastats/older-american-health.htm (2024).</Citation></Reference><Reference><Citation>World Health Organization (WHO). Global report on ageism. https://iris.who.int/bitstream/handle/10665/340208/9789240016866-eng.pdf?sequence=1 (2021).</Citation></Reference><Reference><Citation>Rudnicka, E. et al. The World Health Organization (WHO) approach to healthy ageing. Maturitas139, 6&#x2013;11 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250103</ArticleId><ArticleId IdType="pubmed">32747042</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury, A., Renjilian, E. &amp; Asan, O. Use of machine learning in geriatric clinical care for chronic diseases: a systematic literature review. JAMIA Open.3, 459&#x2013;471 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660963</ArticleId><ArticleId IdType="pubmed">33215079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard, M. A., Clayton, J. A. &amp; Lauer, M. S. Inclusion across the lifespan: NIH policy for clinical research. JAMA320, 1535&#x2013;1536 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30326521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau, S. W. et al. Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019. JAMA Netw. Open.5, e2236149 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568796</ArticleId><ArticleId IdType="pubmed">36239939</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitkala, K. H. &amp; Strandberg, T. E. Clinical trials in older people. Age Ageing51, afab282 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9080968</ArticleId><ArticleId IdType="pubmed">35526845</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: NeuroRPM [Premarket notification submission K221772]. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221772.pdf (2022).</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: icobrain [Premarket notification submission K192130]. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192130.pdf (2019).</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: Knee OsteoArthritis Labeling Assistant (KOALA) [Premarket notification submission K192109]. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192109.pdf (2019).</Citation></Reference><Reference><Citation>De Hond, A. A. H. et al. Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review. npj Digital Med.5, 2 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748878</ArticleId><ArticleId IdType="pubmed">35013569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndubuisi, N. E. Noncommunicable diseases prevention in low- and middle-income countries: an overview of health in all policies (HiAP). Inquiry58, 46958020927885 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385577</ArticleId><ArticleId IdType="pubmed">34420412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathers, C. D. &amp; Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med.3, e442 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1664601</ArticleId><ArticleId IdType="pubmed">17132052</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Action Plan for the Prevention and Control of Noncommunicable Diseases, 2013&#x2013;2020 (World Health Organization, 2013).</Citation></Reference><Reference><Citation>Ciecierski-Holmes, T., Singh, R., Axt, M., Brenner, S. &amp; Barteit, S. Artificial intelligence for strengthening healthcare systems in low- and middle-income countries: a systematic scoping review. Npj Digital Med.5, 162 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614192</ArticleId><ArticleId IdType="pubmed">36307479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tappero, J. W. et al. US Centers for Disease Control and Prevention and its partners&#x2019; contributions to global health security. Emerg. Infect. Dis.23, S5&#x2013;S14 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711315</ArticleId><ArticleId IdType="pubmed">29155656</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah, L. et al. Assessment of performance, interpretability, and explainability in artificial intelligence-based health technologies: what healthcare stakeholders need to know. Mayo Clin. Proc. Digit. Health1, 120&#x2013;138 (2023).</Citation></Reference><Reference><Citation>Amann, J. et al. To explain or not to explain?&#x2014;Artificial intelligence explainability in clinical decision support systems. PLoS Digit. Health1, e0000016 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931364</ArticleId><ArticleId IdType="pubmed">36812545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyaraman, M., Balaji, S., Jeyaraman, N. &amp; Yadav, S. Unraveling the ethical enigma: artificial intelligence in healthcare. Cureus15, e43262 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10492220</ArticleId><ArticleId IdType="pubmed">37692617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sounderajah, V. et al. Ethics methods are required as part of reporting guidelines for artificial intelligence in healthcare. Nat. Mach. Intell.4, 316&#x2013;317 (2022).</Citation></Reference><Reference><Citation>Char, D. S., Shah, N. H. &amp; Magnus, D. Implementing machine learning in health care&#x2014;addressing ethical challenges. N. Engl. J. Med.378, 981&#x2013;983 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962261</ArticleId><ArticleId IdType="pubmed">29539284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, K. &amp; Gattinger, G. The evolving regulatory paradigm of AI in MedTech: a review of perspectives and where we are today. Ther. Innov. Regul. Sci.58, 456&#x2013;464 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11043174</ArticleId><ArticleId IdType="pubmed">38528278</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). 510(k) summary: Brainomix 360 e-ASPECTS [Premarket notification submission K221564]. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221564.pdf (2022).</Citation></Reference><Reference><Citation>Gilbert, S. et al. Algorithm change protocols in the regulation of adaptive machine learning-based medical devices. J. Med. Internet Res.23, e30545 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8579211</ArticleId><ArticleId IdType="pubmed">34697010</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). Summary of Safety and Effectiveness (SSED) Template. 3&#x2013;16. https://www.fda.gov/media/113810/download (2024).</Citation></Reference><Reference><Citation>Abr&#xe0;moff, M. D. et al. Considerations for addressing bias in artificial intelligence for health equity. npj Digital Med.6, 170 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10497548</ArticleId><ArticleId IdType="pubmed">37700029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain, A. et al. Awareness of racial and ethnic bias and potential solutions to address bias with use of health care algorithms. JAMA Health Forum4, e231197 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10238944</ArticleId><ArticleId IdType="pubmed">37266959</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA). Premarket approval (PMA). https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-approval-pma (2019).</Citation></Reference><Reference><Citation>Tricco, A. C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med.169, 467&#x2013;473 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J. &amp; Denniston, A. K. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med.26, 1364&#x2013;1374 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598943</ArticleId><ArticleId IdType="pubmed">32908283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40291206</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of the Impact and Outcome of Loneliness and Self-Isolation on Individuals Living With Cardiovascular Disease.</ArticleTitle><Pagination><StartPage>e81277</StartPage><MedlinePgn>e81277</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e81277</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.81277</ELocationID><Abstract><AbstractText>Social isolation and loneliness seriously impact the physical and mental quality of health and longevity. Social isolation and loneliness are important yet neglected social determinants for people of all ages. Cardiovascular diseases (CVD) are among the leading causes of death globally, and loneliness has been linked to worsening outcomes of CVD. This review aims to evaluate the impact of loneliness/social/self-isolation among adults living with any cardiovascular disease. A systematic search was done from inception to 23rd January 2025 on PubMed and Google Scholar, and 4,198 articles were synthesized; these articles were screened for duplication, and the duplicate articles were removed. A total of 3,606 articles underwent title and abstract screening, and 3,505 articles were removed following the predefined eligibility criteria. One hundred and one articles underwent full-text screening, and only 13 articles were included for qualitative analysis. We included&#xa0;adults aged 18 and above living alone/socially isolated with any cardiovascular disease. This systematic review analyzed 13 studies across eight countries, encompassing 63,978 participants, of whom 12,110 were identified as living alone or socially isolated, 7,264 male and 3,745 female participants; one study included only male participants, while two studies didn't mention the number of male and female participants. The findings provide compelling evidence that loneliness is associated with adverse cardiovascular disease (CVD) outcomes, including increased mortality, recurrent cardiovascular events, and higher hospitalization rates. Addressing&#xa0;loneliness and social isolation should be a priority in cardiovascular disease prevention and management. Integrating social interventions could significantly improve the prognosis of individuals living with CVD, ultimately reducing morbidity and mortality rates in this vulnerable population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Okeke et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okeke</LastName><ForeName>Collins C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Surgery Interest Group of Africa, Lagos, NGA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, University of Port Harcourt, Rivers State, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Afe Babalola University, Ado Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngige</LastName><ForeName>Onyinye</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amuchie</LastName><ForeName>Chukwunomso C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>General Practice, Accra College of Medicine, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obi</LastName><ForeName>Chibuike F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Acute Medicine, Fairfield General Hospital, Bury, GBR.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Surgery Interest Group of Africa, Lagos, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charles</LastName><ForeName>Oyiyechukwu R</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Hematology, Delta State University Teaching Hospital, Oghara, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeocha</LastName><ForeName>Ifunanya R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konyeme</LastName><ForeName>Dumebi C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Paediatrics, Afe Babalola University, Ado Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idion</LastName><ForeName>Kris N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Internal Medicine, Delta State University Teaching Hospital, Oghara, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balogun</LastName><ForeName>Favour O</ForeName><Initials>FO</Initials><AffiliationInfo><Affiliation>Internal Medicine, James Paget University Hospital, Great Yarmouth, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onwuchekwa</LastName><ForeName>Ijeoma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Oncology, Royal Free Hospital, London, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugo-Ihanetu</LastName><ForeName>Euodia A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okafor</LastName><ForeName>Ginika S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Internal Medicine, Federal Teaching Hospital Ido-Ekiti, Ido-Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogona</LastName><ForeName>Davida E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Internal Medicine, Afe Babalola University, Ado Ekiti, NGA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology, Asaba Specialist Hospital, Okpanam, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okoye</LastName><ForeName>Chidera C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Internal Medicine, Asaba Specialist Hospital, Okpanam, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Igboanugo</LastName><ForeName>Somadila A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Cardiology, Rostov State Medical University, Rostov-on-Don, RUS.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">impact</Keyword><Keyword MajorTopicYN="N">loneliness</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">self-isolation</Keyword><Keyword MajorTopicYN="N">&#xa0;cardiovascular diseases</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>17</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>17</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40291206</ArticleId><ArticleId IdType="pmc">PMC12032856</ArticleId><ArticleId IdType="doi">10.7759/cureus.81277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO: Social isolation and loneliness.  [
Feb;
2025 
]. 2025. https://www.who.int/teams/social-determinants-of-health/demographic-change-and-healthy-ageing/social-isolation-and-loneliness https://www.who.int/teams/social-determinants-of-health/demographic-change-and-healthy-ageing/social-isolation-and-loneliness</Citation></Reference><Reference><Citation>Veazie S, Gilbert J, Winchell K, et al. Rockville: Agency for Healthcare Research and Quality; 2019. Addressing Social Isolation to Improve the Health of Older Adults: A Rapid Review.</Citation><ArticleIdList><ArticleId IdType="pubmed">30830728</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute on Aging: Loneliness and social isolation &#x2014; tips for staying connected.  [
Feb;
2025 
]. 2025. https://www.nia.nih.gov/health/loneliness-and-social-isolation/loneliness-and-social-isolation-tips-staying-connected https://www.nia.nih.gov/health/loneliness-and-social-isolation/loneliness-and-social-isolation-tips-staying-connected</Citation></Reference><Reference><Citation>WHO: Cardiovascular diseases.  [
Feb;
2025 
]. 2025. https://www.who.int/health-topics/cardiovascular-diseases https://www.who.int/health-topics/cardiovascular-diseases</Citation></Reference><Reference><Citation>Thiriet M. Vasculopathies. Vol. 8. Springer, Cham; 2019. Cardiovascular disease: an introduction; pp. 1&#x2013;90.</Citation></Reference><Reference><Citation>WHO: New advocacy brief highlights serious consequences of social isolation and loneliness on the health of older people, calls for greater political priority to the issue.  [
Feb;
2025 
];https://www.who.int/news/item/29-07-2021-new-advocacy-brief-highlights-serious-consequences-of-social-isolation-and-loneliness-on-the-health-of-older-people-calls-for-greater-political-priority-to-the-issue 2025 6:29&#x2013;27.</Citation></Reference><Reference><Citation>American Heart Association: Social isolation and loneliness increase the risk of death from heart attack, stroke.  [
Feb;
2025 
]. 2025. https://newsroom.heart.org/news/social-isolation-and-loneliness-increase-the-risk-of-death-from-heart-attack-stroke https://newsroom.heart.org/news/social-isolation-and-loneliness-increase-the-risk-of-death-from-heart-attack-stroke</Citation></Reference><Reference><Citation>Campaign to End Loneliness: Risk factors for loneliness.  [
Feb;
2025 
]. 2025. https://www.campaigntoendloneliness.org/risk-factors-for-loneliness/ https://www.campaigntoendloneliness.org/risk-factors-for-loneliness/</Citation></Reference><Reference><Citation>Risk factors of cardiovascular disease and their related socio-economical, environmental and health behavioral factors: focused on low-middle income countries- a narrative review article. Sun L Y, Lee E W, Zahra A, et al.  https://pmc.ncbi.nlm.nih.gov/articles/PMC4441956/ Iran J Public Health. 2015;44:435&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441956</ArticleId><ArticleId IdType="pubmed">26056662</ArticleId></ArticleIdList></Reference><Reference><Citation>Loneliness and social isolation: determinants of cardiovascular outcomes. Sharma T, Padala PR, Mehta JL. https://doi.org/10.2174/1573403X17666210129101845 Curr Cardiol Rev. 2021;17:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8950500</ArticleId><ArticleId IdType="pubmed">33511946</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayyan: Overview.  [
Feb;
2025 
]. 2025. https://new.rayyan.ai/reviews/1316152/overview https://new.rayyan.ai/reviews/1316152/overview</Citation></Reference><Reference><Citation>JBI: Critical appraisal tools.  [
Oct;
2024 
]. 2024. https://jbi.global/critical-appraisal-tools https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Impact of living alone on the care and outcomes of patients with ST-elevation myocardial infarction. Ohama A, Mizuguchi Y, Hashimoto S, et al.  https://doi.org/10.1016/j.jjcc.2019.11.005. J Cardiol. 2020;75:628&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">31866189</ArticleId></ArticleIdList></Reference><Reference><Citation>Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Brummett BH, Barefoot JC, Siegler IC, et al. Psychosom Med. 2001;63:267&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">11292274</ArticleId></ArticleIdList></Reference><Reference><Citation>Living alone and cardiovascular disease outcomes. Gandhi S, Goodman SG, Greenlaw N, et al. Heart. 2019;105:1087&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">30792241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular and all-cause mortality attributable to loneliness in older Swedish men and women. Novak M, Waern M, Johansson L, et al.  https://doi.org/10.1186/s12877-020-01603-x. BMC Geriatr. 2020;20:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285599</ArticleId><ArticleId IdType="pubmed">32517656</ArticleId></ArticleIdList></Reference><Reference><Citation>Social isolation, loneliness, and all-cause mortality in patients with cardiovascular disease: a 10-year follow-up study. Yu B, Steptoe A, Chen LJ, et al.  https://doi.org/10.1097/PSY.0000000000000777. Psychosom Med. 2020;82:208&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">31842061</ArticleId></ArticleIdList></Reference><Reference><Citation>Perceived loneliness and social support in patients with chronic heart failure. L&#xf6;fvenmark C, Mattiasson AC, Billing E, Edner M. https://doi.org/10.1016/j.ejcnurse.2009.05.001. Eur J Cardiovasc Nurs. 2009;8:251&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">19539533</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of living alone on the care and outcomes of patients with acute stroke. Reeves MJ, Prager M, Fang J, et al.  https://doi.org/10.1161/STROKEAHA.114.006520. Stroke. 2014;45:3083&#x2013;3085.</Citation><ArticleIdList><ArticleId IdType="pubmed">25139877</ArticleId></ArticleIdList></Reference><Reference><Citation>The effects of loneliness and social isolation on all-cause, injury, cancer, and CVD mortality in a cohort of middle-aged Finnish men. A prospective study. Kraav SL, Awoyemi O, Junttila N, et al.  https://doi.org/10.1080/13607863.2020.1830945. Aging Ment Health. 2021;25:2219&#x2013;2228.</Citation><ArticleIdList><ArticleId IdType="pubmed">33939562</ArticleId></ArticleIdList></Reference><Reference><Citation>Living alone and risk of cardiovascular events following discharge after acute myocardial infarction in Japan. Kitamura T, Sakata Y, Nakatani D, et al.  https://doi.org/10.1016/j.jjcc.2013.04.009. J Cardiol. 2013;62:257&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">23778005</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors and prognostic impact of unwanted loneliness in heart failure. Benito T, Zaharia G, P&#xe9;rez A, et al. Sci Rep. 2024;14:22229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11436651</ArticleId><ArticleId IdType="pubmed">39333672</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic value of objective social isolation and loneliness in older patients with heart failure: subanalysis of FRAGILE-HF and Kitasato cohort. Saito H, Maeda D, Kagiyama N, et al.  https://doi.org/10.1161/JAHA.123.032716 J Am Heart Assoc. 2024;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179817</ArticleId><ArticleId IdType="pubmed">38726923</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic value of a brief loneliness questionnaire for patients with coronary heart disease: proposal for a prediction model. Blakoe M, Christensen AV, Palm P, et al.  https://doi.org/10.1111/jocn.16023. J Clin Nurs. 2022;31:1686&#x2013;1696.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473870</ArticleId></ArticleIdList></Reference><Reference><Citation>Living alone after myocardial infarction. Impact on prognosis. Case RB, Moss AJ, Case N, et al.  https://pubmed.ncbi.nlm.nih.gov/1729573/ JAMA. 1992;267:515&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">1729573</ArticleId></ArticleIdList></Reference><Reference><Citation>Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Valtorta NK, Kanaan M, Gilbody S, et al.  https://doi.org/10.1136/heartjnl-2015-308790. Heart. 2016;102:1009&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941172</ArticleId><ArticleId IdType="pubmed">27091846</ArticleId></ArticleIdList></Reference><Reference><Citation>Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Holt-Lunstad J, Smith TB, Baker M, et al.  https://doi.org/10.1177/1745691614568352. Perspect Psychol Sci. 2015;10:227&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">25910392</ArticleId></ArticleIdList></Reference><Reference><Citation>Social relationships and health: the toxic effects of perceived social isolation. Cacioppo JT, Cacioppo S. https://doi.org/10.1111/spc3.12087. Soc Personal Psychol Compass. 2014;8:58&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4021390</ArticleId><ArticleId IdType="pubmed">24839458</ArticleId></ArticleIdList></Reference><Reference><Citation>Social support and quality of life in patients with coronary artery disease. Bosworth H B, Siegler I C, Olsen M K, et al. Qua Lif Res. 2000;9:829&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pubmed">11297025</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients. Wang X, Ma H, Li X, et al. Eur Heart J. 2023;44:2583&#x2013;2591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10361009</ArticleId><ArticleId IdType="pubmed">37385629</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis. Angerer P, Siebert U, Kothny W, et al. Jr Ame Col Car. 36:1781&#x2013;1788.</Citation><ArticleIdList><ArticleId IdType="pubmed">11092644</ArticleId></ArticleIdList></Reference><Reference><Citation>The association between loneliness, social isolation and inflammation: A systematic review and meta-analysis. Smith KJ, Gavey S, RIddell NE, et al.  https://doi.org/10.1016/j.neubiorev.2020.02.002. Neurosci Biobehav Rev. 2020;112:519&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">32092313</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosocial factors and cardiovascular diseases. Everson-Rose SA, Lewis TT. https://doi.org/10.1146/annurev.publhealth.26.021304.144542. Annu Rev Public Health. 2005;26:469&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">15760298</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerotic Cardiovascular Risk in Japan. Nojiri S, Daida H. https://doi.org/10.1177/1179066017712713. Jpn Clin Med. 2017;8:1179066017712713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480958</ArticleId><ArticleId IdType="pubmed">28680271</ArticleId></ArticleIdList></Reference><Reference><Citation>Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women. Hakulinen C, Pulkki-R&#xe5;back L, Virtanen M, et al.  https://doi.org/10.1136/heartjnl-2017-312663. Heart. 2018;104:1536&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pubmed">29588329</ArticleId></ArticleIdList></Reference><Reference><Citation>Social isolation, loneliness, and all-cause mortality in older men and women. Steptoe A, Shankar A, Demakakos P, Wardle J. https://doi.org/10.1073/pnas.1219686110. Proc Natl Acad Sci U S A. 2013;110:5797&#x2013;5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3625264</ArticleId><ArticleId IdType="pubmed">23530191</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of inflammation in cardiovascular disease. Henein MY, Vancheri S, Longo G, Vancheri F. Int J Mol Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9658900</ArticleId><ArticleId IdType="pubmed">36361701</ArticleId></ArticleIdList></Reference><Reference><Citation>Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. Udell JA, Steg PG, Scirica BM, et al.  https://doi.org/10.1001/archinternmed.2012.2782. Arch Intern Med. 2012;172:1086&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">22711020</ArticleId></ArticleIdList></Reference><Reference><Citation>Correlates and predictors of loneliness in older-adults: a review of quantitative results informed by qualitative insights. Cohen-Mansfield J, Hazan H, et al.  https://doi.org/10.1017/S1041610215001532. Int Psychogeriatr. 2016;28:557&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pubmed">26424033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37747485</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-713X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Simulation in healthcare : journal of the Society for Simulation in Healthcare</Title><ISOAbbreviation>Simul Healthc</ISOAbbreviation></Journal><ArticleTitle>A Prospective Randomized Controlled Pilot Simulation Study to Investigate the Effect of Audiovisual Decision Support on Diagnosis and Therapeutic Interventions.</ArticleTitle><Pagination><StartPage>281</StartPage><EndPage>286</EndPage><MedlinePgn>281-286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SIH.0000000000000749</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Combining audiovisual decision support during perioperative critical events might enhance provider diagnostic and therapeutic accuracy and efficiency.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study is a prospective, randomized controlled pilot trial studying the impact of audiovisual decision support on anesthesia professional performance at NorthShore University HealthSystem's high fidelity simulation center. Twenty anesthesia professionals (&gt;2 years of clinical experience in the current role) were randomized to 2 groups (current care model vs. audiovisual assistance) and underwent 3 periprocedural simulation scenarios, where patient deterioration occurs: anaphylaxis, amniotic fluid embolism, and cardiac arrest during dental case.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, there was a statistically significant decrease in the mean and median pooled times to diagnosis in both the amniotic fluid embolism and pediatric dental scenarios. There was a statistically significant increase in the number of participants in the intervention group who made diagnosis 3 before the end of the scene ( P = 0.03) in the amniotic fluid embolism case. In the pediatric dental case, there was a statistically significant reduction in the median time to diagnosis 1 and diagnosis 3 in the intervention group versus control ( P = 0.01 and P = 0.0002). A significant increase in the number of participants in the intervention group versus control made the correct diagnosis 2 before vital sign change 3 ( P = 0.03), and more participants in the intervention group made the correct diagnosis 3 before the end of the scene when compared with control ( P = 0.001). The median time to start intervention 2 during the dental case was statistically significantly greater in the intervention group versus the control ( P = 0.05). All other endpoints were not statistically significant among the 3 simulation scenarios. Six questions were answered by all participants upon immediate completion of the simulation scenarios and revealed that 19 of 20 participants had delivered anesthesia care to patients similar to the 3 simulation scenarios and 18 of 20 participants reported that they would prefer audiovisual assistance to detect abnormalities in vital signs that subsequently provides appropriate diagnostic and therapeutic options.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pilot study suggested some significant improvement in anesthesia professional time to correct diagnosis and completion of identification of the correct diagnosis before the next vital change in the audiovisual cue group versus control, particularly in the outpatient dental case. In addition, the mean and median pooled times to diagnosis were significantly reduced by approximately 1 minute in both evaluated simulation scenarios. The postsimulation survey responses also suggest the desirability of an audiovisual decision support tool among the current anesthesia professional participants. However, overall, there were no significant differences in the time to intervention between groups in all simulation scenarios.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Society for Simulation in Healthcare.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Steven B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>From the NorthShore University HealthSystem (S.B.G., N.B-I., J.C., C.W., C.G.), Evanston, IL; University of Chicago Pritzker School of Medicine (S.B.G.), Chicago, IL; University of Arizona College of Medicine (S.B.), Tucson, AZ; The Mayo Clinic College of Medicine and Science (T.F.D.), Rochester, MN; and Harvard Medical School (F.S.), Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Isvy</LastName><ForeName>Noah</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Cram</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chi</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Dagi</LastName><ForeName>T Forcht</ForeName><Initials>TF</Initials></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Candy</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Fred</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Simul Healthc</MedlineTA><NlmUniqueID>101264408</NlmUniqueID><ISSNLinking>1559-2332</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001296" MajorTopicYN="Y">Audiovisual Aids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="N">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066908" MajorTopicYN="N">Simulation Training</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: Steven Greenberg is the current Editor of the Anesthesia Patient Safety Foundation (APSF) and Secretary of the APSF and has received grants from Merck and Cook Medical for research unrelated to the present topic. Noah Ben-Isvy, John Cram, Chi Wang, Candy Gonzalez, and T. Forcht Dagi declare no conflict of interest. Steven Barker serves as the Chief Science Officer of Massimo and director of the Patient Safety Movement Foundation. Fred Shapiro is a consultant for Fresenius-Kabi, USA, and is on the advisory board for GE Healthcare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37747485</ArticleId><ArticleId IdType="doi">10.1097/SIH.0000000000000749</ArticleId><ArticleId IdType="pii">01266021-202410000-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kent CD, Metzner JI, Domino KB. Anesthesia hazards: lessons from the anesthesia closed claims project. Int Anesthesiol Clin 2020;58(1):7&#x2013;12. doi:10.1097/AIA.0000000000000256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0000000000000256</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DM, Peden CJ, Langness SM, et al. The Anesthesia Patient Safety Foundation Stoelting Conference 2019: perioperative deterioration-early recognition, rapid intervention, and the end of failure-to-rescue. Anesth Analg 2020;131(3):e155&#x2013;e159. doi:10.1213/ANE.0000000000005008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld JM, Rehman MA. Anesthesia information management systems: a review of functionality and installation considerations. J Clin Monit Comput 2011;25:71&#x2013;79. doi:10.1007/s10877-010-9256-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-010-9256-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the lee cardiac risk index. Am J Med 2005;118:1134&#x2013;1141. doi:10.1016/j.amjmed.2005.01.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.01.064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med 2003;348:2526&#x2013;2534. doi:10.1056/NEJMsa0208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa0208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooij FO, Klok T, Hollmann MW, Kal JE. Decision support increases guideline adherence for prescribing postoperative nausea and vomiting prophylaxis. Anesth Analg 2008;106(3):893&#x2013;898. doi:10.1213/ane.0b013e31816194fb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31816194fb</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy MD, Hand WR, Stiegler MP, et al. A smartphone-based decision support tool improves test performance concerning application of the guidelines for managing regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. Anesthesiology 2016;124(1):186&#x2013;198. doi:10.1097/ALN.0000000000000885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000885</ArticleId></ArticleIdList></Reference><Reference><Citation>US outpatient surgical procedures market by surgical procedure type, patient care setting&#x2014;US forecast to 2023. January 2019. https://www.researchandmarkets.com/research/tfnm9z/united_states?w=5 . Accessed April 16, 2021.</Citation></Reference><Reference><Citation>Campbell G, Arfanis K, Smith AF. Distraction and interruption in anaesthetic practice. Br J Anaesth 2012;109(5):707&#x2013;715. doi:10.1093/bja/aes219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt EA, Heine M, Shilkofski NS, et al. Exploration of the impact of a voice activated decision support system (VADSS) with video on resuscitation performance by lay rescuers during simulated cardiopulmonary arrest. Emerg Med J 2015;32(3):189&#x2013;194. doi:10.1136/emermed-2013-202867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2013-202867</ArticleId></ArticleIdList></Reference><Reference><Citation>Faiola A, Belkacem I, Bergey D, Pecci I, Martin B. Towards the design of a smart glasses application for MICU decision-support: assessing the human factors impact of data portability &amp; accessibility. Proc Int Symp Hum Factors Ergon Healthc 2019;8(1):52&#x2013;56. doi:10.1177/2327857919081012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2327857919081012</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison TK, Manser T, Howard SK, Gaba DM. Use of cognitive aids in a simulated anesthetic crisis. Anesth Analg 2006;103(3):551&#x2013;556. doi:10.1213/01.ane.0000229718.02478.c4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000229718.02478.c4</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37526249</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2058-5241</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>EFORT open reviews</Title><ISOAbbreviation>EFORT Open Rev</ISOAbbreviation></Journal><ArticleTitle>Insufficient evidence to confirm benefit of adjuvant distal clavicle resection during rotator cuff repair: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>615</StartPage><EndPage>625</EndPage><MedlinePgn>615-625</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1530/EOR-22-0101</ELocationID><Abstract><AbstractText>The aim of this study is to determine whether adjuvant Distal Clavicle Resection (DCR) improves outcomes of Rotator Cuff Repair (RCR) in terms of ROM, clinical scores as well as reducing complications and/or reoperations. This systematic review conforms to the PRISMA guidelines. Studies were included if they compared outcomes of RCR with and without adjuvant DCR and reported on postoperative ROM, clinical scores, complications, and/or reoperations. Seven studies that comprised 1572 shoulders which underwent RCR at a follow-up ranged 8-54 months: 398 with adjuvant DCR and 1174 without DCR. No significant differences were found between patients that had DCR versus those that did not have DCR, in terms of postoperative clinical scores (ASES, Constant, pVAS), postoperative ROM (AFE, external and internal rotation), retear rate and reoperation rate. There were no significant differences in ROM, clinical scores, or rates of retears and reoperations between patients that underwent RCR with or without adjuvant DCR. There is insufficient evidence to support routine DCR during RCR; the incidence of new or residual acromioclavicular joint (ACJ) pain after RCR with adjuvant DCR is higher than following isolated RCR, which could in fact induce iatrogenic morbidity and therefore does not justify the additional surgery time and costs of routine adjuvant DCR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barth</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinique des C&#xe8;dres, 21 Avenue Albert Londres, 38130 &#xc9;chirolles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garret</LastName><ForeName>Jer&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinique du parc, 155, Boulevard Stalingrad, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nover</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ReSurg SA, Rue Saint Jean 22, Nyon, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rooij</LastName><ForeName>Floris</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3513-0599</Identifier><AffiliationInfo><Affiliation>ReSurg SA, Rue Saint Jean 22, Nyon, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clavert</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Chirurgie du Membre Sup&#xe9;rieur, Haut Pierre 2, CHRU Strasbourg, avenue Moli&#xe8;re, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Soci&#xe9;t&#xe9; Francophone d'Arthroscopie</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EFORT Open Rev</MedlineTA><NlmUniqueID>101695674</NlmUniqueID><ISSNLinking>2058-5241</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clavicle resection</Keyword><Keyword MajorTopicYN="N">clinical scores</Keyword><Keyword MajorTopicYN="N">range of motion</Keyword><Keyword MajorTopicYN="N">rotator cuff repair</Keyword><Keyword MajorTopicYN="N">shoulder</Keyword><Keyword MajorTopicYN="N">tendon tear</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37526249</ArticleId><ArticleId IdType="pmc">PMC10441254</ArticleId><ArticleId IdType="doi">10.1530/EOR-22-0101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell C Adebajo A Hay E &amp; Carr A. Shoulder pain: diagnosis and management in primary care. BMJ 20053311124&#x2013;1128. (10.1136/bmj.331.7525.1124)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.331.7525.1124</ArticleId><ArticleId IdType="pmc">PMC1283277</ArticleId><ArticleId IdType="pubmed">16282408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozer M Ataoglu MB Cetinkaya M Ayanoglu T Kaptan AY &amp; Kanatli U. Do intra-articular pathologies accompanying symptomatic acromioclavicular joint degeneration vary across age groups? Eklem Hastalik Cerrahisi 2019302&#x2013;9. (10.5606/ehc.2019.62431)</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/ehc.2019.62431</ArticleId><ArticleId IdType="pubmed">30885102</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YB Koh KH Shon MS Park YE &amp; Yoo JC. Arthroscopic distal clavicle resection in symptomatic acromioclavicular joint arthritis combined with rotator cuff tear: a prospective randomized trial. American Journal of Sports Medicine 201543985&#x2013;990. (10.1177/0363546514563911)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546514563911</ArticleId><ArticleId IdType="pubmed">25583758</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersson CJ &amp; Gentz CF. Ruptures of the supraspinatus tendon. The significance of distally pointing acromioclavicular osteophytes. Clinical Orthopaedics and Related Research 1983174143&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">6831797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohmann E Tetsworth K &amp; Glatt V. Open versus arthroscopic acromioclavicular joint resection: a systematic review and meta-analysis. Archives of Orthopaedic and Trauma Surgery 2019139685&#x2013;694. (10.1007/s00402-019-03114-w)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-019-03114-w</ArticleId><ArticleId IdType="pubmed">30637505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mall NA Foley E Chalmers PN Cole BJ Romeo AA &amp; Bach BR. Degenerative joint disease of the acromioclavicular joint: a review. American Journal of Sports Medicine 2013412684&#x2013;2692. (10.1177/0363546513485359)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546513485359</ArticleId><ArticleId IdType="pubmed">23649008</ArticleId></ArticleIdList></Reference><Reference><Citation>Menge TJ Boykin RE Bushnell BD &amp; Byram IR. Acromioclavicular osteoarthritis: a common cause of shoulder pain. Southern Medical Journal 2014107324&#x2013;329. (10.1097/SMJ.0000000000000101)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SMJ.0000000000000101</ArticleId><ArticleId IdType="pubmed">24937735</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasiak A Mojzesz M Brzoska R Solecki W &amp; Binkowska A. Results of arthroscopic treatment of rotator cuff tear with the resection of symptomatic acromioclavicular joint with degenerative changes. Polish Orthopedics and Traumatology 201378229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">24231671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallinet D, Barth J, Labattut L, Collin P, Metais P, Bonnevialle N, Godeneche A, Garret J, Clavert P. &amp; Francophone Arthroscopy Society (SFA). Benefits of distal clavicle resection during rotator cuff repair: prospective randomized single-blind study. Orthopaedics and Traumatology, Surgery and Research 2020106S207&#x2013;S211. (10.1016/j.otsr.2020.08.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2020.08.006</ArticleId><ArticleId IdType="pubmed">32943383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J Chung J &amp; Ok H. Asymptomatic acromioclavicular joint arthritis in arthroscopic rotator cuff tendon repair: a prospective randomized comparison study. Archives of Orthopaedic and Trauma Surgery 2011131363&#x2013;369. (10.1007/s00402-010-1216-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-010-1216-y</ArticleId><ArticleId IdType="pubmed">21161250</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh JH Kim JY Choi JH &amp; Park SM. Is arthroscopic distal clavicle resection necessary for patients with radiological acromioclavicular joint arthritis and rotator cuff tears? A prospective randomized comparative study. American Journal of Sports Medicine 2014422567&#x2013;2573. (10.1177/0363546514547254)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546514547254</ArticleId><ArticleId IdType="pubmed">25193889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J Ma JX Zhu SW Jia HB &amp; Ma XL. Does distal clavicle resection decrease pain or improve shoulder function in patients with acromioclavicular joint arthritis and rotator cuff tears? A meta-analysis. Clinical Orthopaedics and Related Research 20184762402&#x2013;2414. (10.1097/CORR.0000000000000424)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CORR.0000000000000424</ArticleId><ArticleId IdType="pmc">PMC6259902</ArticleId><ArticleId IdType="pubmed">30334833</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingstone A Asaid R &amp; Moaveni AK. Is routine distal clavicle resection necessary in rotator cuff repair surgery? A systematic review and meta-analysis. Shoulder and Elbow 201911(1) 39&#x2013;45. (10.1177/1758573217741124)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1758573217741124</ArticleId><ArticleId IdType="pmc">PMC6463380</ArticleId><ArticleId IdType="pubmed">31019561</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011343 d5928. (10.1136/bmj.d5928)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021372 n71. (10.1136/bmj.n71)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns PB Rohrich RJ &amp; Chung KC. The levels of evidence and their role in evidence-based medicine. Plastic and Reconstructive Surgery 2011128305&#x2013;310. (10.1097/PRS.0b013e318219c171)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e318219c171</ArticleId><ArticleId IdType="pmc">PMC3124652</ArticleId><ArticleId IdType="pubmed">21701348</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z Barker TH Moola S Tufanaru C Stern C McArthur A Stephenson M &amp; Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evidence Synthesis 2020182127&#x2013;2133. (10.11124/JBISRIR-D-19-00099)</Citation><ArticleIdList><ArticleId IdType="doi">10.11124/JBISRIR-D-19-00099</ArticleId><ArticleId IdType="pubmed">33038125</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber T Ravaud P Riveros C Perrodeau E &amp; Dechartres A. Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review. BMC Medical Research Methodology 201616 35. (10.1186/s12874-016-0136-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0136-0</ArticleId><ArticleId IdType="pmc">PMC4804609</ArticleId><ArticleId IdType="pubmed">27004721</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S Rucker G &amp; Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evidence-Based Mental Health 201922153&#x2013;160. (10.1136/ebmental-2019-300117)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers PN Granger E Ross H Burks RT &amp; Tashjian RZ. Preoperative factors associated with subsequent distal clavicle resection after rotator cuff repair. Orthopaedic Journal of Sports Medicine 201972325967119844295. (10.1177/2325967119844295)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325967119844295</ArticleId><ArticleId IdType="pmc">PMC6498781</ArticleId><ArticleId IdType="pubmed">31080842</ArticleId></ArticleIdList></Reference><Reference><Citation>Razmjou H ElMaraghy A Dwyer T Fournier-Gosselin S Devereaux M &amp; Holtby R. Outcome of distal clavicle resection in patients with acromioclavicular joint osteoarthritis and full-thickness rotator cuff tear. Knee Surgery, Sports Traumatology, Arthroscopy 201523585&#x2013;590. (10.1007/s00167-014-3114-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-014-3114-2</ArticleId><ArticleId IdType="pubmed">24923688</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliberti GM Kraeutler MJ Trojan JD &amp; Mulcahey MK. Horizontal instability of the acromioclavicular joint: a systematic review. American Journal of Sports Medicine 202048504&#x2013;510. (10.1177/0363546519831013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546519831013</ArticleId><ArticleId IdType="pubmed">31013137</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JH Malik AT Hatef S Neviaser AS Bishop JY &amp; Cvetanovich GL. Cost of arthroscopic rotator cuff repairs is primarily driven by procedure-level factors: a single-institution analysis of an ambulatory surgery center. Arthroscopy 2021371075&#x2013;1083. (10.1016/j.arthro.2020.11.033)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2020.11.033</ArticleId><ArticleId IdType="pubmed">33242633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabesan VJ Shahriar R Chatha K Malone DL Sherwood A Peaguda CF &amp; Whaley JD. Factors affecting the cost and profitability of arthroscopic rotator cuff repair. Arthroscopy 20193538&#x2013;42. (10.1016/j.arthro.2018.07.034)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2018.07.034</ArticleId><ArticleId IdType="pubmed">30473452</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly AR Rajasekaran S &amp; Ashworth N. Ultrasound-guided shoulder girdle injections are more accurate and more effective than landmark-guided injections: a systematic review and meta-analysis. British Journal of Sports Medicine 2015491042&#x2013;1049. (10.1136/bjsports-2014-093573)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2014-093573</ArticleId><ArticleId IdType="pubmed">25403682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannakopoulos CK Vlastos I Theotokatos G &amp; Galanis N. Acromioclavicular joint arthritis is not an indication for routine distal clavicle excision in arthroscopic rotator cuff repair. Knee Surgery, Sports Traumatology, Arthroscopy 2021292090&#x2013;2095. (10.1007/s00167-020-06098-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06098-y</ArticleId><ArticleId IdType="pubmed">32556365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shubin Stein BE Wiater JM Pfaff HC Bigliani LU &amp; Levine WN. Detection of acromioclavicular joint pathology in asymptomatic shoulders with magnetic resonance imaging. Journal of Shoulder and Elbow Surgery 200110204&#x2013;208. (10.1067/mse.2001.113498)</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mse.2001.113498</ArticleId><ArticleId IdType="pubmed">11408899</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler F Mocini F Djemeto DT Cattaneo S Saccomanno MF &amp; Milano G. No differences between conservative and surgical management of acromioclavicular joint osteoarthritis: a scoping review. Knee Surgery, Sports Traumatology, Arthroscopy 2021292194&#x2013;2201. (10.1007/s00167-020-06377-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06377-8</ArticleId><ArticleId IdType="pubmed">33386878</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell G Watson L &amp; Devan H. Current evidence for nonpharmacological interventions and criteria for surgical management of persistent acromioclavicular joint osteoarthritis: a systematic review. Shoulder and Elbow 201911395&#x2013;410. (10.1177/1758573219840673)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1758573219840673</ArticleId><ArticleId IdType="pmc">PMC7094063</ArticleId><ArticleId IdType="pubmed">32269599</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39300723</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2234-5248</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of minimally invasive surgery</Title><ISOAbbreviation>J Minim Invasive Surg</ISOAbbreviation></Journal><ArticleTitle>Analyzing the emergence of surgical robotics in Africa: a scoping review of pioneering procedures, platforms utilized, and outcome meta-analysis.</ArticleTitle><Pagination><StartPage>142</StartPage><EndPage>155</EndPage><MedlinePgn>142-155</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7602/jmis.2024.27.3.142</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Surgical practice globally has undergone significant advancements with the advent of robotic systems. In Africa, a similar trend is emerging with the introduction of robots into various surgical specialties in certain countries. The need to review the robotic procedures performed, platforms utilized, and analyze outcomes such as conversion, morbidity, and mortality associated with robotic surgery in Africa, necessitated this study. This is the first study examining the status and outcomes of robotic surgery in Africa.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A thorough scoping search was performed in PubMed, Google Scholar, Web of Science, and African Journals Online. Of the 1,266 studies identified, 16 studies across 3 countries met the inclusion criteria. A meta-analysis conducted using R statistical software estimated the pooled prevalences with the 95% confidence interval (CI) of conversion, morbidity, and mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Surgical robots are reportedly in use in South Africa, Egypt, and Tunisia. Across four specialties, 1,328 procedures were performed using da Vinci (Intuitive Surgical), Versius (CMR Surgical), and Senhance (Asensus Surgical) surgical robotic platforms. Urological procedures (90.1%) were the major procedures performed, with robotic prostatectomy (49.3%) being the most common procedure. The pooled rate of conversion and prevalence of morbidity from the meta-analysis was 0.21% (95% CI, 0%-0.54%) and 21.15% (95% CI, 7.45%-34.85%), respectively. There was no reported case of mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The outcomes highlight successful implementation and the potential for wider adoption. Based on our findings, we advocate for multidisciplinary and multinational collaboration, investment in surgical training programs, and policy initiatives aimed at addressing barriers to the widespread adoption of robotic surgery in Africa.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falola</LastName><ForeName>Adebayo Feranmi</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-9509-4844</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dada</LastName><ForeName>Oluwasina Samuel</ForeName><Initials>OS</Initials><Identifier Source="ORCID">0000-0002-1056-3742</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1739-5013</Identifier><AffiliationInfo><Affiliation>Significant Polyp and Early Colorectal Cancer (SPECC) Service, King's College Hospital, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Ilorin Teaching Hospital, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezebialu</LastName><ForeName>Chioma Ogechukwu</ForeName><Initials>CO</Initials><Identifier Source="ORCID">0009-0004-9792-0838</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fadairo</LastName><ForeName>Rhoda Tolulope</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0009-0002-0514-7864</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okere</LastName><ForeName>Madeleine Oluomachi</ForeName><Initials>MO</Initials><Identifier Source="ORCID">0000-0001-5120-7851</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, College of Medicine, University of Port Harcourt, Choba, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndong</LastName><ForeName>Abdourahmane</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8103-1375</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Gaston Berger University, Saint-Louis, Senegal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Minim Invasive Surg</MedlineTA><NlmUniqueID>101585410</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Minimally invasive surgical procedures</Keyword><Keyword MajorTopicYN="N">Robotic surgical procedures</Keyword></KeywordList><CoiStatement>
<b>Conflict of interest</b>
. All authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>11</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>11</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39300723</ArticleId><ArticleId IdType="pmc">PMC11416894</ArticleId><ArticleId IdType="doi">10.7602/jmis.2024.27.3.142</ArticleId><ArticleId IdType="pii">jmis.2024.27.3.142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Camarillo DB, Krummel TM, Salisbury JK. Robotic technology in surgery: past, present, and future. Am J Surg. 2004;188:2S&#x2013;15S. doi: 10.1016/j.amjsurg.2004.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2004.08.025</ArticleId><ArticleId IdType="pubmed">15476646</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairag M, Almahdi RH, Siddiqi AA, et al. Robotic revolution in surgery: diverse applications across specialties and future prospects review article. Cureus. 2024;16:e52148. doi: 10.7759/cureus.52148.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.52148</ArticleId><ArticleId IdType="pmc">PMC10858995</ArticleId><ArticleId IdType="pubmed">38344598</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Gharde P, Tayade H, Patil M, Reddy LS, Surya D. Advancements in robotic surgery: a comprehensive overview of current utilizations and upcoming frontiers. Cureus. 2023;15:e50415. doi: 10.7759/cureus.50415.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.50415</ArticleId><ArticleId IdType="pmc">PMC10784205</ArticleId><ArticleId IdType="pubmed">38222213</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters BS, Armijo PR, Krause C, Choudhury SA, Oleynikov D. Review of emerging surgical robotic technology. Surg Endosc. 2018;32:1636&#x2013;1655. doi: 10.1007/s00464-018-6079-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-018-6079-2</ArticleId><ArticleId IdType="pubmed">29442240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwoh YS, Hou J, Jonckheere EA, Hayati S. A robot with improved absolute positioning accuracy for CT guided stereotactic brain surgery. IEEE Trans Biomed Eng. 1988;35:153&#x2013;160. doi: 10.1109/10.1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/10.1354</ArticleId><ArticleId IdType="pubmed">3280462</ArticleId></ArticleIdList></Reference><Reference><Citation>Boal M, Di Girasole CG, Tesfai F, et al. Evaluation status of current and emerging minimally invasive robotic surgical platforms. Surg Endosc. 2024;38:554&#x2013;585. doi: 10.1007/s00464-023-10554-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-023-10554-4</ArticleId><ArticleId IdType="pmc">PMC10830826</ArticleId><ArticleId IdType="pubmed">38123746</ArticleId></ArticleIdList></Reference><Reference><Citation>Millan B, Nagpal S, Ding M, Lee JY, Kapoor A. A scoping review of emerging and established surgical robotic platforms with applications in urologic surgery. Soc Int Urol J. 2021;2:300&#x2013;310. doi: 10.48083/EWWQ2677.</Citation><ArticleIdList><ArticleId IdType="doi">10.48083/EWWQ2677</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers CP, Maggard-Gibbons M. Estimation of the acquisition and operating costs for robotic surgery. JAMA. 2018;320:835&#x2013;836. doi: 10.1001/jama.2018.9219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.9219</ArticleId><ArticleId IdType="pmc">PMC6142989</ArticleId><ArticleId IdType="pubmed">30167686</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager S, Howlett J, Bruwer G, Moolman C. Analysis of the learning curve in robotic-assisted laparoscopic radical prostatectomy in a South African setting. Afr Urol. 2021;1:19&#x2013;24. doi: 10.36303/AUJ.2021.1.1.0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.36303/AUJ.2021.1.1.0002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaghloul A, Abdelbary A, Fergany A, Aboulkassem H, Fadlalla WM. Robotic radical prostatectomy at the Egyptian National Cancer Institute: overcoming the challenges in the initial case series. Open Access Maced J Med Sci. 2021;9:367&#x2013;372. doi: 10.3889/oamjms.2021.6107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2021.6107</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMaio S, Hanuschik M, Kreaden U. In: Surgical robotics. Rosen J, Hannaford B, Satava R, editors. Springer; 2011. The da Vinci surgical system; pp. 199&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-1126-1_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamal A, Moschovas MC, Jaber AR, et al. Clinical applications of robotic surgery platforms: a comprehensive review. J Robot Surg. 2024;18:29. doi: 10.1007/s11701-023-01815-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-023-01815-4</ArticleId><ArticleId IdType="pubmed">38231279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanfani F, Monterossi G, Fagotti A, et al. The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc. 2016;30:215&#x2013;221. doi: 10.1007/s00464-015-4187-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4187-9</ArticleId><ArticleId IdType="pubmed">25840895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu L, Yin C, Jia T, He K, Ma X, Zhang X. Robotic surgery in China. Innovation (Camb) 2023;4:100499. doi: 10.1016/j.xinn.2023.100499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2023.100499</ArticleId><ArticleId IdType="pmc">PMC10495633</ArticleId><ArticleId IdType="pubmed">37705606</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavone M, Marescaux J, Seeliger B. Current status of robotic abdominopelvic surgery. Show-Chwan Med J. 2023;22:468&#x2013;474.</Citation></Reference><Reference><Citation>Oyebamiji TA. Robotic surgery in Nigeria: an uncertain possibility. Int Surg J. 2020;7:3876&#x2013;3879. doi: 10.18203/2349-2902.isj20204713.</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2349-2902.isj20204713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarajah SK, Bundred JR, Marc OS, et al. A systematic review and network meta-analysis of different surgical approaches for pancreaticoduodenectomy. HPB (Oxford) 2020;22:329&#x2013;339. doi: 10.1016/j.hpb.2019.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2019.09.016</ArticleId><ArticleId IdType="pubmed">31676255</ArticleId></ArticleIdList></Reference><Reference><Citation>Alverdy JC. The benefits of robotic surgery: are they technical or molecular? J Gastrointest Surg. 2021;25:578&#x2013;580. doi: 10.1007/s11605-020-04901-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-020-04901-2</ArticleId><ArticleId IdType="pmc">PMC7904706</ArticleId><ArticleId IdType="pubmed">33409821</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO), author WHO fact sheets [Internet] WHO; 2024.  [cited 2024 Mar 10].  Available from: https://www.who.int/news-room/fact-sheets/ </Citation></Reference><Reference><Citation>Mehta A, Cheng Ng J, Andrew Awuah W, et al. Embracing robotic surgery in low- and middle-income countries: potential benefits, challenges, and scope in the future. Ann Med Surg (Lond) 2022;84:104803. doi: 10.1016/j.amsu.2022.104803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104803</ArticleId><ArticleId IdType="pmc">PMC9793116</ArticleId><ArticleId IdType="pubmed">36582867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467&#x2013;473. doi: 10.7326/M18-0850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106:420&#x2013;431. doi: 10.5195/jmla.2018.345.</Citation><ArticleIdList><ArticleId IdType="doi">10.5195/jmla.2018.345</ArticleId><ArticleId IdType="pmc">PMC6148624</ArticleId><ArticleId IdType="pubmed">30271283</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Higgins JP, Elbers RG, Reeves BC the development group for ROBINSI, author.  Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I): detailed guidance [Internet] The authors; 2016.  [cited 2024 Mar 10].  Available from http://www.riskofbias.info .</Citation></Reference><Reference><Citation>McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55&#x2013;61. doi: 10.1002/jrsm.1411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1411</ArticleId><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Debakey Y, Zaghloul A, Farag A, Mahmoud A, Elattar I. Robotic-assisted versus conventional laparoscopic approach for rectal cancer surgery, first Egyptian academic center experience, RCT. Minim Invasive Surg. 2018;2018:5836562. doi: 10.1155/2018/5836562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5836562</ArticleId><ArticleId IdType="pmc">PMC6139204</ArticleId><ArticleId IdType="pubmed">30245874</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas DN, Kamal JM, El Sheikh SM, Mahmod AM. Early experience in anesthesia of robot assisted cystoprostatectomy. Egypt J Anaesth. 2013;29:77&#x2013;81. doi: 10.1016/j.egja.2012.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.egja.2012.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-erRazik MA, Abdel Hamid MA, Rashed AM. Egypt's initial experience with robotic-assisted cystogastrostomy and pancreatic debridement for large walled-off pancreatic necrosis: a report of two cases. Cureus. 2022;14:e32005. doi: 10.7759/cureus.32005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32005</ArticleId><ArticleId IdType="pmc">PMC9798344</ArticleId><ArticleId IdType="pubmed">36589168</ArticleId></ArticleIdList></Reference><Reference><Citation>Forgan T, Lazarus J. Embracing the future: the necessity of implementing robotic surgery in South African training institutions. S Afr J Surg. 2023;61:144&#x2013;149. doi: 10.36303/SAJS.4111.</Citation><ArticleIdList><ArticleId IdType="doi">10.36303/SAJS.4111</ArticleId><ArticleId IdType="pubmed">37381802</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokralla HA, Fathalla AE. Adenocarcinoma of the cervix uteri; does it really carry a worse prognosis? A single institutional review from Egypt. Med Sci. 2021;25:26&#x2013;35.</Citation></Reference><Reference><Citation>Zaghloul AS, El-Minawi AM, ElKordy MA, et al. First experience of the Egyptian National Cancer Institute using the robot-assisted laparoscopic approach in radical hysterectomies for cervical cancer. J Egypt Natl Canc Inst. 2018;30:61&#x2013;67. doi: 10.1016/j.jnci.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnci.2018.03.003</ArticleId><ArticleId IdType="pubmed">29691094</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Merwe B. Establishing ionising radiation safety culture during interventional cardiovascular procedures. Cardiovasc J Afr. 2021;32:271&#x2013;275. doi: 10.5830/CVJA-2021-030.</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2021-030</ArticleId><ArticleId IdType="pmc">PMC8756052</ArticleId><ArticleId IdType="pubmed">34405852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaghloul AS, Mahmoud AM. Preliminary results of robotic colorectal surgery at the National Cancer Institute, Cairo University. J Egypt Natl Canc Inst. 2016;28:169&#x2013;174. doi: 10.1016/j.jnci.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnci.2016.05.003</ArticleId><ArticleId IdType="pubmed">27312241</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tabey NA, Shoma AM. Port site metastases after robot-assisted laparoscopic radical cystectomy. Urology. 2005;66:1110. doi: 10.1016/j.urology.2005.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2005.05.048</ArticleId><ArticleId IdType="pubmed">16286145</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon M, Hemal AK, Tewari A, et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int. 2003;92:232&#x2013;236. doi: 10.1046/j.1464-410X.2003.04329.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1464-410X.2003.04329.x</ArticleId><ArticleId IdType="pubmed">12887473</ArticleId></ArticleIdList></Reference><Reference><Citation>Korany BM. Lived experience of patients following robotic sleeve surgery. Assiut Sci Nurs J. 2023;11:240&#x2013;249. doi: 10.21608/asnj.2023.218845.1616.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/asnj.2023.218845.1616</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag AF, Mahmoud AM, Azmy HM, et al. Robotic-assisted laparoscopic low anterior resection versus trans-anal total mesorectal excision for malignant rectal lesion: a prospective cohort trial. Egypt J Surg. 2023;42:859&#x2013;867. doi: 10.4103/ejs.ejs_167_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ejs.ejs_167_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice K, Moussa H, Hawary R, et al. 484. Robotic assisted prone esophagectomy using versius platform: a promising approach. Dis Esophagus. 2023;36(Suppl 2):doad052.265. doi: 10.1093/dote/doad052.265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doad052.265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassouna BJ, Chemlali M, Slimane M, Rahal K.  Introduction of robotic surgery in gynecologic oncology: a Tunisian experience [Internet]. Presented at: 4th MEMAGO Annual Congress in Association with the 1st Emirates Gynecological Oncology Conference; October 11-12, 2019; Abu Dhabi, UAE. MEMAGO; 2019.  [cited 2024 Jan 5].  Available at: https://memago.org/memagoData/userfiles/file/Jamel-Ben-Hassouna--Introduction.pdf .</Citation></Reference><Reference><Citation>Zabriskie BN, Cole N, Baldauf J, Decker C. The impact of correction methods on rare-event meta-analysis. Res Synth Methods. 2024;15:130&#x2013;151. doi: 10.1002/jrsm.1677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1677</ArticleId><ArticleId IdType="pubmed">37946591</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodie A, Vasdev N. The future of robotic surgery. Ann R Coll Surg Engl. 2018;100(Suppl 7):4&#x2013;13. doi: 10.1308/rcsann.supp2.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.supp2.4</ArticleId><ArticleId IdType="pmc">PMC6216754</ArticleId><ArticleId IdType="pubmed">30179048</ArticleId></ArticleIdList></Reference><Reference><Citation>Stumpo V, Staartjes VE, Klukowska AM, et al. Global adoption of robotic technology into neurosurgical practice and research. Neurosurg Rev. 2021;44:2675&#x2013;2687. doi: 10.1007/s10143-020-01445-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-020-01445-6</ArticleId><ArticleId IdType="pmc">PMC8490223</ArticleId><ArticleId IdType="pubmed">33252717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundram M. Asian robotic experience. Urol Oncol. 2010;28:677&#x2013;681. doi: 10.1016/j.urolonc.2010.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2010.03.003</ArticleId><ArticleId IdType="pubmed">21062651</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AA, Bandari J, Pelzman D, Davies BJ, Jacobs BL. Diffusion and adoption of the surgical robot in urology. Transl Androl Urol. 2021;10:2151&#x2013;2157. doi: 10.21037/tau.2019.11.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tau.2019.11.33</ArticleId><ArticleId IdType="pmc">PMC8185660</ArticleId><ArticleId IdType="pubmed">34159097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantus RJ, Cohen A, Riedinger CB, et al. Facility-level analysis of robot utilization across disciplines in the National Cancer Database. J Robot Surg. 2019;13:293&#x2013;299. doi: 10.1007/s11701-018-0855-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-018-0855-9</ArticleId><ArticleId IdType="pubmed">30062641</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern AL, Friedman C, Torphy RJ, et al. Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database. Surg Endosc. 2020;34:3470&#x2013;3478. doi: 10.1007/s00464-019-07124-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-019-07124-y</ArticleId><ArticleId IdType="pubmed">31591657</ArticleId></ArticleIdList></Reference><Reference><Citation>Samalavicius NE, Janusonis V, Siaulys R, et al. Robotic surgery using Senhance&#xae; robotic platform: single center experience with first 100 cases. J Robot Surg. 2020;14:371&#x2013;376. doi: 10.1007/s11701-019-01000-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-019-01000-6</ArticleId><ArticleId IdType="pubmed">31301021</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti TB, Magna LA, Reis LO. Surgical results and complications for open, laparoscopic, and robot-assisted radical prostatectomy: a reverse systematic review. Eur Urol Open Sci. 2022;44:150&#x2013;161. doi: 10.1016/j.euros.2022.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euros.2022.08.015</ArticleId><ArticleId IdType="pmc">PMC9468352</ArticleId><ArticleId IdType="pubmed">36110904</ArticleId></ArticleIdList></Reference><Reference><Citation>Melling N, Barr J, Schmitz R, et al. Robotic cholecystectomy: first experience with the new Senhance robotic system. J Robot Surg. 2019;13:495&#x2013;500. doi: 10.1007/s11701-018-0877-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-018-0877-3</ArticleId><ArticleId IdType="pubmed">30264180</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguayo E, Dobaria V, Nakhla M, et al. National trends and outcomes of inpatient robotic-assisted versus laparoscopic cholecystectomy. Surgery. 2020;168:625&#x2013;630. doi: 10.1016/j.surg.2020.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2020.06.018</ArticleId><ArticleId IdType="pubmed">32762874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou YC, Yang CK, Chang KS, et al. Prevention and management of complications during robotic-assisted laparoscopic radical prostatectomy following comprehensive planning: a large series involving a single surgeon. Anticancer Res. 2016;36:1991&#x2013;1998.</Citation><ArticleIdList><ArticleId IdType="pubmed">27069192</ArticleId></ArticleIdList></Reference><Reference><Citation>Liss MA, Skarecky D, Morales B, Osann K, Eichel L, Ahlering TE. Preventing perioperative complications of robotic-assisted radical prostatectomy. Urology. 2013;81:319&#x2013;323. doi: 10.1016/j.urology.2012.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2012.09.033</ArticleId><ArticleId IdType="pmc">PMC3952012</ArticleId><ArticleId IdType="pubmed">23374792</ArticleId></ArticleIdList></Reference><Reference><Citation>Falola AF, Fadairo RT, Dada OS, et al. Current state of minimally invasive general surgical practice in Africa: a systematic review and meta-analysis of the laparoscopic procedures performed and outcomes. World J Surg. 2024;48:1634&#x2013;1650. doi: 10.1002/wjs.12195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wjs.12195</ArticleId><ArticleId IdType="pubmed">38809177</ArticleId></ArticleIdList></Reference><Reference><Citation>Onibokun O, Boatin A, Diouf K. The role of minimally invasive gynecologic surgery in Sub Saharan Africa. Curr Obstet Gynecol Rep. 2016;5:333&#x2013;340. doi: 10.1007/s13669-016-0184-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13669-016-0184-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng S, Zhao T, Wang X. Comparison of robot-assisted surgery, laparoscopic-assisted surgery, and open surgery for the treatment of colorectal cancer: a network meta-analysis. Medicine (Baltimore) 2018;97:e11817. doi: 10.1097/MD.0000000000011817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011817</ArticleId><ArticleId IdType="pmc">PMC6112974</ArticleId><ArticleId IdType="pubmed">30142771</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan JJ. Implementing robotic surgery in South African training institutions: fiddling while Rome burns. S Afr J Surg. 2023;61:5&#x2013;6. doi: 10.36303/SAJS.4142.</Citation><ArticleIdList><ArticleId IdType="doi">10.36303/SAJS.4142</ArticleId><ArticleId IdType="pubmed">37381802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris B. Robotic surgery: applications, limitations, and impact on surgical education. MedGenMed. 2005;7:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1681689</ArticleId><ArticleId IdType="pubmed">16369298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39214429</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-3231</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Arthroscopy : the journal of arthroscopic &amp; related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association</Title><ISOAbbreviation>Arthroscopy</ISOAbbreviation></Journal><ArticleTitle>Studies With Direct Industry Affiliation Are More Likely to Report Positive Results in Randomized Controlled Trials for Platelet-Rich Plasma Use in Rotator Cuff Tears: A Systematic Review.</ArticleTitle><Pagination><StartPage>837</StartPage><EndPage>847</EndPage><MedlinePgn>837-847</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arthro.2024.08.025</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0749-8063(24)00623-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To perform a systematic review to evaluate the effect of industry affiliation on the outcomes of randomized controlled trials for platelet-rich plasma (PRP) injections in rotator cuff tears METHODS: The PubMed, SPORTDiscus, and Scopus databases were searched from 2010 to the present for the terms "rotator cuff" and "platelet-rich plasma." The inclusion criteria were randomized controlled trials comparing PRP with controls for the treatment of rotator cuff tears, and the exclusion criteria were systematic reviews, meta-analyses, case reports, cohort studies, basic science studies, studies of Level III or below, and studies not in English. Degree of industry affiliation was categorized into 3 groups: directly, indirectly, and not affiliated. Direct affiliation required the study or its authors to receive financial support from the company manufacturing the devices used in the study to prepare or administer PRP. Indirect affiliation required financial association with a different company that produces or administers PRP than the company in the study. Studies were classified as favorable if study outcomes achieved significance (P &lt; .05) of PRP over controls or as analogous if there was no statistical significance between PRP and controls. Data were analyzed using the &#x3c7;<sup>2</sup> test and Fisher exact test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 47 studies selected for analysis, 8 (17.0%) had no direct industry affiliation; 9 (19.1%) had indirect affiliation; and 30 (63.8%) had no industry affiliation. Of the studies, 22 (46.8%) reported favorable results with PRP compared with controls and 25 (53.2%) showed analogous results between PRP and controls. Degree of industry affiliation was significantly associated with an increased likelihood of reporting favorable study outcomes (P&#xa0;= .041). Directly affiliated studies had a significantly increased likelihood of reporting favorable results (P&#xa0;= .024) compared with indirectly affiliated studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Studies that used PRP produced by companies that directly funded the studies or were financially affiliated with the authors were significantly more likely to report favorable results.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level II, systematic review of Level I and II studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotlier</LastName><ForeName>Jacob L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.. Electronic address: Kotlierja@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freshman</LastName><ForeName>Ryan D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolia</LastName><ForeName>Ioanna K</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Joseph N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrigliano</LastName><ForeName>Frank A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthroscopy</MedlineTA><NlmUniqueID>8506498</NlmUniqueID><ISSNLinking>0749-8063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016265" MajorTopicYN="Y">Conflict of Interest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053657" MajorTopicYN="Y">Platelet-Rich Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070636" MajorTopicYN="Y">Rotator Cuff Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013708" MajorTopicYN="Y">Tendon Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: J.N.L. receives speaking and lecture fees from Stryker Orthopaedics and receives travel reimbursement from Innocoll Biotherapeutics NA. F.A.P. reports a consulting or advisory relationship with Exactech, Stryker Orthopaedics, and OSSIO. All other authors (J.L.K., A.F., E.L., R.D.F., I.K.B.) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>11</Day><Hour>0</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39214429</ArticleId><ArticleId IdType="doi">10.1016/j.arthro.2024.08.025</ArticleId><ArticleId IdType="pii">S0749-8063(24)00623-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31742176</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2249-4863</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of family medicine and primary care</Title><ISOAbbreviation>J Family Med Prim Care</ISOAbbreviation></Journal><ArticleTitle>Flexible nasopharyngolaryngoscopy: Evaluation and appraisal of its effectiveness and diagnostic yield, The Nigerian experience.</ArticleTitle><Pagination><StartPage>3399</StartPage><EndPage>3403</EndPage><MedlinePgn>3399-3403</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jfmpc.jfmpc_489_19</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fiber-optic nasopahryngolaryngoscopy is a visual examination of the larynx and its related structures. It is an effective procedure for ascertaining the causes of laryngeal disorders, pain in the throat, and difficulty in swallowing and hence should be used in all ENT clinics routinely. This study established the diagnostic effectiveness of fiber-optic nasoparyngolaryngoscopy in our clinics in Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria. It also analyzed the indications, findings, and the role it played in the management of the patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This was a one-year (May 2015 to April 2019) prospective study involving 100 patients who had nasolaryngoscopy procedures done in the ear, nose, and throat (ENT) surgery clinics of Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria. A structured proforma was designed for the study. The data collected included the biodata (age and sex), presenting symptoms/indications for the procedure and findings at nasopharyngolaryngoscopy. These were entered into SPSS version 24 computer software and analyzed descriptively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 100 patients had the procedure during the study period. The mean age and standard deviation of respondents were 47.3 &#xb1; 16.4 years with more than half (71.0%) being females. The male to female ratio was 1:2.4. Majority of the patients were in the age range of 60 years and above (28.0%) while the minority were less than 20 years (6.0%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study substantiates the contention that flexible nasopharyngolaryngoscopy is a very effective diagnostic tool for the patients presenting with upper airway related symptoms.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2019 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aremu</LastName><ForeName>Shuaib Kayode</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>ENT Department, Federal Teaching Hospital Ido-Ekiti/Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Goiter</Keyword><Keyword MajorTopicYN="N">hoarseness</Keyword><Keyword MajorTopicYN="N">nasal mass</Keyword><Keyword MajorTopicYN="N">nasopharyngolaryngoscope</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31742176</ArticleId><ArticleId IdType="pmc">PMC6857406</ArticleId><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_489_19</ArticleId><ArticleId IdType="pii">JFMPC-8-3399</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adeyemo A, Ameye SA, Amusa YB, Eziyi JAE, Owojuyigbe AM, Badmus SA, et al. Setting-up office ENT endoscopy in low resource setting in semi-urban Hospital: Adaptations and modifications. Nigerian Journal of Otorhinolaryngology. 2017;14:14&#x2013;7.</Citation></Reference><Reference><Citation>Hormann K, Schmidt H. Flexible endoscopy in the ENT area. HNO. 1998;46:654&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9736939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewitt DE. Fiberoptic rhinolaryngoscopy in primary care. A new direction for expanding in-office diagnostics. Postgrad Med. 1988;84:125&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">3174515</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs GJ. Milestones in endoscope design for minimally invasive urologic surgery: The sentinel role of a pioneer. Surg Endosc. 2006;20(Suppl 2):S493&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16557417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschowitz B. A fiberoptic flexible esophagoscope. JAMA. 1963;2:388.</Citation><ArticleIdList><ArticleId IdType="pubmed">14044296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobler JB, Rosen DI, Burns JA, Akst LM, Broadhurst MS, Zeitels SM, et al. Comparison of a flexible laryngoscope with calibrated sizing function to intraoperative measurements. Ann Otol Rhinol Laryngol. 2006;115:733&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17076094</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraei SA, McPartlin DW, Nouraei SM, Patel A, Ferguson C, Howard DJ, et al. Objective sizing of upper airway stenosis: A quantitative endoscopic approach. Laryngoscope. 2006;116:12&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16481801</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucky OO, Chibuike N. Laryngoscopy: Appraisal of 202 procedures carried out in two centers in Port Harcourt, Nigeria. Niger Health J. 2017;17:256.</Citation></Reference><Reference><Citation>Olaosun AO, Oguntola AS, Adegbosin O, Akinloye A. Mirror laryngoscopy: A review of 43 cases. Surg J. 2009;4:29&#x2013;34.</Citation></Reference><Reference><Citation>Iqbal Z, Rabbani MZ, Zafar MJ. Flexible nasopharyngolaryngoscopy: Diagnostic yield. Rawal Med J. 2009;34:148&#x2013;50.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39704317</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Cell salvage for the management of postpartum haemorrhage.</ArticleTitle><Pagination><StartPage>CD016120</StartPage><MedlinePgn>CD016120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD016120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD016120</ELocationID><Abstract><AbstractText Label="RATIONALE">Postpartum haemorrhage (PPH), defined as a blood loss of 500 mL or more within 24 hours of birth, is the leading global cause of maternal morbidity and mortality. Allogenic blood transfusions are a critical component of PPH management, yet are often unfeasible, particularly in resource-poor settings where maternal morbidity is highest. Autologous cell salvage in the management of PPH has been proposed to combat limitations in access to allogenic blood and potential transfusion-related risks. This review examines the benefits and harms of using cell salvage for pregnant women during birth.</AbstractText><AbstractText Label="OBJECTIVES">To assess the benefits and harms of cell salvage when used during birth.</AbstractText><AbstractText Label="SEARCH METHODS">We searched the CENTRAL, MEDLINE, Ovid Embase, and Global Index Medicus databases and the ICTRP and ClinicalTrials.gov trials registers. We also carried out reference checking and citation searching, and contacted study authors to identify all relevant studies. The latest search date was 8 February 2024.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA">We included randomised controlled trials (RCTs) in pregnant women (24 weeks or more gestation) comparing use of cell salvage following caesarean or vaginal birth with routine care (defined as no cell salvage). We did not place any restrictions on mode of birth, ethnicity, race, socioeconomic status, education level, or place of residence.</AbstractText><AbstractText Label="OUTCOMES">Critical outcomes for this review were risk of allogenic blood transfusion, risk of transfusion-related adverse reactions, risk of haemorrhage, transfer to higher level of care, length of hospitalisation, length of operation, and risk of sepsis. Important outcomes were estimated blood loss, blood loss &#x2265; 500 mL, blood loss &#x2265; 1000 mL, use of additional uterotonics or tranexamic acid, maternal death, postpartum haemoglobin concentration, change in haemoglobin, major surgery including hysterectomy, future major surgery, end-organ dysfunction or failure, amniotic fluid embolism, side effects, clotting abnormalities, maternal experience/satisfaction, maternal well-being, and breastfeeding.</AbstractText><AbstractText Label="RISK OF BIAS">We assessed risk of bias using the Cochrane risk of bias tool (RoB 1) for each critical outcome from each RCT.</AbstractText><AbstractText Label="SYNTHESIS METHODS">We conducted a meta-analysis for each outcome where data were available from more than one study using a random-effects model. If data could not be analysed using meta-analysis, we synthesised results narratively using the Synthesis Without Meta-analysis (SWiM) guidance. We used GRADE to assess the certainty of evidence for each outcome.</AbstractText><AbstractText Label="INCLUDED STUDIES">We included six RCTs with 3476 participants. All trials involved pregnant women having a caesarean birth. Three trials were conducted in high-income countries, and three were conducted in an upper-middle-income country.</AbstractText><AbstractText Label="SYNTHESIS OF RESULTS">Allogenic blood transfusion Intraoperative cell salvage at caesarean birth may reduce the need for allogenic transfusions received by participants, although the 95% confidence interval (CI) includes the possibility of an increase in effect. Low-certainty evidence from three studies found the risk of donor transfusions was possibly lower in participants with cell salvage (risk ratio (RR) 0.45, 95% CI 0.15 to 1.33; P = 0.15, I<sup>2</sup> = 33%; 3 RCTs, 3115 women; low-certainty evidence). The absolute risk of transfusion was very low in the studies (4% in women not treated with cell salvage and 2% in women treated with cell salvage). Transfusion-related adverse reactions The evidence is very uncertain about the risk of transfusion-related adverse reactions in participants with intraoperative cell salvage (RR 0.48, 95% CI 0.09 to 2.62; P = 0.39; 4 RCTs, 3304 women; very low-certainty evidence). Haemorrhage Two studies reported risk of haemorrhage and found that there was probably no difference between arms (RR 0.88, 95% CI 0.67 to 1.15; P = 0.36, I&#xb2; = 0%; 2 RCTs, 3077 women; moderate-certainty evidence). Length of hospitalisation The evidence is very uncertain about whether interoperative cell salvage at caesarean birth affects length of hospitalisation. Three studies reported length of hospitalisation (MD -2.02 days, 95% CI -4.73 to 0.70; P = 0.15, I<sup>2</sup> = 100%; 3 RCTs, 3174 women; very low-certainty evidence). Length of operation Two studies reported on length of operation. However, meta-analysis was not possible due to statistical heterogeneity and divergence of study findings; the direction of effect could not be determined. We evaluated the evidence as very low certainty. Sepsis One study reported risk of sepsis, finding that there was possibly no difference between arms (RR 1.00, 95% CI 0.43 to 2.29; P = 0.99; 1 RCT, 2990 women; low-certainty evidence). Estimated blood loss Cell salvage at caesarean birth may reduce blood loss. Two studies reported that estimated blood loss was possibly lower in women who had cell salvage compared to those who did not (MD -113.59 mL, 95% CI -130.41 to -96.77; P &lt; 0.00001, I<sup>2</sup> = 0%; 2 RCTs, 246 women; low-certainty evidence). Postpartum haemoglobin concentration Cell salvage at caesarean birth may increase day one postpartum haemoglobin. Three studies reported day one postpartum haemoglobin levels (MD 6.14 g/L, 95% CI 1.62 to 10.65; P = 0.008, I<sup>2</sup> = 97%; 3 RCTs, 3070 women; low-certainty evidence). Amniotic fluid embolism Three trials reported risk of amniotic fluid embolism and no cases were observed (n = 3226 women).</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">Cell salvage may reduce the need for allogenic blood transfusion, may reduce blood loss, and may increase day one postpartum haemoglobin in pregnant women having caesarean birth (low certainty). Cell salvage may make little to no difference to the risk of sepsis (low certainty) and probably makes little to no difference to the risk of haemorrhage (moderate certainty). The effect of cell salvage on risk of transfusion-related adverse reactions is very uncertain. The effect of cell salvage on the length of hospital stay was both clinically and statistically heterogenous, with a very low certainty of evidence. The effect of cell salvage on length of operation is divergent and meta-analysis was not possible due to significant statistical heterogeneity; the evidence is of very low certainty. No cases of amniotic fluid embolism were reported among the included trials. Studies in low- and middle-income settings are needed.</AbstractText><AbstractText Label="FUNDING">This review had no dedicated funding.</AbstractText><AbstractText Label="REGISTRATION">This review was registered with PROSPERO (CRD42024554204).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Teesta</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cole</LastName><ForeName>Maia G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Ruaraidh A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaplin</LastName><ForeName>Marty</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huffstetler</LastName><ForeName>Hanna E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Health Behaviour, UNC Gillings School of Global Public Health, Chapel Hill, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Ffion</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006473" MajorTopicYN="Y">Postpartum Hemorrhage</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057725" MajorTopicYN="N">Operative Blood Salvage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036861" MajorTopicYN="N">Delivery, Obstetric</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Teesta Dey declares no conflicts of interest. Daisy Brown declares no conflicts of interest. Maia Cole declares no conflicts of interest. Ruaraidh Hill declares a financial, non&#x2010;personal, non&#x2010;specific interest, having delivered educational workshops on health economics, medicines management, and HTA for cancer specialists supported by unrestricted sponsorship by the pharmaceutical industry and an industry association (Bristol Myers Squibb Company, March 2019). No fees received personally. Marty Chaplin is an Editor for Cochrane Infectious Diseases, but had no involvement in the editorial processing of this review. Hanna Huffstetler is a technical consultant supporting the evidence assessments for the upcoming WHO recommendations related to the joint consolidated guidelines on the prevention, detection, and treatment of postpartum haemorrhage. Ffion Curtis declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39704317</ArticleId><ArticleId IdType="pmc">PMC11660225</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD016120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. WHO, 2023.</Citation></Reference><Reference><Citation>WHO. WHO recommendations for the prevention and treatment of postpartum haemorrhage. WHO, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23586122</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey T, Weeks AD. Identification, prevention and management of post-partum haemorrhage. Obstetrics, Gynaecology &amp; Reproductive Medicine 2020;30(8):231-41.</Citation></Reference><Reference><Citation>Carroll C, Young F. Intraoperative cell salvage. BJA Education 2021;21(3):95e101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892352</ArticleId><ArticleId IdType="pubmed">33664978</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Intraoperative blood cell salvage in obstetrics: Interventional procedures guidance [IPG144]. www.nice.org.uk/guidance/ipg144 2005.</Citation></Reference><Reference><Citation>Lloyd TD, Geneen LJ, Bernhardt K, McClune W, Fernquest SJ, Brown T, et al. Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery. Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No: CD001888. [DOI: 10.1002/14651858.CD001888.pub5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001888.pub5</ArticleId><ArticleId IdType="pmc">PMC10486190</ArticleId><ArticleId IdType="pubmed">37681564</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan KS, Moore P, Wilson M, Hooper R, Allard S, Wrench I, et al. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the salvo (cell salvage in obstetrics) trial. Health Technology Assessment (Winchester, England) 2018;22(2):1-88. [DOI: 10.3310/hta22020]</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta22020</ArticleId><ArticleId IdType="pmc">PMC5776407</ArticleId><ArticleId IdType="pubmed">29318985</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Lasserson T, Thomas J, Flemyng E, Churchill R. Methodological Expectations of Cochrane Intervention Reviews, Version August 2023. London: Cochrane, 2023.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. British Journal of Obstetrics and Gynaecology 2019;126:83-93.</Citation><ArticleIdList><ArticleId IdType="pubmed">29920912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.</Citation></Reference><Reference><Citation>Covidence. Melbourne, Australia: Veritas Health Innovation, accessed 10 January 2024. Available at https://www.covidence.org.</Citation></Reference><Reference><Citation>Weeks J, Cuthbert A, Alfirevic Z. Trustworthiness assessment as an inclusion criterion for systematic reviews&#x2014;What is the impact on results? Cochrane Evidence Synthesis and Methods 2023;1(10):e12037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11795932</ArticleId><ArticleId IdType="pubmed">40476011</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan). Version 7.12.0. The Cochrane Collaboration, 2024. Available at https://revman.cochrane.org.</Citation></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter S, Forbes G, Vazquez Corona M, Miller S, Althabe F, Coomarasamy A, et al. Perceptions and experiences of the prevention, detection, and management of postpartum haemorrhage: a qualitative evidence synthesis. Cochrane Database of Systematic Reviews 2023, Issue 11. Art. No: CD013795. [DOI: 10.1002/14651858.CD013795.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013795.pub2</ArticleId><ArticleId IdType="pmc">PMC10680124</ArticleId><ArticleId IdType="pubmed">38009552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A. GRADE Handbook. GRADE, 2013.</Citation></Reference><Reference><Citation>Cell Salvage During Caesarean Section (CSCS). https://clinicaltrials.gov/study/NCT03429790#participation-criteria.</Citation></Reference><Reference><Citation>Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. International Journal of Obstetric Anesthesia 2015;24(1):86-7. [DOI: 10.1016/j.ijoa.2014.08.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2014.08.003</ArticleId><ArticleId IdType="pubmed">25499013</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr T, Wrench I. Trends in the use of intraoperative cell salvage in a tertiary obstetric centre over eight years. International Journal of Obstetric Anesthesia 2018;35(Suppl 1):S21.</Citation></Reference><Reference><Citation>Khan KS, Moore PAS, Wilson MJ, Hooper R, Allard S, Wrench I, et al; SALVO study group. Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO). PLOS Medicine 2017;4(12):e1002471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736174</ArticleId><ArticleId IdType="pubmed">29261655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei B, Guo M, Deng X, He S, Lu X, Wang Y, et al. Intraoperative cell salvage as an effective intervention for postpartum hemorrhage-evidence from a prospective randomized controlled trial. Frontiers in Immunology 2022;13:953334. [DOI: 10.3389/fimmu.2022.953334]</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.953334</ArticleId><ArticleId IdType="pmc">PMC9589269</ArticleId><ArticleId IdType="pubmed">36300123</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li X, Che X, Zhao G, Xu M. Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial. BMC Pregnancy and Childbirth 2020;20(1):452. [DOI: 10.1186/s12884-020-03138-w]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-020-03138-w</ArticleId><ArticleId IdType="pmc">PMC7412832</ArticleId><ArticleId IdType="pubmed">32767971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R. Blood salvage during caesarean section. British Journal of Anaesthesia 1998;80(2):195-8. [DOI: 10.1093/bja/80.2.195]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.2.195</ArticleId><ArticleId IdType="pubmed">9602584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y-F, Cao Y-D. Effect of intraoperative cell rescue on bleeding related indexes after cesarean section. World Journal of Clinical Cases 2022;10(8):2439-46. [DOI: 10.12998/wjcc.v10.i8.2439]</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i8.2439</ArticleId><ArticleId IdType="pmc">PMC8968603</ArticleId><ArticleId IdType="pubmed">35434071</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeson C, Jones M, Odendaal J, Choksey F, Quenby S. Routine use of cell salvage during cesarean section: a practice evaluation. Acta Obstetricia et Gynecologica Scandinavica 2024;103:498-504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10867391</ArticleId><ArticleId IdType="pubmed">38117692</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer NS, Khanuja K, Roman A, Al-Kouatly HB. Use of cell salvage at the time of cesarean delivery: a meta-analysis of randomized controlled trials. American Journal of Obstetrics &amp; Gynecology MFM 2024;6(2):101257.</Citation><ArticleIdList><ArticleId IdType="pubmed">38109996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim G, Melnyk V, Facco FL, Waters JH, Smith KJ. Cost-effectiveness analysis of intraoperative cell salvage for obstetric hemorrhage. Anesthesiology 2018;128(2):328-37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5771819</ArticleId><ArticleId IdType="pubmed">29194062</ArticleId></ArticleIdList></Reference><Reference><Citation>Obore N; Liuxiao Z; Haomin Y; Yuchen T; Wang L; Hong Y. Intraoperative Cell Salvage for Women at High Risk of Postpartum Hemorrhage During Cesarean Section: a Systematic Review and Meta-analysis. Reproductive sciences 2022;29(11):3161-3176.</Citation><ArticleIdList><ArticleId IdType="pubmed">35023053</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell OM, Cegolon L, Macleod D, Benova L. Length of stay after childbirth in 92 countries and associated factors in 30 low- and middle-income countries: compilation of reported data and a cross-sectional analysis from nationally representative surveys. PLOS Medicine 2016;13(3):e1001972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783077</ArticleId><ArticleId IdType="pubmed">26954561</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwy Al-Beity F, Pembe AB, Kwezi HA, Massawe SN, Hanson C, Baker U. &#x201c;We do what we can do to save a woman&#x201d; health workers&#x2019; perceptions of health facility readiness for management of postpartum haemorrhage. Global Health Action 2020;13(1):1707403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7006654</ArticleId><ArticleId IdType="pubmed">31928163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim G, Kotsis E, Zorn JM, Dalby PL, Ralph CJ, Waters JH. Cell salvage for postpartum haemorrhage during vaginal delivery: a case series.. Blood Transfusion 2018;16(6):498-501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6214826</ArticleId><ArticleId IdType="pubmed">29106356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35549557</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Extracorporeal membrane oxygenation during pregnancy and peripartal. An international retrospective multicenter study.</ArticleTitle><Pagination><StartPage>966</StartPage><EndPage>972</EndPage><MedlinePgn>966-972</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591221090668</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Extracorporeal Membrane Oxygenation (ECMO) may be used in the setting of pregnancy or the peripartal period, however its utility has not been well-characterized. This study aims to give an overview on the prevalence of peripartel ECMO cases and further assess the indications and outcomes of ECMO in this setting across multiple centers and countries.</AbstractText><AbstractText Label="METHODS">A retrospective, multicenter, international cohort study of pregnant and peripartum ECMO cases was performed. Data were collected from six ECMO centers across three continents over a 10-year period.</AbstractText><AbstractText Label="RESULTS">A total of 60 pregnany/peripartal ECMO cases have been identified. Most frequent indications are acute respiratory distress syndrome (<i>n</i> = 30) and pulmonary embolism (<i>n</i> = 5). Veno-venous ECMO mode was applied more often (77%). ECMO treatment during pregnancy was performed in 17 cases. Maternal and fetal survival was high with 87% (<i>n</i> = 52), respectively 73% (<i>n</i> = 44).</AbstractText><AbstractText Label="CONCLUSIONS">Various emergency scenarios during pregnancy and at time of delivery may require ECMO treatment. Peripartal mortality in a well-resourced setting is rare, however emergencies in the labor room occur and knowledge of available rescue therapy is essential to improve outcome. Obstetricians and obstetric anesthesiologists should be aware of the availability of ECMO resource at their hospital or region to ensure immediate contact when needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malfertheiner</LastName><ForeName>S Fill</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0002-4274-2526</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital St. Hedwig of the Order of St. John, Regensburg University, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodie</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burrell</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, The Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taccone</LastName><ForeName>F S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, H&#xf4;pital Erasme, Universit&#xe9; Libre de Bruxelles, ULB, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broman</LastName><ForeName>L M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-4124-4581</Identifier><AffiliationInfo><Affiliation>ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shekar</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agerstrand</LastName><ForeName>C L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>A L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malfertheiner</LastName><ForeName>M V</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-6245-2614</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Cardiology and Pneumology, University Hospital Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">amniotic fluid embolism</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">hemorrhage</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">peripartum</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35549557</ArticleId><ArticleId IdType="pmc">PMC10265280</ArticleId><ArticleId IdType="doi">10.1177/02676591221090668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications. JAMA 2019; 322: 557&#x2013;568. DOI: 10.1001/jama.2019.9302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.9302</ArticleId><ArticleId IdType="pubmed">31408142</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad SA, Broman LM, Taccone FS, et al.The extracorporeal life support organization maastricht treaty for nomenclature in extracorporeal life support. a position paper of the extracorporeal life support organization. Am J Respir Crit Care Med 2018; 198: 447&#x2013;451. DOI: 10.1164/rccm.201710-2130CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-2130CP</ArticleId><ArticleId IdType="pmc">PMC6118026</ArticleId><ArticleId IdType="pubmed">29614239</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman LM, Taccone FS, Lorusso R, et al.The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization. Crit Care 2019; 23: 36. DOI: 10.1186/s13054-019-2334-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2334-8</ArticleId><ArticleId IdType="pmc">PMC6367794</ArticleId><ArticleId IdType="pubmed">30736845</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Brodie D, Strassmann S, et al.Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016; 42: 889&#x2013;896. DOI: 10.1007/s00134-016-4273-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4273-z</ArticleId><ArticleId IdType="pubmed">26942446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappalardo F, Montisci A. What is extracorporeal cardiopulmonary resuscitation? J Thorac Dis 2017; 9: 1415&#x2013;1419. DOI: 10.21037/jtd.2017.05.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.05.33</ArticleId><ArticleId IdType="pmc">PMC5506168</ArticleId><ArticleId IdType="pubmed">28740646</ArticleId></ArticleIdList></Reference><Reference><Citation>Patricio D, Peluso L, Brasseur A, et al.Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study. Crit Care 2019; 23: 27. DOI: 10.1186/s13054-019-2320-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2320-1</ArticleId><ArticleId IdType="pmc">PMC6348681</ArticleId><ArticleId IdType="pubmed">30691512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong J, Zhang JJY, Lorusso R, et al.Extracorporeal membrane oxygenation in pregnancy and the postpartum period: a systematic review of case reports. Int J Obstet Anesth 2020; 43: 106&#x2013;113. DOI: 10.1016/j.ijoa.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2020.04.004</ArticleId><ArticleId IdType="pubmed">32439296</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SA, Dietl CA, Coleman DM. Extracorporeal life support during pregnancy. J Thorac Cardiovasc Surg 2016; 151: 1154&#x2013;1160. DOI: 10.1016/j.jtcvs.2015.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.12.027</ArticleId><ArticleId IdType="pubmed">26825433</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EE, Davis NL, Goodman D, et al.Vital signs: pregnancy-related deaths, United States, 2011-2015, and Strategies for Prevention, 13 States, 2013-2017. MMWR Morbidity Mortality Weekly Rep 2019; 68: 423&#x2013;429. DOI: 10.15585/mmwr.mm6818e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6818e1</ArticleId><ArticleId IdType="pmc">PMC6542194</ArticleId><ArticleId IdType="pubmed">31071074</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg CJ, Callaghan WM, Syverson C, et al.Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010; 116: 1302&#x2013;1309. DOI: 10.1097/AOG.0b013e3181fdfb11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181fdfb11</ArticleId><ArticleId IdType="pubmed">21099595</ArticleId></ArticleIdList></Reference><Reference><Citation>Extracorporeal-life-support-organization . https://www.elso.org/resources/guidelines.aspx2020, (accessed 31.12.2020).</Citation></Reference><Reference><Citation>Dubar G., Azria E., Tesni&#xe8;re A, et al.French experience of 2009 A/H1N1v influenza in pregnant women. PLoS One 2010; 5: e13112. DOI: 10.1371/journal.pone.0013112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013112</ArticleId><ArticleId IdType="pmc">PMC2950136</ArticleId><ArticleId IdType="pubmed">20957195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma NS, Wille KM, Bellot SC, et al.Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J 2015; 61: 110&#x2013;114. DOI: 10.1097/MAT.0000000000000154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000000154</ArticleId><ArticleId IdType="pubmed">25248040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankford AS, Chow JH, Jackson AM, et al.clinical outcomes of pregnant and postpartum extracorporeal membrane oxygenation patients. Anesth Analgesia 2021; 132: 777&#x2013;787. DOI: 10.1213/ANE.0000000000005266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005266</ArticleId><ArticleId IdType="pubmed">33591093</ArticleId></ArticleIdList></Reference><Reference><Citation>Martillotti G, Boehlen F, Robert-Ebadi H, et al.Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost 2017; 15: 1942&#x2013;1950. DOI: 10.1111/jth.13802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13802</ArticleId><ArticleId IdType="pubmed">28805341</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen HP, Chang WC, Yeh LS, et al.Amniotic fluid embolism treated with emergency extracorporeal membrane oxygenation: a case report. J Reproductive Medicine 2009; 54: 706&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">20120905</ArticleId></ArticleIdList></Reference><Reference><Citation>Takacs ME, Damisch KE. Extracorporeal life support as salvage therapy for massive pulmonary embolus and cardiac arrest in pregnancy. J Emerg Med 2018; 55: 121&#x2013;124. DOI: 10.1016/j.jemermed.2018.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2018.04.009</ArticleId><ArticleId IdType="pubmed">29739630</ArticleId></ArticleIdList></Reference><Reference><Citation>Depondt C, Arnaudovski D, Voulgaropoulos A, et al.Venoarterial extracorporeal membrane oxygenation as supportive therapy after cardiac arrest after amniotic fluid embolism: a case report. A&amp;A Pract 2019; 13: 74&#x2013;77. DOI: 10.1213/XAA.0000000000000995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000000995</ArticleId><ArticleId IdType="pubmed">30864952</ArticleId></ArticleIdList></Reference><Reference><Citation>Djordjevic I, Rahmanian P, Zeriouh M, et al.Treatment of cardiogenic shock in peripartum cardiomyopathy: Case series from a tertiary ECMO center, 35, 2019, pp. 254&#x2013;257. DOI: 10.1111/jocs.14324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14324</ArticleId><ArticleId IdType="pubmed">31705816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ull C, Schildhauer TA, Strauch JT, et al.Veno-venous ECMO as a safe bridge to recovery in a patient with severe peripartum cardiomyopathy - learning from errors. Perfusion 2017; 32: 328&#x2013;332. DOI: 10.1177/0267659116681436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659116681436</ArticleId><ArticleId IdType="pubmed">27881700</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K-Y, Li Y-P, Lin S-Y, et al.Extracorporeal membrane oxygenation application in post-partum hemorrhage patients: Is post-partum hemorrhage contraindicated? J Obstet Gynaecol Res 2017; 43: 1649&#x2013;1654. DOI: 10.1111/jog.13426.2017/07/15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.13426</ArticleId><ArticleId IdType="pubmed">28707719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ried M, Bein T, Philipp A, et al.Extracorporeal lung support in trauma patients with severe chest injury and acute lung failure: a 10-year institutional experience. Crit Care (London, England) 2013; 17: R110. DOI: 10.1186/cc12782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12782</ArticleId><ArticleId IdType="pmc">PMC4056791</ArticleId><ArticleId IdType="pubmed">23786965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M-Y, Chou P-L, Wu T-I, et al.Predictors of hospital mortality in adult trauma patients receiving extracorporeal membrane oxygenation for advanced life support: a retrospective cohort study. Scand J Trauma Resuscitation Emerg Med 2018; 26: 14&#x2013;26. DOI: 10.1186/s13049-018-0481-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-018-0481-6</ArticleId><ArticleId IdType="pmc">PMC5806237</ArticleId><ArticleId IdType="pubmed">29422067</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJY, Ong JA-H, Syn NL, et al.Extracorporeal membrane oxygenation in pregnant and postpartum women: a systematic review and meta-regression analysis. J Intensive Care Med 2021; 36: 220&#x2013;228. DOI: 10.1177/0885066619892826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066619892826</ArticleId><ArticleId IdType="pubmed">31829108</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Brodie D, Strassmann S, et al.Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016; 42: 889&#x2013;896. DOI: 10.1007/s00134-016-4273-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4273-z</ArticleId><ArticleId IdType="pubmed">26942446</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Schmidt M, Hodgson CL, et al.Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Med 2020; 46: 2464&#x2013;2476. DOI: 10.1007/s00134-020-06290-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06290-1</ArticleId><ArticleId IdType="pmc">PMC7605473</ArticleId><ArticleId IdType="pubmed">33140180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunz D., Calabr&#xf2; L., Belliato M, et al.Extracorporeal membrane oxygenation for refractory cardiac arrest: a retrospective multicenter study. Intensive Care Med 2020; 46: 973&#x2013;982. DOI: 10.1007/s00134-020-05926-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05926-6</ArticleId><ArticleId IdType="pubmed">32052069</ArticleId></ArticleIdList></Reference><Reference><Citation>Humberg A, H&#xe4;rtel C, Rausch TK, et al.Active perinatal care of preterm infants in the German Neonatal Network. Arch Dis Child - Fetal Neonatal Edition 2020; 105: 190&#x2013;195. DOI: 10.1136/archdischild-2018-316770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2018-316770</ArticleId><ArticleId IdType="pubmed">31248963</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner MV, Philipp A, Lubnow M, et al.Hemostatic changes during extracorporeal membrane oxygenation. Crit Care Medicine 2016; 44: 747&#x2013;754. DOI: 10.1097/CCM.0000000000001482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001482</ArticleId><ArticleId IdType="pubmed">26646464</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner MV, Pimenta LP, Bahr VV, et al.. Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature. Crit Care Resuscitation : Journal Australas Acad Crit Care Med 2017; 19: 45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">29084501</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CM, Smith KA, Manuck TA. Extracorporeal membrane oxygenation in pregnant and postpartum women: a ten-year case series. Am Journal Obstetrics Gynecology MFM 2020; 2: 100108. DOI: 10.1016/j.ajogmf.2020.100108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100108</ArticleId><ArticleId IdType="pmc">PMC7362433</ArticleId><ArticleId IdType="pubmed">32835205</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman LM, Dirnberger DR, Malfertheiner MV, et al.International survey on extracorporeal membrane oxygenation transport. ASAIO J 2020; 66: 214&#x2013;225. DOI: 10.1097/MAT.0000000000000997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000000997</ArticleId><ArticleId IdType="pubmed">30946060</ArticleId></ArticleIdList></Reference><Reference><Citation>Agerstrand C, Abrams D, Biscotti M, et al.Extracorporeal membrane oxygenation for cardiopulmonary failure during pregnancy and postpartum. Ann Thorac Surg 2016; 102: 774&#x2013;779. DOI: 10.1016/j.athoracsur.2016.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.03.005</ArticleId><ArticleId IdType="pubmed">27154158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29528468</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-8785</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American journal of perinatology</Title><ISOAbbreviation>Am J Perinatol</ISOAbbreviation></Journal><ArticleTitle>A Prediction Model for Severe Maternal Morbidity in Laboring Patients at Term.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>14</EndPage><MedlinePgn>8-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0038-1626716</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the factors associated with severe maternal morbidity in a modern cohort of women laboring at term and to create a prediction model.</AbstractText><AbstractText Label="STUDY DESIGN">This is a retrospective cohort study of all term, laboring patients with live births at a single tertiary care center from 2004 to 2014. The primary outcome was composite maternal morbidity including organ failure, amniotic fluid embolism, anesthesia complications, sepsis, shock, thrombotic events, transfusion, or hysterectomy. Multivariable logistic regression was used to identify independent risk factors. Antepartum, intrapartum, and combined risk scores were created and test characteristics were analyzed.</AbstractText><AbstractText Label="RESULTS">Among 19,249 women delivering during the study period, 323 (1.68%) patients experienced severe morbidity, with blood transfusion the most common complication (286, 1.49%). Factors in the antepartum model included advanced maternal age, race, hypertension, nulliparity, history of cesarean delivery, smoking, and unfavorable Bishop score. Intrapartum factors included mode of delivery, use of cervical ripening agents or oxytocin, prolonged second stage, and macrosomia. The combined model had an area under the curve of 0.76 (95% confidence interval [CI], 0.73, 0.79).</AbstractText><AbstractText Label="CONCLUSION">This three-part risk scoring system can help clinicians counsel patients and guide clinical decision making for anticipating severe maternal morbidity and necessary resources.</AbstractText><CopyrightInformation>Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosenbloom</LastName><ForeName>Joshua I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuuli</LastName><ForeName>Methodius G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stout</LastName><ForeName>Molly J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Omar M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolfolk</LastName><ForeName>Candice L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Julia D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macones</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cahill</LastName><ForeName>Alison G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Perinatol</MedlineTA><NlmUniqueID>8405212</NlmUniqueID><ISSNLinking>0735-1631</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036861" MajorTopicYN="Y">Delivery, Obstetric</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013513" MajorTopicYN="Y">Obstetric Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="Y">Pregnancy Complications</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047929" MajorTopicYN="Y">Term Birth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29528468</ArticleId><ArticleId IdType="doi">10.1055/s-0038-1626716</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21720243</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports.</ArticleTitle><Pagination><StartPage>1201</StartPage><EndPage>1208</EndPage><MedlinePgn>1201-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0b013e31821bdcfd</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with amniotic fluid embolism (AFE) (major cardiac and pulmonary symptoms plus consumptive coagulopathy) have high circulating tissue factor concentrations. Recombinant factor VIIa (rVIIa) has been used to treat hemorrhage in AFE patients even though rVIIa can combine with circulating tissue factor and form intravascular clots. A systematic review was done of case reports from 2003 to 2009 of AFE patients with massive hemorrhage who were and were not treated with rVIIa to assess the thrombotic complication risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE was searched for case reports of AFE patients receiving rVIIa (rVIIa cases) and of AFE patients who received surgery to control bleeding but no rVIIa (cohorts who did not receive rVIIa). Additional AFE case reports were obtained from the Food and Drug Administration, the Australian and New Zealand Haemostasis Registry, and scientific meeting abstracts. The risk of a negative outcome (permanent disability or death) in rVIIa cases versus cohorts who did not receive rVIIa was calculated using risk ratio and 95% confidence interval.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen rVIIa cases and 28 cohorts were identified who did not receive rVIIa. All patients had surgery to control bleeding. Death, permanent disability, and full recovery occurred in 8, 6, and 2 rVIIa cases and 7, 4, and 17 cohorts who did not receive rVIIa (risk ratio 2.2, 95% CI 1.4-3.7 for death or permanent disability vs. full recovery).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recombinant factor VIIa cases had significantly worse outcomes than cohorts who did not receive rVIIa. It is recommended that rVIIa be used in AFE patients only when the hemorrhage cannot be stopped by massive blood component replacement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leighton</LastName><ForeName>Barbara L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Washington University in Saint Louis School of Medicine, St. Louis, Missouri 63110, USA. leightob@wustl.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Lockhart</LastName><ForeName>Ellen M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Louise E</ForeName><Initials>LE</Initials></Author><Author ValidYN="Y"><LastName>Zatta</LastName><ForeName>Amanda J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 RR024992</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003029">Coagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>AC71R787OV</RegistryNumber><NameOfSubstance UI="C103587">recombinant FVIIa</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.21</RegistryNumber><NameOfSubstance UI="D015942">Factor VIIa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2012 Aug;117(2):423; author reply 423-4. doi: 10.1097/ALN.0b013e31825b6c77.</RefSource><PMID Version="1">22828419</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003029" MajorTopicYN="N">Coagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015942" MajorTopicYN="N">Factor VIIa</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N">New Zealand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21720243</ArticleId><ArticleId IdType="doi">10.1097/ALN.0b013e31821bdcfd</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31707484</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Risk factors for periprosthetic joint infection after total knee arthroplasty.</ArticleTitle><Pagination><StartPage>239</StartPage><EndPage>245</EndPage><MedlinePgn>239-245</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-019-03304-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Periprosthetic joint infection (PJI) is the most serious and feared complication in total knee arthroplasty (TKA) and can have catastrophic consequences. The number of total knee arthroplasties is increasing, so infections could also be greater in the future. The aim of this study is to identify the most relevant risk factors associated with infection after a total knee arthroplasty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a case-control study of patients who underwent total knee arthroplasty at the University Hospital of Salamanca. We included 66 TKA PJI patients and 66 control TKA patients. Demographic and clinical variables were collected. A descriptive and inferential analysis was performed by logistic regression and attributable risk fraction assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prolonged operative time (&gt;&#x2009;90') and tourniquet time (&gt;&#x2009;60') were the most relevant risk factors described (OR 40.77, AFE 0.97, p&#x2009;&gt;&#x2009;0.001 and OR 37.14, AFE 0.97, p&#x2009;&lt;&#x2009;0.001, respectively). The use of non-antibiotic-laded cement (OR 3.62), obesity (BMI&#x2009;&gt;&#x2009;30, OR 8.86), diabetes (OR 2.33), high ASA grade (III-IV, OR 15.30), and blood transfusion requirement (OR 4.60) were also statistically significant risk factors for TKA PJI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study provides evidence concerning that operative time, tourniquet time, cement type, diabetes, obesity, ASA grade, and blood transfusion requirement as independently associated risk factors for TKA PJI. Modifiable risk factors were specifically relevant, so we should be able to reduce the infection rate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-7803-9149</Identifier><AffiliationInfo><Affiliation>Department of Trauma and Orthopedic Surgery, University Hospital of Salamanca, Salamanca, Spain. jfblanco@usal.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Spain. jfblanco@usal.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az</LastName><ForeName>Agust&#xed;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, University Hospital of Salamanca, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melchor</LastName><ForeName>Francisco R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopedic Surgery, University Hospital of Salamanca, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Casa</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pescador</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopedic Surgery, University Hospital of Salamanca, Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016459" MajorTopicYN="N">Prosthesis-Related Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Periprosthetic joint infection</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31707484</ArticleId><ArticleId IdType="doi">10.1007/s00402-019-03304-6</ArticleId><ArticleId IdType="pii">10.1007/s00402-019-03304-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33595867</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Contribution of blood detection of insulin-like growth factor binding protein-1 for the diagnosis of amniotic-fluid embolism: a retrospective multicentre cohort study.</ArticleTitle><Pagination><StartPage>1966</StartPage><EndPage>1973</EndPage><MedlinePgn>1966-1973</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.16672</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess the contribution of maternal blood detection of IGFBP-1 for the diagnosis of amniotic-fluid embolism in clinical daily practice.</AbstractText><AbstractText Label="DESIGN">A retrospective multicentre cohort study.</AbstractText><AbstractText Label="SETTING">Three tertiary care obstetric units in France.</AbstractText><AbstractText Label="SAMPLE">Data of 86 women for whom amniotic-fluid embolism had been suspected and maternal serum detection of IGFBP-1 had been performed between 2011 and 2019 were analysed.</AbstractText><AbstractText Label="METHODS">The criteria defined by the United Kingdom Obstetric Surveillance System (UKOSS) were used for the retrospective diagnosis of amniotic-fluid embolism. The more structured definition proposed by the Society for Maternal-Fetal Medicine and the Amniotic Fluid Embolism Foundation (SMFM) was also used as secondary endpoint.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Agreements between biological and clinical assessments were tested. The performance of blood detection of IGFBP-1 for the diagnosis of amniotic-fluid embolism according to the UKOSS criteria, and to the SMFM definition, was also assessed.</AbstractText><AbstractText Label="RESULTS">There was only slight agreement between clinical and laboratory diagnosis of amniotic-fluid embolism (Cohen's Kappa coefficient: 0.04). Blood detection of IGFBP-1 had a sensitivity of 16%, a specificity of 88%, a positive and a negative likelihood ratio of 1.3 and 0.95, respectively, and a positive and a negative predictive value of 58 and 50%, respectively, for the diagnosis of amniotic-fluid embolism based on the UKOSS criteria. The use of the more structured SMFM definition of amniotic-fluid embolism did not substantially change the results.</AbstractText><AbstractText Label="CONCLUSION">These results question the usefulness of blood detection of IGFBP-1 for the early diagnosis of amniotic-fluid embolism in daily clinical practice.</AbstractText><AbstractText Label="TWEETABLE ABSTRACT">This retrospective multicentre study questions the contribution of IGFBP-1 detection for the diagnosis of AFE.</AbstractText><CopyrightInformation>&#xa9; 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouvet</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5900-4194</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Femme M&#xe8;re Enfant Hospital, Hospices Civils de Lyon, Bron, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Lyon, Claude Bernard Lyon 1 University, Villeurbanne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APCSe VetAgro Sup UPSP 2016.A101, Marcy l'Etoile, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gariel</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Femme M&#xe8;re Enfant Hospital, Hospices Civils de Lyon, Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charvet</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Femme M&#xe8;re Enfant Hospital, Hospices Civils de Lyon, Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boisson-Gaudin</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Fetal-Maternal Biology, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chassard</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Femme M&#xe8;re Enfant Hospital, Hospices Civils de Lyon, Bron, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Lyon, Claude Bernard Lyon 1 University, Villeurbanne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APCSe VetAgro Sup UPSP 2016.A101, Marcy l'Etoile, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C032231">IGFBP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018970">Insulin-Like Growth Factor Binding Protein 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BJOG. 2021 Nov;128(12):1974. doi: 10.1111/1471-0528.16833.</RefSource><PMID Version="1">34228892</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018970" MajorTopicYN="N">Insulin-Like Growth Factor Binding Protein 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062145" MajorTopicYN="N">Maternal Serum Screening Tests</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amniotic-fluid embolism</Keyword><Keyword MajorTopicYN="N">diagnostic</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">serum marker</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>12</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33595867</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.16672</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Knight M, Bunch K, Tuffnel D, Shakespeare J, Kotnis R, Kenyon S, et&#xa0;al., editors, on behalf of MBRRACE-UK. Saving Lives, Improving Mothers&#x2019; Care - Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015-2017. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2019.</Citation></Reference><Reference><Citation>Bonnet MP, Zlotnik D, Saucedo M, Chassard D, Bouvier-Colle MH, Deneux-Tharaux C. Maternal death due to amniotic fluid embolism: a national study in France. Anesth Analg 2018;126:175-82.</Citation></Reference><Reference><Citation>Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015;125:5-12.</Citation></Reference><Reference><Citation>McDonnell N, Knight M, Peek MJ, Ellwood D, Homer CSE, McLintock C, et&#xa0;al. Amniotic fluid embolism: an Australian-New Zealand population-based study. BMC Pregnancy Childbirth 2015;15:352.</Citation></Reference><Reference><Citation>Sultan P, Seligman K, Carvalho B. Amniotic fluid embolism: update and review. Curr Opin Anaesthesiol 2016;29:288-96.</Citation></Reference><Reference><Citation>Pacheco LD, Saade G, Hankins GD, Clark SL. Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol 2016;215:B16-24.</Citation></Reference><Reference><Citation>Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res 2014;40:1507-17.</Citation></Reference><Reference><Citation>Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T. Determining zinc coproporphyrin in maternal plasma - a new method for diagnosing amniotic fluid embolism. Clin Chem 1992;38:526-9.</Citation></Reference><Reference><Citation>Legrand M, Rossignol M, Dreux S, Luton D, Ventr&#xe9; C, Barranger E, et&#xa0;al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism. Crit Care Med 2012;40:2059-63.</Citation></Reference><Reference><Citation>Rutanen EM, Bohn H, Seppala M. Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 1982;144:460-3.</Citation></Reference><Reference><Citation>Wang HS, Perry LA, Kanisius J, Iles RK, Holly JM, Chard T. Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J Endocrinol 1991;128:161-8.</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, G&#xf8;tzsche PC, Mulrow CD, Pocock SJ, et&#xa0;al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.</Citation></Reference><Reference><Citation>Van Cortenbosch B, Huel C, Houfflin Debarge V, Luton D, Lambaudie E, Porquet D, et&#xa0;al. Biologic tests for the diagnosis of amniotic fluid embolism. Ann Biol Clin (Paris) 2007;65:153-60.</Citation></Reference><Reference><Citation>Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, et&#xa0;al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth 2012;12:7.</Citation></Reference><Reference><Citation>Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey AW, et&#xa0;al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol 2016;215:408-12.</Citation></Reference><Reference><Citation>Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007;5:604-6.</Citation></Reference><Reference><Citation>Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.</Citation></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.</Citation></Reference><Reference><Citation>Stafford IA, Moaddab A, Dildy GA, Klassen M, Belfort MA, Romero R, et&#xa0;al. Evaluation of proposed criteria for research reporting of amniotic fluid embolism. Am J Obstet Gynecol 2019;220:285-7.</Citation></Reference><Reference><Citation>Ponzio-Klijanienko A, Vincent-Rohfritsch A, Girault A, Le Ray C, Goffinet F, Bonnet MP. Evaluation of the 4 diagnosis criteria proposed by the SMFM and the AFE Foundation for amniotic fluid embolism in a monocentric population. J Gynecol Obstet Hum Reprod 2020;49:101821.</Citation></Reference><Reference><Citation>Kramer MS, Rouleau J, Baskett TF, Joseph KS. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006;368:1444-8.</Citation></Reference><Reference><Citation>Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008;199:49.e1-8.</Citation></Reference><Reference><Citation>Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG 2016;123:100-9.</Citation></Reference><Reference><Citation>Clark SL. Amniotic fluid embolism. Obstet Gynecol 2014;123:337-48.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38995808</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-6448</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>NeuroRehabilitation</Title><ISOAbbreviation>NeuroRehabilitation</ISOAbbreviation></Journal><ArticleTitle>Telerehabilitation - Historical Perspectives and Conceptual Framework in Reference to Neurological Disorders: A Narrative Review.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>18</EndPage><MedlinePgn>5-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/NRE-240079</ELocationID><Abstract><AbstractText>BackgroundTelerehabilitation as a new subdiscipline of telehealth is the application of information technology to support and deliver rehabilitation services via two-way or multipoint interactive online telecommunication technology. This enables the therapist to optimize the timing, intensity, and duration of therapy which is often not possible within the constraints of face-to-face treatment protocols in current health systems.ObjectiveTo review the historical perspective and conceptual framework of telerehabilitation in neurological disorders.MethodsA narrative review of the literature was performed for the historical perspective and a systematic review of the conceptual framework was performed using the PRISMA guidelines on chronic neurological disorders; multiple sclerosis, spinal cord injury, stroke, Parkinson's disease, cognitive impairment, and headaches. The search included articles from the past 20 years (2004 to 2024).ResultsTelerehabilitation dates back to the 1960s and early 1970s. Documented effective interventions were mostly on therapies for speech disorders. The conceptual framework consisted of three major components of telerehabilitation programmes including development, implementation, and evaluation. The COVID-19 pandemic suddenly made telerehabilitation come to the limelight because physical distancing became necessary. Out of the 110,000 articles downloaded, 43 met the inclusion criteria for review on the conceptual framework of telerehabilitation in relation to neurological disorders. The articles discussed multiple sclerosis (2), spinal cord disorders (1), stroke (17), Parkinson's disease (15), headaches (3), and cognitive disorders (5). All articles reviewed assessed the effectiveness of telemedicine except for the articles on multiple sclerosis and spinal cord disorders which examined the interphase between the technology and the end users.ConclusionThe future of telerehabilitation looks promising with the subsequent integration of innovative tools and applications. This will require the adaption of technology, continuous capacity building, education, and training of healthcare professionals to ensure that they are adequately equipped with the necessary skills to provide quality virtual reality rehabilitation care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olowoyo</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhamija</LastName><ForeName>Rajinder K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Human Behaviour and Allied Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owolabi</LastName><ForeName>Mayowa O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Neurology Department, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomics and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lebanese American University, Beirut, Lebanon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blossom Specialist Medical Center, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 HG009780</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>D43 TW012030</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UE5 HL172183</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS115944</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS107900</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R13 NS115395</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS114045</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG007479</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>NeuroRehabilitation</MedlineTA><NlmUniqueID>9113791</NlmUniqueID><ISSNLinking>1053-8135</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066530" MajorTopicYN="Y">Neurological Rehabilitation</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069350" MajorTopicYN="Y">Telerehabilitation</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Telerehabilitation</Keyword><Keyword MajorTopicYN="N">conceptual framework</Keyword><Keyword MajorTopicYN="N">historical perspectives</Keyword></KeywordList><CoiStatement>Conflicts of interestsThe authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38995808</ArticleId><ArticleId IdType="mid">NIHMS2059174</ArticleId><ArticleId IdType="pmc">PMC11902888</ArticleId><ArticleId IdType="doi">10.3233/NRE-240079</ArticleId><ArticleId IdType="pii">NRE240079</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akbik F, Hirsch J, Chandra R, Frei D, Patel A, Rabinov J, Rost N, Schwamm L, &amp; Leslie-Mazwi T (2017). Telestroke&#x2014;the promise and the challenge. Part two&#x2014;expansion and horizons. Journal of Neurointerventional Surgery, 9(4), 361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">26984867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernocchi P, Vanoglio F, Baratti D, Morini R, Rocchi S, Luisa A, &amp; Scalvini S (2016). Home-based telesurveillance and rehabilitation after stroke: a real-life study. Top Stroke Rehabil, 23(2), 106&#x2013;115. 10.1080/10749357.2015.1120453</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10749357.2015.1120453</ArticleId><ArticleId IdType="pubmed">27078116</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth S, &amp; Kendall M (2007). Benefits and challenges of providing transitional rehabilitation services to people with spinal cord injury from regional, rural and remote locations. Aust J Rural Health, 15(3), 172&#x2013;178. 10.1111/j.1440-1584.2007.00880.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1584.2007.00880.x</ArticleId><ArticleId IdType="pubmed">17542789</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan D, Tindall L, Theodoros D, Brown J, Campbell M, Christiana D, Smith D, Cason J, &amp; Lee A (2010). A blueprint for telerehabilitation guidelines. Int J Telerehabil, 2(2), 31&#x2013;34. 10.5195/ijt.2010.6063</Citation><ArticleIdList><ArticleId IdType="doi">10.5195/ijt.2010.6063</ArticleId><ArticleId IdType="pmc">PMC4296793</ArticleId><ArticleId IdType="pubmed">25945175</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan DM, Georgeadis AC, Baron CR, &amp; Barker LM (2004). The effect of videoconference-based telerehabilitation on story retelling performance by brain-injured subjects and its implications for remote speech-language therapy. Telemed J E Health, 10(2), 147&#x2013;154. 10.1089/tmj.2004.10.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2004.10.147</ArticleId><ArticleId IdType="pubmed">15319044</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan DM, Mawson S, &amp; Brownsell S (2009). Telerehabilitation: enabling the remote delivery of healthcare, rehabilitation, and self management. Stud Health Technol Inform, 145, 231&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">19592797</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton RL, &amp; O&#x2019;Connell ME (2018). Telehealth Rehabilitation for Cognitive Impairment: Randomized Controlled Feasibility Trial. JMIR Res Protoc, 7(2), e43. 10.2196/resprot.9420</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/resprot.9420</ArticleId><ArticleId IdType="pmc">PMC5824099</ArticleId><ArticleId IdType="pubmed">29422453</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch C, Baumbach C, Willemsen D, Nee O, Gorath T, Hein A, &amp; Scheffold T (2009). Supervised training with wireless monitoring of ECG, blood pressure and oxygen-saturation in cardiac patients. J Telemed Telecare, 15(3), 112&#x2013;114. 10.1258/jtt.2009.003002</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jtt.2009.003002</ArticleId><ArticleId IdType="pubmed">19364889</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacciante L, Piet&#xe0; CD, Rutkowski S, Cie&#x15b;lik B, Szczepa&#x144;ska-Gieracha J, Agostini M, &amp; Kiper P (2022). Cognitive telerehabilitation in neurological patients: systematic review and meta-analysis. Neurol Sci, 43(2), 847&#x2013;862. 10.1007/s10072-021-05770-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05770-6</ArticleId><ArticleId IdType="pmc">PMC8613517</ArticleId><ArticleId IdType="pubmed">34822030</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughlin S, Mehta S, Corriveau H, Eng JJ, Eskes G, Kairy D, Meltzer J, Sakakibara BM, &amp; Teasell R (2020). Implementing telerehabilitation after stroke: lessons learned from Canadian trials. Telemedicine and e-Health, 26(6), 710&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">31633454</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, &amp; Krupp LB (2017). Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial. PloS One, 12(5), e0177177. 10.1371/journal.pone.0177177</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177177</ArticleId><ArticleId IdType="pmc">PMC5426671</ArticleId><ArticleId IdType="pubmed">28493924</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatto CA, York PT, Slade CP, &amp; Hasson SM (2018). Use of a Telehealth System to Enhance a Home Exercise Program for a Person With Parkinson Disease: A Case Report. J Neurol Phys Ther, 42(1), 22&#x2013;29. 10.1097/npt.0000000000000209</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/npt.0000000000000209</ArticleId><ArticleId IdType="pubmed">29206708</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Jin W, Dong WS, Jin Y, Qiao FL, Zhou YF, &amp; Ren CC (2017). Effects of Home-based Telesupervising Rehabilitation on Physical Function for Stroke Survivors with Hemiplegia: A Randomized Controlled Trial. Am J Phys Med Rehabil, 96(3), 152&#x2013;160. 10.1097/phm.0000000000000559</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/phm.0000000000000559</ArticleId><ArticleId IdType="pubmed">27386808</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Sun D, Zhang S, Shi Y, Qiao F, Zhou Y, Liu J, &amp; Ren C (2020). Effects of home-based telerehabilitation in patients with stroke: A randomized controlled trial. Neurology, 95(17), e2318&#x2013;e2330. 10.1212/wnl.0000000000010821</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000010821</ArticleId><ArticleId IdType="pubmed">32999058</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumbler NR, Quigley P, Li X, Morey M, Rose D, Sanford J, Griffiths P, &amp; Hoenig H (2012). Effects of telerehabilitation on physical function and disability for stroke patients: a randomized, controlled trial. Stroke, 43(8), 2168&#x2013;2174.</Citation><ArticleIdList><ArticleId IdType="pubmed">22627983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cikajlo I, Huki&#x107; A, Dolin&#x161;ek I, Zajc D, Vesel M, Krizmani&#x10d; T, Bla&#x17e;ica B, Biasizzo A, Novak F, &amp; Peterlin Potisk K (2018). Can telerehabilitation games lead to functional improvement of upper extremities in individuals with Parkinson&#x2019;s disease? Int J Rehabil Res, 41(3), 230&#x2013;238. 10.1097/mrr.0000000000000291</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mrr.0000000000000291</ArticleId><ArticleId IdType="pmc">PMC6092088</ArticleId><ArticleId IdType="pubmed">29757774</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, &amp; Wootton R (2011). Treating disordered speech and voice in Parkinson&#x2019;s disease online: a randomized controlled non-inferiority trial. Int J Lang Commun Disord, 46(1), 1&#x2013;16. 10.3109/13682822.2010.484848</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13682822.2010.484848</ArticleId><ArticleId IdType="pubmed">21281410</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu GA, Theodoros DG, Russell TG, Ward EC, Wilson SJ, &amp; Wootton R (2010). Homebased speech treatment for Parkinson&#x2019;s disease delivered remotely: a case report. J Telemed Telecare, 16(2), 100&#x2013;104. 10.1258/jtt.2009.090306</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jtt.2009.090306</ArticleId><ArticleId IdType="pubmed">20008051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cramer SC, Dodakian L, Le V, See J, Augsburger R, McKenzie A, Zhou RJ, Chiu NL, Heckhausen J, &amp; Cassidy JM (2019). Efficacy of home-based telerehabilitation vs in-clinic therapy for adults after stroke: a randomized clinical trial. JAMA neurology, 76(9), 1079&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593624</ArticleId><ArticleId IdType="pubmed">31233135</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodakian L, McKenzie AL, Le V, See J, Pearson-Fuhrhop K, Burke Quinlan E, Zhou RJ, Augsberger R, Tran XA, Friedman N, Reinkensmeyer DJ, &amp; Cramer SC (2017). A Home-Based Telerehabilitation Program for Patients With Stroke. Neurorehabil Neural Repair, 31(10&#x2013;11),923&#x2013;933. 10.1177/1545968317733818</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968317733818</ArticleId><ArticleId IdType="pmc">PMC5734923</ArticleId><ArticleId IdType="pubmed">29072556</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy JR, Werven GW, &amp; Aronson AE (1997). Telemedicine and the diagnosis of speech and language disorders. Mayo Clin Proc, 72(12), 1116&#x2013;1122. 10.4065/72.12.1116</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/72.12.1116</ArticleId><ArticleId IdType="pubmed">9413290</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguiluz-Perez G, &amp; Garcia-Zapirain B (2014). Comprehensive verticality analysis and web-based rehabilitation system for people with multiple sclerosis with supervised medical monitoring. Biomed Mater Eng, 24(6), 3493&#x2013;3502. 10.3233/bme-141175</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/bme-141175</ArticleId><ArticleId IdType="pubmed">25227062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pi&#xf1;a IL, Rodney R, Simons-Morton DA, Williams MA, &amp; Bazzarre T (2001). Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation, 104(14), 1694&#x2013;1740. 10.1161/hc3901.095960</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3901.095960</ArticleId><ArticleId IdType="pubmed">11581152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal N, Andrei D, Neme&#x15f; DI, N&#x103;d&#x103;&#x15f;an E, &amp; Stoicu-Tivadar V (2015). A Kinect based intelligent e-rehabilitation system in physical therapy. Stud Health Technol Inform, 210, 489&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandolfi M, Geroin C, Dimitrova E, Boldrini P, Waldner A, Bonadiman S, Picelli A, Regazzo S, Stirbu E, Primon D, Bosello C, Gravina AR, Peron L, Trevisan M, Garcia AC, Menel A, Bloccari L, Val&#xe8; N, Saltuari L,... Smania N (2017). Virtual Reality Telerehabilitation for Postural Instability in Parkinson&#x2019;s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial. Biomed Res Int, 2017, 7962826. 10.1155/2017/7962826</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7962826</ArticleId><ArticleId IdType="pmc">PMC5733154</ArticleId><ArticleId IdType="pubmed">29333454</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Rudolph A, Wright MA, Murillo N, Opisso E, &amp; Medina J (2023). Tele-rehabilitation on independence in activities of daily living after stroke: A Matched Case-Control Study. J Stroke Cerebrovasc Dis, 32(10), 107267. 10.1016/j.jstrokecerebrovasdis.2023.107267</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2023.107267</ArticleId><ArticleId IdType="pubmed">37579640</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg D, &amp; Dhamija RK (2020). Teleneurorehabilitation for Parkinson&#x2019;s disease: a panacea for the times to come? Annals of Indian Academy of Neurology, 23(5), 592&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887501</ArticleId><ArticleId IdType="pubmed">33623256</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg D, Majumdar R, Chauhan S, Preenja R, Parihar J, Saluja A, &amp; Dhamija RK (2021). Teleneurorehabilitation among person with Parkinson&#x2019;s disease in India: The initial experience and barriers to implementation. Annals of Indian Academy of Neurology, 24(4), 536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513956</ArticleId><ArticleId IdType="pubmed">34728947</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgeadis A, Brennan D, Barker L, &amp; Baron C (2004). Telerehabilitation and its effect on story retelling by adults with neurogenic communication disorders. Aphasiology, 18(5&#x2013;7), 639&#x2013;652.</Citation></Reference><Reference><Citation>Griffin M, Bentley J, Shanks J, &amp; Wood C (2018). The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study. J Telemed Telecare, 24(3), 209&#x2013;215. 10.1177/1357633&#xd7;17691865</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633&#xd7;17691865</ArticleId><ArticleId IdType="pubmed">28147896</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison E, Wilson L, &amp; Onslow M (1999). Distance intervention for early stuttering with the Lidcombe Programme. Advances in Speech Language Pathology, 1(1), 31&#x2013;36.</Citation></Reference><Reference><Citation>Hill AJ, Theodoros DG, Russell TG, Cahill LM, Ward EC, &amp; Clark KM (2006). An Internet-based telerehabilitation system for the assessment of motor speech disorders: a pilot study. Am J Speech Lang Pathol, 15(1), 45&#x2013;56. 10.1044/1058-0360(2006/006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1058-0360(2006/006)</ArticleId><ArticleId IdType="pubmed">16533092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann T, Russell T, Thompson L, Vincent A, &amp; Nelson M (2008). Using the Internet to assess activities of daily living and hand function in people with Parkinson&#x2019;s disease. NeuroRehabilitation, 23(3), 253&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">18560142</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden MK, Dyar TA, &amp; Dayan-Cimadoro L (2007). Telerehabilitation using a virtual environment improves upper extremity function in patients with stroke. IEEE Trans Neural Syst Rehabil Eng, 15(1), 36&#x2013;42. 10.1109/tnsre.2007.891388</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/tnsre.2007.891388</ArticleId><ArticleId IdType="pubmed">17436874</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell S, Tripoliti E, &amp; Pring T (2009). Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. Int J Lang Commun Disord, 44(3), 287&#x2013;300. 10.1080/13682820802033968</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13682820802033968</ArticleId><ArticleId IdType="pubmed">18821113</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.allconnect.com/blog/faqs-internet-speeds-what-speed-do-you-need. (Assessed 17 December 2023.).</Citation></Reference><Reference><Citation>https://www.bionity.com/en/encyclopedia/Telerehabilitation.html. (Assessed 30 November, 2023).</Citation></Reference><Reference><Citation>https://www.scribbr.com/methodology/conceptual-framework/. (Assessed 6 December 2023.).</Citation></Reference><Reference><Citation>Jagos H, David V, Haller M, Kotzian S, Hofmann M, Schlossarek S, Eichholzer K, Winkler M, Frohner M, Reichel M, Mayr W, &amp; Rafolt D (2015). A Framework for (Tele-) Monitoring of the Rehabilitation Progress in Stroke Patients: eHealth 2015 Special Issue. Appl Clin Inform, 6(4), 757&#x2013;768. 10.4338/aci-2015-03-ra-0034</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2015-03-ra-0034</ArticleId><ArticleId IdType="pmc">PMC4704043</ArticleId><ArticleId IdType="pubmed">26767068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagos H, David V, Reichel M, Kotzian S, Schlossarek S, Haller M, &amp; Rafolt D (2015). Tele-monitoring of the rehabilitation progress in stroke patients. Stud Health Technol Inform, 211, 311&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">25980890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Daley K, Pruski AD, AlFarra T, Azola A, Gonzalez Fernandez M, Keszler MS, Friedel S, Haaf H, Segall H, Lien P, Cypher J, Mazariegos J, &amp; Raghavan P (2022). Implementation of a Framework for Telerehabilitation in Clinical Care Across the Continuum During COVID-19 and Beyond. Am J Phys Med Rehabil, 101(1), 53&#x2013;60. 10.1097/phm.0000000000001904</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/phm.0000000000001904</ArticleId><ArticleId IdType="pmc">PMC8667677</ArticleId><ArticleId IdType="pubmed">34915545</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaic M, &amp; Galea MP (2020). Using the Technology Acceptance Model to Identify Factors That Predict Likelihood to Adopt Tele-Neurorehabilitation. Front Neurol, 11, 580832. 10.3389/fneur.2020.580832</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.580832</ArticleId><ArticleId IdType="pmc">PMC7738474</ArticleId><ArticleId IdType="pubmed">33343488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JC, Woo J, Hui E, &amp; Chan WM (2004). Telerehabilitation - a new model for community-based stroke rehabilitation. J Telemed Telecare, 10(4), 199&#x2013;205. 10.1258/1357633041424340</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/1357633041424340</ArticleId><ArticleId IdType="pubmed">15273029</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson EB, Feigon M, Gagliardo P, &amp; Dvorkin AY (2014). Virtual reality and cognitive rehabilitation: a review of current outcome research. NeuroRehabilitation, 34(4), 759&#x2013;772. 10.3233/nre-141078</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/nre-141078</ArticleId><ArticleId IdType="pubmed">24820166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lathan CE, Kinsella A, Rosen MJ, Winters J, &amp; Trepagnier C (1999). Aspects of human factors engineering in home telemedicine and telerehabilitation systems. Telemed J, 5(2), 169&#x2013;175. 10.1089/107830299312131</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107830299312131</ArticleId><ArticleId IdType="pubmed">10908429</ArticleId></ArticleIdList></Reference><Reference><Citation>Laver KE, Schoene D, Crotty M, George S, Lannin NA, &amp; Sherrington C (2013). Telerehabilitation services for stroke. Cochrane Database Syst Rev, 2013(12), Cd010255. 10.1002/14651858.CD010255.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010255.pub2</ArticleId><ArticleId IdType="pmc">PMC6464866</ArticleId><ArticleId IdType="pubmed">24338496</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens R, No&#xe9; E, Colomer C, &amp; Alca&#xf1;iz M (2015). Effectiveness, usability, and cost-benefit of a virtual reality-based telerehabilitation program for balance recovery after stroke: a randomized controlled trial. Arch Phys Med Rehabil, 96(3), 418&#x2013;425.e412. 10.1016/j.apmr.2014.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2014.10.019</ArticleId><ArticleId IdType="pubmed">25448245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac&#xed;as-Hern&#xe1;ndez SI, V&#xe1;squez-Sotelo DS, Ferruzca-Navarro MV, S&#xe1;nchez SHB, Guti&#xe9;rrez-Mart&#xed;nez J, N&#xfa;&#xf1;ez-Gaona MA, Meneses HA, Velez-Guti&#xe9;rrez OB, Tapia-Ferrusco I, &amp; de los &#xc1;ngeles Soria-Bastida M (2016). Proposal and evaluation of a telerehabilitation platform designed for patients with partial rotator cuff tears: a preliminary study. Annals of Rehabilitation Medicine, 40(4), 710&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012983</ArticleId><ArticleId IdType="pubmed">27606278</ArticleId></ArticleIdList></Reference><Reference><Citation>McCue MJ, &amp; Palsbo SE (2006). Making the business case for telemedicine: an interactive spreadsheet. Telemedicine Journal &amp; e-Health, 12(2), 99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">16620163</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeary D, &amp; McGeary C (2021). Telerehabilitation for Headache Management. Phys Med Rehabil Clin N Am, 32(2), 373&#x2013;391. 10.1016/j.pmr.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2021.01.005</ArticleId><ArticleId IdType="pubmed">33814063</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros de Bustos E, Vuillier F, Chavot D, &amp; Moulin T (2009). Telemedicine in stroke: organizing a network&#x2013;rationale and baseline principles. Cerebrovascular Diseases, 27(Suppl. 4), 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19546535</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, &amp; Altman DG (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5), 336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller KI, Alstadhaug KB, &amp; Bekkelund SI (2017). A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology, 89(2), 153&#x2013;162. 10.1212/wnl.0000000000004085</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000004085</ArticleId><ArticleId IdType="pmc">PMC5501933</ArticleId><ArticleId IdType="pubmed">28615434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicogossian AE, Pober DF, &amp; Roy SA (2001). Evolution of telemedicine in the space program and earth applications. Telemed J E Health, 7(1), 1&#x2013;15. 10.1089/153056201300093813</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/153056201300093813</ArticleId><ArticleId IdType="pubmed">11321704</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik SM, &amp; Cramer SC (2023). Predicting motor gains with home-based telerehabilitation after stroke. J Telemed Telecare, 29(10), 799&#x2013;807. 10.1177/1357633x211023353</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633x211023353</ArticleId><ArticleId IdType="pubmed">34156873</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretti A, Amenta F, Tayebati SK, Nittari G, &amp; Mahdi SS (2017). Telerehabilitation: Review of the State-of-the-Art and Areas of Application. JMIR Rehabil Assist Technol, 4(2), e7. 10.2196/rehab.7511</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/rehab.7511</ArticleId><ArticleId IdType="pmc">PMC5544892</ArticleId><ArticleId IdType="pubmed">28733271</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman AL, &amp; Witthawaskul W (2002). Real-time remote telefluoroscopic assessment of patients with dysphagia. Dysphagia, 17, 162&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">11956842</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz E, Baranowski R, Bilinska M, Stepnowska M, Piotrowska M, W&#xf3;jcik A, Korewicki J, Chojnowska L, Malek LA, Klopotowski M, Piotrowski W, &amp; Piotrowicz R (2010). A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail, 12(2), 164&#x2013;171. 10.1093/eurjhf/hfp181</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hfp181</ArticleId><ArticleId IdType="pubmed">20042423</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz E, Jasionowska A, Banaszak-Bednarczyk M, Gwilkowska J, &amp; Piotrowicz R (2012). ECG telemonitoring during home-based cardiac rehabilitation in heart failure patients. J Telemed Telecare, 18(4), 193&#x2013;197. 10.1258/jtt.2012.111005</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jtt.2012.111005</ArticleId><ArticleId IdType="pubmed">22604276</ArticleId></ArticleIdList></Reference><Reference><Citation>Piron L, Tonin P, Trivello E, Battistin L, &amp; Dam M (2004). Motor tele-rehabilitation in post-stroke patients. Med Inform Internet Med, 29(2), 119&#x2013;125. 10.1080/14639230410001723428</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14639230410001723428</ArticleId><ArticleId IdType="pubmed">15370992</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon P, Hui E, Dai D, Kwok T, &amp; Woo J (2005). Cognitive intervention for community-dwelling older persons with memory problems: telemedicine versus face-to-face treatment. Int J Geriatr Psychiatry, 20(3), 285&#x2013;286. 10.1002/gps.1282</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1282</ArticleId><ArticleId IdType="pubmed">15717335</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn R, Park S, Theodoros D, &amp; Hill AJ (2019). Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson&#x2019;s disease: A pilot study. Int J Speech Lang Pathol, 21(4), 385&#x2013;394. 10.1080/17549507.2018.1476918</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17549507.2018.1476918</ArticleId><ArticleId IdType="pubmed">29879854</ArticleId></ArticleIdList></Reference><Reference><Citation>Seron P, Oliveros MJ, Gutierrez-Arias R, Fuentes-Aspe R, Torres-Castro RC, Merino-Osorio C, Nahuelhual P, Inostroza J, Jalil Y, Solano R, Marzuca-Nassr GN, Aguilera-Egu&#xed;a R, Lavados-Romo P, Soto-Rodr&#xed;guez FJ, Sabelle C, Villarroel-Silva G, Gomol&#xe1;n P, Huaiquilaf S, &amp; Sanchez P (2021). Effectiveness of Telerehabilitation in Physical Therapy: A Rapid Overview. Phys Ther, 101(6). 10.1093/ptj/pzab053</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzab053</ArticleId><ArticleId IdType="pmc">PMC7928601</ArticleId><ArticleId IdType="pubmed">33561280</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina E, Tedeschi G, Russo A, Trojsi F, Iodice R, Tozza S, Iovino A, Iodice F, Abbadessa G, di Lorenzo F, Miele G, Maida E, Cerullo G, Sparaco M, Silvestro M, Leocani L, Bonavita S, Manganelli F, &amp; Lavorgna L (2022). Telemedicine application to headache: a critical review. Neurol Sci, 43(6), 3795&#x2013;3801. 10.1007/s10072-022-05910-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-05910-6</ArticleId><ArticleId IdType="pmc">PMC8786371</ArticleId><ArticleId IdType="pubmed">35075575</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoli D, &amp; Aeddula NR (2023). Telemedicine. In StatPearls. StatPearls Publishing Copyright &#xa9; 2023, StatPearls Publishing LLC.</Citation></Reference><Reference><Citation>Theodoros D, Aldridge D, Hill AJ, &amp; Russell T (2019). Technology-enabled management of communication and swallowing disorders in Parkinson&#x2019;s disease: a systematic scoping review. International Journal of Language &amp; Communication Disorders, 54(2), 170&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">29923267</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoros D, &amp; Russell T (2008). Telerehabilitation: current perspectives. Stud Health Technol Inform, 131, 191&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">18431862</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoros DG, Hill AJ, &amp; Russell TG (2016). Clinical and Quality of Life Outcomes of Speech Treatment for Parkinson&#x2019;s Disease Delivered to the Home Via Telerehabilitation: A Non-inferiority Randomized Controlled Trial. Am J Speech Lang Pathol, 25(2), 214&#x2013;232.10.1044/2015ajslp-15-0005</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2015ajslp-15-0005</ArticleId><ArticleId IdType="pubmed">27145396</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrisi M, Maresca G, De Cola MC, Cannav&#xf2; A, Sciarrone F, Silvestri G, Bramanti A, De Luca R, &amp; Calabro RS (2019). Using telerehabilitation to improve cognitive function in post-stroke survivors: is this the time for the continuity of care? Int J Rehabil Res, 42(4), 344&#x2013;351. 10.1097/mrr.0000000000000369</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mrr.0000000000000369</ArticleId><ArticleId IdType="pubmed">31464812</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn GR (1976). Tel-communicology: health-care delivery system for persons with communicative disorders. Asha, 18(1), 13&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">1247464</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellata C, Belli S, Balsamo F, Giordano A, Colombo R, &amp; Maggioni G (2021). Effectiveness of Telerehabilitation on Motor Impairments, Non-motor Symptoms and Compliance in Patients With Parkinson&#x2019;s Disease: A Systematic Review. Front Neurol, 12, 627999. 10.3389/fneur.2021.627999</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.627999</ArticleId><ArticleId IdType="pmc">PMC8427282</ArticleId><ArticleId IdType="pubmed">34512495</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt I, Benedict M, Susky M, Scheplitz T, Frankowitz S, Kern R, M&#xfc;ller O, Schlieter H, &amp; Ziemssen T (2020). A Digital Patient Portal for Patients With Multiple Sclerosis. Front Neurol, 11, 400. 10.3389/fneur.2020.00400</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00400</ArticleId><ArticleId IdType="pmc">PMC7326091</ArticleId><ArticleId IdType="pubmed">32670174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wertz RT, Dronkers NF, Bernstein-ellis E, Sterling LK, Shubitowski Y, Elman R, Shenaut GK, Knight RT, &amp; Deal JL (1992). Potential of telephonic and television technology for appraising and diagnosing neurogenic communication disorders in remote settings. Aphasiology, 6(2), 195&#x2013;202.</Citation></Reference><Reference><Citation>White LA, Krousel-Wood MA, &amp; Mather F (2001). Technology meets healthcare: distance learning and telehealth. Ochsner J, 3(1), 22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3116779</ArticleId><ArticleId IdType="pubmed">21765713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson JR, Spindler M, Wood SM, Marcus SC, Weintraub D, Morley JF, Stineman MG, &amp; Duda JE (2016). High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study. Neurol Clin Pract, 6(3), 241&#x2013;251. 10.1212/cpj.0000000000000252</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/cpj.0000000000000252</ArticleId><ArticleId IdType="pmc">PMC4909521</ArticleId><ArticleId IdType="pubmed">27347441</ArticleId></ArticleIdList></Reference><Reference><Citation>Winters JM, &amp; Rosen M (1999). The Rehabilitation Engineering Research Center on telerehabilitation: mission and approaches. Proceedings of the First Joint BMES/EMBS Conference. 1999 IEEE Engineering in Medicine and Biology 21st Annual Conference and the 1999 Annual Fall Meeting of the Biomedical Engineering Society (Cat. N,</Citation></Reference><Reference><Citation>Wu Z, Xu J, Yue C, Li Y, &amp; Liang Y (2020). Collaborative Care Model Based Telerehabilitation Exercise Training Program for Acute Stroke Patients in China: A Randomized Controlled Trial. J Stroke Cerebrovasc Dis, 29(12), 105328. 10.1016/j.jstrokecerebrovasdis.2020.105328</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105328</ArticleId><ArticleId IdType="pubmed">33002792</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40199682</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-2574</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>HPB : the official journal of the International Hepato Pancreato Biliary Association</Title><ISOAbbreviation>HPB (Oxford)</ISOAbbreviation></Journal><ArticleTitle>Implementation of robotic and laparoscopic hepatopancreatobiliary surgery in low- and middle-income settings: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>869</StartPage><EndPage>883</EndPage><MedlinePgn>869-883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hpb.2025.03.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1365-182X(25)00081-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite numerous barriers, the application of minimally invasive surgery (MIS) for hepatopancreatobiliary (HPB) conditions has been increasing globally. This study aims to review the current status of HPB MIS in LMICs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Relevant databases were searched, identifying 3452 publications, 38 of which met the inclusion criteria. Meta-analysis of outcomes was carried out using "R" statistical software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study reviewed reports of application of MIS for HPB conditions in LMICs, analyzing a total of 3272 procedures. India (66.87 %) and Egypt (20.11 %) contributed majorly to the procedures reviewed. Others were from Indonesia (8.68 %), Colombia (3.06 %), Pakistan (0.67 %), Sri Lanka (0.34 %), Trinidad and Tobago (0.18 %), and Nigeria (0.09 %). India was the only LMIC with robotic HPB MIS. The majority of the procedures were biliary (74.88 %). Basic procedures accounted for 55.63 %, while 44.37 % were advanced. The overall conversion rate and prevalence of morbidity were 8 % [95 % CI: 5; 13], and 15 % [95 % CI: 9; 22], respectively. Robotics was associated with higher conversion (14 % vs 6 %, p &lt; 0.01) but lower morbidity (10 % vs 16 %, p = 0.91), compared to laparoscopic surgery. There were 5 cases of mortality from laparoscopy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The outcomes in this systematic review, compared to findings in other settings indicate successful implementation of HPB MIS in LMICs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falola</LastName><ForeName>Adebayo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria; General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria. Electronic address: falolabayo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezebialu</LastName><ForeName>Chioma</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria; General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okeke</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria; General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fadairo</LastName><ForeName>Rhoda T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria; General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dada</LastName><ForeName>Oluwasina S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Ilorin Teaching Hospital, Nigeria; Department of Medicine and Surgery, Afe Babalola University Ado-Ekiti, Nigeria; Significant Polyp and Early Colorectal Cancer Service, King's College Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>HPB (Oxford)</MedlineTA><NlmUniqueID>100900921</NlmUniqueID><ISSNLinking>1365-182X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001662" MajorTopicYN="Y">Biliary Tract Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010182" MajorTopicYN="Y">Pancreatic Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001660" MajorTopicYN="Y">Biliary Tract Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>10</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>8</Day><Hour>21</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40199682</ArticleId><ArticleId IdType="doi">10.1016/j.hpb.2025.03.006</ArticleId><ArticleId IdType="pii">S1365-182X(25)00081-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29318985</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2046-4924</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Health technology assessment (Winchester, England)</Title><ISOAbbreviation>Health Technol Assess</ISOAbbreviation></Journal><ArticleTitle>A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>88</EndPage><MedlinePgn>1-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3310/hta22020</ELocationID><Abstract><AbstractText Label="BACKGROUND">Caesarean section is associated with blood loss and maternal morbidity. Excessive blood loss requires transfusion of donor (allogeneic) blood, which is a finite resource. Cell salvage returns blood lost during surgery to the mother. It may avoid the need for donor blood transfusion, but reliable evidence of its effects is lacking.</AbstractText><AbstractText Label="OBJECTIVES">To determine if routine use of cell salvage during caesarean section in mothers at risk of haemorrhage reduces the rates of blood transfusion and postpartum maternal morbidity, and is cost-effective, in comparison with standard practice without routine salvage use.</AbstractText><AbstractText Label="DESIGN">Individually randomised controlled, multicentre trial with cost-effectiveness analysis. Treatment was not blinded.</AbstractText><AbstractText Label="SETTING">A total of 26 UK obstetric units.</AbstractText><AbstractText Label="PARTICIPANTS">Out of 3054 women recruited between June 2013 and April 2016, we randomly assigned 3028 women at risk of haemorrhage to cell salvage or routine care. Randomisation was stratified using random permuted blocks of variable sizes. Of these, 1672 had emergency and 1356 had elective caesareans. We excluded women for whom cell salvage or donor blood transfusion was contraindicated.</AbstractText><AbstractText Label="INTERVENTIONS">Cell salvage (intervention) versus routine care without salvage (control). In the intervention group, salvage was set up in 95.6% of the women and, of these, 50.8% had salvaged blood returned. In the control group, 3.9% had salvage deployed.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Primary - donor blood transfusion. Secondary - units of donor blood transfused, time to mobilisation, length of hospitalisation, mean fall in haemoglobin, fetomaternal haemorrhage (FMH) measured by Kleihauer-Betke test, and maternal fatigue. Analyses were adjusted for stratification factors and other factors that were believed to be prognostic a priori. Cost-effectiveness outcomes - costs of resources and service provision taking the UK NHS perspective.</AbstractText><AbstractText Label="RESULTS">We analysed 1498 and 1492 participants in the intervention and control groups, respectively. Overall, the transfusion rate was 2.5% in the intervention group and 3.5% in the control group [adjusted odds ratio (OR) 0.65, 95% confidence interval (CI) 0.42 to 1.01; <i>p</i>&#x2009;=&#x2009;0.056]. In a planned subgroup analysis, the transfusion rate was 3.0% in the intervention group and 4.6% in the control group among emergency caesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 1.8% in the intervention group and 2.2% in the control group among elective caesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interaction <i>p</i>&#x2009;=&#x2009;0.46, suggesting that the difference in effect between subgroups was not statistically significant). Secondary outcomes did not differ between groups, except for FMH, which was higher under salvage in rhesus D (RhD)-negative women with RhD-positive babies (25.6% vs. 10.5%, adjusted OR 5.63, 95% CI 1.43 to 22.14; <i>p</i>&#x2009;=&#x2009;0.013). No case of amniotic fluid embolism was observed. The additional cost of routine cell salvage during caesarean was estimated, on average, at &#xa3;8110 per donor blood transfusion avoided.</AbstractText><AbstractText Label="CONCLUSIONS">The modest evidence for an effect of routine use of cell salvage during caesarean section on rates of donor blood transfusion was associated with increased FMH, which emphasises the need for adherence to guidance on anti-D prophylaxis. We are unable to comment on long-term antibody sensitisation effects. Based on the findings of this trial, cell salvage is unlikely to be considered cost-effective.</AbstractText><AbstractText Label="FUTURE WORK">Research into risk of alloimmunisation among women exposed to cell salvage is needed.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Current Controlled Trials ISRCTN66118656.</AbstractText><AbstractText Label="FUNDING">This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in <i>Health Technology Assessment</i>; Vol. 22, No. 2. See the NIHR Journals Library website for further project information.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Khalid S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Selwyn Crawford Department of Anaesthetics, Birmingham Women's Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooper</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allard</LastName><ForeName>Shubha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Haematology, NHS Blood and Transplant, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrench</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Anaesthetics, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Health Economics Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLoughlin</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Economics Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beresford</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geoghegan</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Selwyn Crawford Department of Anaesthetics, Birmingham Women's Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catling</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthetics, Singleton Hospital, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Vicki A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuk</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Women's Services, Royal Victoria Infirmary, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao-Smith</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Perioperative, Critical Care and Trauma Trials Group, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogg</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Economics Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanz</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodds</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN66118656</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>10/57/32</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Technol Assess</MedlineTA><NlmUniqueID>9706284</NlmUniqueID><ISSNLinking>1366-5278</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006295" MajorTopicYN="N">Health Resources</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057725" MajorTopicYN="N">Operative Blood Salvage</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013673" MajorTopicYN="N">Technology Assessment, Biomedical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29318985</ArticleId><ArticleId IdType="pmc">PMC5776407</ArticleId><ArticleId IdType="doi">10.3310/hta22020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29261655</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLoS medicine</Title><ISOAbbreviation>PLoS Med</ISOAbbreviation></Journal><ArticleTitle>Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO).</ArticleTitle><Pagination><StartPage>e1002471</StartPage><MedlinePgn>e1002471</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1002471</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1002471</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Excessive haemorrhage at cesarean section requires donor (allogeneic) blood transfusion. Cell salvage may reduce this requirement.</AbstractText><AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS">We conducted a pragmatic randomised controlled trial (at 26 obstetric units; participants recruited from 4 June 2013 to 17 April 2016) of routine cell salvage use (intervention) versus current standard of care without routine salvage use (control) in cesarean section among women at risk of haemorrhage. Randomisation was stratified, using random permuted blocks of variable sizes. In an intention-to-treat analysis, we used multivariable models, adjusting for stratification variables and prognostic factors identified a priori, to compare rates of donor blood transfusion (primary outcome) and fetomaternal haemorrhage &#x2265;2 ml in RhD-negative women with RhD-positive babies (a secondary outcome) between groups. Among 3,028 women randomised (2,990 analysed), 95.6% of 1,498 assigned to intervention had cell salvage deployed (50.8% had salvaged blood returned; mean 259.9 ml) versus 3.9% of 1,492 assigned to control. Donor blood transfusion rate was 3.5% in the control group versus 2.5% in the intervention group (adjusted odds ratio [OR] 0.65, 95% confidence interval [CI] 0.42 to 1.01, p = 0.056; adjusted risk difference -1.03, 95% CI -2.13 to 0.06). In a planned subgroup analysis, the transfusion rate was 4.6% in women assigned to control versus 3.0% in the intervention group among emergency cesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 2.2% versus 1.8% among elective cesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interaction p = 0.46). No case of amniotic fluid embolism was observed. The rate of fetomaternal haemorrhage was higher with the intervention (10.5% in the control group versus 25.6% in the intervention group, adjusted OR 5.63, 95% CI 1.43 to 22.14, p = 0.013). We are unable to comment on long-term antibody sensitisation effects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall reduction observed in donor blood transfusion associated with the routine use of cell salvage during cesarean section was not statistically significant.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This trial was prospectively registered on ISRCTN as trial number 66118656 and can be viewed on http://www.isrctn.com/ISRCTN66118656.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Khalid S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Philip A S</ForeName><Initials>PAS</Initials><Identifier Source="ORCID">0000-0001-7048-1493</Identifier><AffiliationInfo><Affiliation>Birmingham Women's Hospital, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>School of Health and Related Research, University of Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooper</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allard</LastName><ForeName>Shubha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrench</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beresford</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7754-8053</Identifier><AffiliationInfo><Affiliation>Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Tracy E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0002-0624-0537</Identifier><AffiliationInfo><Affiliation>Health Economics Unit, Institute of Applied Health Research, University of Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLoughlin</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6861-8259</Identifier><AffiliationInfo><Affiliation>Health Economics Unit, Institute of Applied Health Research, University of Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geoghegan</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Birmingham Women's Hospital, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Jane P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-3324-6771</Identifier><AffiliationInfo><Affiliation>Nottingham Clinical Trials Unit, University of Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catling</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Singleton Hospital, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Vicki A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuk</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine, Newcastle University, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao-Smith</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Peri-operative, Critical Care and Trauma Trials Group, University of Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogg</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanz</LastName><ForeName>Doris</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9879-3069</Identifier><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodds</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Women's Health Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SALVO study group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10/57/32</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Med</MedlineTA><NlmUniqueID>101231360</NlmUniqueID><ISSNLinking>1549-1277</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesia. 2018 Dec;73(12):1574-1575. doi: 10.1111/anae.14464.</RefSource><PMID Version="1">30412294</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057725" MajorTopicYN="N">Operative Blood Salvage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="N">Patient Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: Primary NIHR grant supporting the roles of KK, PM, RH, IW, LB, TR, CM, JDa, SR, DL and JDo. PM also declares having been a co-applicant for two other NIHR-funded grants over within the last five years. Other than this, all authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29261655</ArticleId><ArticleId IdType="pmc">PMC5736174</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002471</ArticleId><ArticleId IdType="pii">PMEDICINE-D-17-02640</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Betran AP, Torloni MR, Zhang JJ, G&#xfc;lmezoglu AM, WHO Working Group on Caesarean Section. WHO statement on caesarean section rates. BJOG. 2016;123(5):667&#x2013;70. doi: 10.1111/1471-0528.13526
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.13526</ArticleId><ArticleId IdType="pmc">PMC5034743</ArticleId><ArticleId IdType="pubmed">26681211</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre for Maternal and Child Enquiries. Saving mothers lives: reviewing maternal deaths to make motherhood safer: 2006&#x2013;2008. BJOG. 2011;118(Suppl 1):1&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">21356004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodelon C, Bernabe-Ortiz A, Schiff MA, Reed SD. Factors associated with peripartum hysterectomy. Obstet Gynecol. 2009;114(1):115&#x2013;23. doi: 10.1097/AOG.0b013e3181a81cdd
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181a81cdd</ArticleId><ArticleId IdType="pmc">PMC2714706</ArticleId><ArticleId IdType="pubmed">19546767</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care National Audit &amp; Research Centre. Female admissions (aged 16&#x2013;50 years) to adult, general critical care units in England, Wales and Northern Ireland reported as &#x2018;currently pregnant&#x2019; or &#x2018;recently pregnant&#x2019;. London: Obstetric Anaesthetists&#x2019; Association; 2013.</Citation></Reference><Reference><Citation>Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368&#x2013;73. doi: 10.1213/ANE.0b013e3181d74898
</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181d74898</ArticleId><ArticleId IdType="pubmed">20237047</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Blood and Transplant. Saving and improving lives: strategic plan 2015&#x2013;20. London: NHS Blood and Transplant; 2015.</Citation></Reference><Reference><Citation>Catling S. Intraoperative cell salvage in obstetrics. Clin Risk. 2008;14(1):14&#x2013;7.</Citation></Reference><Reference><Citation>Shander A, Isbister J, Gombotz H. Patient blood management: the global view. Transfusion. 2016;56(Suppl 1):S94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">27001367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, et al. 
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion. 2015;55(12):2807&#x2013;15. doi: 10.1111/trf.13260
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.13260</ArticleId><ArticleId IdType="pubmed">26264557</ArticleId></ArticleIdList></Reference><Reference><Citation>Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105&#x2013;16. doi: 10.1016/S0140-6736(17)30638-4
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30638-4</ArticleId><ArticleId IdType="pmc">PMC5446563</ArticleId><ArticleId IdType="pubmed">28456509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardine JE, Law P, Hogg M, Murphy D, Khan KS, C-SAFETY. Haemorrhage at caesarean section: a framework for prevention and research. Curr Opin Obstet Gynecol. 2016;28(6):492&#x2013;8. doi: 10.1097/GCO.0000000000000328
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GCO.0000000000000328</ArticleId><ArticleId IdType="pubmed">27787286</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess. 2006;10(44):1&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">17049141</ArticleId></ArticleIdList></Reference><Reference><Citation>Carless PA, Henry DA, Moxey AJ, O&#x2019;Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010;2010(3):CD001888.</Citation></Reference><Reference><Citation>White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, et al. 
Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016;26(4):246&#x2013;63. doi: 10.1111/tme.12299
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tme.12299</ArticleId><ArticleId IdType="pubmed">27074872</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, et al. British Committee for Standards in Haematology guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24(1):8&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">25121158</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhariwal SK, Khan KS, Allard S, Wilson M, Moore P, SALVO study group. Does current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section?
Curr Opin Obstet Gynecol. 2014;26(6):425&#x2013;30. doi: 10.1097/GCO.0000000000000116
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GCO.0000000000000116</ArticleId><ArticleId IdType="pmc">PMC4338583</ArticleId><ArticleId IdType="pubmed">25259949</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth. 2015;24(1):86&#x2013;7. doi: 10.1016/j.ijoa.2014.08.003
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2014.08.003</ArticleId><ArticleId IdType="pubmed">25499013</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoghegan J, Daniels JP, Moore PA, Thompson PJ, Khan KS, G&#xfc;lmezoglu AM. Cell salvage at caesarean section: the need for an evidence-based approach. BJOG. 2009;116(6):743&#x2013;7. doi: 10.1111/j.1471-0528.2009.02129.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2009.02129.x</ArticleId><ArticleId IdType="pubmed">19432562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R. Blood salvage during caesarean section. Br J Anaesth. 1998;80(2):195&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9602584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol. 1998;179(3 Pt 1):715&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">9757977</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Obstetricians and Gynaecologists, Royal College of Anaesthetists. Classification of urgency of caesarean section&#x2014;a continuum of risk. Good Practice No. 11. London: Royal College of Obstetricians and Gynaecologists; 2010.</Citation></Reference><Reference><Citation>Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, et al. 
Urgency of caesarean section: a new classification. J R Soc Med. 2000;93(7):346&#x2013;50. doi: 10.1177/014107680009300703
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107680009300703</ArticleId><ArticleId IdType="pmc">PMC1298057</ArticleId><ArticleId IdType="pubmed">10928020</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. Green-top Guideline No. 27. London: Royal College of Obstetricians and Gynaecologists; 2011.</Citation></Reference><Reference><Citation>Haynes SL, Bennett JR, Torella F, McCollum CN. Does washing swabs increase the efficiency of red cell recovery by cell salvage in aortic surgery?
Vox Sang. 2005;88(4):244&#x2013;8. doi: 10.1111/j.1423-0410.2005.00631.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1423-0410.2005.00631.x</ArticleId><ArticleId IdType="pubmed">15877645</ArticleId></ArticleIdList></Reference><Reference><Citation>Working Party of the British Committee for Standards in Haematology Transfusion Taskforce. Guidelines for the estimation of fetomaternal haemorrhage. London: British Society for Haematology; 2009.</Citation></Reference><Reference><Citation>Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40
doi: 10.1136/bmj.d40
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d40</ArticleId><ArticleId IdType="pmc">PMC3230114</ArticleId><ArticleId IdType="pubmed">21300711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahan BC, Jairath V, Dor&#xe9; CJ, Morris TP. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials. 2014;15(1):139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022337</ArticleId><ArticleId IdType="pubmed">24755011</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence; 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">27905712</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999;3(2):1&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">10448202</ArticleId></ArticleIdList></Reference><Reference><Citation>Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8970487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood J, Freemantle N, King M, Nazareth I. Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data. BMJ. 2014;348:g2215
doi: 10.1136/bmj.g2215
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g2215</ArticleId><ArticleId IdType="pubmed">24687314</ArticleId></ArticleIdList></Reference><Reference><Citation>Serious Hazards of Transfusion. Annual SHOT report 2015. Manchester: Serious Hazards of Transfusion; 2016.</Citation></Reference><Reference><Citation>de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang. 2015;109(2):99&#x2013;113. doi: 10.1111/vox.12265
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.12265</ArticleId><ArticleId IdType="pubmed">25899660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36199483</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2691-3593</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of surgery open : perspectives of surgical history, education, and clinical approaches</Title><ISOAbbreviation>Ann Surg Open</ISOAbbreviation></Journal><ArticleTitle>Risk Factors, Diagnosis and Management of Chyle Leak Following Esophagectomy for Cancers: An International Consensus Statement.</ArticleTitle><Pagination><StartPage>e192</StartPage><MedlinePgn>e192</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e192</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/AS9.0000000000000192</ELocationID><Abstract><AbstractText Label="UNLABELLED">This Delphi exercise aimed to gather consensus surrounding risk factors, diagnosis, and management of chyle leaks after esophagectomy and to develop recommendations for clinical practice.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Chyle leaks following esophagectomy for malignancy are uncommon. Although they are associated with increased morbidity and mortality, diagnosis and management of these patients remain controversial and a challenge globally.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a modified Delphi exercise was delivered to clinicians across the oesophagogastric anastomosis collaborative. A 5-staged iterative process was used to gather consensus on clinical practice, including a scoping systematic review (stage 1), 2 rounds of anonymous electronic voting (stages 2 and 3), data-based analysis (stage 4), and guideline and consensus development (stage 5). Stratified analyses were performed by surgeon specialty and surgeon volume.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In stage 1, the steering committee proposed areas of uncertainty across 5 domains: risk factors, intraoperative techniques, and postoperative management (ie, diagnosis, severity, and treatment). In stages 2 and 3, 275 and 250 respondents respectively participated in online voting. Consensus was achieved on intraoperative thoracic duct ligation, postoperative diagnosis by milky chest drain output and biochemical testing with triglycerides and chylomicrons, assessing severity with volume of chest drain over 24 hours and a step-up approach in the management of chyle leaks. Stratified analyses demonstrated consistent results. In stage 4, data from the Oesophagogastric Anastomosis Audit demonstrated that chyle leaks occurred in 5.4% (122/2247). Increasing chyle leak grades were associated with higher rates of pulmonary complications, return to theater, prolonged length of stay, and 90-day mortality. In stage 5, 41 surgeons developed a set of recommendations in the intraoperative techniques, diagnosis, and management of chyle leaks.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Several areas of consensus were reached surrounding diagnosis and management of chyle leaks following esophagectomy for malignancy. Guidance in clinical practice through adaptation of recommendations from this consensus may help in the prevention of, timely diagnosis, and management of chyle leaks.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamarajah</LastName><ForeName>Sivesh K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddaiah-Subramanya</LastName><ForeName>Manjunath</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Education, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parente</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Richard P T</ForeName><Initials>RPT</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Division of Surgical Oncology, Department of Surgery, Afe Babalola University (ABUAD), Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainsworth</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odense University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Alberto M L</ForeName><Initials>AML</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Tumors, National Cancer Institute, Mexico City, MX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charalabopoulos</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laikon General Hospital, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eroglue</LastName><ForeName>Atila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Medical Faculty, Ataturk University, Erzurum, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijnhoven</LastName><ForeName>Bas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donohoe</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trinity College Dublin, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molena</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talavera-Urquijo</LastName><ForeName>Eider</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Flavio Roberto</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Gastroenterology Department, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darling</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Toronto General Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosero</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital San Ignacio-Universidad Javeriana, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piessen</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, University of Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahendran</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital Sultanah Aminah, Johor Bahru, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuei</LastName><ForeName>Hsu Po</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Taipei Veterans General Hospital, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gockel</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Visceral, Transplant, Thoracic and Vascular Surgery, University of Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negoi</LastName><ForeName>Ionut</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Emergency Hospital of Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weindelmayer</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General and Upper G.I. Surgery Division, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasanen</LastName><ForeName>Jari</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekele</LastName><ForeName>Kebebe</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Surgery, Madda Walabu University Goba Referral Hospital, Bale-Goba, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Guowei</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National University Hospital, University Surgical Cluster, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depypere</LastName><ForeName>Lieven</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery and Upper Gastrointestinal Surgery, McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klevebro</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smithers</LastName><ForeName>B Mark</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Berge Henegouwen</LastName><ForeName>Mark I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimminger</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General-, Visceral- and Transplant Surgery, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Digestive and Oncological Surgery, Hirslanden Medical Center, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pramesh</LastName><ForeName>C S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayyed</LastName><ForeName>Raza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Patel Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babor</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mine</LastName><ForeName>Shinji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gisbertz</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bright</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oesophago-gastric Surgery, Flinders Medical Centre, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit D'Journo</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Aix-Marseille University, North Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Donald</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Pritam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Regional Oesophago-Gastric Unit, Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Ewen A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Open</MedlineTA><NlmUniqueID>101769928</NlmUniqueID><ISSNLinking>2691-3593</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chyle leaks</Keyword><Keyword MajorTopicYN="N">esophagectomy</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>2</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36199483</ArticleId><ArticleId IdType="pmc">PMC9508983</ArticleId><ArticleId IdType="doi">10.1097/AS9.0000000000000192</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lagarde SM, Omloo JM, de Jong K, et al. . Incidence and management of chyle leakage after esophagectomy. Ann Thorac Surg. 2005;80:449&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">16039184</ArticleId></ArticleIdList></Reference><Reference><Citation>Milito P, Chmelo J, Dunn L, et al. . Chyle leak following radical en bloc esophagectomy with two-field nodal dissection: predisposing factors, management, and outcomes. Ann Surg Oncol. 2021;28:3963&#x2013;3972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184542</ArticleId><ArticleId IdType="pubmed">33263829</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhao Y, Chen H. Risk factors of chylothorax after esophagectomy. J Thorac Dis. 2019;11:1749&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588759</ArticleId><ArticleId IdType="pubmed">31285865</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkura Y, Ueno M, Shindoh J, et al. . Risk factors for postoperative chylothorax after radical subtotal esophagectomy. Ann Surg Oncol. 2018;25:2739&#x2013;2746.</Citation><ArticleIdList><ArticleId IdType="pubmed">29998406</ArticleId></ArticleIdList></Reference><Reference><Citation>Omloo JM, Lagarde SM, Vrouenraets BC, et al. . Compartimentalization for chylothorax originating from the abdomen after extended esophagectomy. Report of two cases and review of the literature. Dig Surg. 2006;23:86&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb PJ, Dresner SM, Robinson S, et al. . Chylous ascites complicating esophagectomy. Dis Esophagus. 2001;14:67&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">11422311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PK, Saluja SS, Ramaswamy D, et al. . Thoracic duct injury following esophagectomy in carcinoma of the esophagus: ligation by the abdominal approach. World J Surg. 2013;37:141&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">23073504</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah RD, Luketich JD, Schuchert MJ, et al. . Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg. 2012;93:897&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430511</ArticleId><ArticleId IdType="pubmed">22245587</ArticleId></ArticleIdList></Reference><Reference><Citation>Machleder HI, Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery. 1978;84:157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">307281</ArticleId></ArticleIdList></Reference><Reference><Citation>Power R, Smyth P, Donlon NE, et al. . Management of chyle leaks following esophageal resection: a systematic review. Dis Esophagus. 2021;34:doab012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597908</ArticleId><ArticleId IdType="pubmed">33723611</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesophago-Gastric Anastomosis Study Group on the West Midlands Research C. Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study. Br J Surg. 2021;108:66&#x2013;73..</Citation><ArticleIdList><ArticleId IdType="pubmed">33640931</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Aggarwal R, Zevin B, et al. . A global Delphi consensus study on defining and measuring quality in surgical training. J Am Coll Surg. 2014;219:346&#x2013;53.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25026872</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RPT, Singh P, Nepogodiev D, et al. . Study protocol for a multicenter prospective cohort study on esophagogastric anastomoses and anastomotic leak (the Oesophago-Gastric Anastomosis Audit/OGAA). Dis Esophagus. 2020;33:doz007.</Citation><ArticleIdList><ArticleId IdType="pubmed">30888419</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesophago-Gastric Anastomotic Audit Collaborative: Writing C, Steering C, National L, Site L, Collaborators. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: an international cohort study. Eur J Surg Oncol. 2021;47:1481&#x2013;1488..</Citation><ArticleIdList><ArticleId IdType="pubmed">33451919</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE, Kuppusamy MK, Alderson D, et al. . Benchmarking complications associated with esophagectomy. Ann Surg. 2019;269:291&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">29206677</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf LR, Busweiler LAD, van Sandick JW, et al. ; Dutch Upper GICAg. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg. 2019;271:1095&#x2013;1101..</Citation><ArticleIdList><ArticleId IdType="pubmed">30676381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C, Sandford B. The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007;12.</Citation></Reference><Reference><Citation>Palinkas LA, Horwitz SM, Green CA, et al. . Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4012002</ArticleId><ArticleId IdType="pubmed">24193818</ArticleId></ArticleIdList></Reference><Reference><Citation>Turney L, Pocknee C. Virtual focus groups: new frontiers in research. Int J Qual Methods. 2005:10.</Citation></Reference><Reference><Citation>Bland JM, Altman DG. Cronbach&#x2019;s alpha. BMJ. 1997;314:572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2126061</ArticleId><ArticleId IdType="pubmed">9055718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zevin B, Bonrath EM, Aggarwal R, et al. ; ATLAS group. Development, feasibility, validity, and reliability of a scale for objective assessment of operative performance in laparoscopic gastric bypass surgery. J Am Coll Surg. 2013;216:955&#x2013;965.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23490542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagpal K, Arora S, Abboudi M, et al. . Postoperative handover: problems, pitfalls, and prevention of error. Ann Surg. 2010;252:171&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">20505507</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink A, Kosecoff J, Chassin M, et al. . Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74:979&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1651783</ArticleId><ArticleId IdType="pubmed">6380323</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez NF, Gundersen GW, Rahman A, et al. . Clustergrammer, a web-based heatmap visualization and analysis tool for high-dimensional biological data. Sci Data. 2017;4:170151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634325</ArticleId><ArticleId IdType="pubmed">28994825</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HK. A statistical study of the thoracic duct in man. Am J Anatomy. 1915;17:211&#x2013;244..</Citation></Reference><Reference><Citation>Yoshida N, Baba H. Risk factors for chylothorax after esophagectomy. J Thorac Dis. 2019;11(suppl 3):S196&#x2013;S197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424757</ArticleId><ArticleId IdType="pubmed">30997174</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao L, Zhang Y, Hu H, et al. . Incidence and management of chylothorax after esophagectomy. Thorac Cancer. 2015;6:354&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448376</ArticleId><ArticleId IdType="pubmed">26273383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SS, Yang H, Luo KJ, et al. . The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109:2894&#x2013;2903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844915</ArticleId><ArticleId IdType="pubmed">24201750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeppner J, Zirlik K, Brunner T, et al. . Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients. J Surg Oncol. 2014;109:287&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">24277235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gronnier C, Tr&#xe9;chot B, Duhamel A, et al. ; FREGAT Working Group-FRENCH-AFC. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg. 2014;260:764&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">25379847</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevebro F, Alexandersson von D&#xf6;beln G, Wang N, et al. . A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Ann Oncol. 2016;27:660&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">26782957</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hagen P, Hulshof MC, van Lanschot JJ, et al. ; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074&#x2013;2084.</Citation><ArticleIdList><ArticleId IdType="pubmed">22646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Dougenis D, Walker WS, Cameron EW, et al. . Management of chylothorax complicating extensive esophageal resection. Surg Gynecol Obstet. 1992;174:501&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">1595027</ArticleId></ArticleIdList></Reference><Reference><Citation>Merigliano S, Molena D, Ruol A, et al. . Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg. 2000;119:453&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">10694603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wemyss-Holden SA, Launois B, Maddern GJ. Management of thoracic duct injuries after oesophagectomy. Br J Surg. 2001;88:1442&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pubmed">11683738</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshikiri T, Numasaki H, Oguma J, et al. . Prognosis of patients with esophageal carcinoma following routine thoracic duct resection: a propensity-matched analysis of 12,237 patients based on the comprehensive registry of esophageal cancer in Japan. Ann Surg. 2021. doi: 10.1097/SLA.0000000000005340</Citation><ArticleIdList><ArticleId IdType="pubmed">34913902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Li Z, Li G, et al. . Selective en masse ligation of the thoracic duct to prevent chyle leak after esophagectomy. Ann Thorac Surg. 2017;103:1802&#x2013;1807.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchiato M, Martino A, Sponza M, et al. . Thoracic duct identification with indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position. Dis Esophagus. 2020;33:doaa030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7720005</ArticleId><ArticleId IdType="pubmed">32448899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdeva UM, Axtell AL, Kroese TE, et al. . Contributing factors to lymph node recovery with esophagectomy by thoracic surgeons: an analysis of the Society of Thoracic Surgeons General Thoracic Surgery Database. Dis Esophagus. 2022. doi: 10.1093/dote/doab101</Citation><ArticleIdList><ArticleId IdType="pubmed">35091737</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Natta TL, Nguyen AT, Benharash P, et al. . Thoracoscopic thoracic duct ligation for persistent cervical chyle leak: utility of immediate pathologic confirmation. JSLS. 2009;13:430&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3015971</ArticleId><ArticleId IdType="pubmed">19793489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkerson PM, Haque A, Pitkin L, et al. . Thoracoscopic ligation of the thoracic duct complex in the treatment for high-volume chyle leak following modified radical neck dissection: safe, feasible, but underutilised. Clin Otolaryngol. 2014;39:73&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">24575931</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE, Alderson D, Cecconello I, et al. . International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">25607756</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19766473</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Dan G, Jiang J, et al. . A 2-wk conservative treatment regimen preceding thoracic duct ligation is effective and safe for treating post-esophagectomy chylothorax. J Surg Res. 2013;185:784&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">23993201</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher G, Weidemann H, Langrehr JM, et al. . Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomy. Dis Esophagus. 2007;20:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">17227305</ArticleId></ArticleIdList></Reference><Reference><Citation>Choh CT, Rychlik IJ, McManus K, et al. . Is early surgical management of chylothorax following oesophagectomy beneficial? Interact Cardiovasc Thorac Surg. 2014;19:117&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">24667585</ArticleId></ArticleIdList></Reference><Reference><Citation>Orringer MB, Bluett M, Deeb GM. Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery. 1988;104:720&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">3175869</ArticleId></ArticleIdList></Reference><Reference><Citation>Weijs TJ, Ruurda JP, Broekhuizen ME, et al. . Outcome of a step-up treatment strategy for chyle leakage after esophagectomy. Ann Thorac Surg. 2017;104:477&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">28499656</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerfolio RJ. Chylothorax after esophagogastrectomy. Thorac Surg Clin. 2006;16:49&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">16696282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40883552</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1708-0428</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Obesity surgery</Title><ISOAbbreviation>Obes Surg</ISOAbbreviation></Journal><ArticleTitle>Bariatric Procedures in the Sub-Saharan Africa: A Systematic Review of Patterns and Outcomes.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11695-025-08199-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sub-Saharan Africa faces rising obesity rates with limited access to bariatric care due to a scarcity of facilities and trained personnel. This systematic review aimed to analyse the types of bariatric procedures available in sub-Saharan Africa and their outcomes. The results of this study may promote the establishment of a continental registry to improve metabolic care outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was conducted using the Cochrane Library, PubMed, and EBSCOHost. Studies conducted in North Africa were excluded. Quality appraisal was performed using the ROBINS-I tool. We could not perform a meta-analysis because of the heterogeneous data from the different procedures used to treat obesity in sub-Saharan Africa. This study was registered in the PROSPERO registry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Only nine studies (2016-2024) involving 974 patients were included. Most procedures were concentrated in Southern Africa, with no data from East African countries. The patients were predominantly female (80.8%). Gastric banding and intragastric balloon were the most common procedures in Southern Africa and West Africa, respectively. Outcomes were discussed in only seven studies, which included 626 patients. The most prevalent complication was calcium deficiency (8.4%) which was mainly observed in gastric bypass surgeries.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Due to the absence of studies from the East African sub-region, this review highlights the geographic disparity in the availability of bariatric procedures in sub-Saharan Africa. There was variation in the types of bariatric procedures performed by the surgeons in the subregions. Gastric banding is associated with lower estimated weight loss than other bariatric procedures in sub-Saharan Africa. Nutrient deficiencies were more common in gastric bypass procedures.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oyewale</LastName><ForeName>Saburi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Afe Babalola University College of Medicine and Health Sciences, Ado Ekiti, Nigeria. saburioyewale@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariwoola</LastName><ForeName>Azeezat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rutgers, The State University of New Jersey, New Brunswick, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remi-Alo</LastName><ForeName>Damade</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Afe Babalola University College of Medicine and Health Sciences, Ado Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obes Surg</MedlineTA><NlmUniqueID>9106714</NlmUniqueID><ISSNLinking>0960-8923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bariatric procedures</Keyword><Keyword MajorTopicYN="N">Metabolic surgery</Keyword><Keyword MajorTopicYN="N">Morbid obesity</Keyword><Keyword MajorTopicYN="N">Sub-Saharan Africa</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declarations. Ethics Approval and Consent to Participate: This is not applicable to this type of study, as this is a review article. Consent for Publication: This is also not applicable to this type of study because it is a review article. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40883552</ArticleId><ArticleId IdType="doi">10.1007/s11695-025-08199-4</ArticleId><ArticleId IdType="pii">10.1007/s11695-025-08199-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amugsi DA, Dimbuene ZT, Mberu B, et al. Prevalence and time trends in overweight and obesity among urban women: an analysis of demographic and health surveys data from 24 African countries, 1991&#x2013;2014. BMJ Open. 2017;7:e017344. https://doi.org/10.1136/bmjopen-2017-017344 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017344</ArticleId><ArticleId IdType="pubmed">29079606</ArticleId><ArticleId IdType="pmc">5665233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubbe J, Webner A, Potgieter A, et al. Metabolic surgery in South Africa: an initial academic hospital experience. S Afr J Surg. 2019;57:20&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31342680</ArticleId></ArticleIdList></Reference><Reference><Citation>Adenuga AT, Salu IK, Bello UM, Okaro A. Obesity and the need for bariatric surgery in Nigeria: a review. Niger Postgrad Med J. 2024;31:207&#x2013;12. https://doi.org/10.4103/npmj.npmj_157_24 .</Citation></Reference><Reference><Citation>English WJ, Williams DB. Metabolic and bariatric surgery: an effective treatment option for obesity and cardiovascular disease. Prog Cardiovasc Dis. 2018;61:253&#x2013;69. https://doi.org/10.1016/j.pcad.2018.06.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2018.06.003</ArticleId><ArticleId IdType="pubmed">29953878</ArticleId></ArticleIdList></Reference><Reference><Citation>Inocian EP, Nolfi DA, Felicilda-Reynaldo RFD, et al. Bariatric surgery in the Middle East and North Africa: narrative review with focus on culture-specific considerations. Surg Obes Relat Dis. 2021;17:1933&#x2013;41. https://doi.org/10.1016/j.soard.2021.06.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2021.06.015</ArticleId><ArticleId IdType="pubmed">34332910</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown WA, MacCormick AD, McNeil JJ, et al. Bariatric surgery registries: can they contribute to improved outcomes? Curr Obes Rep. 2017;6:414&#x2013;9. https://doi.org/10.1007/s13679-017-0286-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-017-0286-3</ArticleId><ArticleId IdType="pubmed">29076029</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderin C, Gustafsson UO, Heijbel N, et al. Weight loss before bariatric surgery and postoperative complications: data from the Scandinavian Obesity Registry (SOReg). Ann Surg. 2015;261:909&#x2013;13. https://doi.org/10.1097/SLA.0000000000000839 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000839</ArticleId><ArticleId IdType="pubmed">25211265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj HR, Hamza Shah M, Bone M, et al. Exploring the landscape of bariatric surgery in Africa: current provisions, challenges, and future prospects. Ann Med Surg. 2024;86:4957&#x2013;9.</Citation></Reference><Reference><Citation>Ojeola T, Olajugba J, Shekoni O, et al. Awareness of metabolic bariatric surgery among medical students and house officers in Lagos, Nigeria: a cross-sectional online survey. Cureus. 2025;17:e77126. https://doi.org/10.7759/cureus.77126 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.77126</ArticleId><ArticleId IdType="pubmed">39925530</ArticleId><ArticleId IdType="pmc">11803529</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper CE, Davidowitz KJ, Goedecke JH. Perceptions relating to body size, weight loss and weight-loss interventions in black South African women: a qualitative study. Public Health Nutr. 2016;19:548&#x2013;56. https://doi.org/10.1017/S1368980015001688 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980015001688</ArticleId><ArticleId IdType="pubmed">26006784</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzin M, Motamedi MAK, Serahati S, et al. Comparison of the effect of gastric bypass and sleeve gastrectomy on metabolic syndrome and its components in a cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg. 2017;27:1697&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">28054293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId><ArticleId IdType="pmc">5139140</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020. https://doi.org/10.1002/jrsm.1411 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1411</ArticleId><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewar GA, Urry RJ, Clifford S, et al. Bioring(&#xae;) gastric banding for obesity in a private South African hospital. S Afr J Surg. 2020;58:115&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">33231004</ArticleId></ArticleIdList></Reference><Reference><Citation>Loots E, Sartorius B, Paruk IM, et al. The successful implementation of a modified enhanced recovery after surgery (ERAS) program for bariatric surgery in a South African teaching hospital. Surg Laparosc Endosc Percutan Tech. 2018;28:26&#x2013;9. https://doi.org/10.1097/SLE.0000000000000488 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0000000000000488</ArticleId><ArticleId IdType="pubmed">29064879</ArticleId></ArticleIdList></Reference><Reference><Citation>Keto P, Mbombo W, Mamadou BA, et al. Factors associated with anaesthetic complications in bariatric surgery at the Delafontaine Saint-D&#xe9;nis Hospital. Am J Med Clin Res Rev. 2023;2:1&#x2013;14.</Citation></Reference><Reference><Citation>N'Dri K, Blegole O, Sidibe A, Moussa B, Keli E, Aboua A, et al. Calibrated sleeve gastrectomy or sleeve gastrectomy: experiences in Abidjan. Le Mali M&#xe9;dical. 2017;32:19&#x2013;23.</Citation></Reference><Reference><Citation>Sofianos C, Sofianos C. Outcomes of laparoscopic sleeve gastrectomy at a bariatric unit in South Africa. Ann Med Surg. 2016;12:37&#x2013;42.</Citation></Reference><Reference><Citation>Bang GA, Nana Oumarou B, Savom EP, Mbonda JJ, Arthur E. L&#x2019;anneau gastrique ajustable dans la prise en charge chirurgicale de l&#x2019;ob&#xe9;sit&#xe9;: bilan de 9 ann&#xe9;es de pratique au Centre Hospitalier d&#x2019;Essos. Health Sci Dis.&#xa0;2021;23(1). https://doi.org/10.5281/hsd.v23i1.3212 .</Citation></Reference><Reference><Citation>Bang GA, Oumarou BN, Savom EP, et al. Sleeve gastrectomy in the surgical management of obesity in Cameroon (a sub-Saharan country): a single-institute retrospective review of 30-day postoperative morbidity and mortality. Surg Open Sci. 2022;8:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">35392579</ArticleId><ArticleId IdType="pmc">8980483</ArticleId></ArticleIdList></Reference><Reference><Citation>Adisa AO, Lawal OO, Arowolo OA, et al. Local adaptations aid establishment of laparoscopic surgery in a semiurban Nigerian hospital. Surg Endosc. 2013;27:390&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22806524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekwunife OH, Modekwe VI, Ugwu JO, et al. Early experience with laparoscopic management of nonpalpable undescended testes. Niger J Surg. 2017;23:115&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29089736</ArticleId><ArticleId IdType="pmc">5649426</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyewale SO, Ariwoola AO. The challenges and adaptations of laparoscopy for abdominal pathologies in Nigeria: a systematic review. World. 2024;17:114.</Citation></Reference><Reference><Citation>Ray-Offor E, Okoro PE, Gbobo I, et al. Pilot study on laparoscopic surgery in Port-Harcourt, Nigeria. Niger J Surg. 2014;20:23&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24665198</ArticleId><ArticleId IdType="pmc">3953629</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheshe A, Yakubu A, Alhassan S, et al. Early experience with laparoscopic surgical operations in Aminu Kano Teaching Hospital, Kano, Northwestern Nigeria. Arch Int Surg. 2014;4(1):1. https://doi.org/10.4103/2278-9596.136688 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2278-9596.136688</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubakari AR, Lauder W, Agyemang C, et al. Prevalence and time trends in obesity among adult West African populations: a meta-analysis. Obes Rev. 2008;9:297&#x2013;311. https://doi.org/10.1111/j.1467-789X.2007.00462.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-789X.2007.00462.x</ArticleId><ArticleId IdType="pubmed">18179616</ArticleId></ArticleIdList></Reference><Reference><Citation>Neema S, Mutungi G, Mwebaze S, et al. &#x201c;Fat people are more respected&#x2019;&#x2019;: socio-cultural construction of obesity and overweight risk &amp; prevention in Ugandan communities. In: Falade B, Murire M, editors., et al., Health communication and disease in Africa: beliefs, traditions and stigma. Singapore: Springer Singapore; 2021. p. 159&#x2013;80.</Citation></Reference><Reference><Citation>Okoroh JS, Riviello R. Challenges in healthcare financing for surgery in sub-Saharan Africa. Pan Afr Med J. 2021;38:198. https://doi.org/10.11604/pamj.2021.38.198.27115 .</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.198.27115</ArticleId><ArticleId IdType="pubmed">33995804</ArticleId><ArticleId IdType="pmc">8106793</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GA, Ilcisin L, Kayima P, et al. Out-of-pocket payment for surgery in Uganda: the rate of impoverishing and catastrophic expenditure at a government hospital. PLoS One. 2017;12:e0187293. https://doi.org/10.1371/journal.pone.0187293 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187293</ArticleId><ArticleId IdType="pubmed">29088302</ArticleId><ArticleId IdType="pmc">5663485</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen I, Strandberg M, Hurme S, et al. Nutritional deficiencies after sleeve gastrectomy and roux-en-Y gastric bypass at 10 years: secondary analysis of the SLEEVEPASS randomized clinical trial. Br J Surg. 2025. https://doi.org/10.1093/bjs/znaf132 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znaf132</ArticleId><ArticleId IdType="pubmed">40613787</ArticleId><ArticleId IdType="pmc">12231607</ArticleId></ArticleIdList></Reference><Reference><Citation>Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4823&#x2013;43. https://doi.org/10.1210/jc.2009-2128 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-2128</ArticleId><ArticleId IdType="pubmed">21051578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski PK, Olszewski R, Kwiatkowski A, et al. Life with a gastric band. Long-term outcomes of laparoscopic adjustable gastric banding-a retrospective study. Obes Surg. 2017;27:1250&#x2013;3. https://doi.org/10.1007/s11695-016-2435-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-016-2435-2</ArticleId><ArticleId IdType="pubmed">27787760</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L, Hildebrandt C, Bruckner T, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22:721&#x2013;31. https://doi.org/10.1007/s11695-012-0616-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-012-0616-1</ArticleId><ArticleId IdType="pubmed">22411568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40827192</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Hypertension Among Individuals Living With Hemoglobinopathies: A Systematic Review.</ArticleTitle><Pagination><StartPage>e88234</StartPage><MedlinePgn>e88234</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e88234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.88234</ELocationID><Abstract><AbstractText>Hemoglobinopathy has a diverse clinical presentation and complications, and is severe among individuals with the homozygous form. It is the most common cause of chronic anemia among affected individuals. Hemoglobinopathy is an inherited blood disorder arising from mutations in globin genes and is broadly categorized into those involving structural changes that produce abnormal hemoglobin variants or defects in globin chain production. This review aims to evaluate the risk factors and outcomes of pulmonary hypertension among individuals with hemoglobinopathies. A search was conducted on PubMed and Google Scholar databases from inception to April 30, 2025. In total, 1,825 articles were synthesized, of which 13 were included in the final qualitative analysis and data extraction. We included English-language original articles published in peer-reviewed journals that reported the risk factors and outcomes of pulmonary hypertension in patients of any age and gender diagnosed with any type of hemoglobinopathy. This review synthesized 13 articles from 10 countries. A total of 2,873 individuals were diagnosed with hemoglobinopathy (1,031 (36%) with sickle cell disease and 1,842 (64%) with &#x3b2;-thalassemia), and 472 were diagnosed with pulmonary hypertension. Among those with pulmonary hypertension, 289 (61%) had sickle cell disease, while 183 (39%) had &#x3b2;-thalassemia. Older age (&gt;40 years), a history of splenectomy, a hemoglobin level of &lt;8 g/dL, frequent blood transfusions, frequent hospitalization for vaso-occlusive crisis, and &#x3b2;-thalassemia were associated with pulmonary hypertension. Some laboratory parameters (serum creatinine, reticulocyte, albumin, nucleated red blood cells, globulin, cell-free hemoglobin, N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, soluble vascular cell adhesion molecule, platelet, lactate dehydrogenase) were associated with pulmonary hypertension. Overall, the mortality rate was 27 (10%), with respiratory failure, sudden death, and cor pulmonale as the common causes of mortality. Early recognition and risk stratification for pulmonary hypertension must become integral components of hemoglobinopathy care, particularly in adult patients and those with high-risk profiles. Establishment of a standardized treatment guideline and optimizing the use of disease-modifying therapies, such as hydroxyurea and iron chelators, and exploring novel pharmacologic strategies (endothelin receptor antagonist, phosphodiesterase type 5 inhibitors), may hold promise for altering the trajectory of pulmonary hypertension in this vulnerable group. Our findings confirm that pulmonary hypertension is not only a prevalent complication but also a serious prognostic marker associated with increased morbidity and mortality in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Okeke et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okeke</LastName><ForeName>Collins C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Afe Babalola University, Ado-Ekiti, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okere</LastName><ForeName>Madeleine O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>General Practice, University of Port Harcourt Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebiliekwe</LastName><ForeName>Onyinye E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeocha</LastName><ForeName>Ifunanya R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idion</LastName><ForeName>Kris N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Internal Medicine, Delta State University Teaching Hospital, Oghara, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egemonye</LastName><ForeName>Onyeka</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University College of Health Sciences, Awka, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alli</LastName><ForeName>Omosimisola O</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>General Practice, College of Medicine, Lagos State University, Lagos, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugo-Ihanetu</LastName><ForeName>Euodia A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okorienta</LastName><ForeName>Sylvahelen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Public Health, Liberty University, Lynchburg, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyeogulu</LastName><ForeName>Afamefuna O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agidah</LastName><ForeName>Elo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine, Igbinedion University Teaching Hospital, Okada, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nduji</LastName><ForeName>Amarachi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Abia State University, Uturu, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akinteye</LastName><ForeName>Emmanuel I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Bowen University, Iwo, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebiekuraju</LastName><ForeName>Olaoluwa E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>General Surgery, Surgery Interest Group of Africa, Lagos, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egbunike</LastName><ForeName>Joseph O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Family Medicine, Aeon Medical Center, Abuja, NGA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemoglobinopathy</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">sickle cell disease (scd)</Keyword><Keyword MajorTopicYN="N">thalassemia</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>19</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40827192</ArticleId><ArticleId IdType="pmc">PMC12358097</ArticleId><ArticleId IdType="doi">10.7759/cureus.88234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Farmakis D, Aessopos A. Circulation. 2011;123:1227&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">21422398</ArticleId></ArticleIdList></Reference><Reference><Citation>The hemoglobinopathies, molecular disease mechanisms and diagnostics. Harteveld CL, Achour A, Arkesteijn SJ, et al. Int J Lab Hematol. 2022;44 Suppl 1:28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9542123</ArticleId><ArticleId IdType="pubmed">36074711</ArticleId></ArticleIdList></Reference><Reference><Citation>The genetics of blood disorders: hereditary hemoglobinopathies. Sonati Mde F, Costa FF. J Pediatr (Rio J) 2008;84:0&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">18791648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Kohne E. https://doi.org/10.3238/arztebl.2011.0532. Dtsch Arztebl Int. 2011;108:532&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3163784</ArticleId><ArticleId IdType="pubmed">21886666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Taylor JG 6th, Ackah D, Cobb C, et al. Am J Hematol. 2008;83:6&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509176</ArticleId><ArticleId IdType="pubmed">17724704</ArticleId></ArticleIdList></Reference><Reference><Citation>The 6th World Symposium on Pulmonary Hypertension: what's old is new. Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. F1000Res. 2019;8:0&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6584967</ArticleId><ArticleId IdType="pubmed">31249672</ArticleId></ArticleIdList></Reference><Reference><Citation>Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement. Garcia-Ribas C, Ble M, G&#xf3;mez M, Mas-Stachurska A, Farr&#xe9;-L&#xf3;pez N, Cladellas M. Front Cardiovasc Med. 2021;8:720643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631497</ArticleId><ArticleId IdType="pubmed">34859063</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension aetiologies in different parts of the world. Butrous G. Int J Cardiol Congenit Heart Dis. 2025;20:100586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12054017</ArticleId><ArticleId IdType="pubmed">40330318</ArticleId></ArticleIdList></Reference><Reference><Citation>Global epidemiology of haemoglobin disorders and derived service indicators. Modell B, Darlison M. Bull World Health Organ. 2008;86:480&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2647473</ArticleId><ArticleId IdType="pubmed">18568278</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension associated with hemolytic anemia. Sun N. https://www.hilarispublisher.com/open-access/pulmonary-hypertension-associated-with-hemolytic-anemia-109141.html J Coronary Heart Dis. 2024;8:1&#x2013;2.</Citation></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayyan. Overview.  [
Feb;
2025 
]. 2025. https://new.rayyan.ai/reviews/1316152/overview https://new.rayyan.ai/reviews/1316152/overview</Citation></Reference><Reference><Citation>JBI Critical Appraisal Tools.  [
Oct;
2024 
]. 2024. https://jbi.global/critical-appraisal-tools https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Ashley-Koch AE, Elliott L, Kail ME, et al. Blood. 2008;111:5721&#x2013;5726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2424164</ArticleId><ArticleId IdType="pubmed">18187665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in non-transfusion-dependent thalassemia: correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron. Inthawong K, Charoenkwan P, Silvilairat S, et al. Hematology. 2015;20:610&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">25964094</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for pulmonary hypertension in patients with &#x3b2; thalassemia intermedia. Karimi M, Musallam KM, Cappellini MD, et al. Eur J Intern Med. 2011;22:607&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">22075289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Castro O, Hoque M, Brown BD. Blood. 2003;101:1257&#x2013;1261.</Citation><ArticleIdList><ArticleId IdType="pubmed">12393669</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/&#x3b2;-thalassemia disease. Atichartakarn V, Chuncharunee S, Archararit N, Udomsubpayakul U, Lee R, Tunhasiriwet A, Aryurachai K. Eur J Haematol. 2014;92:346&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">24330103</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in people with sickle cell disease in a Nigerian tertiary hospital. Odeyemi AO, Oni OO, Odeyemi AO, et al.  https://journals.lww.com/ajim/fulltext/2022/12010/pulmonary_hypertension_in_people_with_sickle_cell.2.aspx Assam J Intern Med. 2022;12:3&#x2013;9.</Citation></Reference><Reference><Citation>Risk factors of pulmonary hypertension in Brazilian patients with sickle cell anemia. Lobo CL, do Nascimento EM, Abelha R, Queiroz AM, Connes P, Cardoso GP, Ballas SK. PLoS one. 2015;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4559447</ArticleId><ArticleId IdType="pubmed">26335226</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factors for pulmonary arterial hypertension in a large group of &#x3b2;-thalassemia patients using right heart catheterization: a Webthal study. Derchi G, Galanello R, Bina P, et al. Circulation. 2014;129:338&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">24081970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia. Peter ID, Asani MO, Abdullahi SU, Aliyu I, Obaro SK, Bode-Thomas F. Trans R Soc Trop Med Hyg. 2019;113:489&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6677931</ArticleId><ArticleId IdType="pubmed">31086994</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of genotype on pulmonary hypertension risk in patients with thalassemia. Teawtrakul N, Ungprasert P, Pussadhamma B, et al. Eur J Haematol. 2014;92:429&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">24400859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Am J Hematol. 2008;83:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17724699</ArticleId></ArticleIdList></Reference><Reference><Citation>Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL. Am J Hematol. 2008;83:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3398810</ArticleId><ArticleId IdType="pubmed">17696198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridging the gaps in newborn screening programmes: challenges and opportunities to detect haemoglobinopathies in Africa. Twum S, Fosu K, Felder RA, Sarpong KA. Afr J Lab Med. 2023;12:2225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10729498</ArticleId><ArticleId IdType="pubmed">38116518</ArticleId></ArticleIdList></Reference><Reference><Citation>African global representation in biomedical sciences. Mulder N, Zass L, Hamdi Y, Othman H, Panji S, Allali I, Fakim YJ. Annu Rev Biomed Data Sci. 2021;4:57&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34465182</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. Gladwin MT, Barst RJ, Gibbs JS, et al. PLoS One. 2014;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079316</ArticleId><ArticleId IdType="pubmed">24988120</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP. Br J Haematol. 2006;134:109&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">16803576</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of pulmonary arterial hypertension in patients with beta thalassemia major. Kahnoji M, Bitaraf S, Soltani N, Esmaeili-Nadimi H. Indian J Hematol Blood Transfus. 2024;40:74&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10831030</ArticleId><ArticleId IdType="pubmed">38312173</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Hum Pathol. 2002;33:1037&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pubmed">12395378</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension in sickle cell disease. Hayes MM, Vedamurthy A, George G, et al. Ann Am Thorac Soc. 2014;11:1488&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473670</ArticleId><ArticleId IdType="pubmed">25423000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Kato GJ, McGowan V, Machado RF, et al. Blood. 2006;107:2279&#x2013;2285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1895723</ArticleId><ArticleId IdType="pubmed">16291595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. Gladwin MT, Sachdev V, Jison ML, et al. N Engl J Med. 2004;350:886&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pubmed">14985486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hydroxyurea-increased fetal hemoglobin is associated with less organ damage and longer survival in adults with sickle cell anemia. Fitzhugh CD, Hsieh MM, Allen D, et al. PLoS One. 2015;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4648496</ArticleId><ArticleId IdType="pubmed">26576059</ArticleId></ArticleIdList></Reference><Reference><Citation>Combination therapy in pulmonary arterial hypertension-targeting the nitric oxide and prostacyclin pathways. Mandras S, Kovacs G, Olschewski H, Broderick M, Nelsen A, Shen E, Champion H. J Cardiovasc Pharmacol Ther. 2021;26:453&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261771</ArticleId><ArticleId IdType="pubmed">33836637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sildenafil: a review of its use in pulmonary arterial hypertension. Croom KF, Curran MP. Drugs. 2008;68:383&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">18257613</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Machado RF, Gladwin MT. Br J Haematol. 2005;129:449&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">15877728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21674669</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0347</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2011</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Head &amp; neck</Title><ISOAbbreviation>Head Neck</ISOAbbreviation></Journal><ArticleTitle>Value of fluorescence endoscopy for the early diagnosis of laryngeal cancer and its precursor lesions.</ArticleTitle><Pagination><StartPage>941</StartPage><EndPage>948</EndPage><MedlinePgn>941-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/hed.21565</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fluorescence endoscopy is used for the early detection and delineation of laryngeal cancer and its precursor lesions. No systematic review of these promising imaging techniques has yet been performed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of the published literature and meta-analysis of data extracted from 16 included studies were performed. A total of 1000 laryngeal lesions were examined by autofluorescence endoscopy (AFE), 318 mucosal changes by induced fluorescence endoscopy (IFE), and 679 laryngeal pathologies underwent normal white light endoscopy (WLE).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In identifying precancerous and cancerous lesions of the larynx, sensitivity (91% vs 73%), specificity (84% vs 79%), and accuracy (88% vs 77%) of AFE were superior to WLE alone, whereas IFE showed an even higher sensitivity (95% vs 73%) at the expense of specificity (62% vs 79%). Therefore, AFE also achieved a higher specificity (84% vs 62%) and accuracy (88% vs 76%) than did IFE in detecting these kinds of lesions. However, the sensitivity (91% vs 95%) did not differ significantly between both methods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis confirms that fluorescence endoscopy is highly effective in the early diagnosis of laryngeal cancer and its precursor lesions. Thus, AFE can be used immediately without drug administration or possible side effects, whereas IFE is more suited for the detection of recurrent disease following initial surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2010 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital AG, Aarau, Switzerland. marcel.kraft@gmx.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betz</LastName><ForeName>Christian Stephan</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Leunig</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Arens</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Head Neck</MedlineTA><NlmUniqueID>8902541</NlmUniqueID><ISSNLinking>1043-3074</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017319">Photosensitizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>88755TAZ87</RegistryNumber><NameOfSubstance UI="D000622">Aminolevulinic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000622" MajorTopicYN="N">Aminolevulinic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007822" MajorTopicYN="N">Laryngeal Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017319" MajorTopicYN="N">Photosensitizing Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077195" MajorTopicYN="N">Squamous Cell Carcinoma of Head and Neck</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21674669</ArticleId><ArticleId IdType="doi">10.1002/hed.21565</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31187764</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1119-3077</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nigerian journal of clinical practice</Title><ISOAbbreviation>Niger J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Comparative analgesic efficacy and tolerability of celecoxib and tramadol on postoperative pain after mandibular third molar extraction: A double blind randomized controlled trial.</ArticleTitle><Pagination><StartPage>796</StartPage><EndPage>800</EndPage><MedlinePgn>796-800</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/njcp.njcp_544_18</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The choice of an efficacious and well-tolerated analgesic for the control of postoperative pain after third molar surgical extraction remains a challenge.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study was to compare analgesic efficacy and tolerability of celecoxib and tramadol following mandibular third molar extraction.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This was a prospective randomized, double blind controlled trial. Ninety patients were randomly assigned equally to either celecoxib or tramadol. Appropriate doses of the assigned drugs were administered orally immediately after the surgical extraction and patients recorded the pain intensity felt before the extraction, immediately after extraction, at 4 h, 8 h, 16 h, 24 h, and 48 h after the extraction using the visual analogue scale (VAS). Adverse effects of the medications were also recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four of the patients dropped out of the study. Fifty five percent of patients in tramadol group experienced adverse effects but none in celecoxib group. The median VAS score of the celecoxib group was lower than tramadol group throughout the postoperative period and there was statistically significant difference in the median VAS score between the two groups 4 hours after drug administration (P = 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In our study, celecoxib was more efficacious and better tolerated than tramadol for the management of pain after surgical extraction of mandibular third molar.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akinbade</LastName><ForeName>A O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Dental and Maxillofacial Surgery, Federal Teaching Hospital Ido-Ekiti P.M.B 201 Ido Ekiti; Faculty of Clinical Sciences, College of Medical and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndukwe</LastName><ForeName>K C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owotade</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department Oral and Maxillofacial Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Niger J Clin Pract</MedlineTA><NlmUniqueID>101150032</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>39J1LGJ30J</RegistryNumber><NameOfSubstance UI="D014147">Tramadol</NameOfSubstance></Chemical><Chemical><RegistryNumber>JCX84Q7J1L</RegistryNumber><NameOfSubstance UI="D000068579">Celecoxib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068579" MajorTopicYN="N">Celecoxib</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008334" MajorTopicYN="N">Mandible</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008964" MajorTopicYN="N">Molar, Third</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014081" MajorTopicYN="N">Tooth Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014147" MajorTopicYN="N">Tramadol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Celecoxib</Keyword><Keyword MajorTopicYN="N">postoperative pain</Keyword><Keyword MajorTopicYN="N">third molar surgery</Keyword><Keyword MajorTopicYN="N">tramadol</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31187764</ArticleId><ArticleId IdType="doi">10.4103/njcp.njcp_544_18</ArticleId><ArticleId IdType="pii">NigerJClinPract_2019_22_6_796_260039</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32865434</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1360-046X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>British journal of neurosurgery</Title><ISOAbbreviation>Br J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Intra-operative wound irrigation with ceftriaxone does not reduce surgical site infection in clean neurosurgical procedures.</ArticleTitle><Pagination><StartPage>766</StartPage><EndPage>769</EndPage><MedlinePgn>766-769</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02688697.2020.1812518</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The spectrum of post-operative infections in neurosurgical practice includes scalp infection, bone flap osteomyelitis, meningitis and intracranial abscesses and is associated with significant morbidity and mortality. There is a wide variation across neurosurgical centres in the use of perioperative antibiotic prophylaxis. The aim of this study was to determine whether intraoperative wound irrigation with ceftriaxone provides additional prevention of surgical site infection (SSI) in patients already receiving the drug parenterally.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective randomized clinical study of patients 18 years and above scheduled for clean neurosurgical procedures and assigned to either study or control group using table of random numbers. Both groups had parenteral ceftriaxone at the induction of anaesthesia and for 24-h post-operation. In the study group, there was intra-operative wound irrigation with a ceftriaxone-in-normal saline solution while the wound in the control group was irrigated with only normal saline. Clinical and or laboratory evidence of SSI was used as the outcome measure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and thirty-two patients aged 18 years and above were recruited for this study. There were 66 patients in each group. The overall frequency of SSI was 2.27% (3 out of 132). The frequency in the ceftriaxone group was 3% (2 out of 66) while that in the control group was 1.5% (1 out of 66). These values were not significantly different (<i>p</i>&#x2009;=&#x2009;1.00). There were four cases of wound edge necrosis, three of which developed SSIs.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study, intraoperative antibiotic irrigation did not confer additional benefit in the prevention of SSI in clean neurosurgical procedures in which prophylactic intravenous antibiotics were administered to the patient. Wound edge necrosis was the most significant but preventable risk factor for the development of SSI in the setting of this work.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okunlola</LastName><ForeName>Abiodun I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Federal Teaching Hospital, Ido-Ekiti/Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeolu</LastName><ForeName>Augustine A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malomo</LastName><ForeName>Adefolarin O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okunlola</LastName><ForeName>Cecilia K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Federal Teaching Hospital, Ido Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shokunbi</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Neurosurg</MedlineTA><NlmUniqueID>8800054</NlmUniqueID><ISSNLinking>0268-8697</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>75J73V1629</RegistryNumber><NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002443" MajorTopicYN="Y">Ceftriaxone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="Y">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007507" MajorTopicYN="N">Therapeutic Irrigation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">irrigation</Keyword><Keyword MajorTopicYN="N">normal saline</Keyword><Keyword MajorTopicYN="N">surgical site infection</Keyword><Keyword MajorTopicYN="N">wound edge necrosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32865434</ArticleId><ArticleId IdType="doi">10.1080/02688697.2020.1812518</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39658673</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Robotic and laparoscopic minimally invasive surgery for colorectal cancer in Africa: an outcome comparison endorsed by the Nigerian society for colorectal disorders.</ArticleTitle><Pagination><StartPage>122</StartPage><EndPage>140</EndPage><MedlinePgn>122-140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-024-11416-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Minimally invasive surgery for colorectal cancer (CRC) offer superior outcomes compared to open surgery. This study aimed to review the robotic and laparoscopic procedures for CRC&#xa0;performed in Africa, and compare the mean surgery duration, blood loss, hospital stay, rate of conversion, and prevalence of morbidity and mortality. This is the first study to compare the outcomes of robotic and laparoscopic surgeries for CRC in Africa.</AbstractText><AbstractText Label="METHODS">A systematic review following the PRISMA guidelines was conducted. PubMed, Google Scholar, Web of Science, AJOL, EMBASE, and CENTRAL were searched, identifying 2,259 publications, 33 of which were deemed eligible. Statistical analysis of outcomes was performed using "R". Methodological quality of the included studies was assessed using the Cochrane ROBINS-I tool.</AbstractText><AbstractText Label="RESULTS">The minimally invasive approach has been applied for CRC treatment in seven African countries: Algeria, Cameroon, Egypt, Morocco, Nigeria, Senegal, and South Africa. Laparoscopic surgeries accounted for 1,485 (95%) of cases, while 71 (5%) were robotic. Robotic procedures were associated with a longer surgery duration (256.41&#xa0;min vs. 190.45&#xa0;min, p&#x2009;&lt;&#x2009;0.0001), higher blood loss (226.48&#xa0;mL vs. 141.55&#xa0;mL, p&#x2009;&lt;&#x2009;0.0001), and a shorter hospital stay (4.52&#xa0;days vs. 6.06&#xa0;days, p&#x2009;=&#x2009;0.85). Robotic procedures had a lower rate of conversion (3% vs. 8%, p&#x2009;=&#x2009;0.29) and a lower prevalence of morbidity (19% vs. 26%, p&#x2009;=&#x2009;0.26). Wound infection (24.49%) and ileus (57.14%) were the most common complications following laparoscopic and robotic procedures, respectively. There was no mortality from robotic surgeries; however, a prevalence of 0.39% (95% CI: 0;1.19) was recorded from laparoscopy.</AbstractText><AbstractText Label="CONCLUSIONS">This study establishes and compares the outcomes of advances in the treatment of CRC in the African setting, providing insights for policymakers, healthcare providers, and international organizations to make decisions regarding optimizing care for CRC patients in Africa.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falola</LastName><ForeName>Adebayo Feranmi</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-9509-4844</Identifier><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria. falolabayo@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria. falolabayo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1739-5013</Identifier><AffiliationInfo><Affiliation>Significant Polyp and Early Colorectal Cancer Service, King's College Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Ilorin Teaching Hospital, Ilorin, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Afe Babalola University, Ado-Ekiti, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shekoni</LastName><ForeName>Oluwatobi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mid and South Essex NHS Foundation Trust, Chelmsford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oluwagbemi</LastName><ForeName>Ayotemi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Marigold Hospital and Critical Care Center, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Effiong-John</LastName><ForeName>Blessing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Ibadan College of Medicine, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogbodu</LastName><ForeName>Emmanuella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asaba Specialist Hospital, Asaba, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dada</LastName><ForeName>Oluwasina Samuel</ForeName><Initials>OS</Initials><Identifier Source="ORCID">0000-0002-1056-3742</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndong</LastName><ForeName>Abdourahmane</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8103-1375</Identifier><AffiliationInfo><Affiliation>General Surgery Community, Surgery Interest Group of Africa, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Gaston Berger University, Saint-Louis, Senegal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061887" MajorTopicYN="N">Conversion to Open Surgery</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Laparoscopic</Keyword><Keyword MajorTopicYN="N">Robotic</Keyword></KeywordList><CoiStatement>Declarations. Disclosures: Drs. Adebayo Feranmi Falola, Ademola Adeyeye, Oluwatobi Shekoni, Ayotemi Oluwagbemi, Blessing Effiong-John, Emmanuella Ogbodu, Oluwasina Samuel Dada, and Abdourahmane Ndong have no conflicts of interest or financial ties to disclose. Ethical approval: Not applicable. Consent to participate: Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>24</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>11</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>10</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39658673</ArticleId><ArticleId IdType="doi">10.1007/s00464-024-11416-3</ArticleId><ArticleId IdType="pii">10.1007/s00464-024-11416-3</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229&#x2013;263. https://doi.org/10.3322/caac.21834</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21834</ArticleId><ArticleId IdType="pubmed">38572751</ArticleId></ArticleIdList></Reference><Reference><Citation>Awedew AF, Asefa Z, Belay WB (2022) Burden and trend of colorectal cancer in 54 countries of Africa 2010&#x2013;2019: a systematic examination for global burden of disease. BMC Gastroenterol 22(1):204. https://doi.org/10.1186/s12876-022-02275-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-022-02275-0</ArticleId><ArticleId IdType="pubmed">35468750</ArticleId><ArticleId IdType="pmc">9036749</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinji S, Yamada T, Matsuda A, Sonoda H, Ohta R, Iwai T, Takeda K, Yonaga K, Masuda Y, Yoshida H (2022) Recent advances in the treatment of colorectal cancer: a review. J Nippon Med Sch. https://doi.org/10.1272/jnms.JNMS.2022_89-310</Citation><ArticleIdList><ArticleId IdType="doi">10.1272/jnms.JNMS.2022_89-310</ArticleId><ArticleId IdType="pubmed">35644555</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek SJ, Piozzi GN, Kim SH (2021) Optimizing outcomes of colorectal cancer surgery with robotic platforms. Surg Oncol 1(37):101559. https://doi.org/10.1016/j.suronc.2021.101559</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2021.101559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper LE, Morant L, Anderson M, Bedra M, Boutros CN (2023) Analysis of 10 years of open, laparoscopic, and robotic rectal surgeries in the community setting. Surg Open Sci 16:165&#x2013;170. https://doi.org/10.1016/j.sopen.2023.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sopen.2023.10.011</ArticleId><ArticleId IdType="pubmed">38026827</ArticleId><ArticleId IdType="pmc">10656262</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2017.7219</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.7219</ArticleId><ArticleId IdType="pubmed">29067426</ArticleId><ArticleId IdType="pmc">5818805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohrn N, Klein MF, G&#xf6;genur I (2021) Robotic versus laparoscopic right colectomy for colon cancer: a nationwide cohort study. Int J Colorectal Dis 36(10):2147&#x2013;2158. https://doi.org/10.1007/s00384-021-03966-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-021-03966-y</ArticleId><ArticleId IdType="pubmed">34076746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettiarachchi TS, Askari A, Rudge E, Hao LT, Sarwar S, Dowsett D, El Hadi A, Shaikh I (2023) Comparison of robotic vs laparoscopic left-sided colorectal cancer resections. J Robot Surg 17(1):205&#x2013;213</Citation><ArticleIdList><ArticleId IdType="pubmed">35610541</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8479591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev 5:1&#x2013;10. https://doi.org/10.1186/s13643-016-0384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksen MB, Frandsen TF (2018) The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. JMLA 106(4):420. https://doi.org/10.5195/jmla.2018.345</Citation><ArticleIdList><ArticleId IdType="doi">10.5195/jmla.2018.345</ArticleId><ArticleId IdType="pubmed">30271283</ArticleId><ArticleId IdType="pmc">6148624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. https://doi.org/10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pubmed">27737834</ArticleId><ArticleId IdType="pmc">5063034</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xfc;ni P, Loke Y, Pigott T, Ramsay C, Regidor D, Rothstein H, Sandhu L, Santaguida PL, Sch&#xfc;nemann HJ, Shea B (2016) Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance. Br Med J 355:i4919</Citation></Reference><Reference><Citation>McGuinness LA, Higgins JP (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments&#x201d;. Res Synth Methods 12(1):55&#x2013;61. https://doi.org/10.1002/jrsm.1411</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1411</ArticleId><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sow O, Thioubou A, Saidy R, Traor&#xe9; A, Ndiaye MD, Gueye ML, Ka I, Dieng M (2023) The first cases of laparoscopic colectomy for cancer in Ziguinchor peace hospital. Surg Sci 14:550&#x2013;556. https://doi.org/10.4236/ss.2023.148059</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ss.2023.148059</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Haggag AA, El-Haggag A, Ibraheem El-Anany M, Abd El-Aziz AE (2021) Comparative study between laparoscopic versus open right hemicolectomy. Al-Azhar Med J 50(1):117&#x2013;132</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/amj.2021.139694</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnagar M, Hany D (2017) Comparative study of short term outcome of laparoscopically assisted versus totally laparoscopic right colectomy for right Sid-Ed cancer colon. Ain Shams J Surg 10(2):156&#x2013;165</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/asjs.2017.178394</ArticleId></ArticleIdList></Reference><Reference><Citation>Arafa MW, Ali A, Abdelhameed HF, Mohamed AE (2022) Complications of laparoscopic restorative rectal carcinoma resection. Egypt J Hosp Med 87(1):1913&#x2013;1919</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejhm.2022.231656</ArticleId></ArticleIdList></Reference><Reference><Citation>Enein H, Hameed M, Hassib A, Mohamed AM, Ismail SD (2018) Feasibility and benefits of laparoscopic colectomy versus open surgery-a clinical trial study. Int J Sci Res Sci Technol 4:1255&#x2013;1259</Citation></Reference><Reference><Citation>El-Fol HA, Ammar MS, Abdelaziz TF, Elbalshy MA, Elabassy MM (2019) Laparoscopic versus open complete mesocolic excision with central vascular ligation in right colon cancer. Int Surg J 6(5):1566&#x2013;1573</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2349-2902.isj20191871</ArticleId></ArticleIdList></Reference><Reference><Citation>Abozeid MA, Abou-Zeid AA, Hussein HM, Omar MA (2021) Totally versus planned conversion laparoscopic colectomy for colorectal cancers: the beginning of the learning curve. J Med Sci. https://doi.org/10.21608/svuijm.2021.83691.1189</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/svuijm.2021.83691.1189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arafa MW, Ali A, Abdelhameed HF, Mohammed AE (2021) Evaluation of laparoscopic sphincter saving surgery in management of rectal cancer. Egypt J Hosp Med 85(2):4208&#x2013;4217</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejhm.2021.208076</ArticleId></ArticleIdList></Reference><Reference><Citation>Torky RA, Helmy AA, Ali A, Abdallah AB, Zayan AT (2019) The effect of laparoscopically assisted versus open resection of rectal cancer on short-term and pathological outcomes: a randomized controlled trial. Egypt J Surg 38:214&#x2013;220. https://doi.org/10.4103/ejs.ejs_167_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ejs.ejs_167_18</ArticleId></ArticleIdList></Reference><Reference><Citation>Nada A, Helmy H, Nashed G, Yehia M, Shoukry A (2011) Early experience in laparoscopic colorectal resection for colorectal carcinoma: a retrospective study. Egypt J Surg 30:69&#x2013;77</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejsur.2011.367375</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shafei MA, Amer MA, Darwish AA, Eskandaros MS, Hosny AA (2018) Comparative study between laparoscopic assisted versus open left sided hemicolectomy and sigmoidectomy for cancer colon. Egypt J Hosp Med 72(1):3741&#x2013;3748</Citation></Reference><Reference><Citation>Abd-Elshafy YM, Mohammad IM, Ashry HN, Zaitoun MA (2022) Laparoscopic versus open surgery for treatment of colorectal cancer. Egypt J Hosp Med. https://doi.org/10.21608/ejhm.2022.213811</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejhm.2022.213811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawfik Amin A, Elsaba TM, Amira G (2014) Three ports laparoscopic resection for colorectal cancer: a step on refining of reduced port surgery. ISRN Surg. https://doi.org/10.1155/2014/781549</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/781549</ArticleId><ArticleId IdType="pubmed">25006515</ArticleId><ArticleId IdType="pmc">3972942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zedan A, Elshiekh E, Omar MI, Raafat M, Khallaf SM, Atta H, Hussien MT (2021) Laparoscopic versus open complete mesocolic excision for right colon cancer. Int J Surg Oncol. https://doi.org/10.1155/2021/8859879</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8859879</ArticleId><ArticleId IdType="pubmed">33604087</ArticleId><ArticleId IdType="pmc">7872753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa Balbola MM, Elramah AF, Ibrahim AR, Khafaga ME (2022) Laparoscopic versus open rectosigmoid cancer resection: a comparative study. Int J Med Arts. https://doi.org/10.21608/ijma.2022.125469.1438</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ijma.2022.125469.1438</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad HA, Fayed WI, Talha AI, Al-Sherif AM, Selima MA (2021) Comparative study of totally laparoscopic right hemicolectomy versus laparoscopic-assisted right hemicolectomy for the treatment of right-sided colonic cancer. Egypt J Surg 40:316&#x2013;321. https://doi.org/10.4103/ejs.ejs_344_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ejs.ejs_344_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud AM, Moneer MM (2017) Toward standardization of laparoscopic resection for colorectal cancer in developing countries: a step by step module. J Egypt Natl Cancer Inst. https://doi.org/10.1016/j.jnci.2017.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnci.2017.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag AF, Mahmoud AMA, Azmy HM, Mashhour AN, Khalifa AS, Debakey Y, Elbarmelgi MY (2023) Robotic-assisted laparoscopic low anterior resection versus trans-anal total mesorectal excision for malignant rectal lesion: a prospective cohort trial. Egypt J Surg 42:859&#x2013;867. https://doi.org/10.4103/ejs.ejs_167_23</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ejs.ejs_167_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Debakey Y, Zaghloul A, Farag A, Mahmoud A, Elattar I (2018) 2018 Robotic-assisted versus conventional laparoscopic approach for rectal cancer surgery, first Egyptian academic center experience. RCT. Minimal Invasive Surg 1:5836562</Citation></Reference><Reference><Citation>El Yaakoubi A, Lahmadi S, Benkabbou A, Mohsine R, Belkouchi A, El Harroudi T, El Malki HO, Hrora A, Souadka A, Majbar MA (2022) Audit of laparoscopic surgery for colon cancer in Morocco: a report of the results of a prospective multicentre cohort study. Ann Med Surg (Lond) 80:104290. https://doi.org/10.1016/j.amsu.2022.104290</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104290</ArticleId><ArticleId IdType="pubmed">35992209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafour MA, Amira G, Abou Elmagd M, Amin AT, Eleuon IA (2014) Outcome of laparoscopic colectomy in colorectal cancer at south Egypt cancer institute: a randomized controlled study. SECI Oncol J. https://doi.org/10.21608/secioj.2014.5680</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/secioj.2014.5680</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximous DW, Alshoieby MH, Hozayen HF, Asaad BM, Ahmed BM (2021) Retrospective study of surgical outcome and predictive factors for anastomotic complications after laparoscopic colectomy at south Egypt cancer institute. SECI Oncol J 4:203&#x2013;212</Citation></Reference><Reference><Citation>Boudiaf Z, Bouzid C, Cherchar K, Chibane A, Kheloufi M, Boutekedjiret IH, Hattou Z, Bentabak K (2022) Outcomes of laparoscopic combined surgery for colorectal cancer with synchronous liver metastases: a prospective comparative study. Gulf J Oncolog 1:47&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">35695346</ArticleId></ArticleIdList></Reference><Reference><Citation>Majbar AM, Abid M, Alaoui M, Sabbah F, Raiss M, Ahallat M, Hrora A (2016) Impact of conversion to open surgery on early postoperative morbidity after laparoscopic resection for rectal adenocarcinoma: a retrospective study. J Laparoendosc Adv Surg Tech A 26:697&#x2013;701. https://doi.org/10.1089/lap.2016.0027</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2016.0027</ArticleId><ArticleId IdType="pubmed">27388931</ArticleId></ArticleIdList></Reference><Reference><Citation>Adisa AO, Alatise OI, Agbakwuru EA, Akinola DO, Adejuyigbe O (2014) Wound complications following laparoscopic surgery in a Nigerian hospital. Niger J Surg 20:92&#x2013;95. https://doi.org/10.4103/1117-6806.137310</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1117-6806.137310</ArticleId><ArticleId IdType="pubmed">25191101</ArticleId><ArticleId IdType="pmc">4141453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaghloul AS, Mahmoud AM (2016) Preliminary results of robotic colorectal surgery at the national cancer institute, Cairo university. J Egypt Natl Cancer Inst 28:169&#x2013;174. https://doi.org/10.1016/j.jnci.2016.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnci.2016.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin AT, Ahmed BM, Khallaf SM (2015) Safety and feasibility of laparoscopic colo-rectal surgery for cancer at a tertiary center in a developing country: Egypt as an example. J Egypt Natl Cancer Inst. https://doi.org/10.1016/j.jnci.2015.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnci.2015.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Awab A, El Mansoury D, Benkabbou A, Elmoussaoui R, Elhijri A, Alilou M, Azzouzi A (2012) Acute compartment syndrome following laparoscopic colorectal surgery. Colorectal Dis 14:e76. https://doi.org/10.1111/j.1463-1318.2011.02654.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2011.02654.x</ArticleId><ArticleId IdType="pubmed">21689335</ArticleId></ArticleIdList></Reference><Reference><Citation>Adisa AO, Lawal OO, Arowolo OA, Alatise OI (2013) Local adaptations aid establishment of laparoscopic surgery in a semiurban Nigerian hospital. Surg Endosc 27:390&#x2013;393. https://doi.org/10.1007/s00464-012-2463-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-012-2463-5</ArticleId><ArticleId IdType="pubmed">22806524</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghahowa ME, Salu IK, Esomonu SN, Umar MU, Bello O, Gali BM (2022) Laparoscopic general surgeries in a developing country: a 5-year private hospital experience in Abuja, federal capital territory. Nigeria Borno Med J 19:94&#x2013;101</Citation></Reference><Reference><Citation>Moodley K, Kader S, Naidoo M, Madiba TE (2021) Clinicopathological spectrum and management of rectal cancer in Durban, South Africa. Surg Chronicles 26</Citation></Reference><Reference><Citation>Oodit R, Constant DA, Maree F, Lorrimer I, Dalwai EK, Moodley J (2021) Colorectal surgical outcomes following implementation of an enhanced recovery after surgery programme in Cape town. S Afr J Surg 59:157&#x2013;163</Citation><ArticleIdList><ArticleId IdType="doi">10.17159/2078-5151/2021/v59n4a3512</ArticleId><ArticleId IdType="pubmed">34889539</ArticleId></ArticleIdList></Reference><Reference><Citation>Oumarou BN, Bang GA, Dominique NO, Noah EP, Guifo ML, Essomba AG (2017) Diagnostic laparoscopy in digestive cancers: is it useful? The experience of a Third World low-volume institute after 70 consecutives cases. J Gen Emerg Med 2(5):1&#x2013;5</Citation></Reference><Reference><Citation>Race AJ, Horgan S (2021) Overview of current robotic technology. In: Horgan S, Fuchs KH (eds) Innovative endoscopic and surgical technology in the GI tract. Springer, Champ, pp. 1&#x2013;17</Citation></Reference><Reference><Citation>Ng AT, Tam PC (2014) Current status of robot-assisted surgery. Hong Kong Med J 20(3):241&#x2013;250. https://doi.org/10.12809/hkmj134167</Citation></Reference><Reference><Citation>Karcz WK, von Braun W (2016) Minimally invasive surgery for the treatment of colorectal cancer. Visc Med 32:192&#x2013;198. https://doi.org/10.1159/000445815</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000445815</ArticleId><ArticleId IdType="pubmed">27493947</ArticleId><ArticleId IdType="pmc">4945781</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr FW, Falk V, Diegeler A, Autschback R (1999) Computer-enhanced coronary artery bypass surgery. J Thorac Cardiovasc Surg. https://doi.org/10.1016/S0022-5223(99)70261-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(99)70261-8</ArticleId><ArticleId IdType="pubmed">10384184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi S, Matsuyama T, Tokunaga M, Kinugasa Y (2021) Minimally invasive surgery for colorectal cancer. JMA J. https://doi.org/10.31662/jmaj.2020-0089</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2020-0089</ArticleId><ArticleId IdType="pubmed">33575499</ArticleId><ArticleId IdType="pmc">7872784</ArticleId></ArticleIdList></Reference><Reference><Citation>Martel G, Boushey RP (2006) Laparoscopic colon surgery: past, present and future. Surg Clin 86(4):867&#x2013;897</Citation></Reference><Reference><Citation>Jacobs M, Verdeja JC, Goldstein H (1991) Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc Percutaneous Tech 1(3):144&#x2013;150</Citation></Reference><Reference><Citation>Lacy AM, Garc&#xed;a-Valdecasas JC, Delgado S, Castells A, Taur&#xe1; P, Piqu&#xe9; JM, Visa J (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet 359:2224&#x2013;2229. https://doi.org/10.1016/S0140-6736(02)09290-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09290-5</ArticleId><ArticleId IdType="pubmed">12103285</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G (2002) Clinical Outcomes of Surgical Therapy (COST) Study Group, Clinical Outcomes of Surgical Therapy (COST) Study Group Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA 287(3):321&#x2013;328</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.287.3.321</ArticleId><ArticleId IdType="pubmed">11790211</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14:101174. https://doi.org/10.1016/j.tranon.2021.101174</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tranon.2021.101174</ArticleId><ArticleId IdType="pubmed">34243011</ArticleId><ArticleId IdType="pmc">8273208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdi Y, Abdeljaoued-Tej I, Zatchi AA, Abdelhak S, Boubaker S, Brown JS, Benkahla A (2021) Cancer in Africa: the untold story. Front Oncol 11:650117. https://doi.org/10.3389/fonc.2021.650117</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.650117</ArticleId><ArticleId IdType="pubmed">33937056</ArticleId><ArticleId IdType="pmc">8082106</ArticleId></ArticleIdList></Reference><Reference><Citation>Arhin N, Ssentongo P, Taylor M, Olecki EJ, Pameijer C, Shen C, Oh J, Eng C (2022) Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysis. BMJ Open 12(1):e052376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052376</ArticleId><ArticleId IdType="pubmed">35039287</ArticleId><ArticleId IdType="pmc">8765019</ArticleId></ArticleIdList></Reference><Reference><Citation>Falola AF, Dada OS, Ndong A, Akande DG (2024) Etiology and management outcomes of adult mechanical bowel obstruction in Nigeria: a systematic review and meta-analysis. World J Surg 48:29&#x2013;39. https://doi.org/10.1002/wjs.12017</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wjs.12017</ArticleId><ArticleId IdType="pubmed">38686745</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga M, Vignali A, Gianotti L, Zuliani W, Radaelli G, Gruarin P, Dellabona P, Di Carlo V (2002) Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Annal Surg 236(6):759&#x2013;767</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200212000-00008</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldkamp R (2005) COlon cancer laparoscopic or open resection study group (COLOR): laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6:477&#x2013;484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(05)70221-7</ArticleId><ArticleId IdType="pubmed">15992696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtani H, Tamamori Y, Azuma T, Mori Y, Nishiguchi Y, Maeda K, Hirakawa K (2011) A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer. J Gastrointest Surg 15:1375&#x2013;1385. https://doi.org/10.1007/s11605-011-1547-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-011-1547-1</ArticleId><ArticleId IdType="pubmed">21557014</ArticleId></ArticleIdList></Reference><Reference><Citation>Heroor A, Khan A, Jain K, Patil A, Singhavi HR (2021) Robotic versus laparoscopic colorectal surgeries: a systematic review and meta-analysis. Indian J Colo Rect Surg 4:12&#x2013;24. https://doi.org/10.4103/ijcs.ijcs_41_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijcs.ijcs_41_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik SH (2008) Robotic colorectal surgery. Yonsei Med J 49:891&#x2013;896</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2008.49.6.891</ArticleId><ArticleId IdType="pubmed">19108010</ArticleId><ArticleId IdType="pmc">2628019</ArticleId></ArticleIdList></Reference><Reference><Citation>Manilich E, Vogel JD, Kiran RP, Church JM, Seyidova-Khoshknabi D, Remzi FH (2013) Key factors associated with postoperative complications in patients undergoing colorectal surgery. Dis Colon Rectum 56:64&#x2013;71. https://doi.org/10.1097/DCR.0b013e31827175f6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0b013e31827175f6</ArticleId><ArticleId IdType="pubmed">23222282</ArticleId></ArticleIdList></Reference><Reference><Citation>Casillas MA Jr, Leichtle SW, Wahl WL, Lampman RM, Welch KB, Wellock T, Madden EB, Cleary RK (2014) Improved perioperative and short-term outcomes of robotic versus conventional laparoscopic colorectal operations. Am J Surg 208:33&#x2013;40. https://doi.org/10.1016/j.amjsurg.2013.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.08.028</ArticleId><ArticleId IdType="pubmed">24239530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketelaers SHJ, Orsini RG, Burger JWA, Nieuwenhuijzen GAP, Rutten HJT (2019) Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years. Eur J Surg Oncol 45:2052&#x2013;2058. https://doi.org/10.1016/j.ejso.2019.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2019.06.017</ArticleId><ArticleId IdType="pubmed">31255442</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Zhang W, Guo Y, Wang X, Yu H, Du B, Yang X, Luo Y (2019) Robotic versus laparoscopic rectal surgery for rectal cancer: a meta-analysis of 7 randomized controlled trials. Surg Innov. https://doi.org/10.1177/1553350619839853</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1553350619839853</ArticleId><ArticleId IdType="pubmed">31874595</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertani E (2017) Laparoscopic vs. robotic colorectal resections: new insights from the American college of surgeons national surgical quality improvement program. Ann Laparosc Endosc Surg 2:37&#x2013;37</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/ales.2017.02.08</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KT, Tsia AKV, Chong VYL (2019) Robotic versus conventional laparoscopic surgery for colorectal cancer: a systematic review and meta-analysis with trial sequential analysis. World J Surg 43:1146&#x2013;1161. https://doi.org/10.1007/s00268-018-04896-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-04896-7</ArticleId><ArticleId IdType="pubmed">30610272</ArticleId></ArticleIdList></Reference><Reference><Citation>Simillis C, Lal N, Thoukididou SN, Kontovounisios C, Smith JJ, Hompes R, Adamina M, Tekkis PP (2019) Open versus laparoscopic versus robotic versus transanal mesorectal excision for rectal cancer: a systematic review and network meta-analysis. Ann Surg. https://doi.org/10.1097/SLA.0000000000003227</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003227</ArticleId><ArticleId IdType="pubmed">30720507</ArticleId></ArticleIdList></Reference><Reference><Citation>Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM (2018) Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 267:1034&#x2013;1046. https://doi.org/10.1097/SLA.0000000000002523</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002523</ArticleId><ArticleId IdType="pubmed">28984644</ArticleId></ArticleIdList></Reference><Reference><Citation>Falola AF, Fadairo RT, Dada OS, Adenikinju JS, Ogbodu E, Effiong-John B, Akande DG, Okere MO, Adelotan A, Ndong A (2024) Current state of minimally invasive general surgical practice in Africa: a systematic review and meta-analysis of the laparoscopic procedures performed and outcomes. World J Surg 48:1634&#x2013;1650. https://doi.org/10.1002/wjs.12195</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wjs.12195</ArticleId><ArticleId IdType="pubmed">38809177</ArticleId></ArticleIdList></Reference><Reference><Citation>Falola AF, Dada OS, Adeyeye A, Ezebialu CO, Fadairo RT, Okere MO, Ndong A (2024) Analyzing the emergence of surgical robotics in Africa: a scoping review of pioneering procedures, platforms utilized, and outcome meta-analysis. J Minim Invasive Surg 27:142&#x2013;155. https://doi.org/10.7602/jmis.2024.27.3.142</Citation><ArticleIdList><ArticleId IdType="doi">10.7602/jmis.2024.27.3.142</ArticleId><ArticleId IdType="pubmed">39300723</ArticleId><ArticleId IdType="pmc">11416894</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyebamiji TA (2020) Robotic surgery in Nigeria: an uncertain possibility. Int Surg J. https://doi.org/10.18203/2349-2902.isj20204713</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2349-2902.isj20204713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrenn SM, Cepeda-Benito A, Ramos-Valadez DI, Cataldo PA (2018) Patient perceptions and quality of life after colon and rectal surgery: what do patients really want? Dis Colon Rectum 61:971&#x2013;978. https://doi.org/10.1097/DCR.0000000000001078</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001078</ArticleId><ArticleId IdType="pubmed">29944576</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinh BB, Jackson NR, Hauch AT, Hu T, Kandil E (2014) Robotic versus laparoscopic colorectal surgery. JSLS 18(4):e2014.00187</Citation></Reference><Reference><Citation>Deutsch GB, Sathyanarayana SA, Gunabushanam V, Mishra N, Rubach E, Zemon H, Klein JDS, DeNoto G (2012) Robotic vs. laparoscopic colorectal surgery: an institutional experience. Surg Endosc 26:956&#x2013;963. https://doi.org/10.1007/s00464-011-1977-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-011-1977-6</ArticleId><ArticleId IdType="pubmed">22044968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed J, Cao H, Panteleimonitis S, Khan J, Parvaiz A (2017) Robotic vs laparoscopic rectal surgery in high-risk patients. Colorectal Dis 19:1092&#x2013;1099. https://doi.org/10.1111/codi.13783</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.13783</ArticleId><ArticleId IdType="pubmed">28644545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirnezami AH, Mirnezami R, Venkatasubramaniam AK, Chandrakumaran K, Cecil TD, Moran BJ (2010) Robotic colorectal surgery: hype or new hope? a systematic review of robotics in colorectal surgery. Colorectal Dis 12(11):1084&#x2013;1093</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1463-1318.2009.01999.x</ArticleId><ArticleId IdType="pubmed">19594601</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JC et al (2024) Minimally invasive surgery for colorectal cancer: benchmarking uptake for a regional improvement programme. Clin Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clcc.2024.05.013</ArticleId><ArticleId IdType="pubmed">39004595</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (2024) Medical Technologies Evaluation Programme: HTE40 robot-assisted surgery for soft tissue procedures (provisional title). Available online: https://www.nice.org.uk/guidance/gid-hte10040/documents/final-scope . Accessed 24 July 2024.</Citation></Reference><Reference><Citation>Warps AK, Saraste D, Westerterp M, Detering R, Sj&#xf6;vall A, Martling A, Dekker JWT, Tollenaar RAEM, Matthiessen P, Tanis PJ, Audit DC, Registry SCC (2022) National differences in implementation of minimally invasive surgery for colorectal cancer and the influence on short-term outcomes. Surg Endosc 36:5986&#x2013;6001. https://doi.org/10.1007/s00464-021-08974-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-021-08974-1</ArticleId><ArticleId IdType="pubmed">35258664</ArticleId><ArticleId IdType="pmc">9283170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A, Ng JC, Awuah WA, Huang H, Kalmanovich J, Agrawal A, Abdul-Rahman T, Hasan MM, Sikora V, Isik A (2022) Embracing robotic surgery in low- and middle-income countries: potential benefits, challenges, and scope in the future. Ann Med Surg 84:104803</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104803</ArticleId></ArticleIdList></Reference><Reference><Citation>Akintoye OO, Adu BG, Otorkpa MJ, Olayode OO, Fodop S, Alemede PO, Enyong RK, Anele FC, Omoregbee BI (2024) The current state of minimally invasive cardiac surgery in Africa: a systematic review and meta-analysis. Cardiothorac Surg 32(1):15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43057-024-00134-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravendran K et al (2023) A review of robotic surgery in colorectal surgery. Cureus 15:e37337</Citation><ArticleIdList><ArticleId IdType="pubmed">37182014</ArticleId><ArticleId IdType="pmc">10169093</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrikandiyur A, Kourounis G, Tingle S, Thambi P (2024) Robotic versus laparoscopic surgery for colorectal disease: a systematic review, meta-analysis and meta-regression of randomised controlled trials. Ann R Coll Surg Eng 106(8):658&#x2013;671</Citation></Reference><Reference><Citation>Kim CW, Kim CH, Baik SH (2014) Outcomes of robotic-assisted colorectal surgery compared with laparoscopic and open surgery: a systematic review. J Gastrointest Surg 18:816&#x2013;830. https://doi.org/10.1007/s11605-014-2469-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-014-2469-5</ArticleId><ArticleId IdType="pubmed">24496745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq HH, Shah SK, Agarwal AK (2019) The current role of robotics in colorectal surgery. Curr Gastroenterol Rep 21:11. https://doi.org/10.1007/s11894-019-0676-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-019-0676-7</ArticleId><ArticleId IdType="pubmed">30840156</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinoglio G, Summa M, Priora F, Quarati R, Testa S (2008) Robotic colorectal surgery: first 50 cases experience. Dis Colon Rectum 51(11):1627&#x2013;1632</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10350-008-9334-0</ArticleId><ArticleId IdType="pubmed">18484134</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MF, Nasir IUI, Parvaiz A (2019) Robotic surgery for colorectal cancer. Visc Med 35:247&#x2013;250. https://doi.org/10.1159/000500785</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000500785</ArticleId><ArticleId IdType="pubmed">31602387</ArticleId><ArticleId IdType="pmc">6738279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu Y, Han G, Yi B, Zhu S (2020) The severity of postoperative complications after robotic versus laparoscopic surgery for rectal cancer: a systematic review, meta-analysis and meta-regression. PLoS ONE 15:e0239909. https://doi.org/10.1371/journal.pone.0239909</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239909</ArticleId><ArticleId IdType="pubmed">33002066</ArticleId><ArticleId IdType="pmc">7529204</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam MS, Kaoutzanis C, Mullard AJ, Regenbogen SE, Franz MG, Hendren S, Krapohl G, Vandewarker JF, Lampman RM, Cleary RK (2016) A population-based study comparing laparoscopic and robotic outcomes in colorectal surgery. Surg Endosc 30:455&#x2013;463. https://doi.org/10.1007/s00464-015-4218-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4218-6</ArticleId><ArticleId IdType="pubmed">25894448</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng S, Zhao T, Wang X (2018) Comparison of robot-assisted surgery, laparoscopic-assisted surgery, and open surgery for the treatment of colorectal cancer: a network meta-analysis. Medicine 97:e11817. https://doi.org/10.1097/MD.0000000000011817</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011817</ArticleId><ArticleId IdType="pubmed">30142771</ArticleId><ArticleId IdType="pmc">6112974</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusticus SA, Lovato CY (2019) Impact of sample size and variability on the power and type I error rates of equivalence tests: a simulation study. Pract Assess Res Eval 19(1):11</Citation></Reference><Reference><Citation>Ndong A, Diallo AC, Rouhi AD, Diao ML, Yi W, Tendeng JN, Williams NN, Ciss&#xe9; M, Dumon KR, Konat&#xe9; I (2023) Evolution of laparoscopic surgery in a sub-Saharan African country: a 30-year literature review in Senegal. Surg Endosc 37(8):6548&#x2013;6557. https://doi.org/10.1007/s00464-023-10192-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-023-10192-w</ArticleId><ArticleId IdType="pubmed">37308759</ArticleId></ArticleIdList></Reference><Reference><Citation>Columb MO, Atkinson MS (2016) Statistical analysis: sample size and power estimations. Bja Educ 16(5):159&#x2013;161. https://doi.org/10.1093/bjaed/mkv034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaed/mkv034</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot S, Calleja-Agius J, Horeman T (2024) A comparison of clinical outcomes of robot-assisted and conventional laparoscopic surgery. Surg Tech Dev 13(1):22&#x2013;57. https://doi.org/10.3390/std13010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/std13010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C (2014) Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol 14:1&#x2013;3. https://doi.org/10.1186/1471-2288-14-120</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-120</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 318(16):1569&#x2013;1580. https://doi.org/10.1001/jama.2017.7219</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.7219</ArticleId><ArticleId IdType="pubmed">29067426</ArticleId><ArticleId IdType="pmc">5818805</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoroh JS, Riviello R (2021) Challenges in healthcare financing for surgery in sub-Saharan Africa. Pan Afr Med J. https://doi.org/10.11604/pamj.2021.38.198.27115</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.198.27115</ArticleId><ArticleId IdType="pubmed">33995804</ArticleId><ArticleId IdType="pmc">8106793</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon Cancer Laparoscopic or Open Resection Study Group (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(05)70221-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(05)70221-7</ArticleId><ArticleId IdType="pubmed">15992696</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Wang X, Zhao C, Liu Q, Zhou H, Zheng Z, Zhou Z, Wang X, Liang J (2019) Laparoscopic vs open colorectal cancer surgery in elderly patients: short-and long-term outcomes and predictors for overall and disease-free survival. BMC surg 19:1&#x2013;8. https://doi.org/10.1186/s12893-019-0596-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12893-019-0596-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen CC, Prasad LM, Abcarian H (2012) Cost-effectiveness of laparoscopic vs open resection for colon and rectal cancer. Dis Colon Rectum 55(10):1017&#x2013;1023. https://doi.org/10.1097/DCR.0b013e3182656898</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0b013e3182656898</ArticleId><ArticleId IdType="pubmed">22965399</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CH, Tan EC, Chen CC, Yang MC (2017) Real-world cost-effectiveness of laparoscopy versus open colectomy for colon cancer: a nationwide population-based study. Surg Endosc 31:1796&#x2013;1805. https://doi.org/10.1007/s00464-016-5176-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-016-5176-3</ArticleId><ArticleId IdType="pubmed">27538935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhardt JM, Werner N, Stroux A, F&#xf6;rster F, Pozios I, Seifarth C, Schineis C, Weixler B, Beyer K, Lauscher JC (2024) Robotic-assisted versus laparoscopic surgery for rectal cancer: an analysis of clinical and financial outcomes from a tertiary referral center. J Clin Med 13(6):1795. https://doi.org/10.3390/jcm13061795</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13061795</ArticleId><ArticleId IdType="pubmed">38542019</ArticleId><ArticleId IdType="pmc">10971725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Fang C, Bi T, Han J, Zhang R, Zhou S (2023) Efficacy of robot-assisted vs. laparoscopy surgery in the treatment of colorectal cancer: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. https://doi.org/10.1016/j.clinre.2023.102176</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinre.2023.102176</ArticleId><ArticleId IdType="pubmed">38065524</ArticleId><ArticleId IdType="pmc">10234691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CC, Hsu WT, Choi JJ, Galm B, Lee MT, Chang CN, Liu CY, Lee CC (2019) Comparison of outcome and cost between the open, laparoscopic, and robotic surgical treatments for colon cancer: a propensity score-matched analysis using nationwide hospital record database. Surg Endosc 33:3757&#x2013;3765. https://doi.org/10.1007/s00464-019-06672-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-019-06672-7</ArticleId><ArticleId IdType="pubmed">30675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaini L, Bazzocchi F, Cavaliere D, Avanzolini A, Cucchetti A, Ercolani G (2018) Robotic versus laparoscopic right colectomy: an updated systematic review and meta-analysis. Surg Endosc 32:1104&#x2013;1110. https://doi.org/10.1007/s00464-017-5980-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-017-5980-4</ArticleId><ArticleId IdType="pubmed">29218671</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah E, Abreu AA, Rail B, Salgado J, Karagkounis G, Zeh HJ III, Polanco PM (2023) Perioperative outcomes of robotic and laparoscopic surgery for colorectal cancer: a propensity score-matched analysis. World J Surg Oncol 21:272. https://doi.org/10.1186/s12957-023-03138-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-023-03138-y</ArticleId><ArticleId IdType="pubmed">37644538</ArticleId><ArticleId IdType="pmc">10466759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28756411</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-6244</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of medical genetics</Title><ISOAbbreviation>J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies.</ArticleTitle><Pagination><StartPage>598</StartPage><EndPage>606</EndPage><MedlinePgn>598-606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jmedgenet-2016-104495</ELocationID><Abstract><AbstractText Label="BACKGROUND">Microdeletions are known to confer risk to epilepsy, particularly at genomic rearrangement 'hotspot' loci. However, microdeletion burden not overlapping these regions or within different epilepsy subtypes has not been ascertained.</AbstractText><AbstractText Label="OBJECTIVE">To decipher the role of microdeletions outside hotspots loci and risk assessment by epilepsy subtype.</AbstractText><AbstractText Label="METHODS">We assessed the burden, frequency and genomic content of rare, large microdeletions found in a previously published cohort of 1366 patients with genetic generalised epilepsy (GGE) in addition to two sets of additional unpublished genome-wide microdeletions found in 281 patients with rolandic epilepsy (RE) and 807 patients with adult focal epilepsy (AFE), totalling 2454 cases. Microdeletions were assessed in a combined and subtype-specific approaches against 6746 controls.</AbstractText><AbstractText Label="RESULTS">When hotspots are considered, we detected an enrichment of microdeletions in the combined epilepsy analysis (adjusted p=1.06&#xd7;10<sup>-6</sup>,OR 1.89, 95%&#x2009;CI 1.51 to 2.35). Epilepsy subtype-specific analyses showed that hotspot microdeletions in the GGE subgroup contribute most of the overall signal (adjusted p=9.79&#xd7;10<sup>-12</sup>, OR 7.45, 95% CI 4.20-13.5). Outside hotspots , microdeletions were enriched in the GGE cohort for neurodevelopmental genes (adjusted p=9.13&#xd7;10<sup>-3</sup>,OR 2.85, 95% CI 1.62-4.94). No additional signal was observed for RE and AFE. Still, gene-content analysis identified known (<i>NRXN1</i>, <i>RBFOX1</i> and <i>PCDH7</i>) and novel (<i>LOC102723362</i>) candidate genes across epilepsy subtypes that were not deleted in controls.</AbstractText><AbstractText Label="CONCLUSIONS">Our results show a heterogeneous effect of recurrent and non-recurrent microdeletions as part of the genetic architecture of GGE and a minor contribution in the aetiology of RE and AFE.</AbstractText><CopyrightInformation>&#xa9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-Palma</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Biological Sciences and Medicine, Center for Biomedical Research, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helbig</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Karl Martin</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Epilepsy Center Hessen, University Hospitals Giessen &amp; Marburg, and University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anttila</LastName><ForeName>Verneri</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinthaler</LastName><ForeName>Eva Maria</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gormley</LastName><ForeName>Padhraig</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganna</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrnes</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernhorst</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toliat</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saarentaus</LastName><ForeName>Elmo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howrigan</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics Department of Biomedicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miquel</LastName><ForeName>Juan Francisco</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Departamento de Gastroenterolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ferrari</LastName><ForeName>Giancarlo V</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>Faculty of Biological Sciences and Medicine, Center for Biomedical Research, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfc;rnberg</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerche</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research,University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimprich</LastName><ForeName>Fritz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neubauer</LastName><ForeName>Bern A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Neuropediatrics, University Medical Center Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Albert J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenow</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Epilepsy Center Hessen, University Hospitals Giessen &amp; Marburg, and University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perucca</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>C. Mondino National Neurological Institute, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zara</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, Neuromuscular Disease Unit, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Yvonne G</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Departamento de Gastroenterolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lal</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Genet</MedlineTA><NlmUniqueID>2985087R</NlmUniqueID><ISSNLinking>0022-2593</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002872" MajorTopicYN="Y">Chromosome Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056915" MajorTopicYN="N">DNA Copy Number Variations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004828" MajorTopicYN="N">Epilepsies, Partial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004829" MajorTopicYN="N">Epilepsy, Generalized</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019305" MajorTopicYN="N">Epilepsy, Rolandic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epilepsy</Keyword><Keyword MajorTopicYN="N">hotspot loci</Keyword><Keyword MajorTopicYN="N">microdeletions</Keyword><Keyword MajorTopicYN="N">neurodevelopmental</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28756411</ArticleId><ArticleId IdType="pmc">PMC5574393</ArticleId><ArticleId IdType="doi">10.1136/jmedgenet-2016-104495</ArticleId><ArticleId IdType="pii">jmedgenet-2016-104495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#xe9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on classification and terminology, 2005-2009. Epilepsia 2010;51:676&#x2013;85.10.1111/j.1528-1167.2010.02522.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2010.02522.x</ArticleId><ArticleId IdType="pubmed">20196795</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009;85:31&#x2013;45.10.1016/j.eplepsyres.2009.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2009.03.003</ArticleId><ArticleId IdType="pmc">PMC2696575</ArticleId><ArticleId IdType="pubmed">19369037</ArticleId></ArticleIdList></Reference><Reference><Citation>Noebels JL. Single-Gene determinants of epilepsy comorbidity. Cold Spring Harb Perspect Med 2015;5:a022756.10.1101/cshperspect.a022756</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a022756</ArticleId><ArticleId IdType="pmc">PMC4632859</ArticleId><ArticleId IdType="pubmed">26525453</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998;43:435&#x2013;45.10.1002/ana.410430405</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430405</ArticleId><ArticleId IdType="pubmed">9546323</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadlamudi L, Milne RL, Lawrence K, Heron SE, Eckhaus J, Keay D, Connellan M, Torn-Broers Y, Howell RA, Mulley JC, Scheffer IE, Dibbens LM, Hopper JL, Berkovic SF. Genetics of Epilepsy: the testimony of twins in the molecular era. Neurology 2014;83:1042&#x2013;8.10.1212/WNL.0000000000000790</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000790</ArticleId><ArticleId IdType="pmc">PMC4166361</ArticleId><ArticleId IdType="pubmed">25107880</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadlamudi L, Kjeldsen MJ, Corey LA, Solaas MH, Friis ML, Pellock JM, Nakken KO, Milne RL, Scheffer IE, Harvey AS, Hopper JL, Berkovic SF. Analyzing the etiology of benign rolandic epilepsy: a multicenter twin collaboration. Epilepsia 2006;47:550&#x2013;5.10.1111/j.1528-1167.2006.00466.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2006.00466.x</ArticleId><ArticleId IdType="pubmed">16529620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, Geider K, Laube B, Schwake M, Finsterwalder K, Franke A, Schilhabel M, J&#xe4;hn JA, Muhle H, Boor R, Van Paesschen W, Caraballo R, Fejerman N, Weckhuysen S, De Jonghe P, Larsen J, M&#xf8;ller RS, Hjalgrim H, Addis L, Tang S, Hughes E, Pal DK, Veri K, Vaher U, Talvik T, Dimova P, Guerrero L&#xf3;pez R, Serratosa JM, Linnankivi T, Lehesjoki AE, Ruf S, Wolff M, Buerki S, Wohlrab G, Kroell J, Datta AN, Fiedler B, Kurlemann G, Kluger G, Hahn A, Haberlandt DE, Kutzer C, Sperner J, Becker F, Weber YG, Feucht M, Steinb&#xf6;ck H, Neophythou B, Ronen GM, Gruber-Sedlmayr U, Geldner J, Harvey RJ, Hoffmann P, Herms S, Altm&#xfc;ller J, Toliat MR, Thiele H, N&#xfc;rnberg P, Wilhelm C, Stephani U, Helbig I, Lerche H, Zimprich F, Neubauer BA, Biskup S, von Spiczak S. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013;45:1067&#x2013;72.10.1038/ng.2728</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2728</ArticleId><ArticleId IdType="pubmed">23933819</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvill GL, Regan BM, Yendle SC, O&#x2019;Roak BJ, Lozovaya N, Bruneau N, Burnashev N, Khan A, Cook J, Geraghty E, Sadleir LG, Turner SJ, Tsai MH, Webster R, Ouvrier R, Damiano JA, Berkovic SF, Shendure J, Hildebrand MS, Szepetowski P, Scheffer IE, Mefford HC. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 2013;45:1073&#x2013;6.10.1038/ng.2727</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2727</ArticleId><ArticleId IdType="pmc">PMC3868952</ArticleId><ArticleId IdType="pubmed">23933818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, Salmi M, Tsintsadze T, Addis L, Motte J, Wright S, Tsintsadze V, Michel A, Doummar D, Lascelles K, Strug L, Waters P, de Bellescize J, Vrielynck P, de Saint Martin A, Ville D, Ryvlin P, Arzimanoglou A, Hirsch E, Vincent A, Pal D, Burnashev N, Sanlaville D, Szepetowski P. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013;45:1061&#x2013;6.10.1038/ng.2726</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2726</ArticleId><ArticleId IdType="pubmed">23933820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet 2015;16:172&#x2013;83.10.1038/nrg3871</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3871</ArticleId><ArticleId IdType="pubmed">25645873</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, Macdonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, Tyler-Smith C, Carter NP, Lee C, Scherer SW, Hurles ME; Wellcome Trust Case Control Consortium. Origins and functional impact of copy number variation in the human genome. Nature 2010;464:704&#x2013;12.10.1038/nature08516</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08516</ArticleId><ArticleId IdType="pmc">PMC3330748</ArticleId><ArticleId IdType="pubmed">19812545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudmant PH, Mallick S, Nelson BJ, Hormozdiari F, Krumm N, Huddleston J, Coe BP, Baker C, Nordenfelt S, Bamshad M, Jorde LB, Posukh OL, Sahakyan H, Watkins WS, Yepiskoposyan L, Abdullah MS, Bravi CM, Capelli C, Hervig T, Wee JT, Tyler-Smith C, van Driem G, Romero IG, Jha AR, Karachanak-Yankova S, Toncheva D, Comas D, Henn B, Kivisild T, Ruiz-Linares A, Sajantila A, Metspalu E, Parik J, Villems R, Starikovskaya EB, Ayodo G, Beall CM, Di Rienzo A, Hammer MF, Khusainova R, Khusnutdinova E, Klitz W, Winkler C, Labuda D, Metspalu M, Tishkoff SA, Dryomov S, Sukernik R, Patterson N, Reich D, Eichler EE, diversity G. Global diversity, population stratification, and selection of human copy-number variation. Science 2015;349:aab376110.1126/science.aab3761</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab3761</ArticleId><ArticleId IdType="pmc">PMC4568308</ArticleId><ArticleId IdType="pubmed">26249230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D, Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E, Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J, Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI, Dong H, Hutman T, Sigman M, Ozonoff S, Klin A, Owley T, Sweeney JA, Brune CW, Cantor RM, Bernier R, Gilbert JR, Cuccaro ML, McMahon WM, Miller J, State MW, Wassink TH, Coon H, Levy SE, Schultz RT, Nurnberger JI, Haines JL, Sutcliffe JS, Cook EH, Minshew NJ, Buxbaum JD, Dawson G, Grant SF, Geschwind DH, Pericak-Vance MA, Schellenberg GD, Hakonarson H. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009;459:528&#x2013;33.10.1038/nature07999</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07999</ArticleId><ArticleId IdType="pmc">PMC2943511</ArticleId><ArticleId IdType="pubmed">19404256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam GW, Redon R, Carter NP, Grant SG. The role of DNA copy number variation in schizophrenia. Biol Psychiatry 2009;66:1005&#x2013;12.10.1016/j.biopsych.2009.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.07.027</ArticleId><ArticleId IdType="pubmed">19748074</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, B&#xf6;lte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL, Hallmayer J, Miller J, Monaco AP, Nurnberger JI, Paterson AD, Pericak-Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368&#x2013;72.10.1038/nature09146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09146</ArticleId><ArticleId IdType="pmc">PMC3021798</ArticleId><ArticleId IdType="pubmed">20531469</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvill GL, Mefford HC. Microdeletion syndromes. Curr Opin Genet Dev 2013;23:232&#x2013;9.10.1016/j.gde.2013.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2013.03.004</ArticleId><ArticleId IdType="pubmed">23664828</ArticleId></ArticleIdList></Reference><Reference><Citation>Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, Franke A, Muhle H, de Kovel C, Baker C, von Spiczak S, Kron KL, Steinich I, Kleefuss-Lie AA, Leu C, Gaus V, Schmitz B, Klein KM, Reif PS, Rosenow F, Weber Y, Lerche H, Zimprich F, Urak L, Fuchs K, Feucht M, Genton P, Thomas P, Visscher F, de Haan GJ, M&#xf8;ller RS, Hjalgrim H, Luciano D, Wittig M, Nothnagel M, Elger CE, N&#xfc;rnberg P, Romano C, Malafosse A, Koeleman BP, Lindhout D, Stephani U, Schreiber S, Eichler EE, Sander T. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009;41:160&#x2013;2.10.1038/ng.292</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.292</ArticleId><ArticleId IdType="pmc">PMC3026630</ArticleId><ArticleId IdType="pubmed">19136953</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, Obermeier T, Kleefuss-Lie AA, Hallmann K, Steffens M, Gaus V, Klein KM, Hamer HM, Rosenow F, Brilstra EH, Trenit&#xe9; DK, Swinkels ME, Weber YG, Unterberger I, Zimprich F, Urak L, Feucht M, Fuchs K, M&#xf8;ller RS, Hjalgrim H, De Jonghe P, Suls A, R&#xfc;ckert IM, Wichmann HE, Franke A, Schreiber S, N&#xfc;rnberg P, Elger CE, Lerche H, Stephani U, Koeleman BP, Lindhout D, Eichler EE, Sander T. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010;133(Pt 1):23&#x2013;32.10.1093/brain/awp262</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp262</ArticleId><ArticleId IdType="pmc">PMC2801323</ArticleId><ArticleId IdType="pubmed">19843651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, Baker C, Franke A, Malafosse A, Genton P, Thomas P, Gurnett CA, Schreiber S, Bassuk AG, Guipponi M, Stephani U, Helbig I, Eichler EE. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010;6:e1000962.10.1371/journal.pgen.1000962</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000962</ArticleId><ArticleId IdType="pmc">PMC2873910</ArticleId><ArticleId IdType="pubmed">20502679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Ruppert AK, Trucks H, Schulz H, de Kovel CG, Kasteleijn-Nolst Trenit&#xe9; D, Sonsma AC, Koeleman BP, Lindhout D, Weber YG, Lerche H, Kapser C, Schankin CJ, Kunz WS, Surges R, Elger CE, Gaus V, Schmitz B, Helbig I, Muhle H, Stephani U, Klein KM, Rosenow F, Neubauer BA, Reinthaler EM, Zimprich F, Feucht M, M&#xf8;ller RS, Hjalgrim H, De Jonghe P, Suls A, Lieb W, Franke A, Strauch K, Gieger C, Schurmann C, Schminke U, N&#xfc;rnberg P, Sander T; EPICURE Consortium. Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies. PLoS Genet 2015;11:e1005226.10.1371/journal.pgen.1005226</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005226</ArticleId><ArticleId IdType="pmc">PMC4423931</ArticleId><ArticleId IdType="pubmed">25950944</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinthaler EM, Lal D, Lebon S, Hildebrand MS, Dahl HH, Regan BM, Feucht M, Steinbock H, Neophytou B, Ronen GM, Roche L, Gruber-Sedlmayr U, Geldner J, Haberlandt E, Hoffmann P, Herms S, Gieger C, Waldenberger M, Franke A, Wittig M, Schoch S, Becker AJ, Hahn A, Mannik K, Toliat MR, Winterer G. p11.2 European C, Lerche H, Nurnberg P, mefford H, Scheffer IE, Berkovic SF, Beckmann JS, Consortium E, Euro EC, Sander T, Jacquemont S, Reymond A, Zimprich F, Neubauer BA. 16p11.2 600 kb duplications confer risk for typical and atypical rolandic epilepsy. Human molecular genetics 2014;23:6069&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">24939913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Pernhorst K, Klein KM, Reif P, Tozzi R, Toliat MR, Winterer G, Neubauer B, N&#xfc;rnberg P, Rosenow F, Becker F, Lerche H, Kunz WS, Kurki MI, Hoffmann P, Becker AJ, Perucca E, Zara F, Sander T, Weber YG. Extending the phenotypic spectrum of RBFOX1 deletions: sporadic focal epilepsy. Epilepsia 2015;56:e129&#x2013;e133.10.1111/epi.13076</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13076</ArticleId><ArticleId IdType="pubmed">26174448</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumm N, O&#x2019;Roak BJ, Karakoc E, Mohajeri K, Nelson B, Vives L, Jacquemont S, Munson J, Bernier R, Eichler EE. Transmission disequilibrium of small CNVs in simplex autism. Am J Hum Genet 2013;93:595&#x2013;606.10.1016/j.ajhg.2013.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.07.024</ArticleId><ArticleId IdType="pmc">PMC3791263</ArticleId><ArticleId IdType="pubmed">24035194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Trucks H, M&#xf8;ller RS, Hjalgrim H, Koeleman BP, de Kovel CG, Visscher F, Weber YG, Lerche H, Becker F, Schankin CJ, Neubauer BA, Surges R, Kunz WS, Zimprich F, Franke A, Illig T, Ried JS, Leu C, N&#xfc;rnberg P, Sander T, Consortium EM; EMINet Consortium EPICURE Consortium. Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. Epilepsia 2013;54:265&#x2013;71.10.1111/epi.12084</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12084</ArticleId><ArticleId IdType="pubmed">23350840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Reinthaler EM, Altm&#xfc;ller J, Toliat MR, Thiele H, N&#xfc;rnberg P, Lerche H, Hahn A, M&#xf8;ller RS, Muhle H, Sander T, Zimprich F, Neubauer BA. RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PLoS One 2013;8:e7332310.1371/journal.pone.0073323</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073323</ArticleId><ArticleId IdType="pmc">PMC3765197</ArticleId><ArticleId IdType="pubmed">24039908</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller RS, Weber YG, Klitten LL, Trucks H, Muhle H, Kunz WS, Mefford HC, Franke A, Kautza M, Wolf P, Dennig D, Schreiber S, R&#xfc;ckert IM, Wichmann HE, Ernst JP, Schurmann C, Grabe HJ, Tommerup N, Stephani U, Lerche H, Hjalgrim H, Helbig I, Sander T, Consortium E; EPICURE Consortium. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia 2013;54:256&#x2013;64.10.1111/epi.12078</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12078</ArticleId><ArticleId IdType="pubmed">23294455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M. PennCNV: an integrated Hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007;17:1665&#x2013;74.10.1101/gr.6861907</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.6861907</ArticleId><ArticleId IdType="pmc">PMC2045149</ArticleId><ArticleId IdType="pubmed">17921354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T, Lionel AC, Thiruvahindrapuram B, Macdonald JR, Mills R, Prasad A, Noonan K, Gribble S, Prigmore E, Donahoe PK, Smith RS, Park JH, Hurles ME, Carter NP, Lee C, Scherer SW, Feuk L. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 2011;29:512&#x2013;20.10.1038/nbt.1852</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1852</ArticleId><ArticleId IdType="pmc">PMC3270583</ArticleId><ArticleId IdType="pubmed">21552272</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RR. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2010. (01/19).</Citation></Reference><Reference><Citation>Uddin M, Tammimies K, Pellecchia G, Alipanahi B, Hu P, Wang Z, Pinto D, Lau L, Nalpathamkalam T, Marshall CR, Blencowe BJ, Frey BJ, Merico D, Yuen RK, Scherer SW. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat Genet 2014;46:742&#x2013;7.10.1038/ng.2980</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2980</ArticleId><ArticleId IdType="pubmed">24859339</ArticleId></ArticleIdList></Reference><Reference><Citation>Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP. DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl Resources. Am J Hum Genet 2009;84:524&#x2013;33.10.1016/j.ajhg.2009.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.03.010</ArticleId><ArticleId IdType="pmc">PMC2667985</ArticleId><ArticleId IdType="pubmed">19344873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O&#x2019;Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285-91.10.1038/nature19057</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, Thiruvahindrapuram B, Xu X, Ziman R, Wang Z, Vorstman JA, Thompson A, Regan R, Pilorge M, Pellecchia G, Pagnamenta AT, Oliveira B, Marshall CR, Magalhaes TR, Lowe JK, Howe JL, Griswold AJ, Gilbert J, Duketis E, Dombroski BA, De Jonge MV, Cuccaro M, Crawford EL, Correia CT, Conroy J, Concei&#xe7;&#xe3;o IC, Chiocchetti AG, Casey JP, Cai G, Cabrol C, Bolshakova N, Bacchelli E, Anney R, Gallinger S, Cotterchio M, Casey G, Zwaigenbaum L, Wittemeyer K, Wing K, Wallace S, van Engeland H, Tryfon A, Thomson S, Soorya L, Rog&#xe9; B, Roberts W, Poustka F, Mouga S, Minshew N, McInnes LA, McGrew SG, Lord C, Leboyer M, Le Couteur AS, Kolevzon A, Jim&#xe9;nez Gonz&#xe1;lez P, Jacob S, Holt R, Guter S, Green J, Green A, Gillberg C, Fernandez BA, Duque F, Delorme R, Dawson G, Chaste P, Caf&#xe9; C, Brennan S, Bourgeron T, Bolton PF, B&#xf6;lte S, Bernier R, Baird G, Bailey AJ, Anagnostou E, Almeida J, Wijsman EM, Vieland VJ, Vicente AM, Schellenberg GD, Pericak-Vance M, Paterson AD, Parr JR, Oliveira G, Nurnberger JI, Monaco AP, Maestrini E, Klauck SM, Hakonarson H, Haines JL, Geschwind DH, Freitag CM, Folstein SE, Ennis S, Coon H, Battaglia A, Szatmari P, Sutcliffe JS, Hallmayer J, Gill M, Cook EH, Buxbaum JD, Devlin B, Gallagher L, Betancur C, Scherer SW. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet 2014;94:677&#x2013;94.10.1016/j.ajhg.2014.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.03.018</ArticleId><ArticleId IdType="pmc">PMC4067558</ArticleId><ArticleId IdType="pubmed">24768552</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545&#x2013;50.10.1073/pnas.0506580102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Trost B, Arsenault R, Griebel P, Napper S, Kusalik A. DAPPLE: a pipeline for the homology-based prediction of phosphorylation sites. Bioinformatics 2013;29:1693&#x2013;5.10.1093/bioinformatics/btt265</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt265</ArticleId><ArticleId IdType="pubmed">23658419</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen SA, Carvill GL, Bellows S, Bayly MA, Trucks H, Lal D, Sander T, Berkovic SF, Dibbens LM, Scheffer IE, Mefford HC. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013;81:1507&#x2013;14.10.1212/WNL.0b013e3182a95829</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a95829</ArticleId><ArticleId IdType="pmc">PMC3888172</ArticleId><ArticleId IdType="pubmed">24068782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838&#x2013;46.10.1038/ng.909</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.909</ArticleId><ArticleId IdType="pmc">PMC3171215</ArticleId><ArticleId IdType="pubmed">21841781</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo D, Lebon S, Chen Q, Martin-Brevet S, Snyder LG, Hippolyte L, Hanson E, Maillard AM, Faucett WA, Mace A, Pain A, Bernier R, Chawner SJ, David A, Andrieux J, Aylward E, Baujat G, Caldeira I, Conus P, Ferrari C, Forzano F, Gerard M, Goin-Kochel RP, Grant E, Hunter JV, Isidor B, Jacquette A, Jonch AE, Keren B, Lacombe D, Le Caignec C, Martin CL, Mannik K, Metspalu A, Mignot C, Mukherjee P, Owen MJ, Passeggeri M, Rooryck-Thambo C, Rosenfeld JA, Spence SJ, Steinman KJ, Tjernagel J, Van Haelst M, Shen Y, Draganski B, Sherr EH, Ledbetter DH, van den Bree MB, Beckmann JS, Spiro JE, Reymond A, Jacquemont S, Chung WK. Cardiff University Experiences of Children With Copy Number Variants S,. p11.2 European C, Simons variation in individuals Project C. defining the effect of the 16p11.2 Duplication on cognition, behavior, and medical comorbidities. JAMA psychiatry 2016;73:20&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5894477</ArticleId><ArticleId IdType="pubmed">26629640</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, Bjornsdottir G, Walters GB, Jonsdottir GA, Doyle OM, Tost H, Grimm O, Kristjansdottir S, Snorrason H, Davidsdottir SR, Gudmundsson LJ, Jonsson GF, Stefansdottir B, Helgadottir I, Haraldsson M, Jonsdottir B, Thygesen JH, Schwarz AJ, Didriksen M, Stensb&#xf8;l TB, Brammer M, Kapur S, Halldorsson JG, Hreidarsson S, Saemundsen E, Sigurdsson E, Stefansson K. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2014;505:361&#x2013;6.10.1038/nature12818</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12818</ArticleId><ArticleId IdType="pubmed">24352232</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Pernhorst K, Klein KM, Reif P, Tozzi R, Toliat MR, Winterer G, Neubauer B, N&#xfc;rnberg P, Rosenow F, Becker F, Lerche H, Kunz WS, Kurki MI, Hoffmann P, Becker AJ, Perucca E, Zara F, Sander T, Weber YG. Extending the phenotypic spectrum of RBFOX1 deletions: sporadic focal epilepsy. Epilepsia 2015;56:e129&#x2013;e133.10.1111/epi.13076</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13076</ArticleId><ArticleId IdType="pubmed">26174448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, Lapointe M, Spiegelman D, Noreau A, Lafreni&#xe8;re RG, Fathalli F, Joober R, Krebs MO, DeLisi LE, Mottron L, Fombonne E, Michaud JL, Drapeau P, Carbonetto S, Craig AM, Rouleau GA. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011;130:563&#x2013;73.10.1007/s00439-011-0975-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-011-0975-z</ArticleId><ArticleId IdType="pmc">PMC3204930</ArticleId><ArticleId IdType="pubmed">21424692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37481105</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of shoulder and elbow surgery</Title><ISOAbbreviation>J Shoulder Elbow Surg</ISOAbbreviation></Journal><ArticleTitle>Pseudoparesis and pseudoparalysis in the setting of massive irreparable rotator cuff tear: demographic, anatomic, and radiographic risk factors.</ArticleTitle><Pagination><StartPage>e88</StartPage><EndPage>e96</EndPage><MedlinePgn>e88-e96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jse.2023.06.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1058-2746(23)00528-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The primary purpose of this study was to identify demographic, anatomic, and radiographic risk factors for active forward elevation (AFE)&#xa0;&lt;90&#xb0; in the setting of massive, irreparable rotator cuff tear (miRCT). The secondary purpose was to identify characteristics differentiating between patients with pseudoparalysis (AFE &lt;45&#xb0;) and pseudoparesis (AFE &gt;45&#xb0; but &lt;90&#xb0;).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective case-control study reviewing patients with miRCTs at a single institution between January 12, 2016 and November 26, 2020. Patients were separated into 2 cohorts based on presence or absence of preoperative AFE &lt;90&#xb0; with maintained passive range of motion. Demographics, RCT pattern, and radiographic parameters were assessed as risk factors for AFE &lt;90&#xb0;. A secondary analysis was conducted to compare patients with pseudoparalysis and pseudoparesis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 79 patients in the AFE &lt;90&#xb0; cohort and 50 patients in the control cohort. Univariate analysis confirmed significant differences between the AFE &lt;90&#xb0; and control cohort in age (71.9&#xa0;&#xb1;&#xa0;11.0 vs. 65.9&#xa0;&#xb1;&#xa0;9.1 years), arthritis severity (34.2% vs. 16.0% grade 3 Samilson-Prieto), acromiohumeral distance (AHD; 4.8&#xa0;&#xb1;&#xa0;2.7 vs. 7.6&#xa0;&#xb1;&#xa0;2.6 mm), fatty infiltration of the supraspinatus (3.3&#xa0;&#xb1;&#xa0;0.9 vs. 2.8&#xa0;&#xb1;&#xa0;0.8) and subscapularis (2.0&#xa0;&#xb1;&#xa0;1.2 vs. 1.5&#xa0;&#xb1;&#xa0;1.0), and proportion of subscapularis tears (55.7% vs. 34.0%). On multivariate analysis, age (odds ratio [OR] 1.08, P&#xa0;=&#xa0;.014), decreased AHD (OR 0.67, P &lt; .001), severe arthritis (OR 2.84, P&#xa0;=&#xa0;.041), and subscapularis tear (OR 6.29, P&#xa0;=&#xa0;.015) were independent factors predictive of AFE &lt;90&#xb0;. Secondary analysis revealed tobacco use (OR 3.54, P&#xa0;=&#xa0;.026) and grade 4 fatty infiltration of the supraspinatus (OR 2.22, P&#xa0;=&#xa0;.015) and subscapularis (OR 3.12, P&#xa0;=&#xa0;.042) as significant predictors for pseudoparalysis compared to pseudoparesis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with miRCT, increased age, decreased AHD, severe arthritis, and subscapularis tear are associated with AFE &lt;90&#xb0;. Furthermore, patients with AFE &lt;90&#xb0; tend to have greater supraspinatus and subscapularis fatty infiltration. Lastly, among patients with AFE &lt;90&#xb0;, tobacco use and grade 4 fatty infiltration of the supraspinatus and subscapularis are associated with pseudoparalysis compared with pseudoparesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Rajiv P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabzevari</LastName><ForeName>Soheil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karimi</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadoo</LastName><ForeName>Sahil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramraj</LastName><ForeName>Raghav</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issa</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charles</LastName><ForeName>Shaquille</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Como</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh-Varma</LastName><ForeName>Anya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Como</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, UPMC Freddie Fu Sports Medicine Center, Pittsburgh, PA, USA. Electronic address: lina2@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Shoulder Elbow Surg</MedlineTA><NlmUniqueID>9206499</NlmUniqueID><ISSNLinking>1058-2746</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070636" MajorTopicYN="Y">Rotator Cuff Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012785" MajorTopicYN="Y">Shoulder Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012421" MajorTopicYN="N">Rupture</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022125" MajorTopicYN="Y">Lacerations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="Y">Arthritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pseudoparalysis</Keyword><Keyword MajorTopicYN="N">massive rotator cuff tear</Keyword><Keyword MajorTopicYN="N">pseudoparesis</Keyword><Keyword MajorTopicYN="N">range of motion</Keyword><Keyword MajorTopicYN="N">rotator cuff</Keyword><Keyword MajorTopicYN="N">rotator cuff tear</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>23</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37481105</ArticleId><ArticleId IdType="doi">10.1016/j.jse.2023.06.020</ArticleId><ArticleId IdType="pii">S1058-2746(23)00528-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16946213</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0029-7844</ISSN><JournalIssue CitedMedium="Print"><Volume>108</Volume><Issue>3 Pt 1</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Obstetrics and gynecology</Title><ISOAbbreviation>Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Postpartum maternal mortality and cesarean delivery.</ArticleTitle><Pagination><StartPage>541</StartPage><EndPage>548</EndPage><MedlinePgn>541-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">A continuous rise in the rate of cesarean delivery has been reported in many countries during the past decades. This trend has prompted the emergence of a controversial debate on the risks and benefits associated with cesarean delivery. Our objective was to provide a valid estimate of the risk of postpartum maternal death directly associated with cesarean as compared with vaginal delivery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A population-based case-control study was designed, with subjects selected from recent nationwide surveys in France. To control for indication bias, maternal deaths due to antenatal morbidities were excluded. For the 5-year study period 1996-2000, 65 cases were included. The control group was selected from the 1998 French National Perinatal Survey and included 10,244 women. Multivariable logistic regression analysis was used to adjust for confounders.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After adjustment for potential confounders, the risk of postpartum death was 3.6 times higher after cesarean than after vaginal delivery (odds ratio 3.64 95% confidence interval 2.15-6.19). Both prepartum and intrapartum cesarean delivery were associated with a significantly increased risk. Cesarean delivery was associated with a significantly increased risk of maternal death from complications of anesthesia, puerperal infection, and venous thromboembolism. The risk of death from postpartum hemorrhage did not differ significantly between vaginal and cesarean deliveries.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cesarean delivery is associated with an increased risk of postpartum maternal death. Knowledge of the causes of death associated with this excess risk informs contemporary discussion about cesarean delivery on request and should inform preventive strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deneux-Tharaux</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INSERM, Unite Mixte de Recherche S149, Institut Federatif de Recherche 69, Epidemiological Research Unit on Perinatal and Women's Health, Hopital Tenon, Paris, France. cdeneux.u149@chusa.jussieu.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmona</LastName><ForeName>Elodie</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bouvier-Colle</LastName><ForeName>Marie-H&#xe9;lene</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Br&#xe9;art</LastName><ForeName>G&#xe9;rard</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obstet Gynecol</MedlineTA><NlmUniqueID>0401101</NlmUniqueID><ISSNLinking>0029-7844</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036861" MajorTopicYN="N">Delivery, Obstetric</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004619" MajorTopicYN="N">Embolism, Amniotic Fluid</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006771" MajorTopicYN="N">Hospitals, Maternity</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="Y">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006473" MajorTopicYN="N">Postpartum Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>10</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16946213</ArticleId><ArticleId IdType="doi">10.1097/01.AOG.0000233154.62729.24</ArticleId><ArticleId IdType="pii">108/3/541</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36319696</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>2005</StartPage><EndPage>2013</EndPage><MedlinePgn>2005-2013</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-022-02289-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Oral microbial therapy has been studied as an intervention for a range of gastrointestinal disorders. Though research suggests that microbial exposure may affect the gastrointestinal system, motility, and host immunity in a pediatric population, data have been inconsistent, with most prior studies being in neither a randomized nor placebo-controlled setting. The aim of this randomized,&#xa0;placebo-controlled study was to evaluate the efficacy of a synbiotic on increasing weekly bowel movements (WBMs) in constipated children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-four children (3-17 years of age) were randomized to receive a synbiotic (n&#x2009;=&#x2009;33) comprising mixed-chain length oligosaccharides and nine microbial strains, or placebo (n&#x2009;=&#x2009;31) for 84 days. Stool microbiota was analyzed on samples collected at baseline and completion. The primary outcome was a change from baseline of WBMs in the treatment group compared to placebo.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Treatment increased (p&#x2009;&lt;&#x2009;0.05) the number of WBMs in children with low baseline WBMs, despite broadly distinctive baseline microbiome signatures. Sequencing revealed that low baseline microbial richness in the treatment group significantly anticipated improvements in constipation (p&#x2009;=&#x2009;0.00074).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest the potential for (i) multi-species-synbiotic interventions to improve digestive health in a pediatric population and (ii) bioinformatics-based methods to predict response to microbial interventions in children.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">Synbiotic microbial treatment improved the number of spontaneous weekly bowel movements in children compared to placebo. Intervention induced an increased abundance of bifidobacteria in children, compared to placebo. All administered probiotic species were enriched in the gut microbiome of the intervention group compared to placebo. Baseline microbial richness demonstrated potential as a predictive biomarker for response to intervention.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tierney</LastName><ForeName>Braden T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Versalovic</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Texas Children's Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fasano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mucosal Immunology and Biology Research Center, Center for Celiac Research and Treatment and Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrosino</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chumpitazi</LastName><ForeName>Bruno P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurogastroenterology and Motility Program, Texas Children's Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Emeran A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>G Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boetes</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smits</LastName><ForeName>Gerard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkar</LastName><ForeName>Shanthi G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voreades</LastName><ForeName>Noah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kartal</LastName><ForeName>Ece</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Computational Biomedicine, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ghalith</LastName><ForeName>Gabriel A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pane</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bron</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Human Microbiome and Probiotic Research, Lawson Health Research Institute, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Microbiology and Immunology and Surgery, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhir</LastName><ForeName>Raja</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Seed Health, Venice, CA, USA. raja@seed.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA. chm2042@med.cornell.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058616" MajorTopicYN="Y">Synbiotics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="N">Constipation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>B.T.T. and G.S. led data analysis and were not involved in study design or trial execution. R.D. is a co-founder and CEO of Seed Health (SH) and Luca Biologics.&#xa0;J.V., A.F., E.A.M., C.E.M., and J.F.P. are members of the SH&#xa0; Scientific board. SH Scientific board members and employees hold equity positions in SH&#xa0;unless otherwise stated.&#xa0;B.T.T., G.S., N.V., P.A.B., G.R., and E.K. are consultants for SH and were not involved in the microbial synbiotic or clinical trial design. B.T.T. additionally consults for Enzymetrics Bioscience and holds an equity position in SH.&#xa0;S.G.P. and G.A.G.&#xa0;are employed by SH and were&#xa0;not involved in microbial synbiotic or clinical trial design.&#xa0;B.P.C. receives potential royalties from the Rome Foundation for the usage of the modified Bristol Stool Form Scale for Children, which is not used in this study. A.F. is additionally a cofounder and stockholder of Alba Therapeutics, a company developing treatments complementary to the gluten-free diet by exploiting gut permeability. E.A.M. is additionally on the Scientific Advisory Board of Axial Biotherapeutics, Pendulum Therapeutics, Bloom Science, Mahana Therapeutics, APC Ireland, Danone, and Amare. J.F.P. is the Founder and Chief Scientific Officer of Diversigen, Inc. and is on the Scientific Advisory Board for 4D Pharma, PLC. C.E.M. is cofounder of Biotia and Onegevity Health.&#xa0;J.V. is&#xa0;on the scientific advisory boards for Biomica and Plexus Worldwide.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36319696</ArticleId><ArticleId IdType="pmc">PMC10313516</ArticleId><ArticleId IdType="doi">10.1038/s41390-022-02289-0</ArticleId><ArticleId IdType="pii">10.1038/s41390-022-02289-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Manor O, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat. Commun. 2020;11:5206. doi: 10.1038/s41467-020-18871-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18871-1</ArticleId><ArticleId IdType="pmc">PMC7562722</ArticleId><ArticleId IdType="pubmed">33060586</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanahan F, Ghosh TS, O&#x2019;Toole PW. The healthy microbiome-what is the definition of a healthy gut microbiome? Gastroenterology. 2021;160:483&#x2013;494. doi: 10.1053/j.gastro.2020.09.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.09.057</ArticleId><ArticleId IdType="pubmed">33253682</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson JK, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262&#x2013;1267. doi: 10.1126/science.1223813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1223813</ArticleId><ArticleId IdType="pubmed">22674330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Structural changes in the gut microbiome of constipated patients. Physiol. Genomics. 2014;46:679&#x2013;686. doi: 10.1152/physiolgenomics.00082.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00082.2014</ArticleId><ArticleId IdType="pubmed">25073603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Chen Q, Yang B, Qin H, Li N. Analysis of gut microbiome and metabolite characteristics in patients with slow transit constipation. Dig. Dis. Sci. 2021;66:3026&#x2013;3035. doi: 10.1007/s10620-020-06500-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-020-06500-2</ArticleId><ArticleId IdType="pubmed">32767153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-R, et al. High Oscillospira abundance indicates constipation and low BMI in the Guangdong Gut Microbiome Project. Sci. Rep. 2020;10:9364. doi: 10.1038/s41598-020-66369-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66369-z</ArticleId><ArticleId IdType="pmc">PMC7283226</ArticleId><ArticleId IdType="pubmed">32518316</ArticleId></ArticleIdList></Reference><Reference><Citation>Avelar Rodriguez D, Popov J, Ratcliffe EM, Toro Monjaraz EM. Functional constipation and the gut microbiome in children: preclinical and clinical evidence. Front. Pediatr. 2020;8:595531. doi: 10.3389/fped.2020.595531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.595531</ArticleId><ArticleId IdType="pmc">PMC7856458</ArticleId><ArticleId IdType="pubmed">33553067</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes JG, et al. Fecal microbiota and diet of children with chronic constipation. Int. J. Pediatr. 2016;2016:6787269. doi: 10.1155/2016/6787269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6787269</ArticleId><ArticleId IdType="pmc">PMC4935906</ArticleId><ArticleId IdType="pubmed">27418934</ArticleId></ArticleIdList></Reference><Reference><Citation>de Meij TGJ, et al. Characterization of microbiota in children with chronic functional constipation. PLoS One. 2016;11:e0164731. doi: 10.1371/journal.pone.0164731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164731</ArticleId><ArticleId IdType="pmc">PMC5070844</ArticleId><ArticleId IdType="pubmed">27760208</ArticleId></ArticleIdList></Reference><Reference><Citation>Santucci NR, et al. Non-pharmacologic approach to pediatric constipation. Complement. Ther. Med. 2021;59:102711. doi: 10.1016/j.ctim.2021.102711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2021.102711</ArticleId><ArticleId IdType="pubmed">33737146</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijpers MAM, Bongers MEJ, Benninga MA, Berger MY. Functional constipation in children: a systematic review on prognosis and predictive factors. J. Pediatr. Gastroenterol. Nutr. 2010;50:256&#x2013;268. doi: 10.1097/MPG.0b013e3181afcdc3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0b013e3181afcdc3</ArticleId><ArticleId IdType="pubmed">20118805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimidi E, Mark Scott S, Whelan K. Probiotics and constipation: mechanisms of action, evidence for effectiveness and utilisation by patients and healthcare professionals. Proc. Nutr. Soc. 2020;79:147&#x2013;157. doi: 10.1017/S0029665119000934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665119000934</ArticleId><ArticleId IdType="pubmed">31262376</ArticleId></ArticleIdList></Reference><Reference><Citation>Francavilla R, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010;126:e1445&#x2013;e1452. doi: 10.1542/peds.2010-0467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-0467</ArticleId><ArticleId IdType="pubmed">21078735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwoji, I. D., Aiyegoro, O. A., Okpeku, M. &amp; Adeleke, M. A. Multi-strain probiotics: synergy among isolates enhances biological activities. Biology10, 322 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070017</ArticleId><ArticleId IdType="pubmed">33924344</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv. Nutr. 2017;8:484&#x2013;494. doi: 10.3945/an.116.014407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.116.014407</ArticleId><ArticleId IdType="pmc">PMC5421123</ArticleId><ArticleId IdType="pubmed">28507013</ArticleId></ArticleIdList></Reference><Reference><Citation>Closa-Monasterolo R, et al. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. Int. J. Food Sci. Nutr. 2017;68:587&#x2013;594. doi: 10.1080/09637486.2016.1263605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09637486.2016.1263605</ArticleId><ArticleId IdType="pubmed">27931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Waligora-Dupriet A-J, et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int. J. Food Microbiol. 2007;113:108&#x2013;113. doi: 10.1016/j.ijfoodmicro.2006.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijfoodmicro.2006.07.009</ArticleId><ArticleId IdType="pubmed">16996154</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunser O, et al. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr. Res. 2006;59:451&#x2013;456. doi: 10.1203/01.pdr.0000198773.40937.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.pdr.0000198773.40937.61</ArticleId><ArticleId IdType="pubmed">16492988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume MP, Nicolucci AC, Reimer RA. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am. J. Clin. Nutr. 2017;105:790&#x2013;799. doi: 10.3945/ajcn.116.140947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.116.140947</ArticleId><ArticleId IdType="pubmed">28228425</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams SA, Griffin IJ, Hawthorne KM. Young adolescents who respond to an inulin-type fructan substantially increase total absorbed calcium and daily calcium accretion to the skeleton. J. Nutr. 2007;137:2524S&#x2013;2526S. doi: 10.1093/jn/137.11.2524S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/137.11.2524S</ArticleId><ArticleId IdType="pubmed">17951496</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer D, Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur. J. Clin. Nutr. 2009;63:1277&#x2013;1289. doi: 10.1038/ejcn.2009.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2009.64</ArticleId><ArticleId IdType="pubmed">19690573</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol. Ecol. 2014;87:30&#x2013;40. doi: 10.1111/1574-6941.12186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1574-6941.12186</ArticleId><ArticleId IdType="pubmed">23909466</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vuyst L, Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 2011;149:73&#x2013;80. doi: 10.1016/j.ijfoodmicro.2011.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijfoodmicro.2011.03.003</ArticleId><ArticleId IdType="pubmed">21450362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu L-N, Chang M-H, Ni Y-H, Chen H-L, Cheng C-C. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr. Int. 2007;49:485&#x2013;490. doi: 10.1111/j.1442-200X.2007.02397.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.2007.02397.x</ArticleId><ArticleId IdType="pubmed">17587273</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai TT, et al. Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children. Eur. J. Clin. Nutr. 2021;75:513&#x2013;520. doi: 10.1038/s41430-020-00754-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-00754-9</ArticleId><ArticleId IdType="pmc">PMC7943424</ArticleId><ArticleId IdType="pubmed">32981933</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrio F, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014;168:228&#x2013;233. doi: 10.1001/jamapediatrics.2013.4367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2013.4367</ArticleId><ArticleId IdType="pubmed">24424513</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LE, Ouwehand AC, Ibarra A. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Ann. Gastroenterol. Hepatol. 2017;30:629&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5670282</ArticleId><ArticleId IdType="pubmed">29118557</ArticleId></ArticleIdList></Reference><Reference><Citation>Loening-Baucke V, Miele E, Staiano A. Fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics. 2004;113:e259&#x2013;e264. doi: 10.1542/peds.113.3.e259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.113.3.e259</ArticleId><ArticleId IdType="pubmed">14993586</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais MB, V&#xed;tolo MR, Aguirre AN, Fagundes-Neto U. Measurement of low dietary fiber intake as a risk factor for chronic constipation in children. J. Pediatr. Gastroenterol. Nutr. 1999;29:132&#x2013;135. doi: 10.1097/00005176-199908000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-199908000-00007</ArticleId><ArticleId IdType="pubmed">10435648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranz S, Brauchla M, Slavin JL, Miller KB. What do we know about dietary fiber intake in children and health? The effects of fiber intake on constipation, obesity, and diabetes in children. Adv. Nutr. 2012;3:47&#x2013;53. doi: 10.3945/an.111.001362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.111.001362</ArticleId><ArticleId IdType="pmc">PMC3262613</ArticleId><ArticleId IdType="pubmed">22332100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford AC, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am. J. Gastroenterol. 2014;109:1547&#x2013;1561. doi: 10.1038/ajg.2014.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2014.202</ArticleId><ArticleId IdType="pubmed">25070051</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L, et al. Systematic review and meta-analysis of the effect of probiotic supplementation on functional constipation in children. Medicine. 2018;97:e12174. doi: 10.1097/MD.0000000000012174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000012174</ArticleId><ArticleId IdType="pmc">PMC6181519</ArticleId><ArticleId IdType="pubmed">30278490</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe4;rtty, A., Rautava, S. &amp; Kalliom&#xe4;ki, M. Probiotics on pediatric functional gastrointestinal disorders. Nutrients10, 1836 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6316480</ArticleId><ArticleId IdType="pubmed">30501103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtyniak K, Szajewska H. Systematic review: probiotics for functional constipation in children. Eur. J. Pediatr. 2017;176:1155&#x2013;1162. doi: 10.1007/s00431-017-2972-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-017-2972-2</ArticleId><ArticleId IdType="pmc">PMC5563334</ArticleId><ArticleId IdType="pubmed">28762070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez RN. SAS. Wiley Interdiscip. Rev. Comput. Stat. 2011;3:1&#x2013;11. doi: 10.1002/wics.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wics.131</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, R. C. R: A Language and Environment for Statistical Computing. r.meteo.uni.wroc.pl.</Citation></Reference><Reference><Citation>Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404&#x2013;413. doi: 10.1093/biomet/26.4.404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/26.4.404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushnell, B. BBTools software package. http://sourceforge.net/projects/bbmap 578, 579 (2014).</Citation></Reference><Reference><Citation>Yost S, Duran-Pinedo AE, Teles R, Krishnan K, Frias-Lopez J. Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med. 2015;7:27. doi: 10.1186/s13073-015-0153-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0153-3</ArticleId><ArticleId IdType="pmc">PMC4410737</ArticleId><ArticleId IdType="pubmed">25918553</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife10, e65088 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096432</ArticleId><ArticleId IdType="pubmed">33944776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257. doi: 10.1186/s13059-019-1891-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1891-0</ArticleId><ArticleId IdType="pmc">PMC6883579</ArticleId><ArticleId IdType="pubmed">31779668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, J., Breitwieser, F. P., Thielen, P. &amp; Salzberg, S. L. Bracken: estimating species abundance in metagenomics data. PeerJ Comput. Sci. 3, e104 (2017).</Citation></Reference><Reference><Citation>Dixon P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 2003;14:927&#x2013;930. doi: 10.1111/j.1654-1103.2003.tb02228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1654-1103.2003.tb02228.x</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurdie PJ, Holmes S. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Comput. Biol. 2014;10:e1003531. doi: 10.1371/journal.pcbi.1003531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003531</ArticleId><ArticleId IdType="pmc">PMC3974642</ArticleId><ArticleId IdType="pubmed">24699258</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmont TO, Eren AM. Linking pangenomes and metagenomes: the Prochlorococcus metapangenome. PeerJ. 2018;6:e4320. doi: 10.7717/peerj.4320.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.4320</ArticleId><ArticleId IdType="pmc">PMC5804319</ArticleId><ArticleId IdType="pubmed">29423345</ArticleId></ArticleIdList></Reference><Reference><Citation>Utter DR, Borisy GG, Eren AM, Cavanaugh CM, Mark Welch JL. Metapangenomics of the oral microbiome provides insights into habitat adaptation and cultivar diversity. Genome Biol. 2020;21:293. doi: 10.1186/s13059-020-02200-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-020-02200-2</ArticleId><ArticleId IdType="pmc">PMC7739467</ArticleId><ArticleId IdType="pubmed">33323129</ArticleId></ArticleIdList></Reference><Reference><Citation>Enck P, Klosterhalfen S. Placebo responses and placebo effects in functional gastrointestinal disorders. Front. Psychiatry. 2020;11:797. doi: 10.3389/fpsyt.2020.00797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.00797</ArticleId><ArticleId IdType="pmc">PMC7477083</ArticleId><ArticleId IdType="pubmed">33192627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2010;32:144&#x2013;158. doi: 10.1111/j.1365-2036.2010.04328.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2010.04328.x</ArticleId><ArticleId IdType="pubmed">20412064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurko S, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J. Pediatr. 2008;153:254&#x2013;261. doi: 10.1016/j.jpeds.2008.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2008.01.039</ArticleId><ArticleId IdType="pubmed">18534221</ArticleId></ArticleIdList></Reference><Reference><Citation>Savino F, et al. Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative. BMC Pediatr. 2012;12:178. doi: 10.1186/1471-2431-12-178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-12-178</ArticleId><ArticleId IdType="pmc">PMC3511173</ArticleId><ArticleId IdType="pubmed">23152962</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskuijl W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004;53:1590&#x2013;1594. doi: 10.1136/gut.2004.043620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2004.043620</ArticleId><ArticleId IdType="pmc">PMC1774276</ArticleId><ArticleId IdType="pubmed">15479678</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoemaker, M. H. et al. Prebiotic galacto-oligosaccharides impact stool frequency and fecal microbiota in self-reported constipated adults: a randomized clinical trial. Nutrients14, 309 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8780623</ArticleId><ArticleId IdType="pubmed">35057489</ArticleId></ArticleIdList></Reference><Reference><Citation>Calgaro M, et al. Metabarcoding analysis of gut microbiota of healthy individuals reveals impact of probiotic and maltodextrin consumption. Benef. Microbes. 2021;12:121&#x2013;136. doi: 10.3920/BM2020.0137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2020.0137</ArticleId><ArticleId IdType="pubmed">33789555</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi, R., Basson, A. R., Wearsh, P., Cominelli, F. &amp; Rodriguez-Palacios, A. Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials. Eur. J. Nutr. 61, 2853&#x2013;2871 10.1007/s00394-022-02802-5 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9835112</ArticleId><ArticleId IdType="pubmed">35230477</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman, D. A. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology10.1053/j.gastro.2016.02.032 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27144617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmora N, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174:1388&#x2013;1405.e21. doi: 10.1016/j.cell.2018.08.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.041</ArticleId><ArticleId IdType="pubmed">30193112</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39578689</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>LigaSure versus conventional Milligan MORGAN hemorrhoidectomy in Nigerian patients with symptomatic hemorrhoids.</ArticleTitle><Pagination><StartPage>334</StartPage><EndPage>342</EndPage><MedlinePgn>334-342</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/wjs.12416</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hemorrhoidectomy is considered as the most effective approach for patients with grade III and grade IV hemorrhoids; the operative procedure may be associated with significant postoperative pain and other complications. Several surgical techniques and devices have been developed to overcome these postoperative problems.</AbstractText><AbstractText Label="OBJECTIVE">To compare perioperative and postoperative outcomes of hemorrhoidectomy performed with the LigaSure and the conventional Milligan-Morgan hemorrhoidectomy among Nigerian patients with symptomatic hemorrhoids.</AbstractText><AbstractText Label="METHODOLOGY">All consenting adult patients who fulfilled the inclusion criteria were randomized to either conventional Milligan-Morgan or LigaSure hemorrhoidectomy. Outcome measures were the duration of the procedure, estimated blood loss, and resolution of symptoms, which were assessed using the Sodergren hemorrhoids severity score (SHSS). Postoperative pain was evaluated using the visual analog scale (VAS), and the short-term recurrence rate was also checked at 3&#xa0;months. Data were analyzed using the computer software IBM SPSS version 23.</AbstractText><AbstractText Label="RESULTS">Fifty-two patients were randomized equally into the two arms. The median blood loss in the LigaSure group was 10.0&#xa0;mL, whereas the median blood loss in the Milligan-Morgan group was 26.5&#xa0;mL, (p&#xa0;=&#xa0;0.0001). The median postoperative pain at 2&#xa0;weeks using the VAS was 5.5 in the LigaSure group, and in the Milligan-Morgan group, it was 6.0 (p&#xa0;=&#xa0;0.002). The mean duration of surgery in the LigaSure group was 18.04&#xa0;min and 34.19&#xa0;min in the Milligan-Morgan group (p&#xa0;=&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSION">LigaSure hemorrhoidectomy is faster and associated with less blood loss compared to conventional Milligan-Morgan hemorrhoidectomy.</AbstractText><CopyrightInformation>&#xa9; 2024 International Society of Surgery/Soci&#xe9;t&#xe9; Internationale de Chirurgie (ISS/SIC).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mustapha</LastName><ForeName>Babatunde</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6688-174X</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola Teaching Hospital Complex, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alatise</LastName><ForeName>Olusegun Isaac</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olasehinde</LastName><ForeName>Olalekan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adisa</LastName><ForeName>Adewale</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuraola</LastName><ForeName>Funmilayo Olanike</ForeName><Initials>FO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Tajudeen Olakunle</ForeName><Initials>TO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aderounmu</LastName><ForeName>Adewale</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Abiyere Omagbeitse</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola Teaching Hospital Complex, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adesunkanmi</LastName><ForeName>AbdulHafiz Oladapo</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyeye</LastName><ForeName>Ademola</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola Teaching Hospital Complex, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qozeem</LastName><ForeName>Asafa Opeyemi</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0000-0003-3875-381X</Identifier><AffiliationInfo><Affiliation>UniOsun Teaching Hospital, Osogbo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Maigana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Modibo Adama University Teaching Hospital, Yola, Adamawa State, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>D43 CA260646</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World J Surg. 2025 Aug;49(8):2277-2278. doi: 10.1002/wjs.12597.</RefSource><PMID Version="1">40252207</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006484" MajorTopicYN="Y">Hemorrhoids</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061865" MajorTopicYN="Y">Hemorrhoidectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008026" MajorTopicYN="N">Ligation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LigaSure</Keyword><Keyword MajorTopicYN="N">hemorrhoidectomy</Keyword><Keyword MajorTopicYN="N">hemorrhoids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>6</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>23</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>23</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39578689</ArticleId><ArticleId IdType="doi">10.1002/wjs.12416</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mott, T., K. Latimer, and C. Edwards. 2018. &#x201c;Hemorrhoids: Diagnosis and Treatment Options.&#x201d; American Family Physician 97, no. 3: 172&#x2013;179.</Citation></Reference><Reference><Citation>Johanson, J. F., and A. Sonnenberg. 1990. &#x201c;The Prevalence of Hemorrhoids and Chronic Constipation: an Epidemiologic Study.&#x201d; Gastroenterology 98, no. 2: 380&#x2013;386. https://doi.org/10.1016/0016&#x2010;5085(90)90828&#x2010;o.</Citation></Reference><Reference><Citation>Lohsiriwat, V. 2012. &#x201c;Hemorrhoids: from Basic Pathophysiology to Clinical Management.&#x201d; World Journal of Gastroenterology: WJG 18, no. 17: 2009. https://doi.org/10.3748/wjg.v18.i17.2009.</Citation></Reference><Reference><Citation>Azeez, A., and U. C. Isiugo&#x2010;Abanihe. 2017. &#x201c;Sociocultural Context and Determinants of Treatments for Hemorrhoids Among the Nigerian Police, Oyo State Command.&#x201d; Journal of Social, Behavioral, and Health Sciences 11, no. 1: 3. https://doi.org/10.5590/jsbhs.2017.11.1.02.</Citation></Reference><Reference><Citation>Kadhim, T. J. 2018. &#x201c;Postoperative Complication of Haemorrhoidectomy Done by LigaSure.&#x201d; Pain 132: 26.24.</Citation></Reference><Reference><Citation>Lunniss, P. J. 2008. Bailey and Love&#x2019;s Short Practice of Surgery. 25th ed. British Medical Journal Publishing Group.1255.</Citation></Reference><Reference><Citation>Kendirci, M., &#x130;. T. &#x15e;ahiner, Y. &#x15e;ahiner, and G. G&#xfc;ney. 2018. &#x201c;Comparison of Effects of Vessel&#x2010;Sealing Devices and Conventional Hemorrhoidectomy on Postoperative Pain and Quality of Life.&#x201d; Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 24: 2173&#x2013;2179. https://doi.org/10.12659/msm.909750.</Citation></Reference><Reference><Citation>Ghnnam, W. M. 2017. &#x201c;Prospective, Randomized Controlled Trial of LigaSure&#x2122; versus Conventional Hemorrhoidectomy for Grade III and IV Hemorrhoids.&#x201d; International Journal of Surgery and Medicine 3, no. 1: 8&#x2013;13.</Citation></Reference><Reference><Citation>Armstrong, D. N., W. L. Ambroze, M. E. Schertzer, and G. R. Orangio. 2001. &#x201c;Harmonic Scalpel&#xae; vs. Electrocautery Hemorrhoidectomy: a Prospective Evaluation.&#x201d; Diseases of the Colon &amp; Rectum 44, no. 4: 558&#x2013;564. https://doi.org/10.1007/bf02234329.</Citation></Reference><Reference><Citation>Sayfan, J., A. Becker, and L. Koltun. 2001. &#x201c;Sutureless Closed Hemorrhoidectomy: A New Technique.&#x201d; Annals of surgery 234, no. 1: 21&#x2013;24. https://doi.org/10.1097/00000658&#x2010;200107000&#x2010;00004.</Citation></Reference><Reference><Citation>Nakeeb, A. M. El, A. A. Fikry, W. H. Omar, E. M. Fouda, T. A. El Metwally, H. E. Ghazy, S. A. Badr, et&#xa0;al. 2008. &#x201c;Rubber Band Ligation for 750 Cases of Symptomatic Hemorrhoids Out of 2200 Cases.&#x201d; World Journal of Gastroenterology: WJG 14, no. 42: 6525. https://doi.org/10.3748/wjg.14.6525.</Citation></Reference><Reference><Citation>Gentile, M., M. De Rosa, G. Carbone, V. Pilone, F. Mosella, and P. Forestieri. 2010. &#x201c;LigaSure Haemorrhoidectomy versus Conventional Diathermy for IV&#x2010;Degree Haemorrhoids: Is it the Treatment of Choice? A Randomized, Clinical Trial.&#x201d; ISRN gastroenterology 2011: 1&#x2013;6. https://doi.org/10.5402/2011/467258.</Citation></Reference><Reference><Citation>Wang, J.&#x2010;Y., C.&#x2010;Y. Lu, H.&#x2010;L. Tsai, F.&#x2010;M. Chen, C.&#x2010;J. Huang, Y.&#x2010;S. Huang, T.&#x2010;J. Huang, and J.&#x2010;S. Hsieh. 2006. &#x201c;Randomized Controlled Trial of LigaSure with Submucosal Dissection versus Ferguson Hemorrhoidectomy for Prolapsed Hemorrhoids.&#x201d; World Journal of Surgery 30, no. 3: 462&#x2013;466. https://doi.org/10.1007/s00268&#x2010;005&#x2010;0297&#x2010;1.</Citation></Reference><Reference><Citation>El Sayed, M.E., O.I. El Sebaei, A.A. A. El Sisi, and M.S. Amar. 2015. &#x201c;Randomized Comparative Study of LigaSure versus Conventional (Milligan&#x2010;Morgan) Hemorrhoidectomy.&#x201d; Menoufia Medical Journal 28, no. 1: 27. https://doi.org/10.4103/1110&#x2010;2098.155930.</Citation></Reference><Reference><Citation>Wang, J.&#x2010;Y., H.&#x2010;L. Tsai, F.&#x2010;M. Chen, K. S. Chu, H.&#x2010;M. Chan, C.&#x2010;J. Huang, and J.&#x2010;S. Hsieh. 2007. &#x201c;Prospective, Randomized, Controlled Trial of Starion&#x2122; vs. LigaSure&#x2122; Hemorrhoidectomy for Prolapsed Hemorrhoids.&#x201d; Diseases of the Colon &amp; Rectum 50, no. 8: 1146&#x2013;1151. https://doi.org/10.1007/s10350&#x2010;007&#x2010;0260&#x2010;3.</Citation></Reference><Reference><Citation>Khanna, R., S. Khanna, S. Bhadani, S. Singh, and A. K. Khanna. 2010. &#x201c;Comparison of LigaSure Hemorrhoidectomy with Conventional Ferguson&#x2019;s Hemorrhoidectomy.&#x201d; Indian Journal of Surgery 72, no. 4: 294&#x2013;297. https://doi.org/10.1007/s12262&#x2010;010&#x2010;0192&#x2010;3.</Citation></Reference><Reference><Citation>Milito, G., F. Cadeddu, M. G. Muzi, C. Nigro, and A. M. Farinon. 2010. &#x201c;Haemorrhoidectomy with LigaSure&#x2122; vs Conventional Excisional Techniques: Meta&#x2010;analysis of Randomized Controlled Trials.&#x201d; Colorectal Disease 12, no. 2: 85&#x2013;93. https://doi.org/10.1111/j.1463&#x2010;1318.2009.01807.x.</Citation></Reference><Reference><Citation>Schulz, K. F., D. G. Altman, and D. Moher, and for the CONSORT Group. CONSORT 2010 Atatement: Update Guidelines for Reporting Parallel Group Randomised Trials.</Citation></Reference><Reference><Citation>Olasehinde, O., A. Owojuyigbe, A. Adeyemo, A. Mosanya, O. Aaron, F. Wuraola, T. Owoniya, T. Owojuyigbe, O. Alatise, and A. Adisa. 2022. &#x201c;Use of Energy Device in General Surgical Operations: Impact on Peri&#x2010;Operative Outcomes.&#x201d; BMC Surgery 22, no. 1: 1&#x2013;5. https://doi.org/10.1186/s12893&#x2010;022&#x2010;01540&#x2010;z.</Citation></Reference><Reference><Citation>Wadhawan, G., B. Soni, and K. Vyas. 2018. &#x201c;LigaSure Haemorrhoidectomy in Comparison With Conventional Haemorrhoidectomy&#x2010;A Case Study on 100 Patients.&#x201d; Journal of Evolution of Medical and Dental Sciences&#x2010;JEMDS 7, no. 37: 4891&#x2013;4894.</Citation></Reference><Reference><Citation>Pattana&#x2010;arun, J., W. Wesarachawit, K. Tantiphlachiva, P. Atithansakul, C. Sahakitrungruang, and A. Rojanasakul. 2009. &#x201c;A Comparison of Early Postoperative Results between Urgent Closed Hemorrhoidectomy for Prolapsed Thrombosed Hemorrhoids and Elective Closed Hemorrhoidectomy.&#x201d; Medical Journal of the Medical Association of Thailand 92, no. 12: 1610.</Citation></Reference><Reference><Citation>Onur G&#xfc;lseren, M., T. Dinc, V. &#xd6;zer, B. Yildiz, M. Cete, and F. Coskun. 2015. &#x201c;Randomized Controlled Trial Comparing the Effects of Vessel Sealing Device and Milligan Morgan Technique on Postoperative Pain Perception after Hemorrhoidectomy.&#x201d; Digestive Surgery 32, no. 4: 258&#x2013;261. https://doi.org/10.1159/000381754.</Citation></Reference><Reference><Citation>Pattana&#x2010;arun, J., N. Sooriprasoet, C. Sahakijrungruang, K. Tantiphlachiva, and A. Rojanasakul. 2006. &#x201c;Closed vs LigaSure Hemorrhoidectomy: a Prospective, Randomized Clinical Trial.&#x201d; Journal of the Medical Association of Thailand 89, no. 4: 453.</Citation></Reference><Reference><Citation>Nienhuijs, S., and I. de Hingh. 2010. &#x201c;Pain after Conventional versus LigaSure Haemorrhoidectomy. A Meta&#x2010;Analysis.&#x201d; International Journal of Surgery 8, no. 4: 269&#x2013;273. https://doi.org/10.1016/j.ijsu.2010.04.001.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22017328</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1619-3997</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of perinatal medicine</Title><ISOAbbreviation>J Perinat Med</ISOAbbreviation></Journal><ArticleTitle>Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>49</EndPage><MedlinePgn>43-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/JPM.2011.109</ELocationID><ELocationID EIdType="pii" ValidYN="Y">/j/jpme.2012.40.issue-1/jpm.2011.109/jpm.2011.109.xml</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effectiveness of human recombinant activated factor VII (rhFVIIa, NovoSeven) in avoiding hysterectomy postpartum in the management of severe postpartum hemorrhage (PPH).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a prospective cohort study at our university tertiary care center. Patients with severe post partum hemorrhage (blood loss &gt;2000 mL) and failed medical and uterus-preserving surgical management, were treated with intravenous bolus administration of rhVIIa. Main outcome measures were cessation of bleeding, postpartum hysterectomy and thromboembolic events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 20/22 patients included, PPH was caused primarily by uterine atony, including 7 (32%) with additional lower genital tract lesion; in two women, it was due to pathologic placentation (placenta increta, 9%). One case of amniotic fluid embolism and one woman with uterine inversion were included. Recombinant hFVIIa was successful in stopping the PPH and in preventing a hysterectomy in 20/22 women (91%). The remaining two patients with persistent bleeding despite rhFVIIa treatment, who underwent postpartum hysterectomy, had placenta increta. No thromboembolic event was noticed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study describes the largest single center series of rhFVIIa treatment for fertility preservation in severe postpartum hemorrhage published to date. Our data suggest that administration of rhFVIIa is effective in avoiding postpartum hysterectomy after conservative medical and surgical measures have failed. Although randomized studies are lacking, rhFVIIa should be considered as a second-line therapeutic option of life-threatening postpartal bleeding, in particular if preservation of fertility is warranted and hysterectomy is to be avoided.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Alexander W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Inselspital University Hospital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raio</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Alberio</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ghezzi</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Surbek</LastName><ForeName>Daniel V</ForeName><Initials>DV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Perinat Med</MedlineTA><NlmUniqueID>0361031</NlmUniqueID><ISSNLinking>0300-5577</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>AC71R787OV</RegistryNumber><NameOfSubstance UI="C103587">recombinant FVIIa</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.21</RegistryNumber><NameOfSubstance UI="D015942">Factor VIIa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015942" MajorTopicYN="N">Factor VIIa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059247" MajorTopicYN="N">Fertility Preservation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006403" MajorTopicYN="N">Hematologic Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="N">Hysterectomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006473" MajorTopicYN="N">Postpartum Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22017328</ArticleId><ArticleId IdType="doi">10.1515/JPM.2011.109</ArticleId><ArticleId IdType="pii">/j/jpme.2012.40.issue-1/jpm.2011.109/jpm.2011.109.xml</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18008201</PMID><DateCompleted><Year>2008</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1438-8812</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>11</Issue><PubDate><Year>2007</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Endoscopy</Title><ISOAbbreviation>Endoscopy</ISOAbbreviation></Journal><ArticleTitle>Autofluorescence endoscopy versus conventional white light endoscopy for the detection of superficial gastric neoplasia: a prospective comparative study.</ArticleTitle><Pagination><StartPage>937</StartPage><EndPage>941</EndPage><MedlinePgn>937-41</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND AND STUDY AIMS" NlmCategory="OBJECTIVE">Preliminary studies have suggested autofluorescence endoscopy (AFE) to be accurate in the diagnosis of gastric tumors. Our prospective blinded study systematically compared AFE with white light endoscopy (WLE) for the detection of superficial gastric neoplasia.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">An enriched population included 33 patients with superficial gastric neoplasia referred for endoscopic submucosal dissection (ESD), and 18 control patients undergoing follow-up endoscopy after curative ESD. At the direction of a study coordinator, two endoscopists who were blinded to the patient's history and to each other's findings, performed WLE followed by AFE or performed AFE alone, in random order. Both endoscopists independently recorded the presence of lesions seen at AFE and WLE. All lesions identified in either test were biopsied and the pathological results were used as the gold standard.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">39 gastric neoplasias were histologically confirmed and 52 non-neoplastic lesions were found to be either WLE- and/or AFE-positive. Sensitivities of WLE and AFE alone were 74 % vs. 64 % (n. s.) and specificities were 83 % vs. 40 % ( P = 0.0003), respectively. WLE followed by AFE had a sensitivity of 69 % (n. s.) and a specificity of 64 % ( P = 0.046 compared with WLE alone). Of all neoplasias finally diagnosed, 13 % (or in the case of elevated neoplasias, 23 %) were detected by AFE but not by WLE.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although one quarter of elevated gastric neoplasias were detected only by AFE, its specificity is poor; therefore its clinical value is limited.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaise</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yonezawa</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tajiri</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Endoscopy</MedlineTA><NlmUniqueID>0215166</NlmUniqueID><ISSNLinking>0013-726X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Endoscopy. 2007 Nov;39(11):1021-2. doi: 10.1055/s-2007-966986.</RefSource><PMID Version="1">18008209</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001707" MajorTopicYN="N">Biopsy, Needle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005188" MajorTopicYN="N">False Negative Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020699" MajorTopicYN="Y">Gastroscopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005773" MajorTopicYN="N">Gastroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18008201</ArticleId><ArticleId IdType="doi">10.1055/s-2007-966857</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16981102</PMID><DateCompleted><Year>2007</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2006</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0013-726X</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Endoscopy</Title><ISOAbbreviation>Endoscopy</ISOAbbreviation></Journal><ArticleTitle>Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.</ArticleTitle><Pagination><StartPage>867</StartPage><EndPage>872</EndPage><MedlinePgn>867-72</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND AND STUDY AIMS" NlmCategory="OBJECTIVE">The reference surveillance method in patients with Barrett's esophagus is careful endoscopic observation, with targeted as well as random four-quadrant biopsies. Autofluorescence endoscopy (AFE) may make it easier to locate neoplasia. The aim of this study was to elucidate the diagnostic accuracy of surveillance with AFE-guided plus four-quadrant biopsies in comparison with the conventional approach.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A total of 187 of 200 consecutive Barrett's esophagus patients who were initially enrolled (73 % male, mean age 67 years, mean Barrett's segment length 4.6 cm), who underwent endoscopy for Barrett's esophagus in four study centers, were randomly assigned to undergo either AFE-targeted biopsy followed by four-quadrant biopsies or conventional endoscopic surveillance, also including four-quadrant biopsies (study phase 1). After exclusion of patients with early cancer or high-grade dysplasia, who underwent endoscopic or surgical treatment, as well as those who declined to participate in phase 2 of the study, 130 patients remained. These patients were examined again with the alternative method after a mean of 10 weeks, using the same methods described. The main study parameter was the detection of early cancer/adenocarcinoma or high-grade dysplasia (HGD), comparing both approaches in study phase 1; the secondary study aim in phase 2 was to assess the additional value of the AFE-guided approach after conventional surveillance, and vice versa. Test accuracy measures were derived from study phase 1.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In study phase 1, the AFE and conventional approaches yielded adenocarcinoma/HGD rates of 12 % and 5.3 %, respectively, on a per-patient basis. With AFE, four previously unrecognized adenocarcinoma/HGD lesions were identified (4.3 % of the patients); with the conventional approach, one new lesion (1.1 %) was identified. Of the 19 adenocarcinoma/HGD lesions detected during AFE endoscopy in study phase 1, eight were visualized, while 11 were only detected using untargeted four-quadrant biopsies (sensitivity 42 %). Of the 766 biopsies classified at histology as being nonneoplastic, 58 appeared suspicious (specificity 92 %, positive predictive value 12 %, negative predictive value 98.5 %). In study phase 2, AFE detected two further lesions in addition to the initial alternative approach in 3.2 % of cases, in comparison with one lesion with conventional endoscopy (1.7 %).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this referral Barrett's esophagus population with a higher prevalence of neoplastic lesions, the AFE-guided approach improved the diagnostic yield for neoplasia in comparison with the conventional approach using four-quadrant biopsies. However, AFE alone was not suitable for replacing the standard four-quadrant biopsy protocol.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borovicka</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology/Hepatology, Dept. of Internal Medicine, Cantonal Hospital, St. Gallen, Switzerland. jan.borovicka@kssg.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Neuweiler</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Netzer</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gschossmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ehmann</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bauerfeind</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Dorta</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Z&#xfc;rcher</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Binek</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Meyenberger</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Endoscopy</MedlineTA><NlmUniqueID>0215166</NlmUniqueID><ISSNLinking>0013-726X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001471" MajorTopicYN="N">Barrett Esophagus</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016099" MajorTopicYN="N">Endoscopy, Gastrointestinal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16981102</ArticleId><ArticleId IdType="doi">10.1055/s-2006-944726</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">30614315</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4954</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>17</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title><ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation></Journal><ArticleTitle>The use of Zhukovsky vaginal and intrauterine balloons to improve the outcome of postpartum hysterectomies in patients with severe bleeding.</ArticleTitle><Pagination><StartPage>2955</StartPage><EndPage>2960</EndPage><MedlinePgn>2955-2960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2019.1566309</ELocationID><Abstract><AbstractText><b>Aim:</b> To assess the efficacy of a Zhukovsky obstetric double balloon for improving outcomes in women undergoing hysterectomy for postpartum hemorrhage.<b>Materials and methods:</b> This was a randomized controlled study. Participants were divided into two groups to undergo insertion of a Zhukovsky obstetric double balloon prior to hysterectomy (<i>n</i>&#x2009;=&#x2009;16) or conventional hysterectomy (<i>n</i>&#x2009;=&#x2009;25).<b>Results:</b> The main reasons for major obstetric hemorrhage were placenta accreta (53.6%), uterine atony (26.8%), uteroplacental apoplexy (14.6%), and amniotic fluid embolism (4.8%). The use of a Zhukovsky obstetric double balloon during postpartum hysterectomy was associated with a 1.7-fold reduction in blood loss and a 2.3-fold reduction in blood loss &gt; 2000&#x2009;ml compared with conventional hysterectomy.<b>Conclusion:</b> The use of a Zhukovsky obstetric double balloon represents a potent tool for improvement of immediate outcomes of hysterectomy in women with severe postpartum bleeding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barinov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0002-0357-7097</Identifier><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medjannikova</LastName><ForeName>Irina V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirskaya</LastName><ForeName>Yuliya I</ForeName><Initials>YI</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuprinin</LastName><ForeName>Vladimir D</ForeName><Initials>VD</Initials><AffiliationInfo><Affiliation>Ministry of Health of Russia, National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khilkevich</LastName><ForeName>Elena G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Ministry of Health of Russia, National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savelyeva</LastName><ForeName>Irina V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamina</LastName><ForeName>Inna V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borisova</LastName><ForeName>Anna V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazareva</LastName><ForeName>Oksana V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Russian Ministry of Health, Federal State Budget Educational Institution of Higher Education Omsk State Medical University, Omsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Matern Fetal Neonatal Med</MedlineTA><NlmUniqueID>101136916</NlmUniqueID><ISSNLinking>1476-4954</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="N">Hysterectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010921" MajorTopicYN="Y">Placenta Accreta</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006473" MajorTopicYN="Y">Postpartum Hemorrhage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014593" MajorTopicYN="Y">Uterine Inertia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Zhukovsky intrauterine balloon</Keyword><Keyword MajorTopicYN="N">Zhukovsky vaginal balloon</Keyword><Keyword MajorTopicYN="N">cesarean section</Keyword><Keyword MajorTopicYN="N">delivery</Keyword><Keyword MajorTopicYN="N">hysterectomy</Keyword><Keyword MajorTopicYN="N">obstetric hemorrhage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30614315</ArticleId><ArticleId IdType="doi">10.1080/14767058.2019.1566309</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>